data_1h9c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1h9c _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mttp . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.25 147.8 26.22 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 126.002 2.064 . . . . 0.0 111.521 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -105.26 115.78 30.83 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 123.154 1.454 . . . . 0.0 112.25 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.7 mt -116.92 102.45 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.38 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -108.62 127.42 53.95 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.278 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.51 135.59 45.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.872 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 113.429 -1.714 . . . . 0.0 113.208 -176.716 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.93 -31.68 8.23 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.88 -0.34 59.15 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -102.12 -36.84 8.4 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 118.375 2.732 . . . . 0.0 118.375 -168.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 m -69.62 -31.92 70.31 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.099 1.318 . . . . 0.0 113.609 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 p -62.67 -18.98 63.38 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.862 1.665 . . . . 0.0 114.49 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -53.96 -41.73 68.12 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.27 -42.74 83.33 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.937 0.495 . . . . 0.0 111.861 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.16 -45.69 90.34 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.393 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.23 -50.52 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.369 1.068 . . . . 0.0 109.86 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.8 t -54.7 -46.02 74.07 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.275 1.03 . . . . 0.0 112.782 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.52 -42.86 82.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.374 0.67 . . . . 0.0 112.801 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 96.5 mtp -59.3 -43.66 92.6 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.173 0.92 . . . . 0.0 110.699 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -62.45 -48.28 80.34 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.355 1.062 . . . . 0.0 111.687 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.09 79.72 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -79.0 -32.17 45.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.785 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.02 -35.15 79.78 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.857 0.863 . . . . 0.0 111.474 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -69.91 -46.65 64.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.865 0.866 . . . . 0.0 110.944 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.81 -40.81 94.09 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.02 0.928 . . . . 0.0 113.162 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -104.2 24.59 11.25 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 31.95 56.92 0.34 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.525 2.33 . . . . 0.0 116.223 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.74 108.43 51.16 Favored Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 112.691 -2.05 . . . . 0.0 107.737 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.12 87.1 1.56 Allowed 'Trans proline' 0 C--N 1.33 -0.425 0 C-N-CA 122.111 1.874 . . . . 0.0 113.363 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 m -139.15 148.39 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 113.168 -1.833 . . . . 0.0 113.032 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.7 mt -106.83 115.94 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 113.056 -1.883 . . . . 0.0 107.438 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -119.28 114.63 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.419 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -139.56 147.7 41.54 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.755 1.284 . . . . 0.0 111.929 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.12 137.74 48.42 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.384 -1.735 . . . . 0.0 112.253 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -139.59 154.18 71.08 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.347 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -70.58 152.74 65.29 Favored 'Trans proline' 0 C--N 1.33 -0.424 0 C-N-CA 122.001 1.801 . . . . 0.0 112.341 168.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.424 ' HG3' ' HE3' ' A' ' 63' ' ' MET . 0.0 OUTLIER -57.72 -26.33 61.63 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.108 1.763 . . . . 0.0 114.893 -173.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.6 p -56.07 -32.97 64.59 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.017 1.727 . . . . 0.0 113.624 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.5 mt -96.51 15.4 21.61 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.82 90.96 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.222 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.25 -63.06 4.38 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' OE2' ' HE2' ' A' ' 47' ' ' LYS . 27.4 tt0 -57.66 -49.19 77.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 112.964 -1.618 . . . . 0.0 113.808 -168.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HE2' ' OE2' ' A' ' 46' ' ' GLU . 5.0 mptp? -90.17 -31.25 17.14 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.19 -24.26 63.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.897 0.76 . . . . 0.0 113.228 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -57.99 -29.91 65.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.319 1.447 . . . . 0.0 114.221 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -106.08 4.51 29.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.6 142.88 33.62 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.193 0.521 . . . . 0.0 110.273 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -89.05 -29.52 19.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.465 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.9 p -146.25 142.68 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.789 1.281 . . . . 0.0 109.259 162.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.59 123.27 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 112.279 -2.237 . . . . 0.0 107.142 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.491 HD13 ' HB1' ' A' ' 96' ' ' ALA . 80.0 mt -113.19 132.9 55.31 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.858 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.5 mt -110.62 142.29 42.69 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 113.133 -1.849 . . . . 0.0 112.357 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.82 136.84 38.53 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.685 169.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.3 -27.68 68.07 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.32 2.014 . . . . 0.0 114.506 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -61.81 -28.53 69.54 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 63' ' ' MET . 8.8 pt -113.71 26.97 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.999 0.904 . . . . 0.0 111.918 175.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.25 -31.29 72.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.33 -21.04 64.97 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 60' ' ' ILE . 78.2 mtp -86.63 -0.26 55.87 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.666 1.187 . . . . 0.0 114.12 176.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 12.6 tp -52.82 -50.15 82.83 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 114.104 -2.855 . . . . 0.0 112.414 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.01 -37.9 86.54 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 122.583 2.189 . . . . 0.0 113.876 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 4.9 tp10 -78.41 -37.57 43.64 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.3 mt -75.9 -33.82 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.753 1.221 . . . . 0.0 110.901 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -58.72 -40.79 84.75 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.682 0.793 . . . . 0.0 110.557 168.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.512 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 5.7 tmm_? -60.89 -45.0 96.32 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.669 1.188 . . . . 0.0 111.436 173.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.8 mt -63.96 -42.9 97.15 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.57 1.148 . . . . 0.0 113.011 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -124.02 71.01 51.91 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.317 1.447 . . . . 0.0 110.846 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.21 -8.68 18.81 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 122.029 1.819 . . . . 0.0 115.044 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -109.85 4.46 21.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -121.62 134.25 24.53 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.52 117.54 5.13 Favored 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 122.077 1.851 . . . . 0.0 110.812 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.9 t -121.01 114.28 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 111.078 -2.783 . . . . 0.0 108.114 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -128.59 154.86 45.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 112.827 -1.988 . . . . 0.0 111.56 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.1 t -96.23 139.8 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.143 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.0 mt -74.4 129.28 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.42 131.03 48.88 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 113.726 -1.579 . . . . 0.0 112.229 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.3 t -48.2 -46.89 35.6 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 111.909 -2.405 . . . . 0.0 113.858 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.3 tp -70.41 -43.82 69.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.998 0.919 . . . . 0.0 111.964 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.76 -38.97 83.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.05 0.94 . . . . 0.0 112.789 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -68.68 -45.68 71.05 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.802 1.241 . . . . 0.0 111.162 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.84 -35.78 92.46 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.784 1.183 . . . . 0.0 112.886 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -83.02 -17.04 44.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.906 1.283 . . . . 0.0 113.055 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.0 t 45.36 65.1 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 128.377 2.671 . . . . 0.0 111.046 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -102.49 93.52 5.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 112.62 -2.082 . . . . 0.0 110.098 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.47 -43.13 90.47 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 111.875 -2.421 . . . . 0.0 113.865 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.2 tp -67.23 -43.95 80.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.772 0.429 . . . . 0.0 112.14 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.73 -48.63 65.15 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.998 1.761 . . . . 0.0 111.85 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.79 -39.84 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 114.68 -0.76 . . . . 0.0 110.829 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.0 tp -61.16 -44.44 97.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.824 0.85 . . . . 0.0 110.934 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -63.11 -40.12 96.71 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.81 0.844 . . . . 0.0 112.306 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.31 87.53 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.138 0.899 . . . . 0.0 112.108 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.491 ' HB1' HD13 ' A' ' 55' ' ' LEU . . . -65.19 -46.86 79.06 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.555 1.142 . . . . 0.0 112.292 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.2 t -66.24 -39.39 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.062 1.345 . . . . 0.0 110.408 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.87 98.59 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.706 1.202 . . . . 0.0 110.944 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 C-N-CA 124.146 0.978 . . . . 0.0 112.484 177.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.8 mttt . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 120.941 0.401 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -102.85 148.12 26.04 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 125.846 1.967 . . . . 0.0 110.638 172.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -108.11 120.6 42.78 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.629 -1.168 . . . . 0.0 112.008 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.8 mt -120.76 108.89 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.513 -1.676 . . . . 0.0 106.495 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -114.85 125.76 54.03 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.214 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.37 127.51 46.67 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.382 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.47 0.553 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.275 -178.281 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.85 -15.16 11.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.77 45.25 76.57 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.896 0.76 . . . . 0.0 112.605 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 24.8 mmt -115.25 -71.15 0.76 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 p -66.83 -18.67 65.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -60.32 -28.97 68.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.166 1.387 . . . . 0.0 114.626 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.7 p -60.14 -34.59 73.76 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -65.88 -46.25 79.07 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.394 0.678 . . . . 0.0 111.551 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 tp -62.24 -43.35 99.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.609 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.573 HG23 ' HB3' ' A' ' 38' ' ' ALA . 74.6 t -61.82 -43.67 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.427 1.091 . . . . 0.0 110.742 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -60.51 -44.7 95.74 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.529 0.732 . . . . 0.0 112.557 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -66.21 -39.15 89.42 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.489 ' HB3' HD12 ' A' ' 36' ' ' ILE . 95.7 mtp -64.72 -40.62 95.64 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.978 0.799 . . . . 0.0 111.625 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -67.54 -41.86 83.64 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.976 0.91 . . . . 0.0 112.786 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.03 -39.25 90.05 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.811 0.815 . . . . 0.0 112.827 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -77.44 -29.24 52.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.645 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.57 78.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.535 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -72.27 -41.18 67.0 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.015 0.822 . . . . 0.0 111.676 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -63.66 -51.61 64.34 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.485 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -90.64 23.2 3.15 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 29.28 63.19 0.14 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 124.853 2.263 . . . . 0.0 115.047 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.67 108.81 59.28 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 112.403 -2.18 . . . . 0.0 106.815 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.16 89.44 1.17 Allowed 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 122.296 1.997 . . . . 0.0 112.601 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 m -144.91 150.3 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.804 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -110.72 106.6 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.027 176.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 23' ' ' MET . 14.6 mt -111.48 112.3 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.011 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -134.59 151.92 51.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.644 1.178 . . . . 0.0 111.931 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.573 ' HB3' HG23 ' A' ' 20' ' ' VAL . . . -119.14 137.47 53.58 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.612 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -144.25 154.37 57.32 Favored Pre-proline 0 N--CA 1.47 0.526 0 O-C-N 124.75 1.282 . . . . 0.0 112.552 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -62.19 152.29 77.0 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 122.379 2.053 . . . . 0.0 112.62 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.448 ' HG3' ' HE3' ' A' ' 63' ' ' MET . 0.0 OUTLIER -57.6 -22.77 47.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.032 1.733 . . . . 0.0 114.827 -173.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.3 p -58.42 -29.89 66.45 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.682 1.593 . . . . 0.0 113.702 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.7 mt -99.75 20.68 13.68 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.92 -45.3 64.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.107 -0.952 . . . . 0.0 113.075 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.12 -15.89 76.71 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.758 0.694 . . . . 0.0 113.833 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -97.13 -57.91 2.15 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.7 0.882 . . . . 0.0 112.884 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -85.25 -27.6 25.92 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.95 -15.98 56.58 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.112 0.863 . . . . 0.0 113.863 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -60.5 -27.0 67.25 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.771 1.228 . . . . 0.0 114.079 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -117.37 24.39 11.16 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.15 138.38 32.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.41 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.87 -23.23 24.04 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.342 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.56 133.76 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 122.442 1.115 . . . . 0.0 109.64 160.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.5 t -97.73 119.06 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 112.644 -2.071 . . . . 0.0 106.256 172.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.9 mt -107.09 134.15 50.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.15 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.53 140.26 47.42 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.66 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.13 144.51 48.76 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.396 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.1 -26.82 83.12 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 C-N-CA 122.265 1.977 . . . . 0.0 114.291 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -64.69 -28.63 69.73 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 pt -114.71 30.09 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 122.411 1.1 . . . . 0.0 111.734 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.98 64.83 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -64.02 -22.59 66.99 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.448 ' HE3' ' HG3' ' A' ' 41' ' ' GLU . 84.7 mtp -85.3 6.45 26.21 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.26 -51.35 81.53 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-O 115.189 -2.339 . . . . 0.0 113.159 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.99 -28.05 80.19 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 CA-C-N 122.872 2.062 . . . . 0.0 114.031 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 2.0 tt0 -80.21 -37.79 32.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.3 mt -79.75 -29.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.813 1.245 . . . . 0.0 111.35 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -34.22 75.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.113 0.565 . . . . 0.0 110.552 171.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -61.77 -43.37 98.99 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.911 0.884 . . . . 0.0 110.74 172.036 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.1 mt -66.37 -42.22 88.31 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.984 0.914 . . . . 0.0 112.808 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.8 mt -124.1 76.69 59.6 Favored Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 124.931 1.293 . . . . 0.0 110.149 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.44 -11.26 10.71 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 121.895 1.73 . . . . 0.0 115.57 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -105.75 15.45 26.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.261 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.29 137.92 31.67 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.814 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.53 117.71 5.28 Favored 'Trans proline' 0 C--N 1.33 -0.421 0 C-N-CA 122.441 2.094 . . . . 0.0 110.34 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 t -120.73 110.71 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 111.956 -2.383 . . . . 0.0 106.835 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.12 146.81 50.59 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 125.866 1.979 . . . . 0.0 111.309 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.66 136.53 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.619 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.4 mt -70.48 133.71 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.409 1.083 . . . . 0.0 108.311 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.31 127.43 32.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.653 1.216 . . . . 0.0 110.957 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.1 m -56.21 -36.02 67.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 113.167 -1.833 . . . . 0.0 114.095 -174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.9 tp -78.8 -36.51 42.65 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.206 0.603 . . . . 0.0 112.55 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.3 mt -60.46 -35.46 75.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.296 0.638 . . . . 0.0 112.713 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -67.84 -39.41 83.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.302 1.441 . . . . 0.0 111.23 174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.5 -47.77 80.52 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.127 1.346 . . . . 0.0 112.452 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.99 -28.56 70.18 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.391 1.076 . . . . 0.0 112.244 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 t 53.67 62.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 127.511 2.325 . . . . 0.0 108.531 -170.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -100.73 92.32 5.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 112.184 -2.28 . . . . 0.0 109.908 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.69 -38.06 93.26 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 111.943 -2.39 . . . . 0.0 113.232 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.9 tp -71.79 -40.58 69.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.422 0.689 . . . . 0.0 111.908 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.71 -45.37 96.55 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.282 1.42 . . . . 0.0 112.733 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.17 -32.63 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.782 0.833 . . . . 0.0 110.997 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -44.74 95.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.416 0.627 . . . . 0.0 111.503 175.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -66.78 -33.74 76.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.223 1.009 . . . . 0.0 113.026 176.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.72 -34.36 67.05 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.204 0.94 . . . . 0.0 112.677 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.22 -43.08 71.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.01 0.924 . . . . 0.0 111.704 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.16 -36.6 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.595 1.158 . . . . 0.0 110.705 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.73 81.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.913 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 123.648 0.779 . . . . 0.0 112.806 175.898 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 89.0 mttt . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 120.897 0.379 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -102.1 148.07 25.84 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 125.859 1.974 . . . . 0.0 111.646 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -106.16 118.85 37.69 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.343 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.8 mt -118.83 105.54 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -110.09 128.4 55.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.503 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -100.48 134.94 42.68 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.012 -1.903 . . . . 0.0 110.077 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.47 0.54 0 CA-C-N 113.601 -1.636 . . . . 0.0 113.245 -177.348 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.68 -34.32 7.02 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.62 37.12 12.36 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 123.943 0.782 . . . . 0.0 113.448 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 8.9 ptp -121.44 -48.93 2.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.7 m -63.63 -32.73 74.3 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 p -64.58 -24.36 67.57 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.2 p -58.83 -35.82 73.52 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.0 tp -69.31 -45.72 68.84 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.66 0.384 . . . . 0.0 111.441 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 23' ' ' MET . 1.0 OUTLIER -60.89 -35.62 77.13 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 175.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 36' ' ' ILE . 74.7 t -61.83 -48.72 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.429 1.091 . . . . 0.0 110.252 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.7 p -68.52 -26.85 65.65 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -65.0 -44.35 89.53 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.175 0.99 . . . . 0.0 112.3 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 18.3 ptm -85.01 -13.0 51.96 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -71.96 -41.53 67.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.544 0.338 . . . . 0.0 110.938 164.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.81 86.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.691 0.758 . . . . 0.0 112.242 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.419 HE21 ' HB2' ' A' ' 90' ' ' LEU . 15.2 mm100 -70.17 -34.62 73.22 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.611 173.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.5 98.76 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.18 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.16 -33.48 73.47 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.698 0.799 . . . . 0.0 112.486 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -65.49 -51.83 57.23 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.206 0.603 . . . . 0.0 111.015 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -90.24 24.57 2.48 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.863 0.865 . . . . 0.0 113.305 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 28.31 64.85 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 124.947 2.308 . . . . 0.0 115.192 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.08 105.49 57.29 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-N 112.885 -1.961 . . . . 0.0 107.084 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.403 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 76.3 Cg_endo -75.81 93.99 1.0 Allowed 'Trans proline' 0 C--N 1.331 -0.371 0 C-N-CA 122.396 2.064 . . . . 0.0 112.183 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.07 152.68 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 113.915 -1.493 . . . . 0.0 114.319 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.99 107.13 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 112.179 -2.282 . . . . 0.0 107.144 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.592 HG21 HG11 ' A' ' 20' ' ' VAL . 20.6 mt -112.6 113.35 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.102 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -136.58 148.78 47.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 125.311 1.632 . . . . 0.0 112.201 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.96 139.62 46.14 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.036 -1.438 . . . . 0.0 113.101 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -142.57 152.18 59.29 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.477 1.111 . . . . 0.0 113.128 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.23 154.08 75.29 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.376 2.051 . . . . 0.0 113.128 167.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -22.59 63.93 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.577 1.551 . . . . 0.0 114.154 -175.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 p -60.36 -31.02 69.94 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.507 1.523 . . . . 0.0 113.164 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -98.77 21.79 10.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.29 1.036 . . . . 0.0 113.093 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.3 -48.91 77.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.057 -0.973 . . . . 0.0 112.673 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.27 -57.61 17.49 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.148 0.905 . . . . 0.0 111.589 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.21 -53.57 53.37 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 113.231 -1.484 . . . . 0.0 113.59 -170.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -80.45 -31.53 37.43 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.339 1.236 . . . . 0.0 114.339 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.33 -20.21 54.47 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.73 1.157 . . . . 0.0 113.643 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -59.68 -32.7 70.74 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.244 1.018 . . . . 0.0 113.396 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.5 -16.38 18.34 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.677 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.53 135.47 48.58 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.143 0.497 . . . . 0.0 111.087 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -86.55 -26.22 24.63 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.391 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.17 140.62 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 122.191 0.996 . . . . 0.0 109.248 163.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.578 ' HB ' HG23 ' A' ' 76' ' ' VAL . 94.5 t -109.12 126.55 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.349 175.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.496 HD13 ' HB1' ' A' ' 96' ' ' ALA . 84.2 mt -115.96 122.82 46.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.245 -1.798 . . . . 0.0 111.356 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 mt -100.45 142.08 32.41 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.421 -1.718 . . . . 0.0 111.925 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.23 144.14 49.07 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.668 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.66 -24.93 77.36 Favored 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 122.272 1.981 . . . . 0.0 114.335 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -67.8 -28.66 67.78 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 pt -113.12 25.29 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 122.053 0.93 . . . . 0.0 112.141 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.3 -29.21 65.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.992 -1.003 . . . . 0.0 113.437 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -61.52 -24.24 66.48 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.675 173.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.0 mtm -87.74 7.43 30.29 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.1 tp -50.86 -46.2 87.22 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 116.418 -1.753 . . . . 0.0 113.823 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.6 -29.12 61.01 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 122.192 1.928 . . . . 0.0 114.827 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -81.61 -36.96 28.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.725 0.774 . . . . 0.0 112.846 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 mm -65.39 -40.55 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.029 1.332 . . . . 0.0 109.509 173.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -73.58 -25.54 60.4 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -65.07 -39.81 93.77 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 170.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.7 mt -65.62 -53.6 39.33 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.537 1.135 . . . . 0.0 112.338 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.87 75.49 71.15 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 124.369 1.068 . . . . 0.0 111.481 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.96 -22.31 23.27 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.256 1.971 . . . . 0.0 115.629 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -86.38 -0.73 56.57 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.46 134.46 20.83 Favored Pre-proline 0 N--CA 1.47 0.526 0 C-N-CA 123.217 0.607 . . . . 0.0 110.771 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.93 116.88 4.88 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 122.42 2.08 . . . . 0.0 110.513 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.578 HG23 ' HB ' ' A' ' 54' ' ' VAL . 59.9 t -123.58 119.59 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 112.087 -2.324 . . . . 0.0 108.352 -175.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -125.51 158.48 34.42 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 126.24 2.213 . . . . 0.0 111.753 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.8 t -99.79 138.22 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.419 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.0 mt -72.11 126.64 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.14 131.45 50.54 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.676 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.1 m -57.83 -34.35 69.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 112.85 -1.977 . . . . 0.0 113.907 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -38.61 53.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.595 0.758 . . . . 0.0 112.48 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.58 -38.25 86.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.325 0.65 . . . . 0.0 112.092 171.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -66.57 -41.38 88.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.568 1.547 . . . . 0.0 111.331 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.58 -43.02 99.6 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.071 1.319 . . . . 0.0 112.498 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -75.54 -28.25 58.97 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t 58.35 70.22 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 127.376 2.271 . . . . 0.0 108.078 -168.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.86 99.49 8.39 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 113.198 -1.819 . . . . 0.0 110.589 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.81 -43.19 98.15 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 111.77 -2.468 . . . . 0.0 113.867 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.419 ' HB2' HE21 ' A' ' 26' ' ' GLN . 65.0 tp -64.22 -43.27 95.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.86 -42.22 91.95 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 124.708 1.146 . . . . 0.0 112.743 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.9 t -77.75 -38.21 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.668 0.787 . . . . 0.0 110.993 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.94 -39.66 95.3 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.773 0.829 . . . . 0.0 111.603 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -64.8 -43.26 93.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.902 1.281 . . . . 0.0 111.278 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.44 83.7 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.058 0.849 . . . . 0.0 112.381 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.496 ' HB1' HD13 ' A' ' 55' ' ' LEU . . . -67.85 -44.12 77.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.163 -1.38 . . . . 0.0 112.35 176.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.53 -27.58 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 121.814 -0.554 . . . . 0.0 112.209 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.85 83.85 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.187 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 C-N-CA 123.679 0.792 . . . . 0.0 113.045 176.332 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.9 mttt . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 122.632 1.206 . . . . 0.0 113.886 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -110.06 143.71 39.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 112.908 -1.951 . . . . 0.0 112.227 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -101.69 116.69 33.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.958 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.7 mt -114.4 103.02 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.309 -1.769 . . . . 0.0 106.471 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -110.29 127.17 54.88 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 122.731 1.253 . . . . 0.0 112.45 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -101.17 133.09 46.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.72 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 N--CA 1.469 0.481 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.678 -177.45 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.65 -23.56 11.75 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.71 23.55 77.7 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.341 0.972 . . . . 0.0 114.87 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.7 ptp -118.32 -37.56 3.32 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.3 m -65.57 -29.88 70.54 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.113 0.87 . . . . 0.0 112.198 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 p -71.71 -20.2 61.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.726 1.61 . . . . 0.0 114.505 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.0 p -63.13 -34.98 78.79 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 tp -65.94 -44.53 84.79 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.101 0.561 . . . . 0.0 111.691 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 tt -62.16 -40.82 97.28 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.13 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 38' ' ' ALA . 73.1 t -61.47 -45.0 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.488 1.115 . . . . 0.0 109.717 175.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -59.08 -40.35 84.98 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -65.87 -44.23 86.0 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.9 ptm -77.99 -21.56 50.67 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -67.34 -46.07 74.51 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.857 0.863 . . . . 0.0 111.52 166.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.37 84.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.006 0.908 . . . . 0.0 112.758 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -75.6 -33.12 60.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.88 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.61 84.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.928 0.491 . . . . 0.0 111.323 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.76 -42.78 77.03 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 111.332 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -63.53 -52.09 62.65 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.444 0.698 . . . . 0.0 111.764 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -85.04 11.8 8.9 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 51.88 51.06 17.29 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 123.958 1.837 . . . . 0.0 112.774 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.2 t -102.05 111.66 64.51 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 112.971 -1.922 . . . . 0.0 107.977 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.71 87.6 1.5 Allowed 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 121.995 1.797 . . . . 0.0 112.781 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.07 152.37 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.589 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.4 mt -112.18 105.75 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.395 -1.73 . . . . 0.0 107.91 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.406 HG21 HG11 ' A' ' 20' ' ' VAL . 23.2 mt -105.78 118.97 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.83 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -149.44 139.34 21.94 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.457 1.098 . . . . 0.0 112.606 -171.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 20' ' ' VAL . . . -104.23 138.15 41.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 113.248 -1.796 . . . . 0.0 112.684 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -139.32 151.49 67.26 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.777 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -66.36 152.95 79.8 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 122.412 2.075 . . . . 0.0 112.7 168.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -22.73 62.74 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.076 -1.42 . . . . 0.0 114.664 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -60.32 -28.34 68.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.386 1.474 . . . . 0.0 113.667 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.6 mt -99.08 19.81 14.51 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.14 86.75 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.89 -51.96 31.57 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -61.21 -59.3 5.53 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.642 -1.279 . . . . 0.0 112.918 -172.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -78.85 -24.35 44.41 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.21 -29.37 72.76 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.869 0.747 . . . . 0.0 113.577 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.07 -29.57 70.7 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -109.95 30.09 7.02 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.026 0.917 . . . . 0.0 112.439 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.33 140.55 45.81 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.481 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.34 -49.8 11.02 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.084 170.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.3 140.85 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 122.089 0.947 . . . . 0.0 110.46 171.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.94 122.01 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 113.074 -1.875 . . . . 0.0 107.811 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.5 mt -116.94 115.51 25.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 113.553 -1.658 . . . . 0.0 112.688 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.2 mt -88.89 139.29 30.61 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 112.508 -2.133 . . . . 0.0 112.095 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.02 140.83 45.87 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 113.747 -1.569 . . . . 0.0 110.083 167.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -58.58 -24.85 72.1 Favored 'Trans proline' 0 C--N 1.331 -0.386 0 C-N-CA 122.299 1.999 . . . . 0.0 114.428 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 -64.79 -31.42 72.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.48 26.82 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.159 0.981 . . . . 0.0 111.988 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.56 -29.33 68.68 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.419 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -64.29 -21.8 66.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.1 mtm -89.26 13.25 13.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.6 tp -55.7 -50.71 85.49 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-O 114.903 -2.475 . . . . 0.0 112.382 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.46 -28.84 87.45 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 CA-C-N 122.716 2.006 . . . . 0.0 114.471 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -78.12 -43.39 29.03 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -76.5 -31.42 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.513 1.125 . . . . 0.0 111.539 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -72.35 -31.01 65.25 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.862 0.465 . . . . 0.0 111.247 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.8 ttp-105 -64.48 -43.24 94.8 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.853 0.461 . . . . 0.0 110.292 172.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.0 mt -62.73 -44.35 96.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.372 1.069 . . . . 0.0 112.305 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -124.67 80.27 62.01 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 124.712 1.205 . . . . 0.0 110.179 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.84 -22.71 3.49 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 121.505 1.47 . . . . 0.0 115.621 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -97.72 14.06 28.19 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -127.2 129.65 23.89 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 118.067 -0.968 . . . . 0.0 108.646 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.45 119.14 6.12 Favored 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 122.656 2.238 . . . . 0.0 112.09 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -122.47 112.56 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 111.556 -2.566 . . . . 0.0 107.879 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -126.65 159.79 32.59 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 125.717 1.886 . . . . 0.0 111.267 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.9 t -98.37 140.78 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.559 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.78 132.32 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.4 1.08 . . . . 0.0 108.411 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.445 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 13.7 t0 -59.68 125.36 23.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.248 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -54.39 -33.06 58.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.517 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 49.5 tp -72.57 -46.51 54.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.674 1.19 . . . . 0.0 112.271 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.16 -37.36 79.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.699 0.8 . . . . 0.0 112.56 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -65.72 -40.39 92.17 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.216 1.406 . . . . 0.0 111.354 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.32 -47.96 79.21 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.003 1.287 . . . . 0.0 112.066 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.73 -30.66 71.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.557 0.743 . . . . 0.0 112.586 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 t 57.09 63.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 127.522 2.329 . . . . 0.0 108.241 -169.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -105.7 94.17 5.05 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 112.604 -2.089 . . . . 0.0 109.089 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.72 -46.94 91.67 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 111.751 -2.477 . . . . 0.0 112.869 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.4 tp -63.58 -37.18 86.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.475 0.71 . . . . 0.0 112.302 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.94 -46.06 94.21 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.577 1.56 . . . . 0.0 112.448 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -73.02 -33.84 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.096 0.959 . . . . 0.0 110.929 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.25 -43.58 98.64 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.65 0.78 . . . . 0.0 110.614 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.91 -35.26 76.63 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.431 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.06 81.86 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.191 0.932 . . . . 0.0 111.926 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.06 -43.93 77.51 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.027 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.64 -31.62 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.324 0.65 . . . . 0.0 111.215 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.99 -37.3 83.97 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.987 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.53 0 C-N-CA 123.559 0.744 . . . . 0.0 112.929 176.119 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 11.4 tptt . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.53 ' HB2' HG13 ' A' ' 34' ' ' VAL . 4.4 mptp? -107.37 136.48 47.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.999 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -99.26 110.45 22.98 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.165 1.459 . . . . 0.0 111.71 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.2 mt -111.94 103.69 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.819 -1.991 . . . . 0.0 106.633 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -110.62 126.58 54.62 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.92 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.47 140.04 37.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 112.746 -2.024 . . . . 0.0 111.737 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 N--CA 1.47 0.529 0 CA-C-N 113.872 -1.513 . . . . 0.0 113.828 -176.239 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.87 -26.55 10.19 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.27 40.36 20.11 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.052 0.834 . . . . 0.0 113.859 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.9 mtm -111.71 -58.09 2.17 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 92.3 p -60.56 -29.65 69.29 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 p -61.4 -25.18 67.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.973 1.709 . . . . 0.0 114.429 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.3 p -55.9 -40.62 73.31 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -171.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.6 tp -67.45 -43.53 80.88 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.737 0.415 . . . . 0.0 111.606 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.74 -40.49 92.61 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.966 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.44 -45.3 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.583 1.153 . . . . 0.0 110.03 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 t -57.64 -46.86 83.64 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -64.66 -36.19 83.46 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.555 ' HB3' HD12 ' A' ' 36' ' ' ILE . 46.0 mmm -61.71 -47.56 84.74 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.735 1.214 . . . . 0.0 111.436 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -64.99 -38.71 91.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.643 0.777 . . . . 0.0 112.061 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.26 -41.38 81.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -69.49 -30.85 68.81 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.912 0.485 . . . . 0.0 112.276 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.98 92.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.122 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.59 -41.59 79.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.663 0.785 . . . . 0.0 111.818 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -59.32 -42.1 90.64 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.125 0.97 . . . . 0.0 112.91 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -109.54 26.04 11.1 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 22.57 68.29 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 125.374 2.512 . . . . 0.0 115.277 -170.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.9 t -98.32 107.34 41.23 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 112.513 -2.13 . . . . 0.0 106.463 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 72.9 Cg_endo -75.18 87.55 1.33 Allowed 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.189 1.926 . . . . 0.0 112.636 -176.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 4' ' ' LYS . 15.4 m -141.93 152.21 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 113.066 -1.879 . . . . 0.0 113.577 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.84 110.55 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 112.333 -2.212 . . . . 0.0 106.671 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.555 HD12 ' HB3' ' A' ' 23' ' ' MET . 8.7 mt -116.25 115.32 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.508 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -145.5 142.84 29.59 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.836 1.335 . . . . 0.0 112.112 -172.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.34 145.64 31.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 113.674 -1.603 . . . . 0.0 113.513 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.36 154.22 56.73 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 125.103 1.361 . . . . 0.0 112.909 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -68.5 155.01 70.53 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 122.355 2.037 . . . . 0.0 113.43 167.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -31.65 67.77 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -170.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 t -62.48 -24.51 67.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.992 1.317 . . . . 0.0 113.942 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.4 mt -95.64 15.73 19.16 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.46 99.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.408 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.06 -62.56 5.33 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.27 -54.68 44.03 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 112.825 -1.688 . . . . 0.0 113.426 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.4 -31.89 29.39 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.57 -23.84 65.39 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.87 0.748 . . . . 0.0 113.282 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -58.03 -29.17 65.13 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.856 1.262 . . . . 0.0 113.983 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -116.78 33.11 5.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.197 0.999 . . . . 0.0 112.228 176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.62 136.71 47.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.812 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -80.55 -29.92 37.08 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.091 173.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.31 138.81 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 122.656 1.217 . . . . 0.0 109.609 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.4 t -104.76 121.26 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 112.262 -2.245 . . . . 0.0 106.734 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.5 mt -113.69 136.4 52.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.793 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.6 mt -111.65 140.55 46.19 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.974 -1.921 . . . . 0.0 112.584 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.81 136.33 41.19 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.149 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.8 -24.44 55.74 Favored 'Trans proline' 0 C--N 1.33 -0.413 0 C-N-CA 122.414 2.076 . . . . 0.0 114.861 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.2 pm0 -65.08 -29.95 70.87 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.605 1.562 . . . . 0.0 115.141 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 pt -110.92 22.33 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.757 0.789 . . . . 0.0 112.037 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.52 -29.22 69.26 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.111 -0.95 . . . . 0.0 113.466 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -60.55 -24.54 65.48 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.0 mtm -88.62 11.04 18.46 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.5 tp -52.97 -47.88 93.83 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-O 114.902 -2.475 . . . . 0.0 112.545 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.38 -35.03 90.93 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 122.335 2.024 . . . . 0.0 114.252 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 7.1 tp10 -78.89 -41.27 30.15 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.811 0.815 . . . . 0.0 112.829 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -67.11 -39.34 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.282 1.033 . . . . 0.0 109.214 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.86 -32.23 71.75 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.606 0.763 . . . . 0.0 111.58 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.6 tmt_? -63.02 -40.13 96.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.052 0.941 . . . . 0.0 110.806 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.8 mt -68.95 -44.76 72.34 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.003 1.321 . . . . 0.0 112.289 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.3 mt -124.35 76.22 61.55 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 124.943 1.297 . . . . 0.0 111.093 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.33 -27.43 5.36 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 C-N-CA 121.612 1.541 . . . . 0.0 114.659 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -97.56 23.85 7.29 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.473 1.13 . . . . 0.0 113.16 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -130.03 133.91 25.52 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.704 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.12 112.56 3.17 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 122.253 1.968 . . . . 0.0 110.149 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -118.26 112.18 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 110.852 -2.885 . . . . 0.0 108.07 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -127.16 153.45 46.03 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.12 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.0 t -93.55 136.04 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.842 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.6 mt -69.53 128.76 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 27.6 t70 -56.61 125.85 24.07 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.754 -1.566 . . . . 0.0 111.42 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.5 p -54.26 -34.99 62.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.975 -1.92 . . . . 0.0 114.326 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 51.1 tp -74.07 -44.81 52.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.092 1.357 . . . . 0.0 112.081 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.06 -37.75 80.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.948 0.899 . . . . 0.0 112.603 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -66.58 -40.92 89.15 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.346 1.459 . . . . 0.0 111.372 175.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.94 -49.55 62.37 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.019 1.295 . . . . 0.0 112.355 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -66.27 -24.76 66.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.813 0.845 . . . . 0.0 112.968 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 t 56.56 62.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 127.388 2.275 . . . . 0.0 108.458 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -105.92 99.4 8.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 112.522 -2.126 . . . . 0.0 111.261 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.45 -33.52 81.64 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 111.704 -2.498 . . . . 0.0 113.762 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.43 -47.14 57.73 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.63 -0.335 . . . . 0.0 111.276 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.93 -43.97 92.66 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.975 1.274 . . . . 0.0 112.571 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.7 t -75.06 -35.88 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.377 0.671 . . . . 0.0 111.138 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.94 -44.49 96.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.873 0.844 . . . . 0.0 111.712 176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -68.01 -34.15 75.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.307 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.65 -39.88 80.5 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.359 1.037 . . . . 0.0 112.066 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.12 -44.2 84.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.965 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.76 -31.58 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.195 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.28 -36.4 81.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.716 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 C-N-CA 123.683 0.793 . . . . 0.0 112.99 177.074 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.454 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 34.9 mttp . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 121.256 0.551 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -103.1 150.14 23.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 112.542 -2.117 . . . . 0.0 113.251 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -105.4 116.05 31.29 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.943 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.1 mt -115.36 108.5 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 112.588 -2.096 . . . . 0.0 106.52 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -112.44 129.13 56.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 122.418 1.104 . . . . 0.0 112.912 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.02 136.02 46.43 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.153 -1.84 . . . . 0.0 111.102 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 N--CA 1.47 0.528 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.473 -175.255 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.33 -31.86 8.41 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.77 16.33 54.88 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.914 1.245 . . . . 0.0 115.219 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.8 ptp -103.66 -42.04 5.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.4 p -58.47 -36.14 73.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.8 p -64.92 -23.31 67.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.892 2.077 . . . . 0.0 113.885 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.0 t -46.81 -50.41 18.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.14 -45.98 89.4 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -57.34 -45.73 84.01 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.727 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.84 -49.69 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.972 1.309 . . . . 0.0 109.717 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -56.39 -45.05 80.76 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.502 0.721 . . . . 0.0 112.652 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -66.23 -41.43 90.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.41 ' HB3' HD12 ' A' ' 36' ' ' ILE . 97.4 mtp -61.4 -44.03 97.85 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.779 0.832 . . . . 0.0 110.868 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -61.19 -46.08 91.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.534 1.134 . . . . 0.0 112.013 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.88 89.01 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -71.28 -35.91 71.5 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.372 0.669 . . . . 0.0 111.621 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.52 -38.74 92.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.298 1.039 . . . . 0.0 111.067 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.31 -43.75 76.91 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.655 1.182 . . . . 0.0 111.384 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -58.98 -41.94 88.76 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.463 1.105 . . . . 0.0 112.812 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -105.28 24.92 11.3 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 28.07 58.31 0.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.589 2.356 . . . . 0.0 116.558 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.6 t -96.87 111.72 58.39 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 111.922 -2.399 . . . . 0.0 107.94 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 73.1 Cg_endo -78.37 84.21 2.06 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 121.467 1.445 . . . . 0.0 113.16 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.43 152.09 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 112.855 -1.975 . . . . 0.0 112.659 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.5 mt -111.91 109.34 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.285 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 23' ' ' MET . 17.4 mt -109.16 118.4 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 112.664 -2.062 . . . . 0.0 107.535 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -143.98 143.7 31.34 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 126.234 2.209 . . . . 0.0 111.186 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.8 142.11 44.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.186 -1.37 . . . . 0.0 114.224 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -143.25 154.24 60.64 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 124.853 1.261 . . . . 0.0 113.34 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.2 156.03 59.97 Favored 'Trans proline' 0 C--N 1.33 -0.422 0 C-N-CA 122.311 2.008 . . . . 0.0 112.962 166.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -27.11 68.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.816 -1.538 . . . . 0.0 114.258 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.8 p -56.86 -26.32 58.35 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.14 1.776 . . . . 0.0 113.817 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.7 mt -102.57 16.28 26.83 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.388 1.075 . . . . 0.0 113.833 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.56 93.81 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.421 1.088 . . . . 0.0 113.859 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.64 -54.52 35.01 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' OE1' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -61.81 -62.05 2.07 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.213 -0.993 . . . . 0.0 112.554 -171.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.488 ' HE2' ' OE1' ' A' ' 46' ' ' GLU . 74.0 mmtt -72.13 -31.58 66.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.92 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.17 -28.44 66.66 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.905 0.764 . . . . 0.0 113.063 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -61.82 -29.72 70.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.395 1.078 . . . . 0.0 113.504 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -110.31 20.57 17.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.135 0.974 . . . . 0.0 113.602 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.72 145.05 26.15 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.687 170.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -89.69 -29.43 18.77 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.092 168.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.95 141.39 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 122.436 1.112 . . . . 0.0 110.54 163.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.8 t -107.17 121.85 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 112.847 -1.979 . . . . 0.0 107.459 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.4 mt -116.33 127.68 54.89 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.291 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 mt -105.74 141.55 36.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 112.739 -2.028 . . . . 0.0 112.828 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.69 137.26 44.37 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.202 168.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.32 -35.14 43.18 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 123.157 2.571 . . . . 0.0 114.424 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.7 pm0 -60.11 -31.07 69.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.041 1.736 . . . . 0.0 115.19 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 pt -111.34 19.77 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.11 -28.12 69.56 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.281 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -61.17 -23.8 65.83 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.1 mtm -87.63 6.59 33.88 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.8 tp -51.17 -52.15 61.52 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-O 114.435 -2.698 . . . . 0.0 112.812 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.82 -35.24 98.01 Favored 'Trans proline' 0 C--N 1.33 -0.396 0 CA-C-N 122.803 2.037 . . . . 0.0 114.149 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -73.59 -45.28 54.07 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.003 0.906 . . . . 0.0 112.028 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.02 -36.06 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.448 1.099 . . . . 0.0 111.111 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -58.95 -41.46 87.47 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.267 1.027 . . . . 0.0 110.42 171.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -66.02 -40.6 91.19 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.702 1.201 . . . . 0.0 110.957 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.3 -43.53 97.59 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.516 1.526 . . . . 0.0 112.557 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.9 mt -123.16 73.08 47.74 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 124.741 1.216 . . . . 0.0 111.583 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.16 -10.97 14.96 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 121.512 1.474 . . . . 0.0 114.845 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -102.07 17.41 23.33 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -133.6 132.46 21.79 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.03 116.3 4.52 Favored 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 122.024 1.816 . . . . 0.0 109.836 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.9 t -115.83 113.18 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 110.085 -3.234 . . . . 0.0 107.746 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -125.93 154.02 43.41 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 126.306 2.254 . . . . 0.0 111.189 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.43 136.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 113.154 -1.839 . . . . 0.0 108.615 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.26 129.26 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -55.99 126.17 24.73 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.534 1.159 . . . . 0.0 111.39 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 p -54.19 -34.32 60.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.81 -1.995 . . . . 0.0 114.894 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.9 tp -75.32 -47.94 25.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.563 1.145 . . . . 0.0 111.845 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.3 mt -57.34 -39.15 75.32 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.124 1.37 . . . . 0.0 111.742 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.99 -44.52 92.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.275 1.83 . . . . 0.0 111.389 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.07 -45.01 96.41 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.758 1.171 . . . . 0.0 112.191 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -68.75 -19.99 64.36 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.274 1.43 . . . . 0.0 113.563 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . 0.256 2.8 m 39.14 59.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 127.041 2.136 . . . . 0.0 113.048 -163.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -89.91 87.46 6.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 111.803 -2.453 . . . . 0.0 108.739 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.4 -38.07 56.84 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 111.511 -2.586 . . . . 0.0 113.731 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.7 tp -74.04 -44.83 52.95 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.766 0.426 . . . . 0.0 111.875 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.06 -51.19 51.79 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.638 1.59 . . . . 0.0 111.839 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.08 -40.56 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 114.221 -0.99 . . . . 0.0 110.673 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -45.56 91.7 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.285 0.634 . . . . 0.0 110.985 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -61.34 -41.77 97.58 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.82 0.848 . . . . 0.0 112.626 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.99 92.28 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.515 1.135 . . . . 0.0 111.566 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.49 96.58 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.309 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.91 -32.41 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.689 0.796 . . . . 0.0 111.468 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.91 80.59 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.995 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.494 0 C-N-CA 124.427 1.091 . . . . 0.0 112.832 175.702 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 120.971 0.415 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -116.54 149.18 40.03 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.949 2.031 . . . . 0.0 111.909 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -106.85 118.35 36.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.645 -174.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.12 101.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 112.9 -1.955 . . . . 0.0 106.131 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -109.31 127.63 54.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.459 -1.246 . . . . 0.0 112.162 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.15 137.84 40.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.583 -2.098 . . . . 0.0 110.474 -177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 N--CA 1.471 0.589 0 CA-C-N 113.232 -1.804 . . . . 0.0 112.875 -177.818 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.85 -13.73 13.14 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.02 45.71 25.23 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.952 0.787 . . . . 0.0 112.756 -172.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.1 mmt -106.34 -72.36 0.72 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 -174.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 m -61.65 -35.03 76.79 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 p -55.24 -33.05 62.81 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.42 1.488 . . . . 0.0 113.654 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.6 t -54.06 -36.74 63.43 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.7 tp -67.37 -47.18 71.13 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.4 -39.11 93.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.288 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.41 HG23 ' HB3' ' A' ' 38' ' ' ALA . 70.1 t -60.31 -46.12 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.858 1.263 . . . . 0.0 109.992 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.3 t -55.65 -49.77 71.99 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.808 0.843 . . . . 0.0 112.531 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -63.65 -39.51 94.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.563 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.2 ttp -70.52 -37.52 74.13 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.909 0.755 . . . . 0.0 112.797 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.9 mtt-85 -61.16 -45.71 93.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.545 1.138 . . . . 0.0 111.599 171.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.87 92.04 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.2 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.62 -33.9 69.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.976 0.51 . . . . 0.0 112.186 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.02 99.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.463 0.705 . . . . 0.0 111.248 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.94 -41.98 77.36 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.186 0.994 . . . . 0.0 111.614 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -62.07 -42.2 98.95 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.149 0.979 . . . . 0.0 112.651 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -104.87 30.79 5.22 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 32.47 65.05 0.23 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 125.074 2.369 . . . . 0.0 115.537 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -114.21 105.82 53.64 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.456 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.92 87.74 1.46 Allowed 'Trans proline' 0 C--N 1.33 -0.42 0 C-N-CA 122.15 1.9 . . . . 0.0 113.242 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.85 154.3 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 112.96 -1.927 . . . . 0.0 112.767 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.1 mt -113.78 110.41 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.128 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.28 117.54 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.851 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -138.65 149.83 45.59 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 125.073 1.483 . . . . 0.0 110.744 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 20' ' ' VAL . . . -116.11 134.21 55.19 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.311 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -136.05 154.77 77.74 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 113.98 -1.463 . . . . 0.0 112.85 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -67.39 152.23 79.22 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 C-N-CA 122.388 2.059 . . . . 0.0 112.587 169.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -24.49 63.53 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 113.923 -1.49 . . . . 0.0 114.681 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.3 p -57.77 -30.55 65.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.756 1.622 . . . . 0.0 113.894 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.4 mt -98.84 16.53 22.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.39 97.08 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.12 -60.47 6.76 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.66 -55.32 36.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.758 -1.721 . . . . 0.0 113.361 -170.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -83.4 -27.82 29.33 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.12 -24.81 67.5 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.247 0.927 . . . . 0.0 113.341 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -57.91 -30.91 66.29 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.96 1.304 . . . . 0.0 113.467 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -112.48 29.94 7.51 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.334 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.59 140.86 42.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.674 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -82.66 -34.6 27.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.759 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.4 p -140.73 139.98 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 122.479 1.133 . . . . 0.0 109.197 164.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.22 122.08 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.878 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.8 mt -113.47 132.31 55.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.915 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.7 mt -109.46 141.4 41.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.241 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.59 138.73 45.02 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 113.384 -1.734 . . . . 0.0 110.282 167.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.46 -25.02 64.3 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.251 1.967 . . . . 0.0 114.472 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -64.62 -30.71 71.73 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.989 1.315 . . . . 0.0 114.534 173.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 pt -110.89 27.94 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 122.359 1.076 . . . . 0.0 111.446 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.33 65.64 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.084 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -61.8 -22.18 65.23 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 85.4 mtp -86.62 3.25 45.32 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.67 -52.77 64.25 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-O 114.607 -2.616 . . . . 0.0 113.111 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.38 -29.81 91.12 Favored 'Trans proline' 0 C--N 1.33 -0.418 0 CA-C-N 122.971 2.097 . . . . 0.0 114.038 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.96 -45.18 24.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.931 0.872 . . . . 0.0 112.288 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.5 mt -71.55 -34.97 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.812 1.245 . . . . 0.0 111.058 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.77 -37.41 87.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.482 0.713 . . . . 0.0 110.716 172.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -64.2 -40.5 96.21 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.57 0.748 . . . . 0.0 110.979 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.3 mt -65.67 -42.61 91.11 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.954 1.302 . . . . 0.0 112.631 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 mt -123.7 72.63 52.05 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.061 1.344 . . . . 0.0 111.159 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.19 -19.11 12.26 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 121.617 1.545 . . . . 0.0 114.932 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -91.15 9.0 32.88 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -125.52 138.16 31.3 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.876 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.99 112.5 3.31 Favored 'Trans proline' 0 C--N 1.331 -0.386 0 C-N-CA 122.111 1.874 . . . . 0.0 109.92 170.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -116.45 111.81 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 110.789 -2.914 . . . . 0.0 107.175 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -124.81 157.72 35.13 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 125.984 2.052 . . . . 0.0 111.509 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.9 137.63 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 113.393 -1.73 . . . . 0.0 109.263 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.15 123.96 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.48 131.78 43.26 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.072 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 m -52.75 -41.07 63.68 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.05 -1.886 . . . . 0.0 114.006 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.5 tp -72.59 -46.08 56.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.27 1.028 . . . . 0.0 111.874 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.9 mt -58.21 -36.59 73.35 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.09 0.956 . . . . 0.0 112.772 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.06 -42.79 89.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.802 1.641 . . . . 0.0 111.502 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.47 -47.4 78.83 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.852 1.215 . . . . 0.0 112.64 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -61.74 -30.3 70.69 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.905 1.282 . . . . 0.0 112.498 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.4 t 55.59 58.68 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 127.523 2.329 . . . . 0.0 108.485 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -96.06 90.04 5.4 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 112.425 -2.171 . . . . 0.0 110.13 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -52.86 -47.48 59.06 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 111.923 -2.399 . . . . 0.0 112.496 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.01 -41.67 81.88 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.898 -0.651 . . . . 0.0 112.552 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.67 -50.14 70.19 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.577 1.56 . . . . 0.0 112.22 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.0 t -68.42 -34.58 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.777 0.831 . . . . 0.0 110.617 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp -61.04 -45.73 93.61 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.654 0.782 . . . . 0.0 111.018 176.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -66.12 -36.81 84.14 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.36 -36.23 71.41 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.052 0.845 . . . . 0.0 112.501 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.07 -43.31 78.9 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.894 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.7 m -72.36 -24.35 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.39 -41.05 70.12 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 113.13 -1.85 . . . . 0.0 111.356 173.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 124.263 1.025 . . . . 0.0 111.916 171.362 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mttp . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -100.75 139.84 35.87 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 125.672 1.858 . . . . 0.0 111.298 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -102.65 113.83 27.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.879 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.03 106.55 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 113.267 -1.788 . . . . 0.0 106.765 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -113.08 125.5 54.45 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.709 1.242 . . . . 0.0 112.42 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.85 139.84 33.91 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.287 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.47 0.541 0 CA-C-N 113.833 -1.53 . . . . 0.0 113.524 -174.97 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.51 -30.19 12.3 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.81 31.85 47.62 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.257 0.932 . . . . 0.0 114.043 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.1 ptt? -113.9 -42.69 3.36 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.9 m -70.11 -27.86 64.92 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 p -65.57 -20.83 66.48 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.976 1.31 . . . . 0.0 114.283 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.1 p -61.08 -36.66 80.23 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -172.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.13 -43.4 74.48 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.428 0.691 . . . . 0.0 111.769 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 tt -63.54 -40.41 96.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.162 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 38' ' ' ALA . 79.4 t -61.8 -46.54 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.621 1.168 . . . . 0.0 109.799 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 t -60.92 -38.76 86.89 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.235 0.614 . . . . 0.0 112.647 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -66.99 -47.21 72.21 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 17.8 ptm -75.46 -15.36 60.43 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -72.82 -45.01 60.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.35 0.66 . . . . 0.0 111.672 166.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.93 81.11 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.609 1.195 . . . . 0.0 112.358 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -74.61 -32.66 62.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.28 1.032 . . . . 0.0 112.014 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -33.46 75.82 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.739 0.649 . . . . 0.0 111.238 170.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -74.37 -39.46 62.73 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.942 0.776 . . . . 0.0 112.025 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -64.81 -46.02 83.75 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.498 0.719 . . . . 0.0 111.645 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -96.78 22.27 8.43 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.943 0.777 . . . . 0.0 112.619 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 29.53 69.2 0.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.942 2.497 . . . . 0.0 115.2 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.19 110.34 51.1 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 112.024 -2.353 . . . . 0.0 107.021 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.3 90.92 1.15 Allowed 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 122.498 2.132 . . . . 0.0 113.168 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 m -141.23 146.88 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 113.309 -1.769 . . . . 0.0 112.88 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.8 mt -106.43 108.5 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.205 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.411 HG21 HG11 ' A' ' 20' ' ' VAL . 18.4 mt -112.67 111.02 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.66 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -132.48 150.43 52.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.217 1.007 . . . . 0.0 112.325 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB3' HG23 ' A' ' 20' ' ' VAL . . . -110.64 140.94 44.53 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.613 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -142.88 150.8 54.6 Favored Pre-proline 0 N--CA 1.47 0.568 0 O-C-N 124.791 1.307 . . . . 0.0 112.981 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -67.94 156.22 66.73 Favored 'Trans proline' 0 C--N 1.33 -0.415 0 C-N-CA 122.604 2.203 . . . . 0.0 112.128 165.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.493 ' HG3' ' HE3' ' A' ' 63' ' ' MET . 0.0 OUTLIER -61.25 -17.24 52.41 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -175.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -59.34 -28.34 66.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.773 1.629 . . . . 0.0 113.692 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.8 mt -107.13 24.24 13.14 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.31 1.044 . . . . 0.0 113.195 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.47 82.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.58 -60.15 6.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -57.61 -57.08 14.26 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.749 1.22 . . . . 0.0 113.421 -172.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -78.62 -29.63 46.05 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.04 -28.26 68.56 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.015 0.817 . . . . 0.0 113.015 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -61.6 -25.36 67.29 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.434 1.494 . . . . 0.0 114.322 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -113.98 8.81 17.25 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -91.91 142.35 27.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.972 0.415 . . . . 0.0 110.625 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -87.55 -28.73 21.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.215 172.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.22 139.09 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 122.249 1.023 . . . . 0.0 109.168 162.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.7 t -107.52 126.23 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.11 -1.859 . . . . 0.0 106.969 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.472 HD13 ' HB1' ' A' ' 96' ' ' ALA . 70.5 mt -112.45 137.51 50.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.417 -1.72 . . . . 0.0 111.057 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -113.89 141.03 47.87 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 113.013 -1.903 . . . . 0.0 111.892 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.53 140.87 47.54 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.527 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.72 -23.6 72.37 Favored 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.388 2.059 . . . . 0.0 114.605 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -66.19 -30.0 70.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.685 1.194 . . . . 0.0 114.036 173.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.5 pt -111.36 35.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 122.494 1.14 . . . . 0.0 111.916 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.43 -26.28 63.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.538 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -63.97 -21.45 66.49 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.493 ' HE3' ' HG3' ' A' ' 41' ' ' GLU . 43.3 mtp -85.26 -5.93 59.29 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 tp -54.56 -49.66 89.8 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 115.417 -2.23 . . . . 0.0 113.749 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.77 -30.14 84.25 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 CA-C-N 122.758 2.021 . . . . 0.0 114.405 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -82.01 -37.99 25.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.602 0.715 . . . . 0.0 112.8 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 84.1 mt -74.64 -30.07 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.169 0.988 . . . . 0.0 111.217 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.46 -39.06 88.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.281 0.632 . . . . 0.0 111.115 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -43.93 85.18 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.883 1.273 . . . . 0.0 110.384 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.96 -44.23 97.62 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.451 1.1 . . . . 0.0 112.303 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -123.5 78.52 54.73 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 124.748 1.219 . . . . 0.0 109.707 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.72 -26.54 8.17 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.03 1.82 . . . . 0.0 114.476 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -82.15 5.31 20.1 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 51' ' ' ALA . 74.9 mmtt -122.68 134.7 25.11 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.325 -176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -73.13 115.64 4.42 Favored 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 122.397 2.065 . . . . 0.0 110.328 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 t -118.96 114.76 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 111.948 -2.387 . . . . 0.0 107.52 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -121.98 158.9 28.09 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 125.987 2.054 . . . . 0.0 111.774 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.4 t -104.55 136.27 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.783 174.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.5 mt -67.05 129.54 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -58.34 126.79 29.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 125.015 1.447 . . . . 0.0 110.667 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.4 m -55.56 -36.76 67.17 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.961 -173.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.71 -46.84 65.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.009 0.924 . . . . 0.0 111.827 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.84 -35.41 76.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.421 0.688 . . . . 0.0 112.815 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -67.35 -43.54 81.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.483 1.513 . . . . 0.0 111.605 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.16 -49.28 62.73 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.986 1.279 . . . . 0.0 111.999 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -65.28 -26.54 68.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.017 0.927 . . . . 0.0 112.445 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.33 64.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.873 2.469 . . . . 0.0 108.053 -173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -103.23 89.17 3.32 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 112.769 -2.014 . . . . 0.0 108.606 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.92 -41.97 94.53 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 112.164 -2.289 . . . . 0.0 112.869 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.4 tp -66.57 -38.93 88.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.74 0.816 . . . . 0.0 112.027 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.45 -42.6 97.63 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.122 1.344 . . . . 0.0 112.23 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.9 -33.54 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.186 0.994 . . . . 0.0 111.062 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.38 -43.79 96.61 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.853 0.835 . . . . 0.0 110.638 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.9 -34.38 75.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.97 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.52 -34.11 71.94 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.358 1.036 . . . . 0.0 112.263 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.472 ' HB1' HD13 ' A' ' 55' ' ' LEU . . . -71.89 -42.17 67.11 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.808 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.0 -31.42 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.033 0.533 . . . . 0.0 111.166 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.94 -35.57 80.98 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.283 0.99 . . . . 0.0 110.894 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 176.843 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.1 mttp . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 122.47 1.129 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.485 ' HB2' HG13 ' A' ' 34' ' ' VAL . 64.4 mttm -114.31 146.25 40.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.127 -2.306 . . . . 0.0 112.808 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -99.1 116.02 30.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.41 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.6 mt -114.24 99.07 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.4 m-30 -107.36 120.63 42.68 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.638 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -100.21 137.41 38.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.742 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 . . . . . 0 N--CA 1.47 0.537 0 CA-C-N 113.61 -1.632 . . . . 0.0 113.7 -174.784 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.49 -7.41 13.42 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.77 42.69 92.96 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.731 1.158 . . . . 0.0 113.771 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.512 ' HG3' ' H ' ' A' ' 15' ' ' SER . 4.1 ptt? -101.6 -71.37 0.71 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -174.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.512 ' H ' ' HG3' ' A' ' 14' ' ' MET . 96.2 p -68.03 -26.17 65.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.619 1.554 . . . . 0.0 113.517 -174.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.3 p -57.95 -34.24 69.7 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.758 1.223 . . . . 0.0 113.523 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.3 p -58.75 -34.85 71.86 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.4 tp -66.77 -47.2 72.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.783 0.833 . . . . 0.0 111.666 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.62 -40.87 96.39 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.274 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.418 HG23 ' HB3' ' A' ' 38' ' ' ALA . 53.0 t -56.28 -50.67 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.269 1.428 . . . . 0.0 109.346 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -55.15 -42.51 73.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.454 0.702 . . . . 0.0 112.817 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -65.66 -45.1 84.2 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.8 ptm -75.66 -20.93 58.11 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -67.44 -47.36 70.4 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.21 1.004 . . . . 0.0 111.425 166.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.27 -33.93 76.57 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.545 1.164 . . . . 0.0 113.151 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.408 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 73.4 mt-30 -79.28 -27.33 42.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.151 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.04 71.07 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.867 0.467 . . . . 0.0 111.273 168.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.79 -48.51 58.9 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.309 1.044 . . . . 0.0 110.975 171.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.8 -47.06 87.24 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.478 1.111 . . . . 0.0 113.512 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -99.02 20.44 13.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.074 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 30.32 69.76 0.09 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 125.059 2.362 . . . . 0.0 115.167 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.06 108.26 55.4 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 111.929 -2.396 . . . . 0.0 107.839 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.52 85.4 1.8 Allowed 'Trans proline' 0 C--N 1.33 -0.443 0 C-N-CA 122.238 1.959 . . . . 0.0 113.714 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 4' ' ' LYS . 15.2 m -138.32 146.35 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 112.834 -1.985 . . . . 0.0 112.905 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.0 mt -105.73 107.41 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 112.811 -1.995 . . . . 0.0 107.226 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.6 mt -110.36 112.22 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 112.704 -2.044 . . . . 0.0 108.189 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -137.48 143.94 41.99 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 124.588 1.18 . . . . 0.0 111.483 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB3' HG23 ' A' ' 20' ' ' VAL . . . -110.68 134.52 52.38 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 113.227 -1.806 . . . . 0.0 111.955 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -134.36 154.62 79.96 Favored Pre-proline 0 N--CA 1.471 0.575 0 CA-C-N 113.458 -1.701 . . . . 0.0 112.699 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.03 151.51 83.7 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.118 1.879 . . . . 0.0 112.335 166.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' HG3' ' HE3' ' A' ' 63' ' ' MET . 0.1 OUTLIER -59.46 -23.2 62.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.993 -175.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.2 p -54.98 -31.63 60.93 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.597 1.559 . . . . 0.0 113.999 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.75 17.29 18.33 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.75 89.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.435 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.9 -58.47 12.75 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.448 ' OE1' ' HD2' ' A' ' 47' ' ' LYS . 1.5 tm-20 -57.28 -60.0 4.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 112.504 -1.848 . . . . 0.0 112.892 -169.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HD2' ' OE1' ' A' ' 46' ' ' GLU . 5.5 mptp? -77.4 -32.84 55.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.429 -1.26 . . . . 0.0 113.668 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.16 -26.07 65.4 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.419 1.009 . . . . 0.0 113.345 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.01 -30.15 65.86 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.305 1.442 . . . . 0.0 113.981 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -110.96 0.35 17.01 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.37 135.69 40.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.92 0.39 . . . . 0.0 110.002 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -80.0 -29.94 39.55 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.545 172.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.69 141.48 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 122.577 1.18 . . . . 0.0 109.63 162.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -107.44 119.13 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 112.497 -2.138 . . . . 0.0 106.807 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 76.0 mt -112.21 132.07 55.12 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.261 -1.791 . . . . 0.0 112.063 176.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.406 HD22 HG13 ' A' ' 67' ' ' ILE . 10.2 mp -106.09 141.22 37.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 113.426 -1.715 . . . . 0.0 113.487 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.75 136.34 41.37 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.243 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.12 -26.33 68.64 Favored 'Trans proline' 0 C--N 1.329 -0.469 0 C-N-CA 122.371 2.047 . . . . 0.0 114.75 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -65.74 -27.58 68.41 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.2 pt -111.04 22.49 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.666 0.746 . . . . 0.0 112.353 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.09 69.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.391 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -59.37 -26.72 65.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.529 ' HE3' ' HG3' ' A' ' 41' ' ' GLU . 52.3 mtm -85.46 2.73 43.38 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.3 tp -52.25 -48.1 90.27 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 115.025 -2.417 . . . . 0.0 113.053 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.77 -37.92 84.8 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 122.565 2.176 . . . . 0.0 114.227 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 3.9 tp10 -77.78 -38.34 46.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.093 0.949 . . . . 0.0 112.653 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.406 HG13 HD22 ' A' ' 56' ' ' LEU . 48.2 mm -69.65 -39.69 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.424 1.09 . . . . 0.0 109.408 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -60.78 -40.57 93.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.662 1.185 . . . . 0.0 110.828 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.535 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 28.8 tpt85 -60.51 -41.85 95.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.407 1.483 . . . . 0.0 111.643 176.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.5 mt -68.89 -45.69 70.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.604 1.561 . . . . 0.0 112.616 175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -123.29 76.34 52.62 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.912 1.285 . . . . 0.0 110.848 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.2 -21.94 8.78 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 121.391 1.394 . . . . 0.0 113.917 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -86.68 8.09 23.88 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -128.19 140.41 38.21 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-O 118.714 -0.66 . . . . 0.0 110.081 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -71.76 112.72 3.45 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.196 1.931 . . . . 0.0 109.774 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.6 t -117.93 110.29 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 110.675 -2.966 . . . . 0.0 108.006 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -128.34 155.95 43.86 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 112.923 -1.944 . . . . 0.0 112.223 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.11 136.77 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 113.197 -1.819 . . . . 0.0 109.439 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.4 mt -72.87 128.55 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 10.0 t0 -56.22 126.73 27.46 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.959 174.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.0 m -50.75 -35.94 34.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 113.275 -1.784 . . . . 0.0 114.108 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.497 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 46.7 tp -71.41 -47.77 53.96 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.513 1.125 . . . . 0.0 111.944 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.63 -38.13 77.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.143 0.977 . . . . 0.0 112.713 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.35 -41.19 85.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.373 1.469 . . . . 0.0 111.728 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.77 -49.08 61.43 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.155 1.36 . . . . 0.0 112.443 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.73 -25.63 65.74 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.543 0.737 . . . . 0.0 112.648 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 t 56.33 63.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.733 2.413 . . . . 0.0 109.079 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -102.72 90.28 3.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.481 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.5 -45.09 85.29 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 112.227 -2.26 . . . . 0.0 113.341 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.408 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 48.9 tp -67.53 -41.0 85.05 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.218 0.607 . . . . 0.0 112.41 -175.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.39 -46.17 81.12 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.431 1.491 . . . . 0.0 111.69 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.6 t -72.26 -38.24 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.832 0.853 . . . . 0.0 110.587 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.1 tp -60.95 -44.92 96.58 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.274 1.029 . . . . 0.0 111.491 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -67.94 -36.99 81.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.87 85.06 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.092 0.87 . . . . 0.0 111.699 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.79 -42.51 85.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.867 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -31.26 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.935 0.874 . . . . 0.0 111.658 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.73 79.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.43 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 177.557 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.6 108.56 1.42 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.717 1.886 . . . . 0.0 110.426 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -131.16 137.34 48.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.249 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.25 147.8 26.22 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 126.002 2.064 . . . . 0.0 111.521 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -105.26 115.78 30.83 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 123.154 1.454 . . . . 0.0 112.25 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.7 mt -116.92 102.45 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.38 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -108.62 127.42 53.95 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.278 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.51 135.59 45.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.872 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.19 130.1 44.26 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.429 -1.714 . . . . 0.0 113.208 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CSP . . . . . 0.517 ' O3P' ' HB2' ' A' ' 15' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -55.33 -46.22 76.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -173.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.93 -31.68 8.23 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.88 -0.34 59.15 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -102.12 -36.84 8.4 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 118.375 2.732 . . . . 0.0 118.375 -168.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.517 ' HB2' ' O3P' ' A' ' 10' ' ' CSP . 41.0 m -69.62 -31.92 70.31 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.099 1.318 . . . . 0.0 113.609 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 p -62.67 -18.98 63.38 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.862 1.665 . . . . 0.0 114.49 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -53.96 -41.73 68.12 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.27 -42.74 83.33 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.937 0.495 . . . . 0.0 111.861 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.16 -45.69 90.34 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.393 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.23 -50.52 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.369 1.068 . . . . 0.0 109.86 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.8 t -54.7 -46.02 74.07 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.275 1.03 . . . . 0.0 112.782 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.52 -42.86 82.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.374 0.67 . . . . 0.0 112.801 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 96.5 mtp -59.3 -43.66 92.6 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.173 0.92 . . . . 0.0 110.699 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -62.45 -48.28 80.34 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.355 1.062 . . . . 0.0 111.687 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.09 79.72 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -79.0 -32.17 45.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.785 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.02 -35.15 79.78 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.857 0.863 . . . . 0.0 111.474 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -69.91 -46.65 64.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.865 0.866 . . . . 0.0 110.944 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.81 -40.81 94.09 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.02 0.928 . . . . 0.0 113.162 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -104.2 24.59 11.25 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 31.95 56.92 0.34 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.525 2.33 . . . . 0.0 116.223 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.74 108.43 51.16 Favored Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 112.691 -2.05 . . . . 0.0 107.737 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.12 87.1 1.56 Allowed 'Trans proline' 0 C--N 1.33 -0.425 0 C-N-CA 122.111 1.874 . . . . 0.0 113.363 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 m -139.15 148.39 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 113.168 -1.833 . . . . 0.0 113.032 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.7 mt -106.83 115.94 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 113.056 -1.883 . . . . 0.0 107.438 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -119.28 114.63 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.419 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -139.56 147.7 41.54 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.755 1.284 . . . . 0.0 111.929 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.12 137.74 48.42 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.384 -1.735 . . . . 0.0 112.253 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -139.59 154.18 71.08 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.347 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -70.58 152.74 65.29 Favored 'Trans proline' 0 C--N 1.33 -0.424 0 C-N-CA 122.001 1.801 . . . . 0.0 112.341 168.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.424 ' HG3' ' HE3' ' A' ' 63' ' ' MET . 0.0 OUTLIER -57.72 -26.33 61.63 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.108 1.763 . . . . 0.0 114.893 -173.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.6 p -56.07 -32.97 64.59 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.017 1.727 . . . . 0.0 113.624 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.5 mt -96.51 15.4 21.61 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.82 90.96 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.222 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.25 -63.06 4.38 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' OE2' ' HE2' ' A' ' 47' ' ' LYS . 27.4 tt0 -57.66 -49.19 77.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 112.964 -1.618 . . . . 0.0 113.808 -168.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HE2' ' OE2' ' A' ' 46' ' ' GLU . 5.0 mptp? -90.17 -31.25 17.14 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.19 -24.26 63.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.897 0.76 . . . . 0.0 113.228 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -57.99 -29.91 65.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.319 1.447 . . . . 0.0 114.221 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -106.08 4.51 29.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.6 142.88 33.62 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.193 0.521 . . . . 0.0 110.273 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -89.05 -29.52 19.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.465 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.9 p -146.25 142.68 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.789 1.281 . . . . 0.0 109.259 162.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.59 123.27 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 112.279 -2.237 . . . . 0.0 107.142 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.491 HD13 ' HB1' ' A' ' 96' ' ' ALA . 80.0 mt -113.19 132.9 55.31 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.858 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.5 mt -110.62 142.29 42.69 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 113.133 -1.849 . . . . 0.0 112.357 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.82 136.84 38.53 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.685 169.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.3 -27.68 68.07 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.32 2.014 . . . . 0.0 114.506 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -61.81 -28.53 69.54 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 63' ' ' MET . 8.8 pt -113.71 26.97 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.999 0.904 . . . . 0.0 111.918 175.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.25 -31.29 72.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.33 -21.04 64.97 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 60' ' ' ILE . 78.2 mtp -86.63 -0.26 55.87 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.666 1.187 . . . . 0.0 114.12 176.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 12.6 tp -52.82 -50.15 82.83 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 114.104 -2.855 . . . . 0.0 112.414 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.01 -37.9 86.54 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 122.583 2.189 . . . . 0.0 113.876 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 4.9 tp10 -78.41 -37.57 43.64 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.3 mt -75.9 -33.82 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.753 1.221 . . . . 0.0 110.901 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -58.72 -40.79 84.75 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.682 0.793 . . . . 0.0 110.557 168.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.512 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 5.7 tmm_? -60.89 -45.0 96.32 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.669 1.188 . . . . 0.0 111.436 173.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.8 mt -63.96 -42.9 97.15 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.57 1.148 . . . . 0.0 113.011 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -124.02 71.01 51.91 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.317 1.447 . . . . 0.0 110.846 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.21 -8.68 18.81 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 122.029 1.819 . . . . 0.0 115.044 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -109.85 4.46 21.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -121.62 134.25 24.53 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.52 117.54 5.13 Favored 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 122.077 1.851 . . . . 0.0 110.812 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.9 t -121.01 114.28 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 111.078 -2.783 . . . . 0.0 108.114 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -128.59 154.86 45.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 112.827 -1.988 . . . . 0.0 111.56 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.1 t -96.23 139.8 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.143 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.0 mt -74.4 129.28 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.42 131.03 48.88 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 113.726 -1.579 . . . . 0.0 112.229 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.3 t -48.2 -46.89 35.6 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 111.909 -2.405 . . . . 0.0 113.858 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.3 tp -70.41 -43.82 69.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.998 0.919 . . . . 0.0 111.964 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.76 -38.97 83.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.05 0.94 . . . . 0.0 112.789 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -68.68 -45.68 71.05 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.802 1.241 . . . . 0.0 111.162 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.84 -35.78 92.46 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.784 1.183 . . . . 0.0 112.886 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -83.02 -17.04 44.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.906 1.283 . . . . 0.0 113.055 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.0 t 45.36 65.1 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 128.377 2.671 . . . . 0.0 111.046 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -102.49 93.52 5.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 112.62 -2.082 . . . . 0.0 110.098 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.47 -43.13 90.47 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 111.875 -2.421 . . . . 0.0 113.865 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.2 tp -67.23 -43.95 80.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.772 0.429 . . . . 0.0 112.14 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.73 -48.63 65.15 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.998 1.761 . . . . 0.0 111.85 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.79 -39.84 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 114.68 -0.76 . . . . 0.0 110.829 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.0 tp -61.16 -44.44 97.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.824 0.85 . . . . 0.0 110.934 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -63.11 -40.12 96.71 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.81 0.844 . . . . 0.0 112.306 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.31 87.53 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.138 0.899 . . . . 0.0 112.108 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.491 ' HB1' HD13 ' A' ' 55' ' ' LEU . . . -65.19 -46.86 79.06 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.555 1.142 . . . . 0.0 112.292 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.2 t -66.24 -39.39 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.062 1.345 . . . . 0.0 110.408 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.87 98.59 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.706 1.202 . . . . 0.0 110.944 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.59 -38.97 81.09 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.146 0.978 . . . . 0.0 112.484 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.09 -48.6 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.898 0.879 . . . . 0.0 108.718 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -66.91 -27.93 67.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 116.378 -1.772 . . . . 0.0 115.079 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -84.42 12.33 7.03 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 123.445 1.593 . . . . 0.0 111.955 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -119.01 -50.89 2.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 112.729 -2.032 . . . . 0.0 111.658 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.56 -24.2 62.74 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.27 -169.09 1.88 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.342 1.457 . . . . 0.0 109.225 -168.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 32.3 m120 . . . . . 0 C--O 1.249 1.068 0 C-N-CA 127.494 2.317 . . . . 0.0 113.294 169.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.801 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -108.05 105.6 15.43 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 125.53 1.769 . . . . 0.0 109.485 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -132.54 152.79 51.47 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.348 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -102.85 148.12 26.04 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 125.846 1.967 . . . . 0.0 110.638 172.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -108.11 120.6 42.78 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.629 -1.168 . . . . 0.0 112.008 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.8 mt -120.76 108.89 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.513 -1.676 . . . . 0.0 106.495 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -114.85 125.76 54.03 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.214 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.37 127.51 46.67 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.382 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.77 133.93 52.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.275 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CSP . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.8 m -54.61 -48.62 71.98 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -172.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.85 -15.16 11.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.77 45.25 76.57 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.896 0.76 . . . . 0.0 112.605 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 24.8 mmt -115.25 -71.15 0.76 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 p -66.83 -18.67 65.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -60.32 -28.97 68.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.166 1.387 . . . . 0.0 114.626 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.7 p -60.14 -34.59 73.76 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -65.88 -46.25 79.07 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.394 0.678 . . . . 0.0 111.551 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 tp -62.24 -43.35 99.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.609 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.573 HG23 ' HB3' ' A' ' 38' ' ' ALA . 74.6 t -61.82 -43.67 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.427 1.091 . . . . 0.0 110.742 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -60.51 -44.7 95.74 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.529 0.732 . . . . 0.0 112.557 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -66.21 -39.15 89.42 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.489 ' HB3' HD12 ' A' ' 36' ' ' ILE . 95.7 mtp -64.72 -40.62 95.64 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.978 0.799 . . . . 0.0 111.625 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -67.54 -41.86 83.64 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.976 0.91 . . . . 0.0 112.786 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.03 -39.25 90.05 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.811 0.815 . . . . 0.0 112.827 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -77.44 -29.24 52.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.645 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.57 78.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.535 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -72.27 -41.18 67.0 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.015 0.822 . . . . 0.0 111.676 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -63.66 -51.61 64.34 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.485 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -90.64 23.2 3.15 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 29.28 63.19 0.14 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 124.853 2.263 . . . . 0.0 115.047 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.67 108.81 59.28 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 112.403 -2.18 . . . . 0.0 106.815 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.16 89.44 1.17 Allowed 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 122.296 1.997 . . . . 0.0 112.601 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 m -144.91 150.3 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.804 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -110.72 106.6 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.027 176.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 23' ' ' MET . 14.6 mt -111.48 112.3 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.011 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -134.59 151.92 51.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.644 1.178 . . . . 0.0 111.931 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.573 ' HB3' HG23 ' A' ' 20' ' ' VAL . . . -119.14 137.47 53.58 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.612 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -144.25 154.37 57.32 Favored Pre-proline 0 N--CA 1.47 0.526 0 O-C-N 124.75 1.282 . . . . 0.0 112.552 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 9.5 Cg_endo -62.19 152.29 77.0 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 122.379 2.053 . . . . 0.0 112.62 169.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.448 ' HG3' ' HE3' ' A' ' 63' ' ' MET . 0.0 OUTLIER -57.6 -22.77 47.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.032 1.733 . . . . 0.0 114.827 -173.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.3 p -58.42 -29.89 66.45 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.682 1.593 . . . . 0.0 113.702 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.7 mt -99.75 20.68 13.68 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.92 -45.3 64.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.107 -0.952 . . . . 0.0 113.075 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.12 -15.89 76.71 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.758 0.694 . . . . 0.0 113.833 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -97.13 -57.91 2.15 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.7 0.882 . . . . 0.0 112.884 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -85.25 -27.6 25.92 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.95 -15.98 56.58 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.112 0.863 . . . . 0.0 113.863 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -60.5 -27.0 67.25 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.771 1.228 . . . . 0.0 114.079 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -117.37 24.39 11.16 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.15 138.38 32.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.41 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.87 -23.23 24.04 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.342 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.56 133.76 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 122.442 1.115 . . . . 0.0 109.64 160.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.5 t -97.73 119.06 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 112.644 -2.071 . . . . 0.0 106.256 172.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.9 mt -107.09 134.15 50.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.15 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.53 140.26 47.42 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.66 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.13 144.51 48.76 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.396 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.1 -26.82 83.12 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 C-N-CA 122.265 1.977 . . . . 0.0 114.291 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -64.69 -28.63 69.73 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 pt -114.71 30.09 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 122.411 1.1 . . . . 0.0 111.734 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.98 64.83 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -64.02 -22.59 66.99 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.448 ' HE3' ' HG3' ' A' ' 41' ' ' GLU . 84.7 mtp -85.3 6.45 26.21 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.26 -51.35 81.53 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-O 115.189 -2.339 . . . . 0.0 113.159 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.99 -28.05 80.19 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 CA-C-N 122.872 2.062 . . . . 0.0 114.031 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 2.0 tt0 -80.21 -37.79 32.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.3 mt -79.75 -29.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.813 1.245 . . . . 0.0 111.35 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -34.22 75.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.113 0.565 . . . . 0.0 110.552 171.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -61.77 -43.37 98.99 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.911 0.884 . . . . 0.0 110.74 172.036 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.1 mt -66.37 -42.22 88.31 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.984 0.914 . . . . 0.0 112.808 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.8 mt -124.1 76.69 59.6 Favored Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 124.931 1.293 . . . . 0.0 110.149 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.44 -11.26 10.71 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 121.895 1.73 . . . . 0.0 115.57 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -105.75 15.45 26.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.261 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.29 137.92 31.67 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.814 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.53 117.71 5.28 Favored 'Trans proline' 0 C--N 1.33 -0.421 0 C-N-CA 122.441 2.094 . . . . 0.0 110.34 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 t -120.73 110.71 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 111.956 -2.383 . . . . 0.0 106.835 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.12 146.81 50.59 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 125.866 1.979 . . . . 0.0 111.309 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.66 136.53 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.619 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.4 mt -70.48 133.71 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.409 1.083 . . . . 0.0 108.311 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.31 127.43 32.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.653 1.216 . . . . 0.0 110.957 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.1 m -56.21 -36.02 67.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 113.167 -1.833 . . . . 0.0 114.095 -174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.9 tp -78.8 -36.51 42.65 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.206 0.603 . . . . 0.0 112.55 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.3 mt -60.46 -35.46 75.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.296 0.638 . . . . 0.0 112.713 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -67.84 -39.41 83.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.302 1.441 . . . . 0.0 111.23 174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.5 -47.77 80.52 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.127 1.346 . . . . 0.0 112.452 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.99 -28.56 70.18 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.391 1.076 . . . . 0.0 112.244 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 t 53.67 62.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 127.511 2.325 . . . . 0.0 108.531 -170.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -100.73 92.32 5.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 112.184 -2.28 . . . . 0.0 109.908 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.69 -38.06 93.26 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 111.943 -2.39 . . . . 0.0 113.232 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.9 tp -71.79 -40.58 69.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.422 0.689 . . . . 0.0 111.908 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.71 -45.37 96.55 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.282 1.42 . . . . 0.0 112.733 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.17 -32.63 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.782 0.833 . . . . 0.0 110.997 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -44.74 95.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.416 0.627 . . . . 0.0 111.503 175.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -66.78 -33.74 76.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.223 1.009 . . . . 0.0 113.026 176.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.72 -34.36 67.05 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.204 0.94 . . . . 0.0 112.677 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.22 -43.08 71.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.01 0.924 . . . . 0.0 111.704 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.16 -36.6 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.595 1.158 . . . . 0.0 110.705 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.73 81.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.913 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.66 -34.4 71.99 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.648 0.779 . . . . 0.0 112.806 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.1 mt -70.21 -43.8 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.328 0.651 . . . . 0.0 109.306 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -60.42 -41.66 94.42 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.227 0.611 . . . . 0.0 112.567 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -66.35 -41.98 88.75 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.008 0.923 . . . . 0.0 111.101 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.28 99.01 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.794 1.308 . . . . 0.0 112.154 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.43 92.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.886 0.874 . . . . 0.0 111.926 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 137.45 94.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 130.898 3.679 . . . . 0.0 109.794 171.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 C--O 1.25 1.105 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.927 173.341 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tmm? . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -143.71 104.52 4.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 125.068 1.48 . . . . 0.0 109.562 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 89.0 mttt -132.65 144.37 50.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.882 172.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -102.1 148.07 25.84 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 125.859 1.974 . . . . 0.0 111.646 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -106.16 118.85 37.69 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.343 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.8 mt -118.83 105.54 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -110.09 128.4 55.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.503 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -100.48 134.94 42.68 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.012 -1.903 . . . . 0.0 110.077 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -129.84 131.74 46.23 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.601 -1.636 . . . . 0.0 113.245 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CSP . . . . . 0.436 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.0 t -52.29 -45.56 65.56 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.68 -34.32 7.02 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.62 37.12 12.36 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 123.943 0.782 . . . . 0.0 113.448 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 8.9 ptp -121.44 -48.93 2.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.7 m -63.63 -32.73 74.3 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 p -64.58 -24.36 67.57 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.2 p -58.83 -35.82 73.52 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.0 tp -69.31 -45.72 68.84 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.66 0.384 . . . . 0.0 111.441 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 23' ' ' MET . 1.0 OUTLIER -60.89 -35.62 77.13 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 175.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 36' ' ' ILE . 74.7 t -61.83 -48.72 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.429 1.091 . . . . 0.0 110.252 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.7 p -68.52 -26.85 65.65 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -65.0 -44.35 89.53 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.175 0.99 . . . . 0.0 112.3 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 18.3 ptm -85.01 -13.0 51.96 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -71.96 -41.53 67.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.544 0.338 . . . . 0.0 110.938 164.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.81 86.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.691 0.758 . . . . 0.0 112.242 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.419 HE21 ' HB2' ' A' ' 90' ' ' LEU . 15.2 mm100 -70.17 -34.62 73.22 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.611 173.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.5 98.76 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.18 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.16 -33.48 73.47 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.698 0.799 . . . . 0.0 112.486 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -65.49 -51.83 57.23 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.206 0.603 . . . . 0.0 111.015 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -90.24 24.57 2.48 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.863 0.865 . . . . 0.0 113.305 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 28.31 64.85 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 124.947 2.308 . . . . 0.0 115.192 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.08 105.49 57.29 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-N 112.885 -1.961 . . . . 0.0 107.084 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.403 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 76.3 Cg_endo -75.81 93.99 1.0 Allowed 'Trans proline' 0 C--N 1.331 -0.371 0 C-N-CA 122.396 2.064 . . . . 0.0 112.183 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.07 152.68 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 113.915 -1.493 . . . . 0.0 114.319 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.99 107.13 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 112.179 -2.282 . . . . 0.0 107.144 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.592 HG21 HG11 ' A' ' 20' ' ' VAL . 20.6 mt -112.6 113.35 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.102 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -136.58 148.78 47.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 125.311 1.632 . . . . 0.0 112.201 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.96 139.62 46.14 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.036 -1.438 . . . . 0.0 113.101 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -142.57 152.18 59.29 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.477 1.111 . . . . 0.0 113.128 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 10.6 Cg_endo -67.23 154.08 75.29 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.376 2.051 . . . . 0.0 113.128 167.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -22.59 63.93 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.577 1.551 . . . . 0.0 114.154 -175.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 p -60.36 -31.02 69.94 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.507 1.523 . . . . 0.0 113.164 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -98.77 21.79 10.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.29 1.036 . . . . 0.0 113.093 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.3 -48.91 77.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.057 -0.973 . . . . 0.0 112.673 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.27 -57.61 17.49 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.148 0.905 . . . . 0.0 111.589 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.21 -53.57 53.37 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 113.231 -1.484 . . . . 0.0 113.59 -170.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -80.45 -31.53 37.43 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.339 1.236 . . . . 0.0 114.339 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.33 -20.21 54.47 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.73 1.157 . . . . 0.0 113.643 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -59.68 -32.7 70.74 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.244 1.018 . . . . 0.0 113.396 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.5 -16.38 18.34 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.677 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.53 135.47 48.58 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.143 0.497 . . . . 0.0 111.087 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -86.55 -26.22 24.63 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.391 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.17 140.62 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 122.191 0.996 . . . . 0.0 109.248 163.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.578 ' HB ' HG23 ' A' ' 76' ' ' VAL . 94.5 t -109.12 126.55 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.349 175.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.496 HD13 ' HB1' ' A' ' 96' ' ' ALA . 84.2 mt -115.96 122.82 46.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.245 -1.798 . . . . 0.0 111.356 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 mt -100.45 142.08 32.41 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.421 -1.718 . . . . 0.0 111.925 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.23 144.14 49.07 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.668 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.66 -24.93 77.36 Favored 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 122.272 1.981 . . . . 0.0 114.335 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -67.8 -28.66 67.78 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 pt -113.12 25.29 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 122.053 0.93 . . . . 0.0 112.141 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.3 -29.21 65.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.992 -1.003 . . . . 0.0 113.437 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -61.52 -24.24 66.48 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.675 173.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.0 mtm -87.74 7.43 30.29 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.1 tp -50.86 -46.2 87.22 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 116.418 -1.753 . . . . 0.0 113.823 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.6 -29.12 61.01 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 122.192 1.928 . . . . 0.0 114.827 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -81.61 -36.96 28.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.725 0.774 . . . . 0.0 112.846 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 mm -65.39 -40.55 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.029 1.332 . . . . 0.0 109.509 173.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -73.58 -25.54 60.4 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -65.07 -39.81 93.77 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 170.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.7 mt -65.62 -53.6 39.33 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.537 1.135 . . . . 0.0 112.338 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.87 75.49 71.15 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 124.369 1.068 . . . . 0.0 111.481 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.96 -22.31 23.27 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.256 1.971 . . . . 0.0 115.629 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -86.38 -0.73 56.57 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.46 134.46 20.83 Favored Pre-proline 0 N--CA 1.47 0.526 0 C-N-CA 123.217 0.607 . . . . 0.0 110.771 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.93 116.88 4.88 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 122.42 2.08 . . . . 0.0 110.513 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.578 HG23 ' HB ' ' A' ' 54' ' ' VAL . 59.9 t -123.58 119.59 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 112.087 -2.324 . . . . 0.0 108.352 -175.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -125.51 158.48 34.42 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 126.24 2.213 . . . . 0.0 111.753 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.8 t -99.79 138.22 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.419 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.0 mt -72.11 126.64 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.14 131.45 50.54 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.676 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.1 m -57.83 -34.35 69.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 112.85 -1.977 . . . . 0.0 113.907 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -38.61 53.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.595 0.758 . . . . 0.0 112.48 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.58 -38.25 86.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.325 0.65 . . . . 0.0 112.092 171.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -66.57 -41.38 88.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.568 1.547 . . . . 0.0 111.331 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.58 -43.02 99.6 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.071 1.319 . . . . 0.0 112.498 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -75.54 -28.25 58.97 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t 58.35 70.22 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 127.376 2.271 . . . . 0.0 108.078 -168.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.86 99.49 8.39 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 113.198 -1.819 . . . . 0.0 110.589 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.81 -43.19 98.15 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 111.77 -2.468 . . . . 0.0 113.867 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.419 ' HB2' HE21 ' A' ' 26' ' ' GLN . 65.0 tp -64.22 -43.27 95.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.86 -42.22 91.95 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 124.708 1.146 . . . . 0.0 112.743 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.9 t -77.75 -38.21 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.668 0.787 . . . . 0.0 110.993 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.94 -39.66 95.3 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.773 0.829 . . . . 0.0 111.603 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -64.8 -43.26 93.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.902 1.281 . . . . 0.0 111.278 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.44 83.7 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.058 0.849 . . . . 0.0 112.381 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.496 ' HB1' HD13 ' A' ' 55' ' ' LEU . . . -67.85 -44.12 77.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.163 -1.38 . . . . 0.0 112.35 176.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.53 -27.58 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 121.814 -0.554 . . . . 0.0 112.209 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.85 83.85 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.187 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.65 -29.39 61.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.679 0.792 . . . . 0.0 113.045 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.94 -42.58 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -57.68 -39.29 76.76 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.691 ' HA ' ' HB2' ' A' ' 106' ' ' ASN . 65.1 tttp -65.66 -48.88 70.62 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.109 0.88 . . . . 0.0 110.942 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.6 -37.28 72.97 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.438 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.05 -73.99 0.13 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.194 0.998 . . . . 0.0 110.244 173.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.15 87.09 0.16 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.888 0.875 . . . . 0.0 111.414 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.691 ' HB2' ' HA ' ' A' ' 102' ' ' LYS . 26.2 m120 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.925 1.69 . . . . 0.0 110.718 169.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 mmt . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -100.81 -40.07 7.5 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.535 1.772 . . . . 0.0 111.496 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.9 mttt 63.23 146.98 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.757 1.623 . . . . 0.0 113.886 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -110.06 143.71 39.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 112.908 -1.951 . . . . 0.0 112.227 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -101.69 116.69 33.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.958 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.7 mt -114.4 103.02 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.309 -1.769 . . . . 0.0 106.471 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -110.29 127.17 54.88 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 122.731 1.253 . . . . 0.0 112.45 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -101.17 133.09 46.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.72 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -126.23 133.79 51.39 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.678 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CSP . . . . . 0.482 ' O3P' ' HB2' ' A' ' 15' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m -50.32 -45.86 55.13 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.65 -23.56 11.75 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.71 23.55 77.7 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.341 0.972 . . . . 0.0 114.87 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.7 ptp -118.32 -37.56 3.32 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.482 ' HB2' ' O3P' ' A' ' 10' ' ' CSP . 32.3 m -65.57 -29.88 70.54 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.113 0.87 . . . . 0.0 112.198 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 p -71.71 -20.2 61.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.726 1.61 . . . . 0.0 114.505 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.0 p -63.13 -34.98 78.79 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 tp -65.94 -44.53 84.79 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.101 0.561 . . . . 0.0 111.691 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 tt -62.16 -40.82 97.28 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.13 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 38' ' ' ALA . 73.1 t -61.47 -45.0 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.488 1.115 . . . . 0.0 109.717 175.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -59.08 -40.35 84.98 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -65.87 -44.23 86.0 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.9 ptm -77.99 -21.56 50.67 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -67.34 -46.07 74.51 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.857 0.863 . . . . 0.0 111.52 166.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.37 84.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.006 0.908 . . . . 0.0 112.758 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -75.6 -33.12 60.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.88 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.61 84.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.928 0.491 . . . . 0.0 111.323 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.76 -42.78 77.03 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 111.332 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -63.53 -52.09 62.65 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.444 0.698 . . . . 0.0 111.764 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -85.04 11.8 8.9 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 51.88 51.06 17.29 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 123.958 1.837 . . . . 0.0 112.774 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.2 t -102.05 111.66 64.51 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 112.971 -1.922 . . . . 0.0 107.977 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.71 87.6 1.5 Allowed 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 121.995 1.797 . . . . 0.0 112.781 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.07 152.37 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.589 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.4 mt -112.18 105.75 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.395 -1.73 . . . . 0.0 107.91 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.406 HG21 HG11 ' A' ' 20' ' ' VAL . 23.2 mt -105.78 118.97 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.83 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -149.44 139.34 21.94 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.457 1.098 . . . . 0.0 112.606 -171.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 20' ' ' VAL . . . -104.23 138.15 41.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 113.248 -1.796 . . . . 0.0 112.684 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -139.32 151.49 67.26 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.777 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 17.8 Cg_endo -66.36 152.95 79.8 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 122.412 2.075 . . . . 0.0 112.7 168.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -22.73 62.74 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.076 -1.42 . . . . 0.0 114.664 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -60.32 -28.34 68.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.386 1.474 . . . . 0.0 113.667 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.6 mt -99.08 19.81 14.51 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.14 86.75 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.89 -51.96 31.57 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -61.21 -59.3 5.53 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.642 -1.279 . . . . 0.0 112.918 -172.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -78.85 -24.35 44.41 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.21 -29.37 72.76 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.869 0.747 . . . . 0.0 113.577 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.07 -29.57 70.7 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -109.95 30.09 7.02 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.026 0.917 . . . . 0.0 112.439 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.33 140.55 45.81 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.481 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.34 -49.8 11.02 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.084 170.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.3 140.85 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 122.089 0.947 . . . . 0.0 110.46 171.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.94 122.01 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 113.074 -1.875 . . . . 0.0 107.811 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.5 mt -116.94 115.51 25.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 113.553 -1.658 . . . . 0.0 112.688 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.2 mt -88.89 139.29 30.61 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 112.508 -2.133 . . . . 0.0 112.095 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.02 140.83 45.87 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 113.747 -1.569 . . . . 0.0 110.083 167.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -58.58 -24.85 72.1 Favored 'Trans proline' 0 C--N 1.331 -0.386 0 C-N-CA 122.299 1.999 . . . . 0.0 114.428 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 -64.79 -31.42 72.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.48 26.82 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.159 0.981 . . . . 0.0 111.988 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.56 -29.33 68.68 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.419 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -64.29 -21.8 66.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.1 mtm -89.26 13.25 13.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.6 tp -55.7 -50.71 85.49 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-O 114.903 -2.475 . . . . 0.0 112.382 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.46 -28.84 87.45 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 CA-C-N 122.716 2.006 . . . . 0.0 114.471 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -78.12 -43.39 29.03 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -76.5 -31.42 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.513 1.125 . . . . 0.0 111.539 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -72.35 -31.01 65.25 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.862 0.465 . . . . 0.0 111.247 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.8 ttp-105 -64.48 -43.24 94.8 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.853 0.461 . . . . 0.0 110.292 172.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.0 mt -62.73 -44.35 96.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.372 1.069 . . . . 0.0 112.305 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -124.67 80.27 62.01 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 124.712 1.205 . . . . 0.0 110.179 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.84 -22.71 3.49 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 121.505 1.47 . . . . 0.0 115.621 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -97.72 14.06 28.19 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -127.2 129.65 23.89 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 118.067 -0.968 . . . . 0.0 108.646 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.45 119.14 6.12 Favored 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 122.656 2.238 . . . . 0.0 112.09 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -122.47 112.56 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 111.556 -2.566 . . . . 0.0 107.879 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -126.65 159.79 32.59 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 125.717 1.886 . . . . 0.0 111.267 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.9 t -98.37 140.78 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.559 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.78 132.32 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.4 1.08 . . . . 0.0 108.411 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.445 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 13.7 t0 -59.68 125.36 23.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.248 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -54.39 -33.06 58.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.517 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 49.5 tp -72.57 -46.51 54.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.674 1.19 . . . . 0.0 112.271 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.16 -37.36 79.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.699 0.8 . . . . 0.0 112.56 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -65.72 -40.39 92.17 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.216 1.406 . . . . 0.0 111.354 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.32 -47.96 79.21 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.003 1.287 . . . . 0.0 112.066 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.73 -30.66 71.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.557 0.743 . . . . 0.0 112.586 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 t 57.09 63.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 127.522 2.329 . . . . 0.0 108.241 -169.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -105.7 94.17 5.05 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 112.604 -2.089 . . . . 0.0 109.089 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.72 -46.94 91.67 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 111.751 -2.477 . . . . 0.0 112.869 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.4 tp -63.58 -37.18 86.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.475 0.71 . . . . 0.0 112.302 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.94 -46.06 94.21 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.577 1.56 . . . . 0.0 112.448 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -73.02 -33.84 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.096 0.959 . . . . 0.0 110.929 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.25 -43.58 98.64 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.65 0.78 . . . . 0.0 110.614 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.91 -35.26 76.63 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.431 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.06 81.86 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.191 0.932 . . . . 0.0 111.926 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.06 -43.93 77.51 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.027 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.64 -31.62 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.324 0.65 . . . . 0.0 111.215 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.99 -37.3 83.97 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.987 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.78 66.06 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.559 0.744 . . . . 0.0 112.929 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.0 mt -68.59 -44.55 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -61.2 -38.27 85.95 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -66.03 -41.29 91.12 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.541 0.737 . . . . 0.0 110.926 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.09 85.95 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.925 173.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.88 33.39 1.05 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.699 1.2 . . . . 0.0 111.804 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 59.61 105.83 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.39 2.276 . . . . 0.0 113.97 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.156 1.782 . . . . 0.0 107.456 171.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.475 ' O ' ' HD2' ' A' ' 3' ' ' LYS . 5.2 tp10 -121.02 106.53 11.67 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.933 1.396 . . . . 0.0 109.549 -175.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 2' ' ' GLU . 11.4 tptt -150.83 129.11 11.98 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 170.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.53 ' HB2' HG13 ' A' ' 34' ' ' VAL . 4.4 mptp? -107.37 136.48 47.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.999 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -99.26 110.45 22.98 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.165 1.459 . . . . 0.0 111.71 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.2 mt -111.94 103.69 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.819 -1.991 . . . . 0.0 106.633 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -110.62 126.58 54.62 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.92 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.47 140.04 37.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 112.746 -2.024 . . . . 0.0 111.737 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -133.0 129.13 37.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 113.872 -1.513 . . . . 0.0 113.828 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CSP . . . . . 0.419 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -45.37 -47.51 13.47 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -171.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.87 -26.55 10.19 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.27 40.36 20.11 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.052 0.834 . . . . 0.0 113.859 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.9 mtm -111.71 -58.09 2.17 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 92.3 p -60.56 -29.65 69.29 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 p -61.4 -25.18 67.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.973 1.709 . . . . 0.0 114.429 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.3 p -55.9 -40.62 73.31 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -171.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.6 tp -67.45 -43.53 80.88 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.737 0.415 . . . . 0.0 111.606 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.74 -40.49 92.61 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.966 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.44 -45.3 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.583 1.153 . . . . 0.0 110.03 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 t -57.64 -46.86 83.64 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -64.66 -36.19 83.46 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.555 ' HB3' HD12 ' A' ' 36' ' ' ILE . 46.0 mmm -61.71 -47.56 84.74 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.735 1.214 . . . . 0.0 111.436 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -64.99 -38.71 91.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.643 0.777 . . . . 0.0 112.061 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.26 -41.38 81.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -69.49 -30.85 68.81 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.912 0.485 . . . . 0.0 112.276 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.98 92.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.122 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.59 -41.59 79.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.663 0.785 . . . . 0.0 111.818 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -59.32 -42.1 90.64 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.125 0.97 . . . . 0.0 112.91 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -109.54 26.04 11.1 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 22.57 68.29 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 125.374 2.512 . . . . 0.0 115.277 -170.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.9 t -98.32 107.34 41.23 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 112.513 -2.13 . . . . 0.0 106.463 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 72.9 Cg_endo -75.18 87.55 1.33 Allowed 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.189 1.926 . . . . 0.0 112.636 -176.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 4' ' ' LYS . 15.4 m -141.93 152.21 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 113.066 -1.879 . . . . 0.0 113.577 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.84 110.55 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 112.333 -2.212 . . . . 0.0 106.671 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.555 HD12 ' HB3' ' A' ' 23' ' ' MET . 8.7 mt -116.25 115.32 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.508 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -145.5 142.84 29.59 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.836 1.335 . . . . 0.0 112.112 -172.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.34 145.64 31.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 113.674 -1.603 . . . . 0.0 113.513 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.36 154.22 56.73 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 125.103 1.361 . . . . 0.0 112.909 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 14.4 Cg_endo -68.5 155.01 70.53 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 122.355 2.037 . . . . 0.0 113.43 167.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -31.65 67.77 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -170.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 t -62.48 -24.51 67.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.992 1.317 . . . . 0.0 113.942 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.4 mt -95.64 15.73 19.16 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.46 99.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.408 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.06 -62.56 5.33 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.27 -54.68 44.03 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 112.825 -1.688 . . . . 0.0 113.426 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.4 -31.89 29.39 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.57 -23.84 65.39 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.87 0.748 . . . . 0.0 113.282 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -58.03 -29.17 65.13 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.856 1.262 . . . . 0.0 113.983 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -116.78 33.11 5.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.197 0.999 . . . . 0.0 112.228 176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.62 136.71 47.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.812 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -80.55 -29.92 37.08 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.091 173.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.31 138.81 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 122.656 1.217 . . . . 0.0 109.609 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.4 t -104.76 121.26 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 112.262 -2.245 . . . . 0.0 106.734 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.5 mt -113.69 136.4 52.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.793 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.6 mt -111.65 140.55 46.19 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.974 -1.921 . . . . 0.0 112.584 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.81 136.33 41.19 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.149 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.8 -24.44 55.74 Favored 'Trans proline' 0 C--N 1.33 -0.413 0 C-N-CA 122.414 2.076 . . . . 0.0 114.861 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.2 pm0 -65.08 -29.95 70.87 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.605 1.562 . . . . 0.0 115.141 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 pt -110.92 22.33 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.757 0.789 . . . . 0.0 112.037 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.52 -29.22 69.26 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.111 -0.95 . . . . 0.0 113.466 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -60.55 -24.54 65.48 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.0 mtm -88.62 11.04 18.46 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.5 tp -52.97 -47.88 93.83 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-O 114.902 -2.475 . . . . 0.0 112.545 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.38 -35.03 90.93 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 122.335 2.024 . . . . 0.0 114.252 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 7.1 tp10 -78.89 -41.27 30.15 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.811 0.815 . . . . 0.0 112.829 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -67.11 -39.34 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.282 1.033 . . . . 0.0 109.214 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.86 -32.23 71.75 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.606 0.763 . . . . 0.0 111.58 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 4.6 tmt_? -63.02 -40.13 96.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.052 0.941 . . . . 0.0 110.806 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.8 mt -68.95 -44.76 72.34 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.003 1.321 . . . . 0.0 112.289 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.3 mt -124.35 76.22 61.55 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 124.943 1.297 . . . . 0.0 111.093 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.33 -27.43 5.36 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 C-N-CA 121.612 1.541 . . . . 0.0 114.659 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -97.56 23.85 7.29 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.473 1.13 . . . . 0.0 113.16 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -130.03 133.91 25.52 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.704 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.12 112.56 3.17 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 122.253 1.968 . . . . 0.0 110.149 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -118.26 112.18 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 110.852 -2.885 . . . . 0.0 108.07 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -127.16 153.45 46.03 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.12 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.0 t -93.55 136.04 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.842 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.6 mt -69.53 128.76 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 27.6 t70 -56.61 125.85 24.07 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.754 -1.566 . . . . 0.0 111.42 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.5 p -54.26 -34.99 62.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.975 -1.92 . . . . 0.0 114.326 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 51.1 tp -74.07 -44.81 52.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.092 1.357 . . . . 0.0 112.081 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.06 -37.75 80.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.948 0.899 . . . . 0.0 112.603 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -66.58 -40.92 89.15 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.346 1.459 . . . . 0.0 111.372 175.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.94 -49.55 62.37 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.019 1.295 . . . . 0.0 112.355 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -66.27 -24.76 66.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.813 0.845 . . . . 0.0 112.968 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 t 56.56 62.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 127.388 2.275 . . . . 0.0 108.458 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -105.92 99.4 8.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 112.522 -2.126 . . . . 0.0 111.261 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.45 -33.52 81.64 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 111.704 -2.498 . . . . 0.0 113.762 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.43 -47.14 57.73 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.63 -0.335 . . . . 0.0 111.276 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.93 -43.97 92.66 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.975 1.274 . . . . 0.0 112.571 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.7 t -75.06 -35.88 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.377 0.671 . . . . 0.0 111.138 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.94 -44.49 96.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.873 0.844 . . . . 0.0 111.712 176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -68.01 -34.15 75.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.307 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.65 -39.88 80.5 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.359 1.037 . . . . 0.0 112.066 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.12 -44.2 84.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.965 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.76 -31.58 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.195 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.28 -36.4 81.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.716 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.77 -37.05 67.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.683 0.793 . . . . 0.0 112.99 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.2 mt -66.4 -49.5 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -62.49 -32.18 73.04 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -67.91 -47.17 69.51 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.431 0.692 . . . . 0.0 109.137 176.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.03 79.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.201 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.47 -44.22 83.34 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 174.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.19 59.39 0.72 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.199 0.999 . . . . 0.0 110.508 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-N 113.511 -1.677 . . . . 0.0 111.297 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 tpt . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 115.657 -2.115 . . . . 0.0 107.35 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 64.2 126.65 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 125.92 2.012 . . . . 0.0 113.57 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.454 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 34.9 mttp -136.03 137.17 40.9 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.687 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -103.1 150.14 23.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 112.542 -2.117 . . . . 0.0 113.251 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -105.4 116.05 31.29 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.943 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.1 mt -115.36 108.5 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 112.588 -2.096 . . . . 0.0 106.52 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -112.44 129.13 56.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 122.418 1.104 . . . . 0.0 112.912 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.02 136.02 46.43 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.153 -1.84 . . . . 0.0 111.102 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -132.06 133.69 44.66 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.473 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CSP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -53.96 -44.09 70.44 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.33 -31.86 8.41 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.77 16.33 54.88 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.914 1.245 . . . . 0.0 115.219 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.8 ptp -103.66 -42.04 5.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.4 p -58.47 -36.14 73.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.8 p -64.92 -23.31 67.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.892 2.077 . . . . 0.0 113.885 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.0 t -46.81 -50.41 18.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.14 -45.98 89.4 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -57.34 -45.73 84.01 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.727 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.84 -49.69 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.972 1.309 . . . . 0.0 109.717 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -56.39 -45.05 80.76 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.502 0.721 . . . . 0.0 112.652 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -66.23 -41.43 90.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.41 ' HB3' HD12 ' A' ' 36' ' ' ILE . 97.4 mtp -61.4 -44.03 97.85 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.779 0.832 . . . . 0.0 110.868 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -61.19 -46.08 91.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.534 1.134 . . . . 0.0 112.013 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.88 89.01 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -71.28 -35.91 71.5 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.372 0.669 . . . . 0.0 111.621 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.52 -38.74 92.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.298 1.039 . . . . 0.0 111.067 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.31 -43.75 76.91 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.655 1.182 . . . . 0.0 111.384 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -58.98 -41.94 88.76 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.463 1.105 . . . . 0.0 112.812 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -105.28 24.92 11.3 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 28.07 58.31 0.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.589 2.356 . . . . 0.0 116.558 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.6 t -96.87 111.72 58.39 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 111.922 -2.399 . . . . 0.0 107.94 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 73.1 Cg_endo -78.37 84.21 2.06 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 121.467 1.445 . . . . 0.0 113.16 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.43 152.09 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 112.855 -1.975 . . . . 0.0 112.659 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.5 mt -111.91 109.34 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.285 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 23' ' ' MET . 17.4 mt -109.16 118.4 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 112.664 -2.062 . . . . 0.0 107.535 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -143.98 143.7 31.34 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 126.234 2.209 . . . . 0.0 111.186 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.8 142.11 44.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.186 -1.37 . . . . 0.0 114.224 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -143.25 154.24 60.64 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 124.853 1.261 . . . . 0.0 113.34 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.2 156.03 59.97 Favored 'Trans proline' 0 C--N 1.33 -0.422 0 C-N-CA 122.311 2.008 . . . . 0.0 112.962 166.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -27.11 68.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.816 -1.538 . . . . 0.0 114.258 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.8 p -56.86 -26.32 58.35 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.14 1.776 . . . . 0.0 113.817 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.7 mt -102.57 16.28 26.83 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.388 1.075 . . . . 0.0 113.833 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.56 93.81 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.421 1.088 . . . . 0.0 113.859 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.64 -54.52 35.01 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' OE1' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -61.81 -62.05 2.07 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.213 -0.993 . . . . 0.0 112.554 -171.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.488 ' HE2' ' OE1' ' A' ' 46' ' ' GLU . 74.0 mmtt -72.13 -31.58 66.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.92 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.17 -28.44 66.66 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.905 0.764 . . . . 0.0 113.063 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -61.82 -29.72 70.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.395 1.078 . . . . 0.0 113.504 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -110.31 20.57 17.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.135 0.974 . . . . 0.0 113.602 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.72 145.05 26.15 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.687 170.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -89.69 -29.43 18.77 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.092 168.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.95 141.39 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 122.436 1.112 . . . . 0.0 110.54 163.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.8 t -107.17 121.85 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 112.847 -1.979 . . . . 0.0 107.459 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.4 mt -116.33 127.68 54.89 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.291 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 mt -105.74 141.55 36.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 112.739 -2.028 . . . . 0.0 112.828 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.69 137.26 44.37 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.202 168.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.32 -35.14 43.18 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 123.157 2.571 . . . . 0.0 114.424 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.7 pm0 -60.11 -31.07 69.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.041 1.736 . . . . 0.0 115.19 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 pt -111.34 19.77 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.11 -28.12 69.56 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.281 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -61.17 -23.8 65.83 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.1 mtm -87.63 6.59 33.88 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.8 tp -51.17 -52.15 61.52 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-O 114.435 -2.698 . . . . 0.0 112.812 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.82 -35.24 98.01 Favored 'Trans proline' 0 C--N 1.33 -0.396 0 CA-C-N 122.803 2.037 . . . . 0.0 114.149 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -73.59 -45.28 54.07 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.003 0.906 . . . . 0.0 112.028 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.02 -36.06 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.448 1.099 . . . . 0.0 111.111 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -58.95 -41.46 87.47 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.267 1.027 . . . . 0.0 110.42 171.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -66.02 -40.6 91.19 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.702 1.201 . . . . 0.0 110.957 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.3 -43.53 97.59 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.516 1.526 . . . . 0.0 112.557 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.9 mt -123.16 73.08 47.74 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 124.741 1.216 . . . . 0.0 111.583 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.16 -10.97 14.96 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 121.512 1.474 . . . . 0.0 114.845 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -102.07 17.41 23.33 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -133.6 132.46 21.79 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.566 ' HG3' ' HB1' ' A' ' 103' ' ' ALA . 48.6 Cg_endo -70.03 116.3 4.52 Favored 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 122.024 1.816 . . . . 0.0 109.836 173.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.9 t -115.83 113.18 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 110.085 -3.234 . . . . 0.0 107.746 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -125.93 154.02 43.41 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 126.306 2.254 . . . . 0.0 111.189 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.43 136.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 113.154 -1.839 . . . . 0.0 108.615 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.26 129.26 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -55.99 126.17 24.73 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.534 1.159 . . . . 0.0 111.39 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 p -54.19 -34.32 60.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.81 -1.995 . . . . 0.0 114.894 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.9 tp -75.32 -47.94 25.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.563 1.145 . . . . 0.0 111.845 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.3 mt -57.34 -39.15 75.32 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.124 1.37 . . . . 0.0 111.742 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.99 -44.52 92.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.275 1.83 . . . . 0.0 111.389 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.07 -45.01 96.41 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.758 1.171 . . . . 0.0 112.191 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -68.75 -19.99 64.36 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.274 1.43 . . . . 0.0 113.563 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . 0.256 2.8 m 39.14 59.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 127.041 2.136 . . . . 0.0 113.048 -163.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -89.91 87.46 6.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 111.803 -2.453 . . . . 0.0 108.739 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.4 -38.07 56.84 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 111.511 -2.586 . . . . 0.0 113.731 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.7 tp -74.04 -44.83 52.95 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.766 0.426 . . . . 0.0 111.875 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.06 -51.19 51.79 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.638 1.59 . . . . 0.0 111.839 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.08 -40.56 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 114.221 -0.99 . . . . 0.0 110.673 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -45.56 91.7 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.285 0.634 . . . . 0.0 110.985 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -61.34 -41.77 97.58 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.82 0.848 . . . . 0.0 112.626 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.99 92.28 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.515 1.135 . . . . 0.0 111.566 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.49 96.58 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.309 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.475 ' HA ' HD11 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -70.91 -32.41 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.689 0.796 . . . . 0.0 111.468 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.91 80.59 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.995 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.74 -35.63 70.19 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.427 1.091 . . . . 0.0 112.832 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.475 HD11 ' HA ' ' A' ' 97' ' ' VAL . 86.9 mt -62.06 -44.23 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.96 0.904 . . . . 0.0 109.375 171.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 21.3 mtpp -65.58 -36.7 84.51 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 174.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -64.08 -42.6 96.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.541 0.736 . . . . 0.0 109.918 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.566 ' HB1' ' HG3' ' A' ' 75' ' ' PRO . . . -62.61 154.55 28.71 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 113.782 -1.553 . . . . 0.0 107.161 158.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 62.85 -32.61 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -163.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 103' ' ' ALA . . . 120.56 128.82 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 131.472 3.909 . . . . 0.0 113.702 166.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 101' ' ' LYS . 1.1 t-20 . . . . . 0 C--O 1.25 1.122 0 C-N-CA 126.819 2.048 . . . . 0.0 107.116 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.4 tpp . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.77 95.32 4.01 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 125.183 1.552 . . . . 0.0 109.382 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -137.42 155.23 49.59 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.729 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.521 ' HD3' HG22 ' A' ' 100' ' ' ILE . 58.0 mttm -116.54 149.18 40.03 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.949 2.031 . . . . 0.0 111.909 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -106.85 118.35 36.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.645 -174.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.12 101.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 112.9 -1.955 . . . . 0.0 106.131 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -109.31 127.63 54.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.459 -1.246 . . . . 0.0 112.162 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.15 137.84 40.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.583 -2.098 . . . . 0.0 110.474 -177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -130.27 128.94 42.59 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.232 -1.804 . . . . 0.0 112.875 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CSP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 m -43.2 -53.68 4.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -169.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.85 -13.73 13.14 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.02 45.71 25.23 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.952 0.787 . . . . 0.0 112.756 -172.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.1 mmt -106.34 -72.36 0.72 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 -174.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 m -61.65 -35.03 76.79 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 p -55.24 -33.05 62.81 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.42 1.488 . . . . 0.0 113.654 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.6 t -54.06 -36.74 63.43 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.7 tp -67.37 -47.18 71.13 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.4 -39.11 93.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.288 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.41 HG23 ' HB3' ' A' ' 38' ' ' ALA . 70.1 t -60.31 -46.12 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.858 1.263 . . . . 0.0 109.992 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.3 t -55.65 -49.77 71.99 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.808 0.843 . . . . 0.0 112.531 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -63.65 -39.51 94.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.563 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.2 ttp -70.52 -37.52 74.13 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.909 0.755 . . . . 0.0 112.797 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.9 mtt-85 -61.16 -45.71 93.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.545 1.138 . . . . 0.0 111.599 171.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.87 92.04 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.2 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.62 -33.9 69.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.976 0.51 . . . . 0.0 112.186 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.02 99.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.463 0.705 . . . . 0.0 111.248 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.94 -41.98 77.36 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.186 0.994 . . . . 0.0 111.614 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -62.07 -42.2 98.95 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.149 0.979 . . . . 0.0 112.651 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -104.87 30.79 5.22 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 32.47 65.05 0.23 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 125.074 2.369 . . . . 0.0 115.537 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -114.21 105.82 53.64 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.456 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.92 87.74 1.46 Allowed 'Trans proline' 0 C--N 1.33 -0.42 0 C-N-CA 122.15 1.9 . . . . 0.0 113.242 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.85 154.3 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 112.96 -1.927 . . . . 0.0 112.767 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.1 mt -113.78 110.41 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.128 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.28 117.54 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.851 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -138.65 149.83 45.59 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 125.073 1.483 . . . . 0.0 110.744 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 20' ' ' VAL . . . -116.11 134.21 55.19 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.311 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -136.05 154.77 77.74 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 113.98 -1.463 . . . . 0.0 112.85 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -67.39 152.23 79.22 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 C-N-CA 122.388 2.059 . . . . 0.0 112.587 169.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -24.49 63.53 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 113.923 -1.49 . . . . 0.0 114.681 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.3 p -57.77 -30.55 65.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.756 1.622 . . . . 0.0 113.894 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.4 mt -98.84 16.53 22.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.39 97.08 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.12 -60.47 6.76 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.66 -55.32 36.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.758 -1.721 . . . . 0.0 113.361 -170.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -83.4 -27.82 29.33 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.12 -24.81 67.5 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.247 0.927 . . . . 0.0 113.341 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -57.91 -30.91 66.29 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.96 1.304 . . . . 0.0 113.467 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -112.48 29.94 7.51 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.334 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.59 140.86 42.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.674 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -82.66 -34.6 27.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.759 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.4 p -140.73 139.98 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 122.479 1.133 . . . . 0.0 109.197 164.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.22 122.08 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.878 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.8 mt -113.47 132.31 55.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.915 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.7 mt -109.46 141.4 41.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.241 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.59 138.73 45.02 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 113.384 -1.734 . . . . 0.0 110.282 167.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.46 -25.02 64.3 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.251 1.967 . . . . 0.0 114.472 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -64.62 -30.71 71.73 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.989 1.315 . . . . 0.0 114.534 173.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 pt -110.89 27.94 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 122.359 1.076 . . . . 0.0 111.446 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.33 65.64 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.084 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -61.8 -22.18 65.23 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 85.4 mtp -86.62 3.25 45.32 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.67 -52.77 64.25 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-O 114.607 -2.616 . . . . 0.0 113.111 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.38 -29.81 91.12 Favored 'Trans proline' 0 C--N 1.33 -0.418 0 CA-C-N 122.971 2.097 . . . . 0.0 114.038 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.96 -45.18 24.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.931 0.872 . . . . 0.0 112.288 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.5 mt -71.55 -34.97 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.812 1.245 . . . . 0.0 111.058 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.77 -37.41 87.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.482 0.713 . . . . 0.0 110.716 172.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -64.2 -40.5 96.21 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.57 0.748 . . . . 0.0 110.979 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.3 mt -65.67 -42.61 91.11 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.954 1.302 . . . . 0.0 112.631 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 mt -123.7 72.63 52.05 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.061 1.344 . . . . 0.0 111.159 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.19 -19.11 12.26 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 121.617 1.545 . . . . 0.0 114.932 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -91.15 9.0 32.88 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -125.52 138.16 31.3 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.876 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.99 112.5 3.31 Favored 'Trans proline' 0 C--N 1.331 -0.386 0 C-N-CA 122.111 1.874 . . . . 0.0 109.92 170.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -116.45 111.81 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 110.789 -2.914 . . . . 0.0 107.175 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -124.81 157.72 35.13 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 125.984 2.052 . . . . 0.0 111.509 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.9 137.63 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 113.393 -1.73 . . . . 0.0 109.263 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.15 123.96 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.48 131.78 43.26 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.072 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 m -52.75 -41.07 63.68 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.05 -1.886 . . . . 0.0 114.006 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.5 tp -72.59 -46.08 56.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.27 1.028 . . . . 0.0 111.874 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.9 mt -58.21 -36.59 73.35 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.09 0.956 . . . . 0.0 112.772 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.06 -42.79 89.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.802 1.641 . . . . 0.0 111.502 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.47 -47.4 78.83 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.852 1.215 . . . . 0.0 112.64 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -61.74 -30.3 70.69 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.905 1.282 . . . . 0.0 112.498 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.4 t 55.59 58.68 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 127.523 2.329 . . . . 0.0 108.485 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -96.06 90.04 5.4 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 112.425 -2.171 . . . . 0.0 110.13 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -52.86 -47.48 59.06 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 111.923 -2.399 . . . . 0.0 112.496 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.01 -41.67 81.88 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.898 -0.651 . . . . 0.0 112.552 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.67 -50.14 70.19 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.577 1.56 . . . . 0.0 112.22 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.0 t -68.42 -34.58 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.777 0.831 . . . . 0.0 110.617 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp -61.04 -45.73 93.61 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.654 0.782 . . . . 0.0 111.018 176.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -66.12 -36.81 84.14 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.36 -36.23 71.41 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.052 0.845 . . . . 0.0 112.501 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.07 -43.31 78.9 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.894 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.7 m -72.36 -24.35 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.39 -41.05 70.12 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 113.13 -1.85 . . . . 0.0 111.356 173.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 102' ' ' LYS . . . -67.58 -32.9 73.96 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.263 1.025 . . . . 0.0 111.916 171.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 6.7 mt -77.61 179.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 159.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 14.5 mtpp 57.24 -41.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 119.773 -1.829 . . . . 0.0 113.799 -147.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 100' ' ' ILE . 8.5 tmtt? 111.77 84.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 130.96 3.704 . . . . 0.0 107.406 162.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 49.71 43.72 24.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 111.657 -2.519 . . . . 0.0 110.251 -168.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 48.37 76.01 0.13 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.633 1.573 . . . . 0.0 112.501 -166.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 28.39 76.43 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.985 1.714 . . . . 0.0 115.12 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 112.577 -2.101 . . . . 0.0 108.471 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 116.537 -1.697 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 62.41 78.05 0.31 Allowed 'General case' 0 N--CA 1.471 0.624 0 O-C-N 125.917 2.011 . . . . 0.0 112.775 171.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -136.19 155.44 50.14 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.254 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -100.75 139.84 35.87 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 125.672 1.858 . . . . 0.0 111.298 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -102.65 113.83 27.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.879 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.03 106.55 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 113.267 -1.788 . . . . 0.0 106.765 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -113.08 125.5 54.45 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.709 1.242 . . . . 0.0 112.42 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.85 139.84 33.91 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.287 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.01 133.83 39.84 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.833 -1.53 . . . . 0.0 113.524 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CSP . . . . . 0.448 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m -47.07 -46.47 22.5 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -170.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.51 -30.19 12.3 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.81 31.85 47.62 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.257 0.932 . . . . 0.0 114.043 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.1 ptt? -113.9 -42.69 3.36 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.9 m -70.11 -27.86 64.92 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 p -65.57 -20.83 66.48 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.976 1.31 . . . . 0.0 114.283 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.1 p -61.08 -36.66 80.23 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -172.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.13 -43.4 74.48 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.428 0.691 . . . . 0.0 111.769 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 tt -63.54 -40.41 96.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.162 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 38' ' ' ALA . 79.4 t -61.8 -46.54 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.621 1.168 . . . . 0.0 109.799 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 t -60.92 -38.76 86.89 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.235 0.614 . . . . 0.0 112.647 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -66.99 -47.21 72.21 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 17.8 ptm -75.46 -15.36 60.43 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -72.82 -45.01 60.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.35 0.66 . . . . 0.0 111.672 166.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.93 81.11 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.609 1.195 . . . . 0.0 112.358 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -74.61 -32.66 62.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.28 1.032 . . . . 0.0 112.014 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -33.46 75.82 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.739 0.649 . . . . 0.0 111.238 170.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -74.37 -39.46 62.73 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.942 0.776 . . . . 0.0 112.025 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -64.81 -46.02 83.75 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.498 0.719 . . . . 0.0 111.645 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -96.78 22.27 8.43 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.943 0.777 . . . . 0.0 112.619 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 29.53 69.2 0.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.942 2.497 . . . . 0.0 115.2 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.19 110.34 51.1 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 112.024 -2.353 . . . . 0.0 107.021 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.3 90.92 1.15 Allowed 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 122.498 2.132 . . . . 0.0 113.168 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 m -141.23 146.88 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 113.309 -1.769 . . . . 0.0 112.88 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.8 mt -106.43 108.5 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.205 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.411 HG21 HG11 ' A' ' 20' ' ' VAL . 18.4 mt -112.67 111.02 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.66 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -132.48 150.43 52.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.217 1.007 . . . . 0.0 112.325 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB3' HG23 ' A' ' 20' ' ' VAL . . . -110.64 140.94 44.53 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.613 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -142.88 150.8 54.6 Favored Pre-proline 0 N--CA 1.47 0.568 0 O-C-N 124.791 1.307 . . . . 0.0 112.981 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 16.5 Cg_endo -67.94 156.22 66.73 Favored 'Trans proline' 0 C--N 1.33 -0.415 0 C-N-CA 122.604 2.203 . . . . 0.0 112.128 165.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.493 ' HG3' ' HE3' ' A' ' 63' ' ' MET . 0.0 OUTLIER -61.25 -17.24 52.41 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -175.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -59.34 -28.34 66.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.773 1.629 . . . . 0.0 113.692 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.8 mt -107.13 24.24 13.14 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.31 1.044 . . . . 0.0 113.195 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.47 82.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.58 -60.15 6.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -57.61 -57.08 14.26 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.749 1.22 . . . . 0.0 113.421 -172.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -78.62 -29.63 46.05 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.04 -28.26 68.56 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.015 0.817 . . . . 0.0 113.015 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -61.6 -25.36 67.29 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.434 1.494 . . . . 0.0 114.322 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -113.98 8.81 17.25 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -91.91 142.35 27.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.972 0.415 . . . . 0.0 110.625 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -87.55 -28.73 21.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.215 172.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.22 139.09 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 122.249 1.023 . . . . 0.0 109.168 162.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.7 t -107.52 126.23 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.11 -1.859 . . . . 0.0 106.969 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.472 HD13 ' HB1' ' A' ' 96' ' ' ALA . 70.5 mt -112.45 137.51 50.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.417 -1.72 . . . . 0.0 111.057 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -113.89 141.03 47.87 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 113.013 -1.903 . . . . 0.0 111.892 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.53 140.87 47.54 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.527 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.72 -23.6 72.37 Favored 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.388 2.059 . . . . 0.0 114.605 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -66.19 -30.0 70.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.685 1.194 . . . . 0.0 114.036 173.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.5 pt -111.36 35.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 122.494 1.14 . . . . 0.0 111.916 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.43 -26.28 63.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.538 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -63.97 -21.45 66.49 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.493 ' HE3' ' HG3' ' A' ' 41' ' ' GLU . 43.3 mtp -85.26 -5.93 59.29 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 tp -54.56 -49.66 89.8 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 115.417 -2.23 . . . . 0.0 113.749 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.77 -30.14 84.25 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 CA-C-N 122.758 2.021 . . . . 0.0 114.405 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -82.01 -37.99 25.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.602 0.715 . . . . 0.0 112.8 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 84.1 mt -74.64 -30.07 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.169 0.988 . . . . 0.0 111.217 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.46 -39.06 88.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.281 0.632 . . . . 0.0 111.115 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -43.93 85.18 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.883 1.273 . . . . 0.0 110.384 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.96 -44.23 97.62 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.451 1.1 . . . . 0.0 112.303 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -123.5 78.52 54.73 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 124.748 1.219 . . . . 0.0 109.707 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.72 -26.54 8.17 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.03 1.82 . . . . 0.0 114.476 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -82.15 5.31 20.1 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 51' ' ' ALA . 74.9 mmtt -122.68 134.7 25.11 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.325 -176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -73.13 115.64 4.42 Favored 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 122.397 2.065 . . . . 0.0 110.328 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 t -118.96 114.76 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 111.948 -2.387 . . . . 0.0 107.52 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -121.98 158.9 28.09 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 125.987 2.054 . . . . 0.0 111.774 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.4 t -104.55 136.27 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.783 174.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.5 mt -67.05 129.54 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -58.34 126.79 29.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 125.015 1.447 . . . . 0.0 110.667 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.4 m -55.56 -36.76 67.17 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.961 -173.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.71 -46.84 65.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.009 0.924 . . . . 0.0 111.827 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.84 -35.41 76.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.421 0.688 . . . . 0.0 112.815 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -67.35 -43.54 81.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.483 1.513 . . . . 0.0 111.605 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.16 -49.28 62.73 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.986 1.279 . . . . 0.0 111.999 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -65.28 -26.54 68.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.017 0.927 . . . . 0.0 112.445 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.33 64.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.873 2.469 . . . . 0.0 108.053 -173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -103.23 89.17 3.32 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 112.769 -2.014 . . . . 0.0 108.606 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.92 -41.97 94.53 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 112.164 -2.289 . . . . 0.0 112.869 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.4 tp -66.57 -38.93 88.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.74 0.816 . . . . 0.0 112.027 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.45 -42.6 97.63 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.122 1.344 . . . . 0.0 112.23 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.9 -33.54 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.186 0.994 . . . . 0.0 111.062 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.38 -43.79 96.61 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.853 0.835 . . . . 0.0 110.638 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.9 -34.38 75.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.97 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.52 -34.11 71.94 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.358 1.036 . . . . 0.0 112.263 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.472 ' HB1' HD13 ' A' ' 55' ' ' LEU . . . -71.89 -42.17 67.11 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.808 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.436 ' HA ' HD11 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -71.0 -31.42 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.033 0.533 . . . . 0.0 111.166 178.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.94 -35.57 80.98 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.283 0.99 . . . . 0.0 110.894 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.78 -32.82 63.96 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.436 HD11 ' HA ' ' A' ' 97' ' ' VAL . 58.2 mt -69.65 -48.72 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -60.1 -38.1 81.97 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.5 0.72 . . . . 0.0 112.879 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -70.7 -43.03 69.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.517 1.127 . . . . 0.0 110.619 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.15 89.05 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 125.544 1.777 . . . . 0.0 111.883 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.11 -68.44 0.33 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.183 170.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 159.92 98.97 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.516 2.726 . . . . 0.0 107.854 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.293 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.79 127.85 34.16 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.912 1.382 . . . . 0.0 110.428 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.1 mttp 67.53 147.6 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.433 1.893 . . . . 0.0 112.708 -165.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.545 ' HD3' HG22 ' A' ' 100' ' ' ILE . 64.4 mttm -114.31 146.25 40.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.127 -2.306 . . . . 0.0 112.808 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -99.1 116.02 30.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.41 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.6 mt -114.24 99.07 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.4 m-30 -107.36 120.63 42.68 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.638 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -100.21 137.41 38.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.742 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -130.06 129.32 43.49 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 113.61 -1.632 . . . . 0.0 113.7 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CSP . . . . . 0.447 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.9 m -42.8 -50.71 5.62 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 -165.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.49 -7.41 13.42 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.77 42.69 92.96 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.731 1.158 . . . . 0.0 113.771 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.512 ' HG3' ' H ' ' A' ' 15' ' ' SER . 4.1 ptt? -101.6 -71.37 0.71 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -174.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.512 ' H ' ' HG3' ' A' ' 14' ' ' MET . 96.2 p -68.03 -26.17 65.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.619 1.554 . . . . 0.0 113.517 -174.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.3 p -57.95 -34.24 69.7 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.758 1.223 . . . . 0.0 113.523 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.3 p -58.75 -34.85 71.86 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.4 tp -66.77 -47.2 72.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.783 0.833 . . . . 0.0 111.666 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.62 -40.87 96.39 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.274 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.418 HG23 ' HB3' ' A' ' 38' ' ' ALA . 53.0 t -56.28 -50.67 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.269 1.428 . . . . 0.0 109.346 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -55.15 -42.51 73.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.454 0.702 . . . . 0.0 112.817 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -65.66 -45.1 84.2 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.8 ptm -75.66 -20.93 58.11 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -67.44 -47.36 70.4 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.21 1.004 . . . . 0.0 111.425 166.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.27 -33.93 76.57 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.545 1.164 . . . . 0.0 113.151 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.408 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 73.4 mt-30 -79.28 -27.33 42.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.151 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.04 71.07 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.867 0.467 . . . . 0.0 111.273 168.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.79 -48.51 58.9 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.309 1.044 . . . . 0.0 110.975 171.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.8 -47.06 87.24 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.478 1.111 . . . . 0.0 113.512 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -99.02 20.44 13.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.074 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 30.32 69.76 0.09 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 125.059 2.362 . . . . 0.0 115.167 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.06 108.26 55.4 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 111.929 -2.396 . . . . 0.0 107.839 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.52 85.4 1.8 Allowed 'Trans proline' 0 C--N 1.33 -0.443 0 C-N-CA 122.238 1.959 . . . . 0.0 113.714 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 4' ' ' LYS . 15.2 m -138.32 146.35 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 112.834 -1.985 . . . . 0.0 112.905 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.0 mt -105.73 107.41 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 112.811 -1.995 . . . . 0.0 107.226 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.6 mt -110.36 112.22 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 112.704 -2.044 . . . . 0.0 108.189 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -137.48 143.94 41.99 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 124.588 1.18 . . . . 0.0 111.483 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB3' HG23 ' A' ' 20' ' ' VAL . . . -110.68 134.52 52.38 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 113.227 -1.806 . . . . 0.0 111.955 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -134.36 154.62 79.96 Favored Pre-proline 0 N--CA 1.471 0.575 0 CA-C-N 113.458 -1.701 . . . . 0.0 112.699 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 9.4 Cg_endo -66.03 151.51 83.7 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.118 1.879 . . . . 0.0 112.335 166.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' HG3' ' HE3' ' A' ' 63' ' ' MET . 0.1 OUTLIER -59.46 -23.2 62.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.993 -175.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.2 p -54.98 -31.63 60.93 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.597 1.559 . . . . 0.0 113.999 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.75 17.29 18.33 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.75 89.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.435 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.9 -58.47 12.75 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.448 ' OE1' ' HD2' ' A' ' 47' ' ' LYS . 1.5 tm-20 -57.28 -60.0 4.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 112.504 -1.848 . . . . 0.0 112.892 -169.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HD2' ' OE1' ' A' ' 46' ' ' GLU . 5.5 mptp? -77.4 -32.84 55.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.429 -1.26 . . . . 0.0 113.668 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.16 -26.07 65.4 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.419 1.009 . . . . 0.0 113.345 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.01 -30.15 65.86 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.305 1.442 . . . . 0.0 113.981 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -110.96 0.35 17.01 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.37 135.69 40.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.92 0.39 . . . . 0.0 110.002 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -80.0 -29.94 39.55 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.545 172.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.69 141.48 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 122.577 1.18 . . . . 0.0 109.63 162.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -107.44 119.13 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 112.497 -2.138 . . . . 0.0 106.807 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 76.0 mt -112.21 132.07 55.12 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.261 -1.791 . . . . 0.0 112.063 176.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.406 HD22 HG13 ' A' ' 67' ' ' ILE . 10.2 mp -106.09 141.22 37.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 113.426 -1.715 . . . . 0.0 113.487 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.75 136.34 41.37 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.243 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.12 -26.33 68.64 Favored 'Trans proline' 0 C--N 1.329 -0.469 0 C-N-CA 122.371 2.047 . . . . 0.0 114.75 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -65.74 -27.58 68.41 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.2 pt -111.04 22.49 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.666 0.746 . . . . 0.0 112.353 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.09 69.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.391 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -59.37 -26.72 65.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.529 ' HE3' ' HG3' ' A' ' 41' ' ' GLU . 52.3 mtm -85.46 2.73 43.38 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.3 tp -52.25 -48.1 90.27 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 115.025 -2.417 . . . . 0.0 113.053 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.77 -37.92 84.8 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 122.565 2.176 . . . . 0.0 114.227 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 3.9 tp10 -77.78 -38.34 46.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.093 0.949 . . . . 0.0 112.653 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.406 HG13 HD22 ' A' ' 56' ' ' LEU . 48.2 mm -69.65 -39.69 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.424 1.09 . . . . 0.0 109.408 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -60.78 -40.57 93.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.662 1.185 . . . . 0.0 110.828 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.535 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 28.8 tpt85 -60.51 -41.85 95.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.407 1.483 . . . . 0.0 111.643 176.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.5 mt -68.89 -45.69 70.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.604 1.561 . . . . 0.0 112.616 175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -123.29 76.34 52.62 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.912 1.285 . . . . 0.0 110.848 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.2 -21.94 8.78 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 121.391 1.394 . . . . 0.0 113.917 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -86.68 8.09 23.88 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -128.19 140.41 38.21 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-O 118.714 -0.66 . . . . 0.0 110.081 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -71.76 112.72 3.45 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.196 1.931 . . . . 0.0 109.774 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.6 t -117.93 110.29 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 110.675 -2.966 . . . . 0.0 108.006 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -128.34 155.95 43.86 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 112.923 -1.944 . . . . 0.0 112.223 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.11 136.77 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 113.197 -1.819 . . . . 0.0 109.439 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.4 mt -72.87 128.55 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 10.0 t0 -56.22 126.73 27.46 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.959 174.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.0 m -50.75 -35.94 34.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 113.275 -1.784 . . . . 0.0 114.108 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.497 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 46.7 tp -71.41 -47.77 53.96 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.513 1.125 . . . . 0.0 111.944 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.63 -38.13 77.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.143 0.977 . . . . 0.0 112.713 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.35 -41.19 85.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.373 1.469 . . . . 0.0 111.728 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.77 -49.08 61.43 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.155 1.36 . . . . 0.0 112.443 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.73 -25.63 65.74 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.543 0.737 . . . . 0.0 112.648 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 t 56.33 63.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.733 2.413 . . . . 0.0 109.079 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -102.72 90.28 3.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.481 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.5 -45.09 85.29 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 112.227 -2.26 . . . . 0.0 113.341 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.408 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 48.9 tp -67.53 -41.0 85.05 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.218 0.607 . . . . 0.0 112.41 -175.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.39 -46.17 81.12 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.431 1.491 . . . . 0.0 111.69 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.6 t -72.26 -38.24 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.832 0.853 . . . . 0.0 110.587 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.1 tp -60.95 -44.92 96.58 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.274 1.029 . . . . 0.0 111.491 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -67.94 -36.99 81.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.87 85.06 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.092 0.87 . . . . 0.0 111.699 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.79 -42.51 85.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.867 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.466 ' HA ' HD13 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -70.06 -31.26 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.935 0.874 . . . . 0.0 111.658 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.73 79.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.43 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.7 -29.98 70.59 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.545 HG22 ' HD3' ' A' ' 4' ' ' LYS . 81.4 mt -68.09 -47.14 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.909 0.883 . . . . 0.0 109.155 171.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -61.56 1.09 0.25 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 170.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 75.33 70.48 0.09 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 129.24 3.016 . . . . 0.0 109.913 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 44.95 45.08 8.5 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 109.293 -3.594 . . . . 0.0 110.937 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 50.24 62.76 2.51 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.139 1.775 . . . . 0.0 113.203 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 28.14 81.25 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 111.527 -2.578 . . . . 0.0 114.45 -174.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 C--O 1.249 1.079 0 CA-C-N 111.795 -2.457 . . . . 0.0 110.136 179.216 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mttp . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.25 147.8 26.22 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 126.002 2.064 . . . . 0.0 111.521 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -105.26 115.78 30.83 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 123.154 1.454 . . . . 0.0 112.25 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.7 mt -116.92 102.45 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.38 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -108.62 127.42 53.95 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.278 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.51 135.59 45.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.872 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 113.429 -1.714 . . . . 0.0 113.208 -176.716 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.93 -31.68 8.23 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.88 -0.34 59.15 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -102.12 -36.84 8.4 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 118.375 2.732 . . . . 0.0 118.375 -168.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 m -69.62 -31.92 70.31 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.099 1.318 . . . . 0.0 113.609 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 p -62.67 -18.98 63.38 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.862 1.665 . . . . 0.0 114.49 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -53.96 -41.73 68.12 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.27 -42.74 83.33 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.937 0.495 . . . . 0.0 111.861 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.16 -45.69 90.34 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.393 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.23 -50.52 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.369 1.068 . . . . 0.0 109.86 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.8 t -54.7 -46.02 74.07 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.275 1.03 . . . . 0.0 112.782 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.52 -42.86 82.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.374 0.67 . . . . 0.0 112.801 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 96.5 mtp -59.3 -43.66 92.6 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.173 0.92 . . . . 0.0 110.699 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -62.45 -48.28 80.34 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.355 1.062 . . . . 0.0 111.687 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.09 79.72 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -79.0 -32.17 45.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.785 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.02 -35.15 79.78 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.857 0.863 . . . . 0.0 111.474 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -69.91 -46.65 64.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.865 0.866 . . . . 0.0 110.944 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.81 -40.81 94.09 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.02 0.928 . . . . 0.0 113.162 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -104.2 24.59 11.25 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 31.95 56.92 0.34 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.525 2.33 . . . . 0.0 116.223 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.74 108.43 51.16 Favored Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 112.691 -2.05 . . . . 0.0 107.737 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.12 87.1 1.56 Allowed 'Trans proline' 0 C--N 1.33 -0.425 0 C-N-CA 122.111 1.874 . . . . 0.0 113.363 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 m -139.15 148.39 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 113.168 -1.833 . . . . 0.0 113.032 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.7 mt -106.83 115.94 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 113.056 -1.883 . . . . 0.0 107.438 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -119.28 114.63 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.419 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -139.56 147.7 41.54 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.755 1.284 . . . . 0.0 111.929 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.12 137.74 48.42 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.384 -1.735 . . . . 0.0 112.253 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -139.59 154.18 71.08 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.347 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -70.58 152.74 65.29 Favored 'Trans proline' 0 C--N 1.33 -0.424 0 C-N-CA 122.001 1.801 . . . . 0.0 112.341 168.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -26.33 61.63 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.108 1.763 . . . . 0.0 114.893 -173.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.6 p -56.07 -32.97 64.59 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.017 1.727 . . . . 0.0 113.624 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.5 mt -96.51 15.4 21.61 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.82 90.96 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.222 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.25 -63.06 4.38 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -57.66 -49.19 77.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 112.964 -1.618 . . . . 0.0 113.808 -168.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -90.17 -31.25 17.14 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.19 -24.26 63.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.897 0.76 . . . . 0.0 113.228 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -57.99 -29.91 65.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.319 1.447 . . . . 0.0 114.221 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -106.08 4.51 29.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.6 142.88 33.62 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.193 0.521 . . . . 0.0 110.273 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -89.05 -29.52 19.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.465 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.9 p -146.25 142.68 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.789 1.281 . . . . 0.0 109.259 162.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.59 123.27 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 112.279 -2.237 . . . . 0.0 107.142 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 96' ' ' ALA . 80.0 mt -113.19 132.9 55.31 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.858 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.5 mt -110.62 142.29 42.69 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 113.133 -1.849 . . . . 0.0 112.357 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.82 136.84 38.53 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.685 169.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.3 -27.68 68.07 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.32 2.014 . . . . 0.0 114.506 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -61.81 -28.53 69.54 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 pt -113.71 26.97 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.999 0.904 . . . . 0.0 111.918 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.25 -31.29 72.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.33 -21.04 64.97 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 78.2 mtp -86.63 -0.26 55.87 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.666 1.187 . . . . 0.0 114.12 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 12.6 tp -52.82 -50.15 82.83 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 114.104 -2.855 . . . . 0.0 112.414 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.01 -37.9 86.54 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 122.583 2.189 . . . . 0.0 113.876 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 4.9 tp10 -78.41 -37.57 43.64 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.3 mt -75.9 -33.82 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.753 1.221 . . . . 0.0 110.901 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -58.72 -40.79 84.75 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.682 0.793 . . . . 0.0 110.557 168.185 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 5.7 tmm_? -60.89 -45.0 96.32 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.669 1.188 . . . . 0.0 111.436 173.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.8 mt -63.96 -42.9 97.15 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.57 1.148 . . . . 0.0 113.011 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -124.02 71.01 51.91 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.317 1.447 . . . . 0.0 110.846 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.21 -8.68 18.81 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 122.029 1.819 . . . . 0.0 115.044 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -109.85 4.46 21.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -121.62 134.25 24.53 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.52 117.54 5.13 Favored 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 122.077 1.851 . . . . 0.0 110.812 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.9 t -121.01 114.28 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 111.078 -2.783 . . . . 0.0 108.114 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -128.59 154.86 45.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 112.827 -1.988 . . . . 0.0 111.56 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.1 t -96.23 139.8 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.143 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.0 mt -74.4 129.28 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.42 131.03 48.88 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 113.726 -1.579 . . . . 0.0 112.229 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.3 t -48.2 -46.89 35.6 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 111.909 -2.405 . . . . 0.0 113.858 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.3 tp -70.41 -43.82 69.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.998 0.919 . . . . 0.0 111.964 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.76 -38.97 83.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.05 0.94 . . . . 0.0 112.789 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -68.68 -45.68 71.05 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.802 1.241 . . . . 0.0 111.162 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.84 -35.78 92.46 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.784 1.183 . . . . 0.0 112.886 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -83.02 -17.04 44.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.906 1.283 . . . . 0.0 113.055 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.0 t 45.36 65.1 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 128.377 2.671 . . . . 0.0 111.046 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -102.49 93.52 5.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 112.62 -2.082 . . . . 0.0 110.098 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.47 -43.13 90.47 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 111.875 -2.421 . . . . 0.0 113.865 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.2 tp -67.23 -43.95 80.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.772 0.429 . . . . 0.0 112.14 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.73 -48.63 65.15 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.998 1.761 . . . . 0.0 111.85 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.79 -39.84 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 114.68 -0.76 . . . . 0.0 110.829 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.0 tp -61.16 -44.44 97.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.824 0.85 . . . . 0.0 110.934 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -63.11 -40.12 96.71 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.81 0.844 . . . . 0.0 112.306 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.31 87.53 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.138 0.899 . . . . 0.0 112.108 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -65.19 -46.86 79.06 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.555 1.142 . . . . 0.0 112.292 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.2 t -66.24 -39.39 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.062 1.345 . . . . 0.0 110.408 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.87 98.59 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.706 1.202 . . . . 0.0 110.944 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 C-N-CA 124.146 0.978 . . . . 0.0 112.484 177.914 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.8 mttt . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 120.941 0.401 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -102.85 148.12 26.04 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 125.846 1.967 . . . . 0.0 110.638 172.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -108.11 120.6 42.78 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.629 -1.168 . . . . 0.0 112.008 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.8 mt -120.76 108.89 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.513 -1.676 . . . . 0.0 106.495 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -114.85 125.76 54.03 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.214 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.37 127.51 46.67 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.382 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.47 0.553 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.275 -178.281 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.85 -15.16 11.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.77 45.25 76.57 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.896 0.76 . . . . 0.0 112.605 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 24.8 mmt -115.25 -71.15 0.76 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 p -66.83 -18.67 65.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -60.32 -28.97 68.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.166 1.387 . . . . 0.0 114.626 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.7 p -60.14 -34.59 73.76 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -65.88 -46.25 79.07 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.394 0.678 . . . . 0.0 111.551 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 tp -62.24 -43.35 99.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.609 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.585 HG21 ' HB2' ' A' ' 38' ' ' ALA . 74.6 t -61.82 -43.67 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.427 1.091 . . . . 0.0 110.742 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -60.51 -44.7 95.74 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.529 0.732 . . . . 0.0 112.557 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -66.21 -39.15 89.42 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.503 ' HB3' HD13 ' A' ' 36' ' ' ILE . 95.7 mtp -64.72 -40.62 95.64 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.978 0.799 . . . . 0.0 111.625 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -67.54 -41.86 83.64 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.976 0.91 . . . . 0.0 112.786 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.03 -39.25 90.05 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.811 0.815 . . . . 0.0 112.827 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -77.44 -29.24 52.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.645 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.57 78.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.535 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -72.27 -41.18 67.0 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.015 0.822 . . . . 0.0 111.676 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -63.66 -51.61 64.34 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.485 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -90.64 23.2 3.15 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 29.28 63.19 0.14 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 124.853 2.263 . . . . 0.0 115.047 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.67 108.81 59.28 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 112.403 -2.18 . . . . 0.0 106.815 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.16 89.44 1.17 Allowed 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 122.296 1.997 . . . . 0.0 112.601 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 m -144.91 150.3 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.804 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -110.72 106.6 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.027 176.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.503 HD13 ' HB3' ' A' ' 23' ' ' MET . 14.6 mt -111.48 112.3 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.011 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -134.59 151.92 51.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.644 1.178 . . . . 0.0 111.931 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -119.14 137.47 53.58 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.612 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -144.25 154.37 57.32 Favored Pre-proline 0 N--CA 1.47 0.526 0 O-C-N 124.75 1.282 . . . . 0.0 112.552 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -62.19 152.29 77.0 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 122.379 2.053 . . . . 0.0 112.62 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -22.77 47.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.032 1.733 . . . . 0.0 114.827 -173.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.3 p -58.42 -29.89 66.45 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.682 1.593 . . . . 0.0 113.702 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.7 mt -99.75 20.68 13.68 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.92 -45.3 64.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.107 -0.952 . . . . 0.0 113.075 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.12 -15.89 76.71 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.758 0.694 . . . . 0.0 113.833 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -97.13 -57.91 2.15 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.7 0.882 . . . . 0.0 112.884 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -85.25 -27.6 25.92 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.95 -15.98 56.58 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.112 0.863 . . . . 0.0 113.863 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -60.5 -27.0 67.25 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.771 1.228 . . . . 0.0 114.079 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -117.37 24.39 11.16 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.15 138.38 32.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.41 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.87 -23.23 24.04 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.342 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.56 133.76 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 122.442 1.115 . . . . 0.0 109.64 160.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.5 t -97.73 119.06 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 112.644 -2.071 . . . . 0.0 106.256 172.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 96' ' ' ALA . 74.9 mt -107.09 134.15 50.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.15 176.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.53 140.26 47.42 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.66 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.13 144.51 48.76 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.396 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.1 -26.82 83.12 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 C-N-CA 122.265 1.977 . . . . 0.0 114.291 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -64.69 -28.63 69.73 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 pt -114.71 30.09 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 122.411 1.1 . . . . 0.0 111.734 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.98 64.83 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -64.02 -22.59 66.99 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 84.7 mtp -85.3 6.45 26.21 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.26 -51.35 81.53 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-O 115.189 -2.339 . . . . 0.0 113.159 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.99 -28.05 80.19 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 CA-C-N 122.872 2.062 . . . . 0.0 114.031 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 2.0 tt0 -80.21 -37.79 32.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.3 mt -79.75 -29.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.813 1.245 . . . . 0.0 111.35 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -34.22 75.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.113 0.565 . . . . 0.0 110.552 171.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -61.77 -43.37 98.99 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.911 0.884 . . . . 0.0 110.74 172.036 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.1 mt -66.37 -42.22 88.31 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.984 0.914 . . . . 0.0 112.808 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.8 mt -124.1 76.69 59.6 Favored Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 124.931 1.293 . . . . 0.0 110.149 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.44 -11.26 10.71 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 121.895 1.73 . . . . 0.0 115.57 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -105.75 15.45 26.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.261 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.29 137.92 31.67 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.814 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.53 117.71 5.28 Favored 'Trans proline' 0 C--N 1.33 -0.421 0 C-N-CA 122.441 2.094 . . . . 0.0 110.34 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 t -120.73 110.71 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 111.956 -2.383 . . . . 0.0 106.835 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.12 146.81 50.59 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 125.866 1.979 . . . . 0.0 111.309 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.66 136.53 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.619 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.4 mt -70.48 133.71 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.409 1.083 . . . . 0.0 108.311 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.31 127.43 32.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.653 1.216 . . . . 0.0 110.957 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.1 m -56.21 -36.02 67.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 113.167 -1.833 . . . . 0.0 114.095 -174.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.9 tp -78.8 -36.51 42.65 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.206 0.603 . . . . 0.0 112.55 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.3 mt -60.46 -35.46 75.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.296 0.638 . . . . 0.0 112.713 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -67.84 -39.41 83.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.302 1.441 . . . . 0.0 111.23 174.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.5 -47.77 80.52 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.127 1.346 . . . . 0.0 112.452 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.99 -28.56 70.18 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.391 1.076 . . . . 0.0 112.244 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 t 53.67 62.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 127.511 2.325 . . . . 0.0 108.531 -170.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -100.73 92.32 5.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 112.184 -2.28 . . . . 0.0 109.908 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.69 -38.06 93.26 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 111.943 -2.39 . . . . 0.0 113.232 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.9 tp -71.79 -40.58 69.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.422 0.689 . . . . 0.0 111.908 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.71 -45.37 96.55 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.282 1.42 . . . . 0.0 112.733 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.17 -32.63 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.782 0.833 . . . . 0.0 110.997 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -44.74 95.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.416 0.627 . . . . 0.0 111.503 175.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -66.78 -33.74 76.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.223 1.009 . . . . 0.0 113.026 176.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.72 -34.36 67.05 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.204 0.94 . . . . 0.0 112.677 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.403 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -70.22 -43.08 71.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.01 0.924 . . . . 0.0 111.704 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.16 -36.6 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.595 1.158 . . . . 0.0 110.705 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.73 81.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.913 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 123.648 0.779 . . . . 0.0 112.806 175.898 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 89.0 mttt . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 120.897 0.379 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -102.1 148.07 25.84 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 125.859 1.974 . . . . 0.0 111.646 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -106.16 118.85 37.69 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.343 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.8 mt -118.83 105.54 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -110.09 128.4 55.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.503 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -100.48 134.94 42.68 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.012 -1.903 . . . . 0.0 110.077 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.47 0.54 0 CA-C-N 113.601 -1.636 . . . . 0.0 113.245 -177.348 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.68 -34.32 7.02 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.62 37.12 12.36 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 123.943 0.782 . . . . 0.0 113.448 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 8.9 ptp -121.44 -48.93 2.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.7 m -63.63 -32.73 74.3 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 p -64.58 -24.36 67.57 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.2 p -58.83 -35.82 73.52 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.0 tp -69.31 -45.72 68.84 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.66 0.384 . . . . 0.0 111.441 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' A' ' 23' ' ' MET . 1.0 OUTLIER -60.89 -35.62 77.13 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 175.596 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.606 HG13 HG22 ' A' ' 36' ' ' ILE . 74.7 t -61.83 -48.72 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.429 1.091 . . . . 0.0 110.252 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.7 p -68.52 -26.85 65.65 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -65.0 -44.35 89.53 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.175 0.99 . . . . 0.0 112.3 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 18.3 ptm -85.01 -13.0 51.96 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -71.96 -41.53 67.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.544 0.338 . . . . 0.0 110.938 164.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.81 86.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.691 0.758 . . . . 0.0 112.242 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.456 HE21 ' HB2' ' A' ' 90' ' ' LEU . 15.2 mm100 -70.17 -34.62 73.22 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.611 173.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.5 98.76 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.18 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.16 -33.48 73.47 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.698 0.799 . . . . 0.0 112.486 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -65.49 -51.83 57.23 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.206 0.603 . . . . 0.0 111.015 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -90.24 24.57 2.48 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.863 0.865 . . . . 0.0 113.305 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 28.31 64.85 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 124.947 2.308 . . . . 0.0 115.192 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.08 105.49 57.29 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-N 112.885 -1.961 . . . . 0.0 107.084 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 76.3 Cg_endo -75.81 93.99 1.0 Allowed 'Trans proline' 0 C--N 1.331 -0.371 0 C-N-CA 122.396 2.064 . . . . 0.0 112.183 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.07 152.68 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 113.915 -1.493 . . . . 0.0 114.319 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.99 107.13 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 112.179 -2.282 . . . . 0.0 107.144 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.606 HG22 HG13 ' A' ' 20' ' ' VAL . 20.6 mt -112.6 113.35 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.102 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -136.58 148.78 47.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 125.311 1.632 . . . . 0.0 112.201 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.96 139.62 46.14 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.036 -1.438 . . . . 0.0 113.101 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -142.57 152.18 59.29 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.477 1.111 . . . . 0.0 113.128 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.23 154.08 75.29 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.376 2.051 . . . . 0.0 113.128 167.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -22.59 63.93 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.577 1.551 . . . . 0.0 114.154 -175.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 p -60.36 -31.02 69.94 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.507 1.523 . . . . 0.0 113.164 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -98.77 21.79 10.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.29 1.036 . . . . 0.0 113.093 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.3 -48.91 77.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.057 -0.973 . . . . 0.0 112.673 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.27 -57.61 17.49 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.148 0.905 . . . . 0.0 111.589 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.21 -53.57 53.37 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 113.231 -1.484 . . . . 0.0 113.59 -170.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -80.45 -31.53 37.43 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.339 1.236 . . . . 0.0 114.339 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.33 -20.21 54.47 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.73 1.157 . . . . 0.0 113.643 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -59.68 -32.7 70.74 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.244 1.018 . . . . 0.0 113.396 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.5 -16.38 18.34 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.677 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.53 135.47 48.58 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.143 0.497 . . . . 0.0 111.087 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -86.55 -26.22 24.63 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.391 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.17 140.62 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 122.191 0.996 . . . . 0.0 109.248 163.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 76' ' ' VAL . 94.5 t -109.12 126.55 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.349 175.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 96' ' ' ALA . 84.2 mt -115.96 122.82 46.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.245 -1.798 . . . . 0.0 111.356 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 mt -100.45 142.08 32.41 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.421 -1.718 . . . . 0.0 111.925 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.23 144.14 49.07 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.668 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.66 -24.93 77.36 Favored 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 122.272 1.981 . . . . 0.0 114.335 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -67.8 -28.66 67.78 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 pt -113.12 25.29 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 122.053 0.93 . . . . 0.0 112.141 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.3 -29.21 65.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.992 -1.003 . . . . 0.0 113.437 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -61.52 -24.24 66.48 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.675 173.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.0 mtm -87.74 7.43 30.29 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.1 tp -50.86 -46.2 87.22 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 116.418 -1.753 . . . . 0.0 113.823 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.6 -29.12 61.01 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 122.192 1.928 . . . . 0.0 114.827 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -81.61 -36.96 28.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.725 0.774 . . . . 0.0 112.846 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 mm -65.39 -40.55 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.029 1.332 . . . . 0.0 109.509 173.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -73.58 -25.54 60.4 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -65.07 -39.81 93.77 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 170.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.7 mt -65.62 -53.6 39.33 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.537 1.135 . . . . 0.0 112.338 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.87 75.49 71.15 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 124.369 1.068 . . . . 0.0 111.481 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.96 -22.31 23.27 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.256 1.971 . . . . 0.0 115.629 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -86.38 -0.73 56.57 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.46 134.46 20.83 Favored Pre-proline 0 N--CA 1.47 0.526 0 C-N-CA 123.217 0.607 . . . . 0.0 110.771 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.93 116.88 4.88 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 122.42 2.08 . . . . 0.0 110.513 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.583 HG22 ' HB ' ' A' ' 54' ' ' VAL . 59.9 t -123.58 119.59 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 112.087 -2.324 . . . . 0.0 108.352 -175.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -125.51 158.48 34.42 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 126.24 2.213 . . . . 0.0 111.753 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.8 t -99.79 138.22 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.419 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.0 mt -72.11 126.64 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.14 131.45 50.54 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.676 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.1 m -57.83 -34.35 69.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 112.85 -1.977 . . . . 0.0 113.907 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -38.61 53.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.595 0.758 . . . . 0.0 112.48 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.58 -38.25 86.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.325 0.65 . . . . 0.0 112.092 171.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -66.57 -41.38 88.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.568 1.547 . . . . 0.0 111.331 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.58 -43.02 99.6 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.071 1.319 . . . . 0.0 112.498 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -75.54 -28.25 58.97 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t 58.35 70.22 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 127.376 2.271 . . . . 0.0 108.078 -168.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.86 99.49 8.39 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 113.198 -1.819 . . . . 0.0 110.589 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.81 -43.19 98.15 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 111.77 -2.468 . . . . 0.0 113.867 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HB2' HE21 ' A' ' 26' ' ' GLN . 65.0 tp -64.22 -43.27 95.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.86 -42.22 91.95 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 124.708 1.146 . . . . 0.0 112.743 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.9 t -77.75 -38.21 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.668 0.787 . . . . 0.0 110.993 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.94 -39.66 95.3 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.773 0.829 . . . . 0.0 111.603 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -64.8 -43.26 93.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.902 1.281 . . . . 0.0 111.278 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.44 83.7 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.058 0.849 . . . . 0.0 112.381 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -67.85 -44.12 77.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.163 -1.38 . . . . 0.0 112.35 176.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.53 -27.58 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 121.814 -0.554 . . . . 0.0 112.209 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.85 83.85 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.187 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 C-N-CA 123.679 0.792 . . . . 0.0 113.045 176.332 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.9 mttt . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 122.632 1.206 . . . . 0.0 113.886 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -110.06 143.71 39.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 112.908 -1.951 . . . . 0.0 112.227 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -101.69 116.69 33.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.958 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.7 mt -114.4 103.02 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.309 -1.769 . . . . 0.0 106.471 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -110.29 127.17 54.88 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 122.731 1.253 . . . . 0.0 112.45 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -101.17 133.09 46.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.72 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 N--CA 1.469 0.481 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.678 -177.45 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.65 -23.56 11.75 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.71 23.55 77.7 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.341 0.972 . . . . 0.0 114.87 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.7 ptp -118.32 -37.56 3.32 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.3 m -65.57 -29.88 70.54 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.113 0.87 . . . . 0.0 112.198 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 p -71.71 -20.2 61.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.726 1.61 . . . . 0.0 114.505 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.0 p -63.13 -34.98 78.79 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 tp -65.94 -44.53 84.79 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.101 0.561 . . . . 0.0 111.691 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 tt -62.16 -40.82 97.28 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.13 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 38' ' ' ALA . 73.1 t -61.47 -45.0 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.488 1.115 . . . . 0.0 109.717 175.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -59.08 -40.35 84.98 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -65.87 -44.23 86.0 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.9 ptm -77.99 -21.56 50.67 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -67.34 -46.07 74.51 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.857 0.863 . . . . 0.0 111.52 166.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.37 84.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.006 0.908 . . . . 0.0 112.758 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -75.6 -33.12 60.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.88 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.61 84.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.928 0.491 . . . . 0.0 111.323 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.76 -42.78 77.03 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 111.332 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -63.53 -52.09 62.65 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.444 0.698 . . . . 0.0 111.764 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -85.04 11.8 8.9 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 51.88 51.06 17.29 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 123.958 1.837 . . . . 0.0 112.774 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.2 t -102.05 111.66 64.51 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 112.971 -1.922 . . . . 0.0 107.977 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.71 87.6 1.5 Allowed 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 121.995 1.797 . . . . 0.0 112.781 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.07 152.37 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.589 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.4 mt -112.18 105.75 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.395 -1.73 . . . . 0.0 107.91 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 20' ' ' VAL . 23.2 mt -105.78 118.97 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.83 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -149.44 139.34 21.94 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.457 1.098 . . . . 0.0 112.606 -171.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -104.23 138.15 41.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 113.248 -1.796 . . . . 0.0 112.684 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -139.32 151.49 67.26 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.777 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -66.36 152.95 79.8 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 122.412 2.075 . . . . 0.0 112.7 168.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -22.73 62.74 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.076 -1.42 . . . . 0.0 114.664 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -60.32 -28.34 68.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.386 1.474 . . . . 0.0 113.667 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.6 mt -99.08 19.81 14.51 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.14 86.75 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.89 -51.96 31.57 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -61.21 -59.3 5.53 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.642 -1.279 . . . . 0.0 112.918 -172.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -78.85 -24.35 44.41 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.21 -29.37 72.76 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.869 0.747 . . . . 0.0 113.577 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.07 -29.57 70.7 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -109.95 30.09 7.02 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.026 0.917 . . . . 0.0 112.439 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.33 140.55 45.81 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.481 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.34 -49.8 11.02 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.084 170.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.3 140.85 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 122.089 0.947 . . . . 0.0 110.46 171.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.94 122.01 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 113.074 -1.875 . . . . 0.0 107.811 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.5 mt -116.94 115.51 25.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 113.553 -1.658 . . . . 0.0 112.688 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.2 mt -88.89 139.29 30.61 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 112.508 -2.133 . . . . 0.0 112.095 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.02 140.83 45.87 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 113.747 -1.569 . . . . 0.0 110.083 167.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -58.58 -24.85 72.1 Favored 'Trans proline' 0 C--N 1.331 -0.386 0 C-N-CA 122.299 1.999 . . . . 0.0 114.428 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 -64.79 -31.42 72.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.48 26.82 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.159 0.981 . . . . 0.0 111.988 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.56 -29.33 68.68 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.419 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -64.29 -21.8 66.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.1 mtm -89.26 13.25 13.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.6 tp -55.7 -50.71 85.49 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-O 114.903 -2.475 . . . . 0.0 112.382 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.46 -28.84 87.45 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 CA-C-N 122.716 2.006 . . . . 0.0 114.471 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -78.12 -43.39 29.03 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 70' ' ' LEU . 80.2 mt -76.5 -31.42 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.513 1.125 . . . . 0.0 111.539 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -72.35 -31.01 65.25 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.862 0.465 . . . . 0.0 111.247 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.8 ttp-105 -64.48 -43.24 94.8 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.853 0.461 . . . . 0.0 110.292 172.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 67' ' ' ILE . 35.0 mt -62.73 -44.35 96.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.372 1.069 . . . . 0.0 112.305 174.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -124.67 80.27 62.01 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 124.712 1.205 . . . . 0.0 110.179 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.84 -22.71 3.49 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 121.505 1.47 . . . . 0.0 115.621 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -97.72 14.06 28.19 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -127.2 129.65 23.89 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 118.067 -0.968 . . . . 0.0 108.646 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.45 119.14 6.12 Favored 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 122.656 2.238 . . . . 0.0 112.09 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -122.47 112.56 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 111.556 -2.566 . . . . 0.0 107.879 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -126.65 159.79 32.59 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 125.717 1.886 . . . . 0.0 111.267 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.9 t -98.37 140.78 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.559 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.78 132.32 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.4 1.08 . . . . 0.0 108.411 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 13.7 t0 -59.68 125.36 23.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.248 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -54.39 -33.06 58.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.517 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 49.5 tp -72.57 -46.51 54.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.674 1.19 . . . . 0.0 112.271 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.16 -37.36 79.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.699 0.8 . . . . 0.0 112.56 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -65.72 -40.39 92.17 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.216 1.406 . . . . 0.0 111.354 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.32 -47.96 79.21 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.003 1.287 . . . . 0.0 112.066 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.73 -30.66 71.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.557 0.743 . . . . 0.0 112.586 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 t 57.09 63.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 127.522 2.329 . . . . 0.0 108.241 -169.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -105.7 94.17 5.05 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 112.604 -2.089 . . . . 0.0 109.089 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.72 -46.94 91.67 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 111.751 -2.477 . . . . 0.0 112.869 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.4 tp -63.58 -37.18 86.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.475 0.71 . . . . 0.0 112.302 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.94 -46.06 94.21 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.577 1.56 . . . . 0.0 112.448 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -73.02 -33.84 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.096 0.959 . . . . 0.0 110.929 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.25 -43.58 98.64 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.65 0.78 . . . . 0.0 110.614 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.91 -35.26 76.63 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.431 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.06 81.86 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.191 0.932 . . . . 0.0 111.926 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.06 -43.93 77.51 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.027 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.64 -31.62 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.324 0.65 . . . . 0.0 111.215 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.99 -37.3 83.97 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.987 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.53 0 C-N-CA 123.559 0.744 . . . . 0.0 112.929 176.119 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 11.4 tptt . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.532 ' HB2' HG12 ' A' ' 34' ' ' VAL . 4.4 mptp? -107.37 136.48 47.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.999 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -99.26 110.45 22.98 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.165 1.459 . . . . 0.0 111.71 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.2 mt -111.94 103.69 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.819 -1.991 . . . . 0.0 106.633 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -110.62 126.58 54.62 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.92 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.47 140.04 37.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 112.746 -2.024 . . . . 0.0 111.737 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 N--CA 1.47 0.529 0 CA-C-N 113.872 -1.513 . . . . 0.0 113.828 -176.239 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.87 -26.55 10.19 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.27 40.36 20.11 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.052 0.834 . . . . 0.0 113.859 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.9 mtm -111.71 -58.09 2.17 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 92.3 p -60.56 -29.65 69.29 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 p -61.4 -25.18 67.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.973 1.709 . . . . 0.0 114.429 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.3 p -55.9 -40.62 73.31 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -171.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.6 tp -67.45 -43.53 80.88 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.737 0.415 . . . . 0.0 111.606 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.74 -40.49 92.61 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.966 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.44 -45.3 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.583 1.153 . . . . 0.0 110.03 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 t -57.64 -46.86 83.64 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -64.66 -36.19 83.46 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.597 ' HB3' HD13 ' A' ' 36' ' ' ILE . 46.0 mmm -61.71 -47.56 84.74 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.735 1.214 . . . . 0.0 111.436 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -64.99 -38.71 91.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.643 0.777 . . . . 0.0 112.061 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.26 -41.38 81.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -69.49 -30.85 68.81 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.912 0.485 . . . . 0.0 112.276 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.98 92.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.122 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.59 -41.59 79.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.663 0.785 . . . . 0.0 111.818 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -59.32 -42.1 90.64 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.125 0.97 . . . . 0.0 112.91 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -109.54 26.04 11.1 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 22.57 68.29 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 125.374 2.512 . . . . 0.0 115.277 -170.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.9 t -98.32 107.34 41.23 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 112.513 -2.13 . . . . 0.0 106.463 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 72.9 Cg_endo -75.18 87.55 1.33 Allowed 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.189 1.926 . . . . 0.0 112.636 -176.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 4' ' ' LYS . 15.4 m -141.93 152.21 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 113.066 -1.879 . . . . 0.0 113.577 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.84 110.55 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 112.333 -2.212 . . . . 0.0 106.671 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.597 HD13 ' HB3' ' A' ' 23' ' ' MET . 8.7 mt -116.25 115.32 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.508 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -145.5 142.84 29.59 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.836 1.335 . . . . 0.0 112.112 -172.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.34 145.64 31.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 113.674 -1.603 . . . . 0.0 113.513 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.36 154.22 56.73 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 125.103 1.361 . . . . 0.0 112.909 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -68.5 155.01 70.53 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 122.355 2.037 . . . . 0.0 113.43 167.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -31.65 67.77 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -170.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 t -62.48 -24.51 67.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.992 1.317 . . . . 0.0 113.942 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.4 mt -95.64 15.73 19.16 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.46 99.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.408 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.06 -62.56 5.33 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.27 -54.68 44.03 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 112.825 -1.688 . . . . 0.0 113.426 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.4 -31.89 29.39 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.57 -23.84 65.39 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.87 0.748 . . . . 0.0 113.282 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -58.03 -29.17 65.13 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.856 1.262 . . . . 0.0 113.983 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -116.78 33.11 5.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.197 0.999 . . . . 0.0 112.228 176.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.62 136.71 47.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.812 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -80.55 -29.92 37.08 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.091 173.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.31 138.81 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 122.656 1.217 . . . . 0.0 109.609 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.4 t -104.76 121.26 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 112.262 -2.245 . . . . 0.0 106.734 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.5 mt -113.69 136.4 52.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.793 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.6 mt -111.65 140.55 46.19 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.974 -1.921 . . . . 0.0 112.584 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.81 136.33 41.19 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.149 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.8 -24.44 55.74 Favored 'Trans proline' 0 C--N 1.33 -0.413 0 C-N-CA 122.414 2.076 . . . . 0.0 114.861 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.2 pm0 -65.08 -29.95 70.87 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.605 1.562 . . . . 0.0 115.141 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 pt -110.92 22.33 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.757 0.789 . . . . 0.0 112.037 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.52 -29.22 69.26 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.111 -0.95 . . . . 0.0 113.466 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -60.55 -24.54 65.48 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.0 mtm -88.62 11.04 18.46 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.5 tp -52.97 -47.88 93.83 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-O 114.902 -2.475 . . . . 0.0 112.545 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.38 -35.03 90.93 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 122.335 2.024 . . . . 0.0 114.252 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -78.89 -41.27 30.15 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.811 0.815 . . . . 0.0 112.829 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -67.11 -39.34 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.282 1.033 . . . . 0.0 109.214 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.86 -32.23 71.75 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.606 0.763 . . . . 0.0 111.58 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -63.02 -40.13 96.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.052 0.941 . . . . 0.0 110.806 172.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.8 mt -68.95 -44.76 72.34 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.003 1.321 . . . . 0.0 112.289 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.3 mt -124.35 76.22 61.55 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 124.943 1.297 . . . . 0.0 111.093 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.33 -27.43 5.36 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 C-N-CA 121.612 1.541 . . . . 0.0 114.659 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -97.56 23.85 7.29 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.473 1.13 . . . . 0.0 113.16 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -130.03 133.91 25.52 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.704 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.12 112.56 3.17 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 122.253 1.968 . . . . 0.0 110.149 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -118.26 112.18 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 110.852 -2.885 . . . . 0.0 108.07 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -127.16 153.45 46.03 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.12 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.0 t -93.55 136.04 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.842 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.6 mt -69.53 128.76 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -56.61 125.85 24.07 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.754 -1.566 . . . . 0.0 111.42 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.5 p -54.26 -34.99 62.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.975 -1.92 . . . . 0.0 114.326 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.1 tp -74.07 -44.81 52.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.092 1.357 . . . . 0.0 112.081 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.06 -37.75 80.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.948 0.899 . . . . 0.0 112.603 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -66.58 -40.92 89.15 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.346 1.459 . . . . 0.0 111.372 175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.94 -49.55 62.37 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.019 1.295 . . . . 0.0 112.355 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -66.27 -24.76 66.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.813 0.845 . . . . 0.0 112.968 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 t 56.56 62.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 127.388 2.275 . . . . 0.0 108.458 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -105.92 99.4 8.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 112.522 -2.126 . . . . 0.0 111.261 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.45 -33.52 81.64 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 111.704 -2.498 . . . . 0.0 113.762 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.43 -47.14 57.73 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.63 -0.335 . . . . 0.0 111.276 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.93 -43.97 92.66 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.975 1.274 . . . . 0.0 112.571 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.7 t -75.06 -35.88 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.377 0.671 . . . . 0.0 111.138 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.94 -44.49 96.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.873 0.844 . . . . 0.0 111.712 176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -68.01 -34.15 75.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.307 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.65 -39.88 80.5 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.359 1.037 . . . . 0.0 112.066 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.12 -44.2 84.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.965 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.76 -31.58 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.195 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.28 -36.4 81.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.716 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 C-N-CA 123.683 0.793 . . . . 0.0 112.99 177.074 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.459 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 34.9 mttp . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 121.256 0.551 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -103.1 150.14 23.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 112.542 -2.117 . . . . 0.0 113.251 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -105.4 116.05 31.29 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.943 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.1 mt -115.36 108.5 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 112.588 -2.096 . . . . 0.0 106.52 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -112.44 129.13 56.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 122.418 1.104 . . . . 0.0 112.912 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.02 136.02 46.43 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.153 -1.84 . . . . 0.0 111.102 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 N--CA 1.47 0.528 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.473 -175.255 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.33 -31.86 8.41 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.77 16.33 54.88 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.914 1.245 . . . . 0.0 115.219 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.8 ptp -103.66 -42.04 5.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.4 p -58.47 -36.14 73.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.8 p -64.92 -23.31 67.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.892 2.077 . . . . 0.0 113.885 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.0 t -46.81 -50.41 18.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.14 -45.98 89.4 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -57.34 -45.73 84.01 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.727 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.84 -49.69 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.972 1.309 . . . . 0.0 109.717 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -56.39 -45.05 80.76 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.502 0.721 . . . . 0.0 112.652 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -66.23 -41.43 90.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.447 ' HB3' HD13 ' A' ' 36' ' ' ILE . 97.4 mtp -61.4 -44.03 97.85 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.779 0.832 . . . . 0.0 110.868 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -61.19 -46.08 91.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.534 1.134 . . . . 0.0 112.013 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.88 89.01 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -71.28 -35.91 71.5 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.372 0.669 . . . . 0.0 111.621 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.52 -38.74 92.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.298 1.039 . . . . 0.0 111.067 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.31 -43.75 76.91 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.655 1.182 . . . . 0.0 111.384 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -58.98 -41.94 88.76 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.463 1.105 . . . . 0.0 112.812 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -105.28 24.92 11.3 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 28.07 58.31 0.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.589 2.356 . . . . 0.0 116.558 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.6 t -96.87 111.72 58.39 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 111.922 -2.399 . . . . 0.0 107.94 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 73.1 Cg_endo -78.37 84.21 2.06 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 121.467 1.445 . . . . 0.0 113.16 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.43 152.09 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 112.855 -1.975 . . . . 0.0 112.659 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.5 mt -111.91 109.34 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.285 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 23' ' ' MET . 17.4 mt -109.16 118.4 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 112.664 -2.062 . . . . 0.0 107.535 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -143.98 143.7 31.34 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 126.234 2.209 . . . . 0.0 111.186 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.8 142.11 44.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.186 -1.37 . . . . 0.0 114.224 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -143.25 154.24 60.64 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 124.853 1.261 . . . . 0.0 113.34 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.2 156.03 59.97 Favored 'Trans proline' 0 C--N 1.33 -0.422 0 C-N-CA 122.311 2.008 . . . . 0.0 112.962 166.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -27.11 68.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.816 -1.538 . . . . 0.0 114.258 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.8 p -56.86 -26.32 58.35 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.14 1.776 . . . . 0.0 113.817 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.7 mt -102.57 16.28 26.83 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.388 1.075 . . . . 0.0 113.833 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.56 93.81 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.421 1.088 . . . . 0.0 113.859 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.64 -54.52 35.01 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' OE1' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -61.81 -62.05 2.07 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.213 -0.993 . . . . 0.0 112.554 -171.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE2' ' OE1' ' A' ' 46' ' ' GLU . 74.0 mmtt -72.13 -31.58 66.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.92 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.17 -28.44 66.66 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.905 0.764 . . . . 0.0 113.063 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -61.82 -29.72 70.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.395 1.078 . . . . 0.0 113.504 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -110.31 20.57 17.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.135 0.974 . . . . 0.0 113.602 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.72 145.05 26.15 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.687 170.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -89.69 -29.43 18.77 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.092 168.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.95 141.39 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 122.436 1.112 . . . . 0.0 110.54 163.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.8 t -107.17 121.85 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 112.847 -1.979 . . . . 0.0 107.459 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.4 mt -116.33 127.68 54.89 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.291 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 mt -105.74 141.55 36.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 112.739 -2.028 . . . . 0.0 112.828 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.69 137.26 44.37 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.202 168.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.32 -35.14 43.18 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 123.157 2.571 . . . . 0.0 114.424 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.7 pm0 -60.11 -31.07 69.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.041 1.736 . . . . 0.0 115.19 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 pt -111.34 19.77 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.11 -28.12 69.56 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.281 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -61.17 -23.8 65.83 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.1 mtm -87.63 6.59 33.88 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.8 tp -51.17 -52.15 61.52 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-O 114.435 -2.698 . . . . 0.0 112.812 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.82 -35.24 98.01 Favored 'Trans proline' 0 C--N 1.33 -0.396 0 CA-C-N 122.803 2.037 . . . . 0.0 114.149 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -73.59 -45.28 54.07 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.003 0.906 . . . . 0.0 112.028 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.02 -36.06 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.448 1.099 . . . . 0.0 111.111 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -58.95 -41.46 87.47 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.267 1.027 . . . . 0.0 110.42 171.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -66.02 -40.6 91.19 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.702 1.201 . . . . 0.0 110.957 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.3 -43.53 97.59 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.516 1.526 . . . . 0.0 112.557 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.9 mt -123.16 73.08 47.74 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 124.741 1.216 . . . . 0.0 111.583 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.16 -10.97 14.96 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 121.512 1.474 . . . . 0.0 114.845 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -102.07 17.41 23.33 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -133.6 132.46 21.79 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.03 116.3 4.52 Favored 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 122.024 1.816 . . . . 0.0 109.836 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.9 t -115.83 113.18 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 110.085 -3.234 . . . . 0.0 107.746 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -125.93 154.02 43.41 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 126.306 2.254 . . . . 0.0 111.189 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.43 136.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 113.154 -1.839 . . . . 0.0 108.615 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.26 129.26 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -55.99 126.17 24.73 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.534 1.159 . . . . 0.0 111.39 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 p -54.19 -34.32 60.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.81 -1.995 . . . . 0.0 114.894 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.9 tp -75.32 -47.94 25.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.563 1.145 . . . . 0.0 111.845 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.3 mt -57.34 -39.15 75.32 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.124 1.37 . . . . 0.0 111.742 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.99 -44.52 92.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.275 1.83 . . . . 0.0 111.389 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.07 -45.01 96.41 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.758 1.171 . . . . 0.0 112.191 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -68.75 -19.99 64.36 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.274 1.43 . . . . 0.0 113.563 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . 0.256 2.8 m 39.14 59.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 127.041 2.136 . . . . 0.0 113.048 -163.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -89.91 87.46 6.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 111.803 -2.453 . . . . 0.0 108.739 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.4 -38.07 56.84 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 111.511 -2.586 . . . . 0.0 113.731 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.7 tp -74.04 -44.83 52.95 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.766 0.426 . . . . 0.0 111.875 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.06 -51.19 51.79 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.638 1.59 . . . . 0.0 111.839 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.08 -40.56 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 114.221 -0.99 . . . . 0.0 110.673 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -45.56 91.7 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.285 0.634 . . . . 0.0 110.985 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -61.34 -41.77 97.58 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.82 0.848 . . . . 0.0 112.626 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.99 92.28 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.515 1.135 . . . . 0.0 111.566 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.49 96.58 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.309 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.91 -32.41 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.689 0.796 . . . . 0.0 111.468 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.91 80.59 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.995 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.494 0 C-N-CA 124.427 1.091 . . . . 0.0 112.832 175.702 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 120.971 0.415 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -116.54 149.18 40.03 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.949 2.031 . . . . 0.0 111.909 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -106.85 118.35 36.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.645 -174.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.12 101.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 112.9 -1.955 . . . . 0.0 106.131 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -109.31 127.63 54.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.459 -1.246 . . . . 0.0 112.162 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.15 137.84 40.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.583 -2.098 . . . . 0.0 110.474 -177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 N--CA 1.471 0.589 0 CA-C-N 113.232 -1.804 . . . . 0.0 112.875 -177.818 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.85 -13.73 13.14 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.02 45.71 25.23 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.952 0.787 . . . . 0.0 112.756 -172.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.1 mmt -106.34 -72.36 0.72 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 -174.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 m -61.65 -35.03 76.79 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 p -55.24 -33.05 62.81 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.42 1.488 . . . . 0.0 113.654 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.6 t -54.06 -36.74 63.43 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.7 tp -67.37 -47.18 71.13 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.4 -39.11 93.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.288 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 38' ' ' ALA . 70.1 t -60.31 -46.12 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.858 1.263 . . . . 0.0 109.992 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.3 t -55.65 -49.77 71.99 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.808 0.843 . . . . 0.0 112.531 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -63.65 -39.51 94.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.563 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.2 ttp -70.52 -37.52 74.13 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.909 0.755 . . . . 0.0 112.797 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.9 mtt-85 -61.16 -45.71 93.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.545 1.138 . . . . 0.0 111.599 171.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.87 92.04 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.2 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.62 -33.9 69.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.976 0.51 . . . . 0.0 112.186 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.02 99.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.463 0.705 . . . . 0.0 111.248 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.94 -41.98 77.36 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.186 0.994 . . . . 0.0 111.614 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -62.07 -42.2 98.95 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.149 0.979 . . . . 0.0 112.651 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -104.87 30.79 5.22 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 32.47 65.05 0.23 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 125.074 2.369 . . . . 0.0 115.537 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -114.21 105.82 53.64 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.456 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.92 87.74 1.46 Allowed 'Trans proline' 0 C--N 1.33 -0.42 0 C-N-CA 122.15 1.9 . . . . 0.0 113.242 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.85 154.3 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 112.96 -1.927 . . . . 0.0 112.767 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.1 mt -113.78 110.41 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.128 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.28 117.54 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.851 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -138.65 149.83 45.59 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 125.073 1.483 . . . . 0.0 110.744 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -116.11 134.21 55.19 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.311 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -136.05 154.77 77.74 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 113.98 -1.463 . . . . 0.0 112.85 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -67.39 152.23 79.22 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 C-N-CA 122.388 2.059 . . . . 0.0 112.587 169.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -24.49 63.53 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 113.923 -1.49 . . . . 0.0 114.681 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.3 p -57.77 -30.55 65.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.756 1.622 . . . . 0.0 113.894 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.4 mt -98.84 16.53 22.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.39 97.08 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.12 -60.47 6.76 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.66 -55.32 36.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.758 -1.721 . . . . 0.0 113.361 -170.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -83.4 -27.82 29.33 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.12 -24.81 67.5 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.247 0.927 . . . . 0.0 113.341 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -57.91 -30.91 66.29 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.96 1.304 . . . . 0.0 113.467 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -112.48 29.94 7.51 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.334 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.59 140.86 42.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.674 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -82.66 -34.6 27.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.759 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.4 p -140.73 139.98 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 122.479 1.133 . . . . 0.0 109.197 164.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.22 122.08 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.878 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.8 mt -113.47 132.31 55.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.915 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.7 mt -109.46 141.4 41.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.241 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.59 138.73 45.02 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 113.384 -1.734 . . . . 0.0 110.282 167.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.46 -25.02 64.3 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.251 1.967 . . . . 0.0 114.472 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -64.62 -30.71 71.73 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.989 1.315 . . . . 0.0 114.534 173.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 pt -110.89 27.94 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 122.359 1.076 . . . . 0.0 111.446 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.33 65.64 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.084 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -61.8 -22.18 65.23 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 85.4 mtp -86.62 3.25 45.32 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.67 -52.77 64.25 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-O 114.607 -2.616 . . . . 0.0 113.111 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.38 -29.81 91.12 Favored 'Trans proline' 0 C--N 1.33 -0.418 0 CA-C-N 122.971 2.097 . . . . 0.0 114.038 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.96 -45.18 24.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.931 0.872 . . . . 0.0 112.288 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.5 mt -71.55 -34.97 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.812 1.245 . . . . 0.0 111.058 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.77 -37.41 87.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.482 0.713 . . . . 0.0 110.716 172.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -64.2 -40.5 96.21 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.57 0.748 . . . . 0.0 110.979 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.3 mt -65.67 -42.61 91.11 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.954 1.302 . . . . 0.0 112.631 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 mt -123.7 72.63 52.05 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.061 1.344 . . . . 0.0 111.159 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.19 -19.11 12.26 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 121.617 1.545 . . . . 0.0 114.932 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -91.15 9.0 32.88 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -125.52 138.16 31.3 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.876 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.99 112.5 3.31 Favored 'Trans proline' 0 C--N 1.331 -0.386 0 C-N-CA 122.111 1.874 . . . . 0.0 109.92 170.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -116.45 111.81 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 110.789 -2.914 . . . . 0.0 107.175 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -124.81 157.72 35.13 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 125.984 2.052 . . . . 0.0 111.509 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.9 137.63 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 113.393 -1.73 . . . . 0.0 109.263 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.15 123.96 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.48 131.78 43.26 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.072 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 m -52.75 -41.07 63.68 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.05 -1.886 . . . . 0.0 114.006 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.5 tp -72.59 -46.08 56.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.27 1.028 . . . . 0.0 111.874 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.9 mt -58.21 -36.59 73.35 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.09 0.956 . . . . 0.0 112.772 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.06 -42.79 89.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.802 1.641 . . . . 0.0 111.502 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.47 -47.4 78.83 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.852 1.215 . . . . 0.0 112.64 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -61.74 -30.3 70.69 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.905 1.282 . . . . 0.0 112.498 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.4 t 55.59 58.68 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 127.523 2.329 . . . . 0.0 108.485 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -96.06 90.04 5.4 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 112.425 -2.171 . . . . 0.0 110.13 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -52.86 -47.48 59.06 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 111.923 -2.399 . . . . 0.0 112.496 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.01 -41.67 81.88 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.898 -0.651 . . . . 0.0 112.552 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.67 -50.14 70.19 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.577 1.56 . . . . 0.0 112.22 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.0 t -68.42 -34.58 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.777 0.831 . . . . 0.0 110.617 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp -61.04 -45.73 93.61 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.654 0.782 . . . . 0.0 111.018 176.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -66.12 -36.81 84.14 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.36 -36.23 71.41 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.052 0.845 . . . . 0.0 112.501 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.07 -43.31 78.9 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.894 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.7 m -72.36 -24.35 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.39 -41.05 70.12 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 113.13 -1.85 . . . . 0.0 111.356 173.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 124.263 1.025 . . . . 0.0 111.916 171.362 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mttp . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -100.75 139.84 35.87 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 125.672 1.858 . . . . 0.0 111.298 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -102.65 113.83 27.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.879 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.03 106.55 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 113.267 -1.788 . . . . 0.0 106.765 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -113.08 125.5 54.45 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.709 1.242 . . . . 0.0 112.42 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.85 139.84 33.91 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.287 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.47 0.541 0 CA-C-N 113.833 -1.53 . . . . 0.0 113.524 -174.97 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.51 -30.19 12.3 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.81 31.85 47.62 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.257 0.932 . . . . 0.0 114.043 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.1 ptt? -113.9 -42.69 3.36 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.9 m -70.11 -27.86 64.92 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 p -65.57 -20.83 66.48 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.976 1.31 . . . . 0.0 114.283 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.1 p -61.08 -36.66 80.23 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -172.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.13 -43.4 74.48 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.428 0.691 . . . . 0.0 111.769 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 tt -63.54 -40.41 96.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.162 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.543 HG21 ' HB2' ' A' ' 38' ' ' ALA . 79.4 t -61.8 -46.54 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.621 1.168 . . . . 0.0 109.799 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 t -60.92 -38.76 86.89 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.235 0.614 . . . . 0.0 112.647 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -66.99 -47.21 72.21 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 17.8 ptm -75.46 -15.36 60.43 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -72.82 -45.01 60.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.35 0.66 . . . . 0.0 111.672 166.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.93 81.11 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.609 1.195 . . . . 0.0 112.358 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -74.61 -32.66 62.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.28 1.032 . . . . 0.0 112.014 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -33.46 75.82 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.739 0.649 . . . . 0.0 111.238 170.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -74.37 -39.46 62.73 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.942 0.776 . . . . 0.0 112.025 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -64.81 -46.02 83.75 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.498 0.719 . . . . 0.0 111.645 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -96.78 22.27 8.43 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.943 0.777 . . . . 0.0 112.619 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 29.53 69.2 0.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.942 2.497 . . . . 0.0 115.2 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.19 110.34 51.1 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 112.024 -2.353 . . . . 0.0 107.021 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.3 90.92 1.15 Allowed 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 122.498 2.132 . . . . 0.0 113.168 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 m -141.23 146.88 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 113.309 -1.769 . . . . 0.0 112.88 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.8 mt -106.43 108.5 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.205 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.423 HG22 HG13 ' A' ' 20' ' ' VAL . 18.4 mt -112.67 111.02 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.66 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -132.48 150.43 52.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.217 1.007 . . . . 0.0 112.325 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -110.64 140.94 44.53 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.613 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -142.88 150.8 54.6 Favored Pre-proline 0 N--CA 1.47 0.568 0 O-C-N 124.791 1.307 . . . . 0.0 112.981 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -67.94 156.22 66.73 Favored 'Trans proline' 0 C--N 1.33 -0.415 0 C-N-CA 122.604 2.203 . . . . 0.0 112.128 165.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -17.24 52.41 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -175.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -59.34 -28.34 66.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.773 1.629 . . . . 0.0 113.692 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.8 mt -107.13 24.24 13.14 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.31 1.044 . . . . 0.0 113.195 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.47 82.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.58 -60.15 6.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -57.61 -57.08 14.26 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.749 1.22 . . . . 0.0 113.421 -172.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -78.62 -29.63 46.05 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.04 -28.26 68.56 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.015 0.817 . . . . 0.0 113.015 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -61.6 -25.36 67.29 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.434 1.494 . . . . 0.0 114.322 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -113.98 8.81 17.25 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -91.91 142.35 27.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.972 0.415 . . . . 0.0 110.625 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -87.55 -28.73 21.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.215 172.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.22 139.09 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 122.249 1.023 . . . . 0.0 109.168 162.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.7 t -107.52 126.23 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.11 -1.859 . . . . 0.0 106.969 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 96' ' ' ALA . 70.5 mt -112.45 137.51 50.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.417 -1.72 . . . . 0.0 111.057 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -113.89 141.03 47.87 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 113.013 -1.903 . . . . 0.0 111.892 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.53 140.87 47.54 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.527 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.72 -23.6 72.37 Favored 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.388 2.059 . . . . 0.0 114.605 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -66.19 -30.0 70.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.685 1.194 . . . . 0.0 114.036 173.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.5 pt -111.36 35.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 122.494 1.14 . . . . 0.0 111.916 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.43 -26.28 63.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.538 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -63.97 -21.45 66.49 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 43.3 mtp -85.26 -5.93 59.29 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 tp -54.56 -49.66 89.8 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 115.417 -2.23 . . . . 0.0 113.749 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.77 -30.14 84.25 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 CA-C-N 122.758 2.021 . . . . 0.0 114.405 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -82.01 -37.99 25.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.602 0.715 . . . . 0.0 112.8 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 84.1 mt -74.64 -30.07 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.169 0.988 . . . . 0.0 111.217 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.46 -39.06 88.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.281 0.632 . . . . 0.0 111.115 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -43.93 85.18 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.883 1.273 . . . . 0.0 110.384 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.96 -44.23 97.62 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.451 1.1 . . . . 0.0 112.303 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -123.5 78.52 54.73 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 124.748 1.219 . . . . 0.0 109.707 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.72 -26.54 8.17 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.03 1.82 . . . . 0.0 114.476 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -82.15 5.31 20.1 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 51' ' ' ALA . 74.9 mmtt -122.68 134.7 25.11 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.325 -176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -73.13 115.64 4.42 Favored 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 122.397 2.065 . . . . 0.0 110.328 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 t -118.96 114.76 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 111.948 -2.387 . . . . 0.0 107.52 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -121.98 158.9 28.09 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 125.987 2.054 . . . . 0.0 111.774 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.4 t -104.55 136.27 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.783 174.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.5 mt -67.05 129.54 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -58.34 126.79 29.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 125.015 1.447 . . . . 0.0 110.667 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.4 m -55.56 -36.76 67.17 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.961 -173.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.71 -46.84 65.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.009 0.924 . . . . 0.0 111.827 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.84 -35.41 76.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.421 0.688 . . . . 0.0 112.815 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -67.35 -43.54 81.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.483 1.513 . . . . 0.0 111.605 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.16 -49.28 62.73 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.986 1.279 . . . . 0.0 111.999 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -65.28 -26.54 68.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.017 0.927 . . . . 0.0 112.445 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.33 64.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.873 2.469 . . . . 0.0 108.053 -173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -103.23 89.17 3.32 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 112.769 -2.014 . . . . 0.0 108.606 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.92 -41.97 94.53 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 112.164 -2.289 . . . . 0.0 112.869 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.4 tp -66.57 -38.93 88.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.74 0.816 . . . . 0.0 112.027 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.45 -42.6 97.63 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.122 1.344 . . . . 0.0 112.23 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.9 -33.54 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.186 0.994 . . . . 0.0 111.062 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.38 -43.79 96.61 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.853 0.835 . . . . 0.0 110.638 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.9 -34.38 75.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.97 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.52 -34.11 71.94 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.358 1.036 . . . . 0.0 112.263 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -71.89 -42.17 67.11 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.808 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.0 -31.42 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.033 0.533 . . . . 0.0 111.166 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.94 -35.57 80.98 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.283 0.99 . . . . 0.0 110.894 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 176.843 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.1 mttp . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 122.47 1.129 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.485 ' HB2' HG12 ' A' ' 34' ' ' VAL . 64.4 mttm -114.31 146.25 40.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.127 -2.306 . . . . 0.0 112.808 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -99.1 116.02 30.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.41 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.6 mt -114.24 99.07 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.4 m-30 -107.36 120.63 42.68 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.638 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -100.21 137.41 38.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.742 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 . . . . . 0 N--CA 1.47 0.537 0 CA-C-N 113.61 -1.632 . . . . 0.0 113.7 -174.784 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.49 -7.41 13.42 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.77 42.69 92.96 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.731 1.158 . . . . 0.0 113.771 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.537 ' HG3' ' H ' ' A' ' 15' ' ' SER . 4.1 ptt? -101.6 -71.37 0.71 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -174.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.537 ' H ' ' HG3' ' A' ' 14' ' ' MET . 96.2 p -68.03 -26.17 65.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.619 1.554 . . . . 0.0 113.517 -174.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.3 p -57.95 -34.24 69.7 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.758 1.223 . . . . 0.0 113.523 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.3 p -58.75 -34.85 71.86 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.4 tp -66.77 -47.2 72.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.783 0.833 . . . . 0.0 111.666 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.62 -40.87 96.39 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.274 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 38' ' ' ALA . 53.0 t -56.28 -50.67 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.269 1.428 . . . . 0.0 109.346 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -55.15 -42.51 73.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.454 0.702 . . . . 0.0 112.817 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -65.66 -45.1 84.2 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.8 ptm -75.66 -20.93 58.11 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -67.44 -47.36 70.4 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.21 1.004 . . . . 0.0 111.425 166.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.27 -33.93 76.57 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.545 1.164 . . . . 0.0 113.151 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -79.28 -27.33 42.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.151 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.04 71.07 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.867 0.467 . . . . 0.0 111.273 168.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.79 -48.51 58.9 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.309 1.044 . . . . 0.0 110.975 171.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.8 -47.06 87.24 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.478 1.111 . . . . 0.0 113.512 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -99.02 20.44 13.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.074 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 30.32 69.76 0.09 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 125.059 2.362 . . . . 0.0 115.167 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.06 108.26 55.4 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 111.929 -2.396 . . . . 0.0 107.839 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.52 85.4 1.8 Allowed 'Trans proline' 0 C--N 1.33 -0.443 0 C-N-CA 122.238 1.959 . . . . 0.0 113.714 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 4' ' ' LYS . 15.2 m -138.32 146.35 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 112.834 -1.985 . . . . 0.0 112.905 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.0 mt -105.73 107.41 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 112.811 -1.995 . . . . 0.0 107.226 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.402 HG22 HG13 ' A' ' 20' ' ' VAL . 13.6 mt -110.36 112.22 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 112.704 -2.044 . . . . 0.0 108.189 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -137.48 143.94 41.99 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 124.588 1.18 . . . . 0.0 111.483 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -110.68 134.52 52.38 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 113.227 -1.806 . . . . 0.0 111.955 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -134.36 154.62 79.96 Favored Pre-proline 0 N--CA 1.471 0.575 0 CA-C-N 113.458 -1.701 . . . . 0.0 112.699 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.03 151.51 83.7 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.118 1.879 . . . . 0.0 112.335 166.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -23.2 62.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.993 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.2 p -54.98 -31.63 60.93 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.597 1.559 . . . . 0.0 113.999 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.75 17.29 18.33 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.75 89.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.435 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.9 -58.47 12.75 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 47' ' ' LYS . 1.5 tm-20 -57.28 -60.0 4.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 112.504 -1.848 . . . . 0.0 112.892 -169.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HD2' ' OE1' ' A' ' 46' ' ' GLU . 5.5 mptp? -77.4 -32.84 55.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.429 -1.26 . . . . 0.0 113.668 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.16 -26.07 65.4 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.419 1.009 . . . . 0.0 113.345 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.01 -30.15 65.86 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.305 1.442 . . . . 0.0 113.981 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -110.96 0.35 17.01 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.37 135.69 40.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.92 0.39 . . . . 0.0 110.002 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -80.0 -29.94 39.55 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.545 172.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.69 141.48 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 122.577 1.18 . . . . 0.0 109.63 162.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -107.44 119.13 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 112.497 -2.138 . . . . 0.0 106.807 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 76.0 mt -112.21 132.07 55.12 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.261 -1.791 . . . . 0.0 112.063 176.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.404 HD21 HG13 ' A' ' 67' ' ' ILE . 10.2 mp -106.09 141.22 37.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 113.426 -1.715 . . . . 0.0 113.487 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.75 136.34 41.37 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.243 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.12 -26.33 68.64 Favored 'Trans proline' 0 C--N 1.329 -0.469 0 C-N-CA 122.371 2.047 . . . . 0.0 114.75 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -65.74 -27.58 68.41 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.2 pt -111.04 22.49 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.666 0.746 . . . . 0.0 112.353 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.09 69.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.391 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -59.37 -26.72 65.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.406 ' O ' HG12 ' A' ' 67' ' ' ILE . 52.3 mtm -85.46 2.73 43.38 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.3 tp -52.25 -48.1 90.27 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 115.025 -2.417 . . . . 0.0 113.053 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.77 -37.92 84.8 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 122.565 2.176 . . . . 0.0 114.227 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 3.9 tp10 -77.78 -38.34 46.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.093 0.949 . . . . 0.0 112.653 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 63' ' ' MET . 48.2 mm -69.65 -39.69 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.424 1.09 . . . . 0.0 109.408 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -60.78 -40.57 93.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.662 1.185 . . . . 0.0 110.828 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.525 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 28.8 tpt85 -60.51 -41.85 95.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.407 1.483 . . . . 0.0 111.643 176.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.5 mt -68.89 -45.69 70.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.604 1.561 . . . . 0.0 112.616 175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -123.29 76.34 52.62 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.912 1.285 . . . . 0.0 110.848 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.2 -21.94 8.78 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 121.391 1.394 . . . . 0.0 113.917 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -86.68 8.09 23.88 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -128.19 140.41 38.21 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-O 118.714 -0.66 . . . . 0.0 110.081 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -71.76 112.72 3.45 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.196 1.931 . . . . 0.0 109.774 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.6 t -117.93 110.29 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 110.675 -2.966 . . . . 0.0 108.006 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -128.34 155.95 43.86 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 112.923 -1.944 . . . . 0.0 112.223 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.11 136.77 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 113.197 -1.819 . . . . 0.0 109.439 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.4 mt -72.87 128.55 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 10.0 t0 -56.22 126.73 27.46 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.959 174.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.0 m -50.75 -35.94 34.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 113.275 -1.784 . . . . 0.0 114.108 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 46.7 tp -71.41 -47.77 53.96 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.513 1.125 . . . . 0.0 111.944 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.63 -38.13 77.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.143 0.977 . . . . 0.0 112.713 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.35 -41.19 85.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.373 1.469 . . . . 0.0 111.728 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.77 -49.08 61.43 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.155 1.36 . . . . 0.0 112.443 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.73 -25.63 65.74 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.543 0.737 . . . . 0.0 112.648 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 t 56.33 63.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.733 2.413 . . . . 0.0 109.079 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -102.72 90.28 3.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.481 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.5 -45.09 85.29 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 112.227 -2.26 . . . . 0.0 113.341 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.53 -41.0 85.05 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.218 0.607 . . . . 0.0 112.41 -175.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.39 -46.17 81.12 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.431 1.491 . . . . 0.0 111.69 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.6 t -72.26 -38.24 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.832 0.853 . . . . 0.0 110.587 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.1 tp -60.95 -44.92 96.58 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.274 1.029 . . . . 0.0 111.491 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -67.94 -36.99 81.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.87 85.06 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.092 0.87 . . . . 0.0 111.699 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.79 -42.51 85.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.867 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -31.26 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.935 0.874 . . . . 0.0 111.658 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.73 79.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.43 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 177.557 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.6 108.56 1.42 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.717 1.886 . . . . 0.0 110.426 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -131.16 137.34 48.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.249 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.25 147.8 26.22 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 126.002 2.064 . . . . 0.0 111.521 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -105.26 115.78 30.83 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 123.154 1.454 . . . . 0.0 112.25 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.7 mt -116.92 102.45 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.38 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -108.62 127.42 53.95 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.278 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.51 135.59 45.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.872 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.19 130.1 44.26 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.429 -1.714 . . . . 0.0 113.208 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CSP . . . . . 0.511 ' O3P' ' HB2' ' A' ' 15' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -55.33 -46.22 76.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -173.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.93 -31.68 8.23 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.88 -0.34 59.15 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -102.12 -36.84 8.4 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 118.375 2.732 . . . . 0.0 118.375 -168.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.511 ' HB2' ' O3P' ' A' ' 10' ' ' CSP . 41.0 m -69.62 -31.92 70.31 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.099 1.318 . . . . 0.0 113.609 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 p -62.67 -18.98 63.38 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.862 1.665 . . . . 0.0 114.49 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -53.96 -41.73 68.12 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.27 -42.74 83.33 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.937 0.495 . . . . 0.0 111.861 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.16 -45.69 90.34 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.393 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.23 -50.52 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.369 1.068 . . . . 0.0 109.86 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.8 t -54.7 -46.02 74.07 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.275 1.03 . . . . 0.0 112.782 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.52 -42.86 82.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.374 0.67 . . . . 0.0 112.801 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 96.5 mtp -59.3 -43.66 92.6 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.173 0.92 . . . . 0.0 110.699 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -62.45 -48.28 80.34 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.355 1.062 . . . . 0.0 111.687 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.09 79.72 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -79.0 -32.17 45.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.785 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.02 -35.15 79.78 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.857 0.863 . . . . 0.0 111.474 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -69.91 -46.65 64.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.865 0.866 . . . . 0.0 110.944 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.81 -40.81 94.09 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.02 0.928 . . . . 0.0 113.162 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -104.2 24.59 11.25 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 31.95 56.92 0.34 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.525 2.33 . . . . 0.0 116.223 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.74 108.43 51.16 Favored Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 112.691 -2.05 . . . . 0.0 107.737 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.12 87.1 1.56 Allowed 'Trans proline' 0 C--N 1.33 -0.425 0 C-N-CA 122.111 1.874 . . . . 0.0 113.363 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 m -139.15 148.39 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 113.168 -1.833 . . . . 0.0 113.032 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.7 mt -106.83 115.94 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 113.056 -1.883 . . . . 0.0 107.438 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -119.28 114.63 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.419 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -139.56 147.7 41.54 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.755 1.284 . . . . 0.0 111.929 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.12 137.74 48.42 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.384 -1.735 . . . . 0.0 112.253 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -139.59 154.18 71.08 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.347 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -70.58 152.74 65.29 Favored 'Trans proline' 0 C--N 1.33 -0.424 0 C-N-CA 122.001 1.801 . . . . 0.0 112.341 168.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -26.33 61.63 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.108 1.763 . . . . 0.0 114.893 -173.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.6 p -56.07 -32.97 64.59 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.017 1.727 . . . . 0.0 113.624 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.5 mt -96.51 15.4 21.61 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.82 90.96 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.222 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.25 -63.06 4.38 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -57.66 -49.19 77.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 112.964 -1.618 . . . . 0.0 113.808 -168.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -90.17 -31.25 17.14 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.19 -24.26 63.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.897 0.76 . . . . 0.0 113.228 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -57.99 -29.91 65.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.319 1.447 . . . . 0.0 114.221 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -106.08 4.51 29.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.6 142.88 33.62 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.193 0.521 . . . . 0.0 110.273 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -89.05 -29.52 19.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.465 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.9 p -146.25 142.68 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.789 1.281 . . . . 0.0 109.259 162.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.59 123.27 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 112.279 -2.237 . . . . 0.0 107.142 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 96' ' ' ALA . 80.0 mt -113.19 132.9 55.31 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.858 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.5 mt -110.62 142.29 42.69 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 113.133 -1.849 . . . . 0.0 112.357 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.82 136.84 38.53 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.685 169.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.3 -27.68 68.07 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.32 2.014 . . . . 0.0 114.506 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -61.81 -28.53 69.54 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 pt -113.71 26.97 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.999 0.904 . . . . 0.0 111.918 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.25 -31.29 72.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.33 -21.04 64.97 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 78.2 mtp -86.63 -0.26 55.87 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.666 1.187 . . . . 0.0 114.12 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 12.6 tp -52.82 -50.15 82.83 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 114.104 -2.855 . . . . 0.0 112.414 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.01 -37.9 86.54 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 122.583 2.189 . . . . 0.0 113.876 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 4.9 tp10 -78.41 -37.57 43.64 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.3 mt -75.9 -33.82 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.753 1.221 . . . . 0.0 110.901 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -58.72 -40.79 84.75 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.682 0.793 . . . . 0.0 110.557 168.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 5.7 tmm_? -60.89 -45.0 96.32 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.669 1.188 . . . . 0.0 111.436 173.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.8 mt -63.96 -42.9 97.15 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.57 1.148 . . . . 0.0 113.011 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -124.02 71.01 51.91 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.317 1.447 . . . . 0.0 110.846 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.21 -8.68 18.81 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 122.029 1.819 . . . . 0.0 115.044 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -109.85 4.46 21.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -121.62 134.25 24.53 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.52 117.54 5.13 Favored 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 122.077 1.851 . . . . 0.0 110.812 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.9 t -121.01 114.28 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 111.078 -2.783 . . . . 0.0 108.114 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -128.59 154.86 45.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 112.827 -1.988 . . . . 0.0 111.56 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.1 t -96.23 139.8 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.143 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.0 mt -74.4 129.28 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.42 131.03 48.88 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 113.726 -1.579 . . . . 0.0 112.229 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.3 t -48.2 -46.89 35.6 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 111.909 -2.405 . . . . 0.0 113.858 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.3 tp -70.41 -43.82 69.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.998 0.919 . . . . 0.0 111.964 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.76 -38.97 83.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.05 0.94 . . . . 0.0 112.789 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -68.68 -45.68 71.05 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.802 1.241 . . . . 0.0 111.162 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.84 -35.78 92.46 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.784 1.183 . . . . 0.0 112.886 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -83.02 -17.04 44.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.906 1.283 . . . . 0.0 113.055 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.0 t 45.36 65.1 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 128.377 2.671 . . . . 0.0 111.046 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -102.49 93.52 5.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 112.62 -2.082 . . . . 0.0 110.098 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.47 -43.13 90.47 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 111.875 -2.421 . . . . 0.0 113.865 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.2 tp -67.23 -43.95 80.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.772 0.429 . . . . 0.0 112.14 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.73 -48.63 65.15 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.998 1.761 . . . . 0.0 111.85 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.79 -39.84 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 114.68 -0.76 . . . . 0.0 110.829 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.0 tp -61.16 -44.44 97.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.824 0.85 . . . . 0.0 110.934 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -63.11 -40.12 96.71 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.81 0.844 . . . . 0.0 112.306 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.31 87.53 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.138 0.899 . . . . 0.0 112.108 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -65.19 -46.86 79.06 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.555 1.142 . . . . 0.0 112.292 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.2 t -66.24 -39.39 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.062 1.345 . . . . 0.0 110.408 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.87 98.59 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.706 1.202 . . . . 0.0 110.944 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.59 -38.97 81.09 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.146 0.978 . . . . 0.0 112.484 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.09 -48.6 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.898 0.879 . . . . 0.0 108.718 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -66.91 -27.93 67.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 116.378 -1.772 . . . . 0.0 115.079 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -84.42 12.33 7.03 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 123.445 1.593 . . . . 0.0 111.955 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -119.01 -50.89 2.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 112.729 -2.032 . . . . 0.0 111.658 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.56 -24.2 62.74 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.27 -169.09 1.88 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.342 1.457 . . . . 0.0 109.225 -168.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 32.3 m120 . . . . . 0 C--O 1.249 1.068 0 C-N-CA 127.494 2.317 . . . . 0.0 113.294 169.887 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.801 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -108.05 105.6 15.43 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 125.53 1.769 . . . . 0.0 109.485 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -132.54 152.79 51.47 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.348 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -102.85 148.12 26.04 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 125.846 1.967 . . . . 0.0 110.638 172.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -108.11 120.6 42.78 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.629 -1.168 . . . . 0.0 112.008 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.8 mt -120.76 108.89 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.513 -1.676 . . . . 0.0 106.495 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -114.85 125.76 54.03 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.214 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.37 127.51 46.67 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.382 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.77 133.93 52.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.275 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CSP . . . . . 0.435 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.8 m -54.61 -48.62 71.98 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -172.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.85 -15.16 11.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.77 45.25 76.57 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.896 0.76 . . . . 0.0 112.605 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 24.8 mmt -115.25 -71.15 0.76 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 p -66.83 -18.67 65.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -60.32 -28.97 68.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.166 1.387 . . . . 0.0 114.626 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.7 p -60.14 -34.59 73.76 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -65.88 -46.25 79.07 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.394 0.678 . . . . 0.0 111.551 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 tp -62.24 -43.35 99.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.609 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.585 HG21 ' HB2' ' A' ' 38' ' ' ALA . 74.6 t -61.82 -43.67 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.427 1.091 . . . . 0.0 110.742 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -60.51 -44.7 95.74 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.529 0.732 . . . . 0.0 112.557 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -66.21 -39.15 89.42 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.503 ' HB3' HD13 ' A' ' 36' ' ' ILE . 95.7 mtp -64.72 -40.62 95.64 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.978 0.799 . . . . 0.0 111.625 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -67.54 -41.86 83.64 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.976 0.91 . . . . 0.0 112.786 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.03 -39.25 90.05 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.811 0.815 . . . . 0.0 112.827 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -77.44 -29.24 52.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.645 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.57 78.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.535 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -72.27 -41.18 67.0 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.015 0.822 . . . . 0.0 111.676 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -63.66 -51.61 64.34 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.485 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -90.64 23.2 3.15 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 29.28 63.19 0.14 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 124.853 2.263 . . . . 0.0 115.047 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.67 108.81 59.28 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 112.403 -2.18 . . . . 0.0 106.815 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.16 89.44 1.17 Allowed 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 122.296 1.997 . . . . 0.0 112.601 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 m -144.91 150.3 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.804 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -110.72 106.6 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.027 176.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.503 HD13 ' HB3' ' A' ' 23' ' ' MET . 14.6 mt -111.48 112.3 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.011 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -134.59 151.92 51.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.644 1.178 . . . . 0.0 111.931 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -119.14 137.47 53.58 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.612 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -144.25 154.37 57.32 Favored Pre-proline 0 N--CA 1.47 0.526 0 O-C-N 124.75 1.282 . . . . 0.0 112.552 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 9.5 Cg_endo -62.19 152.29 77.0 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 122.379 2.053 . . . . 0.0 112.62 169.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -22.77 47.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.032 1.733 . . . . 0.0 114.827 -173.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.3 p -58.42 -29.89 66.45 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.682 1.593 . . . . 0.0 113.702 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.7 mt -99.75 20.68 13.68 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.92 -45.3 64.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.107 -0.952 . . . . 0.0 113.075 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.12 -15.89 76.71 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.758 0.694 . . . . 0.0 113.833 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -97.13 -57.91 2.15 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.7 0.882 . . . . 0.0 112.884 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -85.25 -27.6 25.92 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.95 -15.98 56.58 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.112 0.863 . . . . 0.0 113.863 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -60.5 -27.0 67.25 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.771 1.228 . . . . 0.0 114.079 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -117.37 24.39 11.16 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.15 138.38 32.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.41 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.87 -23.23 24.04 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.342 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.56 133.76 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 122.442 1.115 . . . . 0.0 109.64 160.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.5 t -97.73 119.06 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 112.644 -2.071 . . . . 0.0 106.256 172.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 96' ' ' ALA . 74.9 mt -107.09 134.15 50.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.15 176.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.53 140.26 47.42 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.66 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.13 144.51 48.76 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.396 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.1 -26.82 83.12 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 C-N-CA 122.265 1.977 . . . . 0.0 114.291 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -64.69 -28.63 69.73 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 pt -114.71 30.09 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 122.411 1.1 . . . . 0.0 111.734 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.98 64.83 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -64.02 -22.59 66.99 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 84.7 mtp -85.3 6.45 26.21 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.26 -51.35 81.53 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-O 115.189 -2.339 . . . . 0.0 113.159 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.99 -28.05 80.19 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 CA-C-N 122.872 2.062 . . . . 0.0 114.031 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 2.0 tt0 -80.21 -37.79 32.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.3 mt -79.75 -29.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.813 1.245 . . . . 0.0 111.35 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -34.22 75.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.113 0.565 . . . . 0.0 110.552 171.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -61.77 -43.37 98.99 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.911 0.884 . . . . 0.0 110.74 172.036 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.1 mt -66.37 -42.22 88.31 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.984 0.914 . . . . 0.0 112.808 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.8 mt -124.1 76.69 59.6 Favored Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 124.931 1.293 . . . . 0.0 110.149 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.44 -11.26 10.71 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 121.895 1.73 . . . . 0.0 115.57 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -105.75 15.45 26.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.261 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.29 137.92 31.67 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.814 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.53 117.71 5.28 Favored 'Trans proline' 0 C--N 1.33 -0.421 0 C-N-CA 122.441 2.094 . . . . 0.0 110.34 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 t -120.73 110.71 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 111.956 -2.383 . . . . 0.0 106.835 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.12 146.81 50.59 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 125.866 1.979 . . . . 0.0 111.309 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.66 136.53 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.619 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.4 mt -70.48 133.71 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.409 1.083 . . . . 0.0 108.311 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.31 127.43 32.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.653 1.216 . . . . 0.0 110.957 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.1 m -56.21 -36.02 67.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 113.167 -1.833 . . . . 0.0 114.095 -174.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.9 tp -78.8 -36.51 42.65 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.206 0.603 . . . . 0.0 112.55 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.3 mt -60.46 -35.46 75.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.296 0.638 . . . . 0.0 112.713 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -67.84 -39.41 83.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.302 1.441 . . . . 0.0 111.23 174.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.5 -47.77 80.52 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.127 1.346 . . . . 0.0 112.452 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.99 -28.56 70.18 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.391 1.076 . . . . 0.0 112.244 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 t 53.67 62.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 127.511 2.325 . . . . 0.0 108.531 -170.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -100.73 92.32 5.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 112.184 -2.28 . . . . 0.0 109.908 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.69 -38.06 93.26 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 111.943 -2.39 . . . . 0.0 113.232 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.9 tp -71.79 -40.58 69.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.422 0.689 . . . . 0.0 111.908 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.71 -45.37 96.55 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.282 1.42 . . . . 0.0 112.733 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.17 -32.63 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.782 0.833 . . . . 0.0 110.997 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -44.74 95.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.416 0.627 . . . . 0.0 111.503 175.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -66.78 -33.74 76.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.223 1.009 . . . . 0.0 113.026 176.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.72 -34.36 67.05 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.204 0.94 . . . . 0.0 112.677 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.403 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -70.22 -43.08 71.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.01 0.924 . . . . 0.0 111.704 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.16 -36.6 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.595 1.158 . . . . 0.0 110.705 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.73 81.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.913 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.66 -34.4 71.99 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.648 0.779 . . . . 0.0 112.806 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.1 mt -70.21 -43.8 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.328 0.651 . . . . 0.0 109.306 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -60.42 -41.66 94.42 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.227 0.611 . . . . 0.0 112.567 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -66.35 -41.98 88.75 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.008 0.923 . . . . 0.0 111.101 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.28 99.01 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.794 1.308 . . . . 0.0 112.154 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.43 92.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.886 0.874 . . . . 0.0 111.926 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 137.45 94.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 130.898 3.679 . . . . 0.0 109.794 171.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 C--O 1.25 1.105 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.927 173.341 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tmm? . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -143.71 104.52 4.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 125.068 1.48 . . . . 0.0 109.562 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 89.0 mttt -132.65 144.37 50.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.882 172.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -102.1 148.07 25.84 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 125.859 1.974 . . . . 0.0 111.646 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -106.16 118.85 37.69 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.343 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.8 mt -118.83 105.54 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -110.09 128.4 55.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.503 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -100.48 134.94 42.68 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.012 -1.903 . . . . 0.0 110.077 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -129.84 131.74 46.23 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.601 -1.636 . . . . 0.0 113.245 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CSP . . . . . 0.453 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.0 t -52.29 -45.56 65.56 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.68 -34.32 7.02 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.62 37.12 12.36 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 123.943 0.782 . . . . 0.0 113.448 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 8.9 ptp -121.44 -48.93 2.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.7 m -63.63 -32.73 74.3 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 p -64.58 -24.36 67.57 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.2 p -58.83 -35.82 73.52 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.0 tp -69.31 -45.72 68.84 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.66 0.384 . . . . 0.0 111.441 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' A' ' 23' ' ' MET . 1.0 OUTLIER -60.89 -35.62 77.13 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 175.596 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.606 HG13 HG22 ' A' ' 36' ' ' ILE . 74.7 t -61.83 -48.72 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.429 1.091 . . . . 0.0 110.252 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.7 p -68.52 -26.85 65.65 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -65.0 -44.35 89.53 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.175 0.99 . . . . 0.0 112.3 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 18.3 ptm -85.01 -13.0 51.96 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -71.96 -41.53 67.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.544 0.338 . . . . 0.0 110.938 164.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.81 86.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.691 0.758 . . . . 0.0 112.242 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.456 HE21 ' HB2' ' A' ' 90' ' ' LEU . 15.2 mm100 -70.17 -34.62 73.22 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.611 173.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.5 98.76 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.18 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.16 -33.48 73.47 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.698 0.799 . . . . 0.0 112.486 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -65.49 -51.83 57.23 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.206 0.603 . . . . 0.0 111.015 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -90.24 24.57 2.48 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.863 0.865 . . . . 0.0 113.305 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 28.31 64.85 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 124.947 2.308 . . . . 0.0 115.192 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.08 105.49 57.29 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-N 112.885 -1.961 . . . . 0.0 107.084 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 76.3 Cg_endo -75.81 93.99 1.0 Allowed 'Trans proline' 0 C--N 1.331 -0.371 0 C-N-CA 122.396 2.064 . . . . 0.0 112.183 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.07 152.68 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 113.915 -1.493 . . . . 0.0 114.319 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.99 107.13 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 112.179 -2.282 . . . . 0.0 107.144 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.606 HG22 HG13 ' A' ' 20' ' ' VAL . 20.6 mt -112.6 113.35 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.102 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -136.58 148.78 47.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 125.311 1.632 . . . . 0.0 112.201 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.96 139.62 46.14 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.036 -1.438 . . . . 0.0 113.101 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -142.57 152.18 59.29 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.477 1.111 . . . . 0.0 113.128 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 10.6 Cg_endo -67.23 154.08 75.29 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.376 2.051 . . . . 0.0 113.128 167.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -22.59 63.93 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.577 1.551 . . . . 0.0 114.154 -175.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 p -60.36 -31.02 69.94 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.507 1.523 . . . . 0.0 113.164 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -98.77 21.79 10.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.29 1.036 . . . . 0.0 113.093 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.3 -48.91 77.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.057 -0.973 . . . . 0.0 112.673 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.27 -57.61 17.49 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.148 0.905 . . . . 0.0 111.589 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.21 -53.57 53.37 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 113.231 -1.484 . . . . 0.0 113.59 -170.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -80.45 -31.53 37.43 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.339 1.236 . . . . 0.0 114.339 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.33 -20.21 54.47 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.73 1.157 . . . . 0.0 113.643 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -59.68 -32.7 70.74 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.244 1.018 . . . . 0.0 113.396 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.5 -16.38 18.34 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.677 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.53 135.47 48.58 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.143 0.497 . . . . 0.0 111.087 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -86.55 -26.22 24.63 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.391 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.17 140.62 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 122.191 0.996 . . . . 0.0 109.248 163.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 76' ' ' VAL . 94.5 t -109.12 126.55 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.349 175.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 96' ' ' ALA . 84.2 mt -115.96 122.82 46.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.245 -1.798 . . . . 0.0 111.356 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 mt -100.45 142.08 32.41 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.421 -1.718 . . . . 0.0 111.925 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.23 144.14 49.07 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.668 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.66 -24.93 77.36 Favored 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 122.272 1.981 . . . . 0.0 114.335 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -67.8 -28.66 67.78 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 pt -113.12 25.29 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 122.053 0.93 . . . . 0.0 112.141 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.3 -29.21 65.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.992 -1.003 . . . . 0.0 113.437 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -61.52 -24.24 66.48 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.675 173.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.0 mtm -87.74 7.43 30.29 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.1 tp -50.86 -46.2 87.22 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 116.418 -1.753 . . . . 0.0 113.823 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.6 -29.12 61.01 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 122.192 1.928 . . . . 0.0 114.827 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -81.61 -36.96 28.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.725 0.774 . . . . 0.0 112.846 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 mm -65.39 -40.55 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.029 1.332 . . . . 0.0 109.509 173.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -73.58 -25.54 60.4 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -65.07 -39.81 93.77 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 170.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.7 mt -65.62 -53.6 39.33 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.537 1.135 . . . . 0.0 112.338 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.87 75.49 71.15 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 124.369 1.068 . . . . 0.0 111.481 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.96 -22.31 23.27 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.256 1.971 . . . . 0.0 115.629 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -86.38 -0.73 56.57 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.46 134.46 20.83 Favored Pre-proline 0 N--CA 1.47 0.526 0 C-N-CA 123.217 0.607 . . . . 0.0 110.771 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.93 116.88 4.88 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 122.42 2.08 . . . . 0.0 110.513 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.583 HG22 ' HB ' ' A' ' 54' ' ' VAL . 59.9 t -123.58 119.59 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 112.087 -2.324 . . . . 0.0 108.352 -175.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -125.51 158.48 34.42 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 126.24 2.213 . . . . 0.0 111.753 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.8 t -99.79 138.22 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.419 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.0 mt -72.11 126.64 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.14 131.45 50.54 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.676 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.1 m -57.83 -34.35 69.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 112.85 -1.977 . . . . 0.0 113.907 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -38.61 53.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.595 0.758 . . . . 0.0 112.48 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.58 -38.25 86.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.325 0.65 . . . . 0.0 112.092 171.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -66.57 -41.38 88.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.568 1.547 . . . . 0.0 111.331 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.58 -43.02 99.6 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.071 1.319 . . . . 0.0 112.498 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -75.54 -28.25 58.97 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t 58.35 70.22 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 127.376 2.271 . . . . 0.0 108.078 -168.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.86 99.49 8.39 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 113.198 -1.819 . . . . 0.0 110.589 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.81 -43.19 98.15 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 111.77 -2.468 . . . . 0.0 113.867 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HB2' HE21 ' A' ' 26' ' ' GLN . 65.0 tp -64.22 -43.27 95.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.86 -42.22 91.95 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 124.708 1.146 . . . . 0.0 112.743 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.9 t -77.75 -38.21 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.668 0.787 . . . . 0.0 110.993 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.94 -39.66 95.3 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.773 0.829 . . . . 0.0 111.603 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -64.8 -43.26 93.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.902 1.281 . . . . 0.0 111.278 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.44 83.7 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.058 0.849 . . . . 0.0 112.381 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -67.85 -44.12 77.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.163 -1.38 . . . . 0.0 112.35 176.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.53 -27.58 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 121.814 -0.554 . . . . 0.0 112.209 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.85 83.85 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.187 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.65 -29.39 61.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.679 0.792 . . . . 0.0 113.045 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.94 -42.58 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -57.68 -39.29 76.76 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.639 ' HA ' ' HB2' ' A' ' 106' ' ' ASN . 65.1 tttp -65.66 -48.88 70.62 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.109 0.88 . . . . 0.0 110.942 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.6 -37.28 72.97 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.438 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.05 -73.99 0.13 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.194 0.998 . . . . 0.0 110.244 173.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.15 87.09 0.16 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.888 0.875 . . . . 0.0 111.414 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.639 ' HB2' ' HA ' ' A' ' 102' ' ' LYS . 26.2 m120 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.925 1.69 . . . . 0.0 110.718 169.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 mmt . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -100.81 -40.07 7.5 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.535 1.772 . . . . 0.0 111.496 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.9 mttt 63.23 146.98 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.757 1.623 . . . . 0.0 113.886 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -110.06 143.71 39.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 112.908 -1.951 . . . . 0.0 112.227 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -101.69 116.69 33.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.958 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.7 mt -114.4 103.02 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.309 -1.769 . . . . 0.0 106.471 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -110.29 127.17 54.88 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 122.731 1.253 . . . . 0.0 112.45 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -101.17 133.09 46.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.72 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -126.23 133.79 51.39 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.678 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CSP . . . . . 0.494 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m -50.32 -45.86 55.13 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.65 -23.56 11.75 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.71 23.55 77.7 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.341 0.972 . . . . 0.0 114.87 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.7 ptp -118.32 -37.56 3.32 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.477 ' HB2' ' O3P' ' A' ' 10' ' ' CSP . 32.3 m -65.57 -29.88 70.54 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.113 0.87 . . . . 0.0 112.198 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 p -71.71 -20.2 61.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.726 1.61 . . . . 0.0 114.505 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.0 p -63.13 -34.98 78.79 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 tp -65.94 -44.53 84.79 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.101 0.561 . . . . 0.0 111.691 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 tt -62.16 -40.82 97.28 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.13 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 38' ' ' ALA . 73.1 t -61.47 -45.0 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.488 1.115 . . . . 0.0 109.717 175.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -59.08 -40.35 84.98 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -65.87 -44.23 86.0 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.9 ptm -77.99 -21.56 50.67 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -67.34 -46.07 74.51 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.857 0.863 . . . . 0.0 111.52 166.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.37 84.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.006 0.908 . . . . 0.0 112.758 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -75.6 -33.12 60.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.88 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.61 84.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.928 0.491 . . . . 0.0 111.323 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.76 -42.78 77.03 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 111.332 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -63.53 -52.09 62.65 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.444 0.698 . . . . 0.0 111.764 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -85.04 11.8 8.9 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 51.88 51.06 17.29 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 123.958 1.837 . . . . 0.0 112.774 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.2 t -102.05 111.66 64.51 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 112.971 -1.922 . . . . 0.0 107.977 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.71 87.6 1.5 Allowed 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 121.995 1.797 . . . . 0.0 112.781 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.07 152.37 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.589 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.4 mt -112.18 105.75 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.395 -1.73 . . . . 0.0 107.91 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 20' ' ' VAL . 23.2 mt -105.78 118.97 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.83 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -149.44 139.34 21.94 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.457 1.098 . . . . 0.0 112.606 -171.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -104.23 138.15 41.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 113.248 -1.796 . . . . 0.0 112.684 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -139.32 151.49 67.26 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.777 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 17.8 Cg_endo -66.36 152.95 79.8 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 122.412 2.075 . . . . 0.0 112.7 168.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -22.73 62.74 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.076 -1.42 . . . . 0.0 114.664 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -60.32 -28.34 68.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.386 1.474 . . . . 0.0 113.667 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.6 mt -99.08 19.81 14.51 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.14 86.75 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.89 -51.96 31.57 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -61.21 -59.3 5.53 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.642 -1.279 . . . . 0.0 112.918 -172.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -78.85 -24.35 44.41 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.21 -29.37 72.76 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.869 0.747 . . . . 0.0 113.577 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.07 -29.57 70.7 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -109.95 30.09 7.02 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.026 0.917 . . . . 0.0 112.439 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.33 140.55 45.81 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.481 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.34 -49.8 11.02 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.084 170.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.3 140.85 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 122.089 0.947 . . . . 0.0 110.46 171.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.94 122.01 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 113.074 -1.875 . . . . 0.0 107.811 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.5 mt -116.94 115.51 25.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 113.553 -1.658 . . . . 0.0 112.688 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.2 mt -88.89 139.29 30.61 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 112.508 -2.133 . . . . 0.0 112.095 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.02 140.83 45.87 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 113.747 -1.569 . . . . 0.0 110.083 167.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -58.58 -24.85 72.1 Favored 'Trans proline' 0 C--N 1.331 -0.386 0 C-N-CA 122.299 1.999 . . . . 0.0 114.428 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 -64.79 -31.42 72.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.48 26.82 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.159 0.981 . . . . 0.0 111.988 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.56 -29.33 68.68 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.419 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -64.29 -21.8 66.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.1 mtm -89.26 13.25 13.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.6 tp -55.7 -50.71 85.49 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-O 114.903 -2.475 . . . . 0.0 112.382 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.46 -28.84 87.45 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 CA-C-N 122.716 2.006 . . . . 0.0 114.471 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -78.12 -43.39 29.03 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 70' ' ' LEU . 80.2 mt -76.5 -31.42 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.513 1.125 . . . . 0.0 111.539 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -72.35 -31.01 65.25 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.862 0.465 . . . . 0.0 111.247 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.8 ttp-105 -64.48 -43.24 94.8 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.853 0.461 . . . . 0.0 110.292 172.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 67' ' ' ILE . 35.0 mt -62.73 -44.35 96.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.372 1.069 . . . . 0.0 112.305 174.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -124.67 80.27 62.01 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 124.712 1.205 . . . . 0.0 110.179 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.84 -22.71 3.49 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 121.505 1.47 . . . . 0.0 115.621 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -97.72 14.06 28.19 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -127.2 129.65 23.89 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 118.067 -0.968 . . . . 0.0 108.646 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.45 119.14 6.12 Favored 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 122.656 2.238 . . . . 0.0 112.09 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -122.47 112.56 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 111.556 -2.566 . . . . 0.0 107.879 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -126.65 159.79 32.59 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 125.717 1.886 . . . . 0.0 111.267 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.9 t -98.37 140.78 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.559 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.78 132.32 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.4 1.08 . . . . 0.0 108.411 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 13.7 t0 -59.68 125.36 23.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.248 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -54.39 -33.06 58.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.517 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 49.5 tp -72.57 -46.51 54.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.674 1.19 . . . . 0.0 112.271 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.16 -37.36 79.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.699 0.8 . . . . 0.0 112.56 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -65.72 -40.39 92.17 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.216 1.406 . . . . 0.0 111.354 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.32 -47.96 79.21 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.003 1.287 . . . . 0.0 112.066 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.73 -30.66 71.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.557 0.743 . . . . 0.0 112.586 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 t 57.09 63.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 127.522 2.329 . . . . 0.0 108.241 -169.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -105.7 94.17 5.05 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 112.604 -2.089 . . . . 0.0 109.089 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.72 -46.94 91.67 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 111.751 -2.477 . . . . 0.0 112.869 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.4 tp -63.58 -37.18 86.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.475 0.71 . . . . 0.0 112.302 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.94 -46.06 94.21 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.577 1.56 . . . . 0.0 112.448 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -73.02 -33.84 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.096 0.959 . . . . 0.0 110.929 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.25 -43.58 98.64 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.65 0.78 . . . . 0.0 110.614 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.91 -35.26 76.63 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.431 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.06 81.86 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.191 0.932 . . . . 0.0 111.926 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.06 -43.93 77.51 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.027 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.64 -31.62 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.324 0.65 . . . . 0.0 111.215 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.99 -37.3 83.97 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.987 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.78 66.06 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.559 0.744 . . . . 0.0 112.929 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.0 mt -68.59 -44.55 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -61.2 -38.27 85.95 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -66.03 -41.29 91.12 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.541 0.737 . . . . 0.0 110.926 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.09 85.95 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.925 173.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.88 33.39 1.05 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.699 1.2 . . . . 0.0 111.804 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 59.61 105.83 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.39 2.276 . . . . 0.0 113.97 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.156 1.782 . . . . 0.0 107.456 171.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.487 ' O ' ' HD2' ' A' ' 3' ' ' LYS . 5.2 tp10 -121.02 106.53 11.67 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.933 1.396 . . . . 0.0 109.549 -175.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' A' ' 2' ' ' GLU . 11.4 tptt -150.83 129.11 11.98 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 170.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.532 ' HB2' HG12 ' A' ' 34' ' ' VAL . 4.4 mptp? -107.37 136.48 47.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.999 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -99.26 110.45 22.98 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.165 1.459 . . . . 0.0 111.71 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.2 mt -111.94 103.69 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.819 -1.991 . . . . 0.0 106.633 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -110.62 126.58 54.62 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.92 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.47 140.04 37.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 112.746 -2.024 . . . . 0.0 111.737 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -133.0 129.13 37.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 113.872 -1.513 . . . . 0.0 113.828 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CSP . . . . . 0.436 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -45.37 -47.51 13.47 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -171.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.87 -26.55 10.19 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.27 40.36 20.11 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.052 0.834 . . . . 0.0 113.859 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.9 mtm -111.71 -58.09 2.17 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 92.3 p -60.56 -29.65 69.29 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 p -61.4 -25.18 67.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.973 1.709 . . . . 0.0 114.429 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.3 p -55.9 -40.62 73.31 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -171.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.6 tp -67.45 -43.53 80.88 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.737 0.415 . . . . 0.0 111.606 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.74 -40.49 92.61 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.966 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.44 -45.3 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.583 1.153 . . . . 0.0 110.03 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 t -57.64 -46.86 83.64 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -64.66 -36.19 83.46 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.597 ' HB3' HD13 ' A' ' 36' ' ' ILE . 46.0 mmm -61.71 -47.56 84.74 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.735 1.214 . . . . 0.0 111.436 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -64.99 -38.71 91.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.643 0.777 . . . . 0.0 112.061 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.26 -41.38 81.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -69.49 -30.85 68.81 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.912 0.485 . . . . 0.0 112.276 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.98 92.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.122 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.59 -41.59 79.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.663 0.785 . . . . 0.0 111.818 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -59.32 -42.1 90.64 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.125 0.97 . . . . 0.0 112.91 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -109.54 26.04 11.1 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 22.57 68.29 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 125.374 2.512 . . . . 0.0 115.277 -170.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.9 t -98.32 107.34 41.23 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 112.513 -2.13 . . . . 0.0 106.463 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 72.9 Cg_endo -75.18 87.55 1.33 Allowed 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.189 1.926 . . . . 0.0 112.636 -176.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 4' ' ' LYS . 15.4 m -141.93 152.21 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 113.066 -1.879 . . . . 0.0 113.577 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.84 110.55 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 112.333 -2.212 . . . . 0.0 106.671 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.597 HD13 ' HB3' ' A' ' 23' ' ' MET . 8.7 mt -116.25 115.32 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.508 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -145.5 142.84 29.59 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.836 1.335 . . . . 0.0 112.112 -172.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.34 145.64 31.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 113.674 -1.603 . . . . 0.0 113.513 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.36 154.22 56.73 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 125.103 1.361 . . . . 0.0 112.909 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 14.4 Cg_endo -68.5 155.01 70.53 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 122.355 2.037 . . . . 0.0 113.43 167.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -31.65 67.77 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -170.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 t -62.48 -24.51 67.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.992 1.317 . . . . 0.0 113.942 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.4 mt -95.64 15.73 19.16 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.46 99.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.408 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.06 -62.56 5.33 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.27 -54.68 44.03 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 112.825 -1.688 . . . . 0.0 113.426 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.4 -31.89 29.39 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.57 -23.84 65.39 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.87 0.748 . . . . 0.0 113.282 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -58.03 -29.17 65.13 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.856 1.262 . . . . 0.0 113.983 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -116.78 33.11 5.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.197 0.999 . . . . 0.0 112.228 176.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.62 136.71 47.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.812 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -80.55 -29.92 37.08 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.091 173.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.31 138.81 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 122.656 1.217 . . . . 0.0 109.609 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.4 t -104.76 121.26 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 112.262 -2.245 . . . . 0.0 106.734 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.5 mt -113.69 136.4 52.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.793 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.6 mt -111.65 140.55 46.19 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.974 -1.921 . . . . 0.0 112.584 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.81 136.33 41.19 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.149 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.8 -24.44 55.74 Favored 'Trans proline' 0 C--N 1.33 -0.413 0 C-N-CA 122.414 2.076 . . . . 0.0 114.861 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.2 pm0 -65.08 -29.95 70.87 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.605 1.562 . . . . 0.0 115.141 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 pt -110.92 22.33 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.757 0.789 . . . . 0.0 112.037 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.52 -29.22 69.26 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.111 -0.95 . . . . 0.0 113.466 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -60.55 -24.54 65.48 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.0 mtm -88.62 11.04 18.46 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.5 tp -52.97 -47.88 93.83 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-O 114.902 -2.475 . . . . 0.0 112.545 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.38 -35.03 90.93 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 122.335 2.024 . . . . 0.0 114.252 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -78.89 -41.27 30.15 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.811 0.815 . . . . 0.0 112.829 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -67.11 -39.34 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.282 1.033 . . . . 0.0 109.214 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.86 -32.23 71.75 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.606 0.763 . . . . 0.0 111.58 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -63.02 -40.13 96.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.052 0.941 . . . . 0.0 110.806 172.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.8 mt -68.95 -44.76 72.34 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.003 1.321 . . . . 0.0 112.289 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.3 mt -124.35 76.22 61.55 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 124.943 1.297 . . . . 0.0 111.093 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.33 -27.43 5.36 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 C-N-CA 121.612 1.541 . . . . 0.0 114.659 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -97.56 23.85 7.29 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.473 1.13 . . . . 0.0 113.16 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -130.03 133.91 25.52 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.704 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.12 112.56 3.17 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 122.253 1.968 . . . . 0.0 110.149 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -118.26 112.18 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 110.852 -2.885 . . . . 0.0 108.07 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -127.16 153.45 46.03 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.12 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.0 t -93.55 136.04 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.842 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.6 mt -69.53 128.76 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -56.61 125.85 24.07 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.754 -1.566 . . . . 0.0 111.42 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.5 p -54.26 -34.99 62.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.975 -1.92 . . . . 0.0 114.326 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.1 tp -74.07 -44.81 52.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.092 1.357 . . . . 0.0 112.081 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.06 -37.75 80.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.948 0.899 . . . . 0.0 112.603 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -66.58 -40.92 89.15 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.346 1.459 . . . . 0.0 111.372 175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.94 -49.55 62.37 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.019 1.295 . . . . 0.0 112.355 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -66.27 -24.76 66.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.813 0.845 . . . . 0.0 112.968 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 t 56.56 62.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 127.388 2.275 . . . . 0.0 108.458 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -105.92 99.4 8.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 112.522 -2.126 . . . . 0.0 111.261 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.45 -33.52 81.64 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 111.704 -2.498 . . . . 0.0 113.762 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.43 -47.14 57.73 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.63 -0.335 . . . . 0.0 111.276 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.93 -43.97 92.66 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.975 1.274 . . . . 0.0 112.571 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.7 t -75.06 -35.88 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.377 0.671 . . . . 0.0 111.138 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.94 -44.49 96.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.873 0.844 . . . . 0.0 111.712 176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -68.01 -34.15 75.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.307 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.65 -39.88 80.5 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.359 1.037 . . . . 0.0 112.066 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.12 -44.2 84.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.965 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.76 -31.58 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.195 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.28 -36.4 81.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.716 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.77 -37.05 67.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.683 0.793 . . . . 0.0 112.99 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.2 mt -66.4 -49.5 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -62.49 -32.18 73.04 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -67.91 -47.17 69.51 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.431 0.692 . . . . 0.0 109.137 176.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.03 79.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.201 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.47 -44.22 83.34 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 174.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.19 59.39 0.72 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.199 0.999 . . . . 0.0 110.508 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-N 113.511 -1.677 . . . . 0.0 111.297 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 tpt . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 115.657 -2.115 . . . . 0.0 107.35 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 64.2 126.65 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 125.92 2.012 . . . . 0.0 113.57 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.459 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 34.9 mttp -136.03 137.17 40.9 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.687 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -103.1 150.14 23.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 112.542 -2.117 . . . . 0.0 113.251 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -105.4 116.05 31.29 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.943 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.1 mt -115.36 108.5 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 112.588 -2.096 . . . . 0.0 106.52 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -112.44 129.13 56.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 122.418 1.104 . . . . 0.0 112.912 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.02 136.02 46.43 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.153 -1.84 . . . . 0.0 111.102 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -132.06 133.69 44.66 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.473 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CSP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -53.96 -44.09 70.44 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.33 -31.86 8.41 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.77 16.33 54.88 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.914 1.245 . . . . 0.0 115.219 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.8 ptp -103.66 -42.04 5.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.4 p -58.47 -36.14 73.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.8 p -64.92 -23.31 67.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.892 2.077 . . . . 0.0 113.885 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.0 t -46.81 -50.41 18.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.14 -45.98 89.4 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -57.34 -45.73 84.01 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.727 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.84 -49.69 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.972 1.309 . . . . 0.0 109.717 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -56.39 -45.05 80.76 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.502 0.721 . . . . 0.0 112.652 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -66.23 -41.43 90.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.447 ' HB3' HD13 ' A' ' 36' ' ' ILE . 97.4 mtp -61.4 -44.03 97.85 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.779 0.832 . . . . 0.0 110.868 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -61.19 -46.08 91.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.534 1.134 . . . . 0.0 112.013 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.88 89.01 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -71.28 -35.91 71.5 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.372 0.669 . . . . 0.0 111.621 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.52 -38.74 92.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.298 1.039 . . . . 0.0 111.067 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.31 -43.75 76.91 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.655 1.182 . . . . 0.0 111.384 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -58.98 -41.94 88.76 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.463 1.105 . . . . 0.0 112.812 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -105.28 24.92 11.3 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 28.07 58.31 0.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.589 2.356 . . . . 0.0 116.558 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.6 t -96.87 111.72 58.39 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 111.922 -2.399 . . . . 0.0 107.94 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 73.1 Cg_endo -78.37 84.21 2.06 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 121.467 1.445 . . . . 0.0 113.16 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.43 152.09 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 112.855 -1.975 . . . . 0.0 112.659 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.5 mt -111.91 109.34 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.285 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 23' ' ' MET . 17.4 mt -109.16 118.4 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 112.664 -2.062 . . . . 0.0 107.535 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -143.98 143.7 31.34 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 126.234 2.209 . . . . 0.0 111.186 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.8 142.11 44.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.186 -1.37 . . . . 0.0 114.224 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -143.25 154.24 60.64 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 124.853 1.261 . . . . 0.0 113.34 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.2 156.03 59.97 Favored 'Trans proline' 0 C--N 1.33 -0.422 0 C-N-CA 122.311 2.008 . . . . 0.0 112.962 166.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -27.11 68.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.816 -1.538 . . . . 0.0 114.258 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.8 p -56.86 -26.32 58.35 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.14 1.776 . . . . 0.0 113.817 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.7 mt -102.57 16.28 26.83 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.388 1.075 . . . . 0.0 113.833 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.56 93.81 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.421 1.088 . . . . 0.0 113.859 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.64 -54.52 35.01 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' OE1' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -61.81 -62.05 2.07 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.213 -0.993 . . . . 0.0 112.554 -171.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE2' ' OE1' ' A' ' 46' ' ' GLU . 74.0 mmtt -72.13 -31.58 66.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.92 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.17 -28.44 66.66 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.905 0.764 . . . . 0.0 113.063 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -61.82 -29.72 70.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.395 1.078 . . . . 0.0 113.504 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -110.31 20.57 17.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.135 0.974 . . . . 0.0 113.602 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.72 145.05 26.15 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.687 170.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -89.69 -29.43 18.77 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.092 168.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.95 141.39 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 122.436 1.112 . . . . 0.0 110.54 163.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.8 t -107.17 121.85 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 112.847 -1.979 . . . . 0.0 107.459 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.4 mt -116.33 127.68 54.89 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.291 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 mt -105.74 141.55 36.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 112.739 -2.028 . . . . 0.0 112.828 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.69 137.26 44.37 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.202 168.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.32 -35.14 43.18 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 123.157 2.571 . . . . 0.0 114.424 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.7 pm0 -60.11 -31.07 69.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.041 1.736 . . . . 0.0 115.19 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 pt -111.34 19.77 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.11 -28.12 69.56 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.281 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -61.17 -23.8 65.83 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.1 mtm -87.63 6.59 33.88 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.8 tp -51.17 -52.15 61.52 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-O 114.435 -2.698 . . . . 0.0 112.812 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.82 -35.24 98.01 Favored 'Trans proline' 0 C--N 1.33 -0.396 0 CA-C-N 122.803 2.037 . . . . 0.0 114.149 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -73.59 -45.28 54.07 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.003 0.906 . . . . 0.0 112.028 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.02 -36.06 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.448 1.099 . . . . 0.0 111.111 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -58.95 -41.46 87.47 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.267 1.027 . . . . 0.0 110.42 171.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -66.02 -40.6 91.19 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.702 1.201 . . . . 0.0 110.957 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.3 -43.53 97.59 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.516 1.526 . . . . 0.0 112.557 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.9 mt -123.16 73.08 47.74 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 124.741 1.216 . . . . 0.0 111.583 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.16 -10.97 14.96 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 121.512 1.474 . . . . 0.0 114.845 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -102.07 17.41 23.33 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -133.6 132.46 21.79 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.564 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 48.6 Cg_endo -70.03 116.3 4.52 Favored 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 122.024 1.816 . . . . 0.0 109.836 173.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.9 t -115.83 113.18 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 110.085 -3.234 . . . . 0.0 107.746 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -125.93 154.02 43.41 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 126.306 2.254 . . . . 0.0 111.189 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.43 136.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 113.154 -1.839 . . . . 0.0 108.615 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.26 129.26 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -55.99 126.17 24.73 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.534 1.159 . . . . 0.0 111.39 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 p -54.19 -34.32 60.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.81 -1.995 . . . . 0.0 114.894 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.9 tp -75.32 -47.94 25.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.563 1.145 . . . . 0.0 111.845 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.3 mt -57.34 -39.15 75.32 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.124 1.37 . . . . 0.0 111.742 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.99 -44.52 92.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.275 1.83 . . . . 0.0 111.389 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.07 -45.01 96.41 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.758 1.171 . . . . 0.0 112.191 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -68.75 -19.99 64.36 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.274 1.43 . . . . 0.0 113.563 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . 0.256 2.8 m 39.14 59.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 127.041 2.136 . . . . 0.0 113.048 -163.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -89.91 87.46 6.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 111.803 -2.453 . . . . 0.0 108.739 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.4 -38.07 56.84 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 111.511 -2.586 . . . . 0.0 113.731 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.7 tp -74.04 -44.83 52.95 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.766 0.426 . . . . 0.0 111.875 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.06 -51.19 51.79 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.638 1.59 . . . . 0.0 111.839 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.08 -40.56 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 114.221 -0.99 . . . . 0.0 110.673 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -45.56 91.7 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.285 0.634 . . . . 0.0 110.985 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -61.34 -41.77 97.58 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.82 0.848 . . . . 0.0 112.626 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.99 92.28 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.515 1.135 . . . . 0.0 111.566 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.49 96.58 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.309 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.428 ' HA ' HD12 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -70.91 -32.41 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.689 0.796 . . . . 0.0 111.468 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.91 80.59 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.995 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.74 -35.63 70.19 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.427 1.091 . . . . 0.0 112.832 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 97' ' ' VAL . 86.9 mt -62.06 -44.23 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.96 0.904 . . . . 0.0 109.375 171.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 21.3 mtpp -65.58 -36.7 84.51 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 174.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -64.08 -42.6 96.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.541 0.736 . . . . 0.0 109.918 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.564 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -62.61 154.55 28.71 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 113.782 -1.553 . . . . 0.0 107.161 158.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 62.85 -32.61 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -163.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 103' ' ' ALA . . . 120.56 128.82 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 131.472 3.909 . . . . 0.0 113.702 166.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 101' ' ' LYS . 1.1 t-20 . . . . . 0 C--O 1.25 1.122 0 C-N-CA 126.819 2.048 . . . . 0.0 107.116 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.4 tpp . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.77 95.32 4.01 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 125.183 1.552 . . . . 0.0 109.382 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -137.42 155.23 49.59 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.729 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.555 ' HD3' HG21 ' A' ' 100' ' ' ILE . 58.0 mttm -116.54 149.18 40.03 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.949 2.031 . . . . 0.0 111.909 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -106.85 118.35 36.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.645 -174.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.12 101.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 112.9 -1.955 . . . . 0.0 106.131 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -109.31 127.63 54.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.459 -1.246 . . . . 0.0 112.162 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.15 137.84 40.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.583 -2.098 . . . . 0.0 110.474 -177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -130.27 128.94 42.59 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.232 -1.804 . . . . 0.0 112.875 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CSP . . . . . 0.412 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 m -43.2 -53.68 4.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -169.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.85 -13.73 13.14 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.02 45.71 25.23 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.952 0.787 . . . . 0.0 112.756 -172.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.1 mmt -106.34 -72.36 0.72 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 -174.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 m -61.65 -35.03 76.79 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 p -55.24 -33.05 62.81 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.42 1.488 . . . . 0.0 113.654 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.6 t -54.06 -36.74 63.43 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.7 tp -67.37 -47.18 71.13 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.4 -39.11 93.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.288 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 38' ' ' ALA . 70.1 t -60.31 -46.12 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.858 1.263 . . . . 0.0 109.992 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.3 t -55.65 -49.77 71.99 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.808 0.843 . . . . 0.0 112.531 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -63.65 -39.51 94.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.563 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.2 ttp -70.52 -37.52 74.13 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.909 0.755 . . . . 0.0 112.797 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.9 mtt-85 -61.16 -45.71 93.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.545 1.138 . . . . 0.0 111.599 171.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.87 92.04 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.2 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.62 -33.9 69.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.976 0.51 . . . . 0.0 112.186 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.02 99.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.463 0.705 . . . . 0.0 111.248 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.94 -41.98 77.36 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.186 0.994 . . . . 0.0 111.614 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -62.07 -42.2 98.95 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.149 0.979 . . . . 0.0 112.651 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -104.87 30.79 5.22 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 32.47 65.05 0.23 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 125.074 2.369 . . . . 0.0 115.537 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -114.21 105.82 53.64 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.456 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.92 87.74 1.46 Allowed 'Trans proline' 0 C--N 1.33 -0.42 0 C-N-CA 122.15 1.9 . . . . 0.0 113.242 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.85 154.3 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 112.96 -1.927 . . . . 0.0 112.767 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.1 mt -113.78 110.41 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.128 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.28 117.54 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.851 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -138.65 149.83 45.59 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 125.073 1.483 . . . . 0.0 110.744 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -116.11 134.21 55.19 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.311 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -136.05 154.77 77.74 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 113.98 -1.463 . . . . 0.0 112.85 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 18.4 Cg_endo -67.39 152.23 79.22 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 C-N-CA 122.388 2.059 . . . . 0.0 112.587 169.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -24.49 63.53 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 113.923 -1.49 . . . . 0.0 114.681 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.3 p -57.77 -30.55 65.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.756 1.622 . . . . 0.0 113.894 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.4 mt -98.84 16.53 22.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.39 97.08 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.12 -60.47 6.76 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.66 -55.32 36.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.758 -1.721 . . . . 0.0 113.361 -170.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -83.4 -27.82 29.33 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.12 -24.81 67.5 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.247 0.927 . . . . 0.0 113.341 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -57.91 -30.91 66.29 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.96 1.304 . . . . 0.0 113.467 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -112.48 29.94 7.51 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.334 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.59 140.86 42.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.674 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -82.66 -34.6 27.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.759 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.4 p -140.73 139.98 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 122.479 1.133 . . . . 0.0 109.197 164.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.22 122.08 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.878 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.8 mt -113.47 132.31 55.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.915 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.7 mt -109.46 141.4 41.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.241 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.59 138.73 45.02 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 113.384 -1.734 . . . . 0.0 110.282 167.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.46 -25.02 64.3 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.251 1.967 . . . . 0.0 114.472 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -64.62 -30.71 71.73 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.989 1.315 . . . . 0.0 114.534 173.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 pt -110.89 27.94 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 122.359 1.076 . . . . 0.0 111.446 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.33 65.64 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.084 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -61.8 -22.18 65.23 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 85.4 mtp -86.62 3.25 45.32 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.67 -52.77 64.25 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-O 114.607 -2.616 . . . . 0.0 113.111 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.38 -29.81 91.12 Favored 'Trans proline' 0 C--N 1.33 -0.418 0 CA-C-N 122.971 2.097 . . . . 0.0 114.038 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.96 -45.18 24.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.931 0.872 . . . . 0.0 112.288 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.5 mt -71.55 -34.97 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.812 1.245 . . . . 0.0 111.058 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.77 -37.41 87.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.482 0.713 . . . . 0.0 110.716 172.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -64.2 -40.5 96.21 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.57 0.748 . . . . 0.0 110.979 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.3 mt -65.67 -42.61 91.11 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.954 1.302 . . . . 0.0 112.631 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 mt -123.7 72.63 52.05 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.061 1.344 . . . . 0.0 111.159 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.19 -19.11 12.26 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 121.617 1.545 . . . . 0.0 114.932 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -91.15 9.0 32.88 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -125.52 138.16 31.3 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.876 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.99 112.5 3.31 Favored 'Trans proline' 0 C--N 1.331 -0.386 0 C-N-CA 122.111 1.874 . . . . 0.0 109.92 170.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -116.45 111.81 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 110.789 -2.914 . . . . 0.0 107.175 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -124.81 157.72 35.13 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 125.984 2.052 . . . . 0.0 111.509 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.9 137.63 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 113.393 -1.73 . . . . 0.0 109.263 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.15 123.96 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.48 131.78 43.26 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.072 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 m -52.75 -41.07 63.68 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.05 -1.886 . . . . 0.0 114.006 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.5 tp -72.59 -46.08 56.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.27 1.028 . . . . 0.0 111.874 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.9 mt -58.21 -36.59 73.35 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.09 0.956 . . . . 0.0 112.772 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.06 -42.79 89.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.802 1.641 . . . . 0.0 111.502 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.47 -47.4 78.83 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.852 1.215 . . . . 0.0 112.64 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -61.74 -30.3 70.69 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.905 1.282 . . . . 0.0 112.498 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.4 t 55.59 58.68 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 127.523 2.329 . . . . 0.0 108.485 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -96.06 90.04 5.4 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 112.425 -2.171 . . . . 0.0 110.13 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -52.86 -47.48 59.06 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 111.923 -2.399 . . . . 0.0 112.496 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.01 -41.67 81.88 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.898 -0.651 . . . . 0.0 112.552 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.67 -50.14 70.19 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.577 1.56 . . . . 0.0 112.22 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.0 t -68.42 -34.58 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.777 0.831 . . . . 0.0 110.617 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp -61.04 -45.73 93.61 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.654 0.782 . . . . 0.0 111.018 176.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -66.12 -36.81 84.14 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.36 -36.23 71.41 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.052 0.845 . . . . 0.0 112.501 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.07 -43.31 78.9 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.894 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.7 m -72.36 -24.35 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.39 -41.05 70.12 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 113.13 -1.85 . . . . 0.0 111.356 173.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.58 -32.9 73.96 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.263 1.025 . . . . 0.0 111.916 171.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.64 HG22 ' H ' ' A' ' 101' ' ' LYS . 6.7 mt -77.61 179.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 159.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.64 ' H ' HG22 ' A' ' 100' ' ' ILE . 14.5 mtpp 57.24 -41.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 119.773 -1.829 . . . . 0.0 113.799 -147.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 100' ' ' ILE . 8.5 tmtt? 111.77 84.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 130.96 3.704 . . . . 0.0 107.406 162.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 49.71 43.72 24.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 111.657 -2.519 . . . . 0.0 110.251 -168.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 48.37 76.01 0.13 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.633 1.573 . . . . 0.0 112.501 -166.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 28.39 76.43 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.985 1.714 . . . . 0.0 115.12 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 112.577 -2.101 . . . . 0.0 108.471 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 116.537 -1.697 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 62.41 78.05 0.31 Allowed 'General case' 0 N--CA 1.471 0.624 0 O-C-N 125.917 2.011 . . . . 0.0 112.775 171.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -136.19 155.44 50.14 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.254 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -100.75 139.84 35.87 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 125.672 1.858 . . . . 0.0 111.298 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -102.65 113.83 27.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.879 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.03 106.55 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 113.267 -1.788 . . . . 0.0 106.765 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -113.08 125.5 54.45 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.709 1.242 . . . . 0.0 112.42 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.85 139.84 33.91 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.287 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.01 133.83 39.84 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.833 -1.53 . . . . 0.0 113.524 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CSP . . . . . 0.456 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m -47.07 -46.47 22.5 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -170.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.51 -30.19 12.3 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.81 31.85 47.62 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.257 0.932 . . . . 0.0 114.043 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.1 ptt? -113.9 -42.69 3.36 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.9 m -70.11 -27.86 64.92 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 p -65.57 -20.83 66.48 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.976 1.31 . . . . 0.0 114.283 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.1 p -61.08 -36.66 80.23 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -172.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.13 -43.4 74.48 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.428 0.691 . . . . 0.0 111.769 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 tt -63.54 -40.41 96.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.162 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.543 HG21 ' HB2' ' A' ' 38' ' ' ALA . 79.4 t -61.8 -46.54 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.621 1.168 . . . . 0.0 109.799 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 t -60.92 -38.76 86.89 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.235 0.614 . . . . 0.0 112.647 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -66.99 -47.21 72.21 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 17.8 ptm -75.46 -15.36 60.43 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -72.82 -45.01 60.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.35 0.66 . . . . 0.0 111.672 166.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.93 81.11 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.609 1.195 . . . . 0.0 112.358 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -74.61 -32.66 62.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.28 1.032 . . . . 0.0 112.014 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -33.46 75.82 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.739 0.649 . . . . 0.0 111.238 170.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -74.37 -39.46 62.73 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.942 0.776 . . . . 0.0 112.025 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -64.81 -46.02 83.75 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.498 0.719 . . . . 0.0 111.645 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -96.78 22.27 8.43 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.943 0.777 . . . . 0.0 112.619 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 29.53 69.2 0.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.942 2.497 . . . . 0.0 115.2 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.19 110.34 51.1 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 112.024 -2.353 . . . . 0.0 107.021 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.3 90.92 1.15 Allowed 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 122.498 2.132 . . . . 0.0 113.168 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 m -141.23 146.88 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 113.309 -1.769 . . . . 0.0 112.88 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.8 mt -106.43 108.5 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.205 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.423 HG22 HG13 ' A' ' 20' ' ' VAL . 18.4 mt -112.67 111.02 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.66 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -132.48 150.43 52.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.217 1.007 . . . . 0.0 112.325 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -110.64 140.94 44.53 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.613 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -142.88 150.8 54.6 Favored Pre-proline 0 N--CA 1.47 0.568 0 O-C-N 124.791 1.307 . . . . 0.0 112.981 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 16.5 Cg_endo -67.94 156.22 66.73 Favored 'Trans proline' 0 C--N 1.33 -0.415 0 C-N-CA 122.604 2.203 . . . . 0.0 112.128 165.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -17.24 52.41 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -175.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -59.34 -28.34 66.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.773 1.629 . . . . 0.0 113.692 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.8 mt -107.13 24.24 13.14 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.31 1.044 . . . . 0.0 113.195 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.47 82.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.58 -60.15 6.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -57.61 -57.08 14.26 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.749 1.22 . . . . 0.0 113.421 -172.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -78.62 -29.63 46.05 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.04 -28.26 68.56 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.015 0.817 . . . . 0.0 113.015 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -61.6 -25.36 67.29 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.434 1.494 . . . . 0.0 114.322 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -113.98 8.81 17.25 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -91.91 142.35 27.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.972 0.415 . . . . 0.0 110.625 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -87.55 -28.73 21.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.215 172.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.22 139.09 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 122.249 1.023 . . . . 0.0 109.168 162.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.7 t -107.52 126.23 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.11 -1.859 . . . . 0.0 106.969 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 96' ' ' ALA . 70.5 mt -112.45 137.51 50.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.417 -1.72 . . . . 0.0 111.057 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -113.89 141.03 47.87 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 113.013 -1.903 . . . . 0.0 111.892 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.53 140.87 47.54 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.527 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.72 -23.6 72.37 Favored 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.388 2.059 . . . . 0.0 114.605 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -66.19 -30.0 70.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.685 1.194 . . . . 0.0 114.036 173.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.5 pt -111.36 35.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 122.494 1.14 . . . . 0.0 111.916 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.43 -26.28 63.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.538 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -63.97 -21.45 66.49 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 43.3 mtp -85.26 -5.93 59.29 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 tp -54.56 -49.66 89.8 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 115.417 -2.23 . . . . 0.0 113.749 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.77 -30.14 84.25 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 CA-C-N 122.758 2.021 . . . . 0.0 114.405 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -82.01 -37.99 25.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.602 0.715 . . . . 0.0 112.8 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 84.1 mt -74.64 -30.07 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.169 0.988 . . . . 0.0 111.217 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.46 -39.06 88.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.281 0.632 . . . . 0.0 111.115 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -43.93 85.18 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.883 1.273 . . . . 0.0 110.384 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.96 -44.23 97.62 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.451 1.1 . . . . 0.0 112.303 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -123.5 78.52 54.73 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 124.748 1.219 . . . . 0.0 109.707 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.72 -26.54 8.17 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.03 1.82 . . . . 0.0 114.476 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -82.15 5.31 20.1 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 51' ' ' ALA . 74.9 mmtt -122.68 134.7 25.11 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.325 -176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -73.13 115.64 4.42 Favored 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 122.397 2.065 . . . . 0.0 110.328 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 t -118.96 114.76 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 111.948 -2.387 . . . . 0.0 107.52 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -121.98 158.9 28.09 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 125.987 2.054 . . . . 0.0 111.774 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.4 t -104.55 136.27 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.783 174.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.5 mt -67.05 129.54 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -58.34 126.79 29.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 125.015 1.447 . . . . 0.0 110.667 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.4 m -55.56 -36.76 67.17 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.961 -173.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.71 -46.84 65.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.009 0.924 . . . . 0.0 111.827 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.84 -35.41 76.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.421 0.688 . . . . 0.0 112.815 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -67.35 -43.54 81.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.483 1.513 . . . . 0.0 111.605 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.16 -49.28 62.73 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.986 1.279 . . . . 0.0 111.999 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -65.28 -26.54 68.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.017 0.927 . . . . 0.0 112.445 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.33 64.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.873 2.469 . . . . 0.0 108.053 -173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -103.23 89.17 3.32 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 112.769 -2.014 . . . . 0.0 108.606 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.92 -41.97 94.53 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 112.164 -2.289 . . . . 0.0 112.869 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.4 tp -66.57 -38.93 88.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.74 0.816 . . . . 0.0 112.027 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.45 -42.6 97.63 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.122 1.344 . . . . 0.0 112.23 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.9 -33.54 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.186 0.994 . . . . 0.0 111.062 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.38 -43.79 96.61 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.853 0.835 . . . . 0.0 110.638 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.9 -34.38 75.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.97 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.52 -34.11 71.94 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.358 1.036 . . . . 0.0 112.263 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -71.89 -42.17 67.11 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.808 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.0 -31.42 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.033 0.533 . . . . 0.0 111.166 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.94 -35.57 80.98 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.283 0.99 . . . . 0.0 110.894 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.78 -32.82 63.96 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.2 mt -69.65 -48.72 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -60.1 -38.1 81.97 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.5 0.72 . . . . 0.0 112.879 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -70.7 -43.03 69.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.517 1.127 . . . . 0.0 110.619 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.15 89.05 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 125.544 1.777 . . . . 0.0 111.883 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.11 -68.44 0.33 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.183 170.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 159.92 98.97 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.516 2.726 . . . . 0.0 107.854 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.293 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.79 127.85 34.16 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.912 1.382 . . . . 0.0 110.428 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.1 mttp 67.53 147.6 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.433 1.893 . . . . 0.0 112.708 -165.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.542 ' HD3' HG21 ' A' ' 100' ' ' ILE . 64.4 mttm -114.31 146.25 40.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.127 -2.306 . . . . 0.0 112.808 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -99.1 116.02 30.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.41 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.6 mt -114.24 99.07 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.4 m-30 -107.36 120.63 42.68 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.638 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -100.21 137.41 38.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.742 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -130.06 129.32 43.49 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 113.61 -1.632 . . . . 0.0 113.7 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CSP . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.9 m -42.8 -50.71 5.62 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 -165.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.49 -7.41 13.42 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.77 42.69 92.96 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.731 1.158 . . . . 0.0 113.771 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.537 ' HG3' ' H ' ' A' ' 15' ' ' SER . 4.1 ptt? -101.6 -71.37 0.71 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -174.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.537 ' H ' ' HG3' ' A' ' 14' ' ' MET . 96.2 p -68.03 -26.17 65.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.619 1.554 . . . . 0.0 113.517 -174.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.3 p -57.95 -34.24 69.7 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.758 1.223 . . . . 0.0 113.523 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.3 p -58.75 -34.85 71.86 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.4 tp -66.77 -47.2 72.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.783 0.833 . . . . 0.0 111.666 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.62 -40.87 96.39 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.274 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 38' ' ' ALA . 53.0 t -56.28 -50.67 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.269 1.428 . . . . 0.0 109.346 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -55.15 -42.51 73.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.454 0.702 . . . . 0.0 112.817 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -65.66 -45.1 84.2 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.8 ptm -75.66 -20.93 58.11 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -67.44 -47.36 70.4 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.21 1.004 . . . . 0.0 111.425 166.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.27 -33.93 76.57 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.545 1.164 . . . . 0.0 113.151 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -79.28 -27.33 42.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.151 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.04 71.07 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.867 0.467 . . . . 0.0 111.273 168.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.79 -48.51 58.9 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.309 1.044 . . . . 0.0 110.975 171.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.8 -47.06 87.24 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.478 1.111 . . . . 0.0 113.512 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -99.02 20.44 13.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.074 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 30.32 69.76 0.09 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 125.059 2.362 . . . . 0.0 115.167 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.06 108.26 55.4 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 111.929 -2.396 . . . . 0.0 107.839 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.52 85.4 1.8 Allowed 'Trans proline' 0 C--N 1.33 -0.443 0 C-N-CA 122.238 1.959 . . . . 0.0 113.714 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 4' ' ' LYS . 15.2 m -138.32 146.35 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 112.834 -1.985 . . . . 0.0 112.905 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.0 mt -105.73 107.41 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 112.811 -1.995 . . . . 0.0 107.226 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.402 HG22 HG13 ' A' ' 20' ' ' VAL . 13.6 mt -110.36 112.22 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 112.704 -2.044 . . . . 0.0 108.189 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -137.48 143.94 41.99 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 124.588 1.18 . . . . 0.0 111.483 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -110.68 134.52 52.38 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 113.227 -1.806 . . . . 0.0 111.955 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -134.36 154.62 79.96 Favored Pre-proline 0 N--CA 1.471 0.575 0 CA-C-N 113.458 -1.701 . . . . 0.0 112.699 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 9.4 Cg_endo -66.03 151.51 83.7 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.118 1.879 . . . . 0.0 112.335 166.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -23.2 62.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.993 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.2 p -54.98 -31.63 60.93 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.597 1.559 . . . . 0.0 113.999 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.75 17.29 18.33 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.75 89.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.435 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.9 -58.47 12.75 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 47' ' ' LYS . 1.5 tm-20 -57.28 -60.0 4.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 112.504 -1.848 . . . . 0.0 112.892 -169.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HD2' ' OE1' ' A' ' 46' ' ' GLU . 5.5 mptp? -77.4 -32.84 55.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.429 -1.26 . . . . 0.0 113.668 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.16 -26.07 65.4 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.419 1.009 . . . . 0.0 113.345 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.01 -30.15 65.86 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.305 1.442 . . . . 0.0 113.981 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -110.96 0.35 17.01 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.37 135.69 40.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.92 0.39 . . . . 0.0 110.002 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -80.0 -29.94 39.55 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.545 172.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.69 141.48 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 122.577 1.18 . . . . 0.0 109.63 162.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -107.44 119.13 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 112.497 -2.138 . . . . 0.0 106.807 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 76.0 mt -112.21 132.07 55.12 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.261 -1.791 . . . . 0.0 112.063 176.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.404 HD21 HG13 ' A' ' 67' ' ' ILE . 10.2 mp -106.09 141.22 37.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 113.426 -1.715 . . . . 0.0 113.487 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.75 136.34 41.37 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.243 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.12 -26.33 68.64 Favored 'Trans proline' 0 C--N 1.329 -0.469 0 C-N-CA 122.371 2.047 . . . . 0.0 114.75 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -65.74 -27.58 68.41 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.2 pt -111.04 22.49 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.666 0.746 . . . . 0.0 112.353 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.09 69.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.391 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -59.37 -26.72 65.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.406 ' O ' HG12 ' A' ' 67' ' ' ILE . 52.3 mtm -85.46 2.73 43.38 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.3 tp -52.25 -48.1 90.27 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 115.025 -2.417 . . . . 0.0 113.053 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.77 -37.92 84.8 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 122.565 2.176 . . . . 0.0 114.227 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 3.9 tp10 -77.78 -38.34 46.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.093 0.949 . . . . 0.0 112.653 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 63' ' ' MET . 48.2 mm -69.65 -39.69 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.424 1.09 . . . . 0.0 109.408 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -60.78 -40.57 93.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.662 1.185 . . . . 0.0 110.828 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.525 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 28.8 tpt85 -60.51 -41.85 95.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.407 1.483 . . . . 0.0 111.643 176.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.5 mt -68.89 -45.69 70.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.604 1.561 . . . . 0.0 112.616 175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -123.29 76.34 52.62 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.912 1.285 . . . . 0.0 110.848 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.2 -21.94 8.78 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 121.391 1.394 . . . . 0.0 113.917 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -86.68 8.09 23.88 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -128.19 140.41 38.21 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-O 118.714 -0.66 . . . . 0.0 110.081 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -71.76 112.72 3.45 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.196 1.931 . . . . 0.0 109.774 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.6 t -117.93 110.29 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 110.675 -2.966 . . . . 0.0 108.006 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -128.34 155.95 43.86 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 112.923 -1.944 . . . . 0.0 112.223 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.11 136.77 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 113.197 -1.819 . . . . 0.0 109.439 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.4 mt -72.87 128.55 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 10.0 t0 -56.22 126.73 27.46 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.959 174.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.0 m -50.75 -35.94 34.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 113.275 -1.784 . . . . 0.0 114.108 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 46.7 tp -71.41 -47.77 53.96 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.513 1.125 . . . . 0.0 111.944 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.63 -38.13 77.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.143 0.977 . . . . 0.0 112.713 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.35 -41.19 85.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.373 1.469 . . . . 0.0 111.728 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.77 -49.08 61.43 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.155 1.36 . . . . 0.0 112.443 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.73 -25.63 65.74 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.543 0.737 . . . . 0.0 112.648 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 t 56.33 63.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.733 2.413 . . . . 0.0 109.079 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -102.72 90.28 3.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.481 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.5 -45.09 85.29 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 112.227 -2.26 . . . . 0.0 113.341 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.53 -41.0 85.05 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.218 0.607 . . . . 0.0 112.41 -175.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.39 -46.17 81.12 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.431 1.491 . . . . 0.0 111.69 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.6 t -72.26 -38.24 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.832 0.853 . . . . 0.0 110.587 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.1 tp -60.95 -44.92 96.58 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.274 1.029 . . . . 0.0 111.491 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -67.94 -36.99 81.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.87 85.06 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.092 0.87 . . . . 0.0 111.699 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.79 -42.51 85.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.867 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -70.06 -31.26 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.935 0.874 . . . . 0.0 111.658 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.73 79.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.43 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.7 -29.98 70.59 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.542 HG21 ' HD3' ' A' ' 4' ' ' LYS . 81.4 mt -68.09 -47.14 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.909 0.883 . . . . 0.0 109.155 171.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -61.56 1.09 0.25 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 170.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 75.33 70.48 0.09 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 129.24 3.016 . . . . 0.0 109.913 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 44.95 45.08 8.5 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 109.293 -3.594 . . . . 0.0 110.937 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 50.24 62.76 2.51 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.139 1.775 . . . . 0.0 113.203 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 28.14 81.25 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 111.527 -2.578 . . . . 0.0 114.45 -174.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 C--O 1.249 1.079 0 CA-C-N 111.795 -2.457 . . . . 0.0 110.136 179.216 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mttp . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.25 147.8 26.22 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 126.002 2.064 . . . . 0.0 111.521 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -105.26 115.78 30.83 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 123.154 1.454 . . . . 0.0 112.25 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.7 mt -116.92 102.45 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.38 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -108.62 127.42 53.95 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.278 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.51 135.59 45.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.872 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 113.429 -1.714 . . . . 0.0 113.208 -176.716 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.93 -31.68 8.23 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.88 -0.34 59.15 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -102.12 -36.84 8.4 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 118.375 2.732 . . . . 0.0 118.375 -168.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 m -69.62 -31.92 70.31 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.099 1.318 . . . . 0.0 113.609 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 p -62.67 -18.98 63.38 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.862 1.665 . . . . 0.0 114.49 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -53.96 -41.73 68.12 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.27 -42.74 83.33 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.937 0.495 . . . . 0.0 111.861 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.16 -45.69 90.34 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.393 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.23 -50.52 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.369 1.068 . . . . 0.0 109.86 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.8 t -54.7 -46.02 74.07 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.275 1.03 . . . . 0.0 112.782 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.52 -42.86 82.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.374 0.67 . . . . 0.0 112.801 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 96.5 mtp -59.3 -43.66 92.6 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.173 0.92 . . . . 0.0 110.699 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -62.45 -48.28 80.34 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.355 1.062 . . . . 0.0 111.687 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.09 79.72 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -79.0 -32.17 45.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.785 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.02 -35.15 79.78 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.857 0.863 . . . . 0.0 111.474 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -69.91 -46.65 64.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.865 0.866 . . . . 0.0 110.944 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.81 -40.81 94.09 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.02 0.928 . . . . 0.0 113.162 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -104.2 24.59 11.25 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 31.95 56.92 0.34 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.525 2.33 . . . . 0.0 116.223 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.74 108.43 51.16 Favored Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 112.691 -2.05 . . . . 0.0 107.737 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.12 87.1 1.56 Allowed 'Trans proline' 0 C--N 1.33 -0.425 0 C-N-CA 122.111 1.874 . . . . 0.0 113.363 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 m -139.15 148.39 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 113.168 -1.833 . . . . 0.0 113.032 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.7 mt -106.83 115.94 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 113.056 -1.883 . . . . 0.0 107.438 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -119.28 114.63 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.419 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -139.56 147.7 41.54 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.755 1.284 . . . . 0.0 111.929 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.12 137.74 48.42 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.384 -1.735 . . . . 0.0 112.253 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -139.59 154.18 71.08 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.347 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -70.58 152.74 65.29 Favored 'Trans proline' 0 C--N 1.33 -0.424 0 C-N-CA 122.001 1.801 . . . . 0.0 112.341 168.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -26.33 61.63 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.108 1.763 . . . . 0.0 114.893 -173.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.6 p -56.07 -32.97 64.59 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.017 1.727 . . . . 0.0 113.624 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.5 mt -96.51 15.4 21.61 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.82 90.96 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.222 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.25 -63.06 4.38 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -57.66 -49.19 77.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 112.964 -1.618 . . . . 0.0 113.808 -168.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -90.17 -31.25 17.14 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.19 -24.26 63.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.897 0.76 . . . . 0.0 113.228 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -57.99 -29.91 65.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.319 1.447 . . . . 0.0 114.221 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -106.08 4.51 29.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.6 142.88 33.62 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.193 0.521 . . . . 0.0 110.273 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -89.05 -29.52 19.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.465 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.9 p -146.25 142.68 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.789 1.281 . . . . 0.0 109.259 162.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.59 123.27 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 112.279 -2.237 . . . . 0.0 107.142 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 96' ' ' ALA . 80.0 mt -113.19 132.9 55.31 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.858 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.5 mt -110.62 142.29 42.69 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 113.133 -1.849 . . . . 0.0 112.357 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.82 136.84 38.53 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.685 169.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.3 -27.68 68.07 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.32 2.014 . . . . 0.0 114.506 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -61.81 -28.53 69.54 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 pt -113.71 26.97 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.999 0.904 . . . . 0.0 111.918 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.25 -31.29 72.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.33 -21.04 64.97 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 78.2 mtp -86.63 -0.26 55.87 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.666 1.187 . . . . 0.0 114.12 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 12.6 tp -52.82 -50.15 82.83 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 114.104 -2.855 . . . . 0.0 112.414 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.01 -37.9 86.54 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 122.583 2.189 . . . . 0.0 113.876 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 4.9 tp10 -78.41 -37.57 43.64 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.3 mt -75.9 -33.82 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.753 1.221 . . . . 0.0 110.901 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -58.72 -40.79 84.75 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.682 0.793 . . . . 0.0 110.557 168.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 5.7 tmm_? -60.89 -45.0 96.32 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.669 1.188 . . . . 0.0 111.436 173.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.8 mt -63.96 -42.9 97.15 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.57 1.148 . . . . 0.0 113.011 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -124.02 71.01 51.91 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.317 1.447 . . . . 0.0 110.846 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.21 -8.68 18.81 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 122.029 1.819 . . . . 0.0 115.044 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -109.85 4.46 21.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -121.62 134.25 24.53 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.52 117.54 5.13 Favored 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 122.077 1.851 . . . . 0.0 110.812 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.9 t -121.01 114.28 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 111.078 -2.783 . . . . 0.0 108.114 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -128.59 154.86 45.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 112.827 -1.988 . . . . 0.0 111.56 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.1 t -96.23 139.8 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.143 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.0 mt -74.4 129.28 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.42 131.03 48.88 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 113.726 -1.579 . . . . 0.0 112.229 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.3 t -48.2 -46.89 35.6 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 111.909 -2.405 . . . . 0.0 113.858 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.3 tp -70.41 -43.82 69.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.998 0.919 . . . . 0.0 111.964 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.76 -38.97 83.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.05 0.94 . . . . 0.0 112.789 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -68.68 -45.68 71.05 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.802 1.241 . . . . 0.0 111.162 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.84 -35.78 92.46 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.784 1.183 . . . . 0.0 112.886 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -83.02 -17.04 44.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.906 1.283 . . . . 0.0 113.055 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.0 t 45.36 65.1 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 128.377 2.671 . . . . 0.0 111.046 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -102.49 93.52 5.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 112.62 -2.082 . . . . 0.0 110.098 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.47 -43.13 90.47 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 111.875 -2.421 . . . . 0.0 113.865 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.2 tp -67.23 -43.95 80.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.772 0.429 . . . . 0.0 112.14 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.73 -48.63 65.15 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.998 1.761 . . . . 0.0 111.85 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.79 -39.84 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 114.68 -0.76 . . . . 0.0 110.829 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.0 tp -61.16 -44.44 97.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.824 0.85 . . . . 0.0 110.934 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -63.11 -40.12 96.71 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.81 0.844 . . . . 0.0 112.306 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.31 87.53 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.138 0.899 . . . . 0.0 112.108 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -65.19 -46.86 79.06 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.555 1.142 . . . . 0.0 112.292 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.2 t -66.24 -39.39 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.062 1.345 . . . . 0.0 110.408 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.87 98.59 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.706 1.202 . . . . 0.0 110.944 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 C-N-CA 124.146 0.978 . . . . 0.0 112.484 177.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.8 mttt . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 120.941 0.401 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -102.85 148.12 26.04 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 125.846 1.967 . . . . 0.0 110.638 172.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -108.11 120.6 42.78 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.629 -1.168 . . . . 0.0 112.008 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.8 mt -120.76 108.89 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.513 -1.676 . . . . 0.0 106.495 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -114.85 125.76 54.03 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.214 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.37 127.51 46.67 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.382 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.47 0.553 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.275 -178.281 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.85 -15.16 11.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.77 45.25 76.57 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.896 0.76 . . . . 0.0 112.605 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 24.8 mmt -115.25 -71.15 0.76 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 p -66.83 -18.67 65.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -60.32 -28.97 68.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.166 1.387 . . . . 0.0 114.626 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.7 p -60.14 -34.59 73.76 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -65.88 -46.25 79.07 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.394 0.678 . . . . 0.0 111.551 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 tp -62.24 -43.35 99.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.609 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.585 HG21 ' HB2' ' A' ' 38' ' ' ALA . 74.6 t -61.82 -43.67 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.427 1.091 . . . . 0.0 110.742 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -60.51 -44.7 95.74 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.529 0.732 . . . . 0.0 112.557 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -66.21 -39.15 89.42 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.503 ' HB3' HD13 ' A' ' 36' ' ' ILE . 95.7 mtp -64.72 -40.62 95.64 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.978 0.799 . . . . 0.0 111.625 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -67.54 -41.86 83.64 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.976 0.91 . . . . 0.0 112.786 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.03 -39.25 90.05 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.811 0.815 . . . . 0.0 112.827 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -77.44 -29.24 52.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.645 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.57 78.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.535 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -72.27 -41.18 67.0 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.015 0.822 . . . . 0.0 111.676 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -63.66 -51.61 64.34 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.485 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -90.64 23.2 3.15 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 29.28 63.19 0.14 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 124.853 2.263 . . . . 0.0 115.047 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.67 108.81 59.28 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 112.403 -2.18 . . . . 0.0 106.815 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.16 89.44 1.17 Allowed 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 122.296 1.997 . . . . 0.0 112.601 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 m -144.91 150.3 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.804 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -110.72 106.6 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.027 176.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.503 HD13 ' HB3' ' A' ' 23' ' ' MET . 14.6 mt -111.48 112.3 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.011 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -134.59 151.92 51.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.644 1.178 . . . . 0.0 111.931 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -119.14 137.47 53.58 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.612 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -144.25 154.37 57.32 Favored Pre-proline 0 N--CA 1.47 0.526 0 O-C-N 124.75 1.282 . . . . 0.0 112.552 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -62.19 152.29 77.0 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 122.379 2.053 . . . . 0.0 112.62 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -22.77 47.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.032 1.733 . . . . 0.0 114.827 -173.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.3 p -58.42 -29.89 66.45 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.682 1.593 . . . . 0.0 113.702 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.7 mt -99.75 20.68 13.68 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.92 -45.3 64.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.107 -0.952 . . . . 0.0 113.075 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.12 -15.89 76.71 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.758 0.694 . . . . 0.0 113.833 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -97.13 -57.91 2.15 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.7 0.882 . . . . 0.0 112.884 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -85.25 -27.6 25.92 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.95 -15.98 56.58 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.112 0.863 . . . . 0.0 113.863 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -60.5 -27.0 67.25 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.771 1.228 . . . . 0.0 114.079 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -117.37 24.39 11.16 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.15 138.38 32.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.41 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.87 -23.23 24.04 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.342 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.56 133.76 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 122.442 1.115 . . . . 0.0 109.64 160.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.5 t -97.73 119.06 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 112.644 -2.071 . . . . 0.0 106.256 172.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 96' ' ' ALA . 74.9 mt -107.09 134.15 50.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.15 176.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.53 140.26 47.42 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.66 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.13 144.51 48.76 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.396 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.1 -26.82 83.12 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 C-N-CA 122.265 1.977 . . . . 0.0 114.291 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -64.69 -28.63 69.73 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 pt -114.71 30.09 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 122.411 1.1 . . . . 0.0 111.734 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.98 64.83 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -64.02 -22.59 66.99 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 84.7 mtp -85.3 6.45 26.21 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.26 -51.35 81.53 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-O 115.189 -2.339 . . . . 0.0 113.159 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.99 -28.05 80.19 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 CA-C-N 122.872 2.062 . . . . 0.0 114.031 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 2.0 tt0 -80.21 -37.79 32.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.3 mt -79.75 -29.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.813 1.245 . . . . 0.0 111.35 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -34.22 75.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.113 0.565 . . . . 0.0 110.552 171.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -61.77 -43.37 98.99 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.911 0.884 . . . . 0.0 110.74 172.036 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.1 mt -66.37 -42.22 88.31 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.984 0.914 . . . . 0.0 112.808 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.8 mt -124.1 76.69 59.6 Favored Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 124.931 1.293 . . . . 0.0 110.149 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.44 -11.26 10.71 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 121.895 1.73 . . . . 0.0 115.57 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -105.75 15.45 26.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.261 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.29 137.92 31.67 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.814 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.53 117.71 5.28 Favored 'Trans proline' 0 C--N 1.33 -0.421 0 C-N-CA 122.441 2.094 . . . . 0.0 110.34 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 t -120.73 110.71 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 111.956 -2.383 . . . . 0.0 106.835 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.12 146.81 50.59 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 125.866 1.979 . . . . 0.0 111.309 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.66 136.53 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.619 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.4 mt -70.48 133.71 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.409 1.083 . . . . 0.0 108.311 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.31 127.43 32.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.653 1.216 . . . . 0.0 110.957 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.1 m -56.21 -36.02 67.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 113.167 -1.833 . . . . 0.0 114.095 -174.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.9 tp -78.8 -36.51 42.65 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.206 0.603 . . . . 0.0 112.55 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.3 mt -60.46 -35.46 75.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.296 0.638 . . . . 0.0 112.713 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -67.84 -39.41 83.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.302 1.441 . . . . 0.0 111.23 174.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.5 -47.77 80.52 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.127 1.346 . . . . 0.0 112.452 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.99 -28.56 70.18 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.391 1.076 . . . . 0.0 112.244 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 t 53.67 62.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 127.511 2.325 . . . . 0.0 108.531 -170.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -100.73 92.32 5.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 112.184 -2.28 . . . . 0.0 109.908 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.69 -38.06 93.26 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 111.943 -2.39 . . . . 0.0 113.232 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.9 tp -71.79 -40.58 69.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.422 0.689 . . . . 0.0 111.908 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.71 -45.37 96.55 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.282 1.42 . . . . 0.0 112.733 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.17 -32.63 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.782 0.833 . . . . 0.0 110.997 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -44.74 95.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.416 0.627 . . . . 0.0 111.503 175.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -66.78 -33.74 76.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.223 1.009 . . . . 0.0 113.026 176.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.72 -34.36 67.05 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.204 0.94 . . . . 0.0 112.677 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.403 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -70.22 -43.08 71.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.01 0.924 . . . . 0.0 111.704 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.16 -36.6 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.595 1.158 . . . . 0.0 110.705 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.73 81.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.913 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 123.648 0.779 . . . . 0.0 112.806 175.898 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 89.0 mttt . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 120.897 0.379 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -102.1 148.07 25.84 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 125.859 1.974 . . . . 0.0 111.646 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -106.16 118.85 37.69 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.343 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.8 mt -118.83 105.54 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -110.09 128.4 55.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.503 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -100.48 134.94 42.68 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.012 -1.903 . . . . 0.0 110.077 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.47 0.54 0 CA-C-N 113.601 -1.636 . . . . 0.0 113.245 -177.348 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.68 -34.32 7.02 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.62 37.12 12.36 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 123.943 0.782 . . . . 0.0 113.448 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 8.9 ptp -121.44 -48.93 2.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.7 m -63.63 -32.73 74.3 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 p -64.58 -24.36 67.57 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.2 p -58.83 -35.82 73.52 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.0 tp -69.31 -45.72 68.84 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.66 0.384 . . . . 0.0 111.441 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' A' ' 23' ' ' MET . 1.0 OUTLIER -60.89 -35.62 77.13 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 175.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.606 HG13 HG22 ' A' ' 36' ' ' ILE . 74.7 t -61.83 -48.72 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.429 1.091 . . . . 0.0 110.252 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.7 p -68.52 -26.85 65.65 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -65.0 -44.35 89.53 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.175 0.99 . . . . 0.0 112.3 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 18.3 ptm -85.01 -13.0 51.96 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -71.96 -41.53 67.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.544 0.338 . . . . 0.0 110.938 164.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.81 86.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.691 0.758 . . . . 0.0 112.242 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.456 HE21 ' HB2' ' A' ' 90' ' ' LEU . 15.2 mm100 -70.17 -34.62 73.22 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.611 173.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.5 98.76 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.18 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.16 -33.48 73.47 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.698 0.799 . . . . 0.0 112.486 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -65.49 -51.83 57.23 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.206 0.603 . . . . 0.0 111.015 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -90.24 24.57 2.48 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.863 0.865 . . . . 0.0 113.305 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 28.31 64.85 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 124.947 2.308 . . . . 0.0 115.192 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.08 105.49 57.29 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-N 112.885 -1.961 . . . . 0.0 107.084 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 76.3 Cg_endo -75.81 93.99 1.0 Allowed 'Trans proline' 0 C--N 1.331 -0.371 0 C-N-CA 122.396 2.064 . . . . 0.0 112.183 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.07 152.68 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 113.915 -1.493 . . . . 0.0 114.319 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.99 107.13 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 112.179 -2.282 . . . . 0.0 107.144 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.606 HG22 HG13 ' A' ' 20' ' ' VAL . 20.6 mt -112.6 113.35 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.102 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -136.58 148.78 47.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 125.311 1.632 . . . . 0.0 112.201 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.96 139.62 46.14 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.036 -1.438 . . . . 0.0 113.101 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -142.57 152.18 59.29 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.477 1.111 . . . . 0.0 113.128 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.23 154.08 75.29 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.376 2.051 . . . . 0.0 113.128 167.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -22.59 63.93 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.577 1.551 . . . . 0.0 114.154 -175.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 p -60.36 -31.02 69.94 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.507 1.523 . . . . 0.0 113.164 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -98.77 21.79 10.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.29 1.036 . . . . 0.0 113.093 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.3 -48.91 77.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.057 -0.973 . . . . 0.0 112.673 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.27 -57.61 17.49 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.148 0.905 . . . . 0.0 111.589 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.21 -53.57 53.37 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 113.231 -1.484 . . . . 0.0 113.59 -170.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -80.45 -31.53 37.43 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.339 1.236 . . . . 0.0 114.339 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.33 -20.21 54.47 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.73 1.157 . . . . 0.0 113.643 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -59.68 -32.7 70.74 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.244 1.018 . . . . 0.0 113.396 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.5 -16.38 18.34 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.677 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.53 135.47 48.58 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.143 0.497 . . . . 0.0 111.087 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -86.55 -26.22 24.63 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.391 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.17 140.62 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 122.191 0.996 . . . . 0.0 109.248 163.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 76' ' ' VAL . 94.5 t -109.12 126.55 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.349 175.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 96' ' ' ALA . 84.2 mt -115.96 122.82 46.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.245 -1.798 . . . . 0.0 111.356 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 mt -100.45 142.08 32.41 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.421 -1.718 . . . . 0.0 111.925 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.23 144.14 49.07 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.668 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.66 -24.93 77.36 Favored 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 122.272 1.981 . . . . 0.0 114.335 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -67.8 -28.66 67.78 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 pt -113.12 25.29 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 122.053 0.93 . . . . 0.0 112.141 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.3 -29.21 65.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.992 -1.003 . . . . 0.0 113.437 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -61.52 -24.24 66.48 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.675 173.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.0 mtm -87.74 7.43 30.29 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.1 tp -50.86 -46.2 87.22 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 116.418 -1.753 . . . . 0.0 113.823 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.6 -29.12 61.01 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 122.192 1.928 . . . . 0.0 114.827 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -81.61 -36.96 28.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.725 0.774 . . . . 0.0 112.846 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 mm -65.39 -40.55 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.029 1.332 . . . . 0.0 109.509 173.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -73.58 -25.54 60.4 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -65.07 -39.81 93.77 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 170.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.7 mt -65.62 -53.6 39.33 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.537 1.135 . . . . 0.0 112.338 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.87 75.49 71.15 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 124.369 1.068 . . . . 0.0 111.481 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.96 -22.31 23.27 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.256 1.971 . . . . 0.0 115.629 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -86.38 -0.73 56.57 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.46 134.46 20.83 Favored Pre-proline 0 N--CA 1.47 0.526 0 C-N-CA 123.217 0.607 . . . . 0.0 110.771 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.93 116.88 4.88 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 122.42 2.08 . . . . 0.0 110.513 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.583 HG22 ' HB ' ' A' ' 54' ' ' VAL . 59.9 t -123.58 119.59 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 112.087 -2.324 . . . . 0.0 108.352 -175.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -125.51 158.48 34.42 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 126.24 2.213 . . . . 0.0 111.753 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.8 t -99.79 138.22 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.419 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.0 mt -72.11 126.64 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.14 131.45 50.54 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.676 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.1 m -57.83 -34.35 69.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 112.85 -1.977 . . . . 0.0 113.907 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -38.61 53.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.595 0.758 . . . . 0.0 112.48 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.58 -38.25 86.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.325 0.65 . . . . 0.0 112.092 171.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -66.57 -41.38 88.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.568 1.547 . . . . 0.0 111.331 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.58 -43.02 99.6 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.071 1.319 . . . . 0.0 112.498 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -75.54 -28.25 58.97 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t 58.35 70.22 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 127.376 2.271 . . . . 0.0 108.078 -168.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.86 99.49 8.39 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 113.198 -1.819 . . . . 0.0 110.589 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.81 -43.19 98.15 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 111.77 -2.468 . . . . 0.0 113.867 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HB2' HE21 ' A' ' 26' ' ' GLN . 65.0 tp -64.22 -43.27 95.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.86 -42.22 91.95 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 124.708 1.146 . . . . 0.0 112.743 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.9 t -77.75 -38.21 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.668 0.787 . . . . 0.0 110.993 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.94 -39.66 95.3 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.773 0.829 . . . . 0.0 111.603 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -64.8 -43.26 93.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.902 1.281 . . . . 0.0 111.278 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.44 83.7 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.058 0.849 . . . . 0.0 112.381 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -67.85 -44.12 77.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.163 -1.38 . . . . 0.0 112.35 176.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.53 -27.58 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 121.814 -0.554 . . . . 0.0 112.209 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.85 83.85 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.187 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 C-N-CA 123.679 0.792 . . . . 0.0 113.045 176.332 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.9 mttt . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 122.632 1.206 . . . . 0.0 113.886 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -110.06 143.71 39.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 112.908 -1.951 . . . . 0.0 112.227 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -101.69 116.69 33.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.958 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.7 mt -114.4 103.02 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.309 -1.769 . . . . 0.0 106.471 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -110.29 127.17 54.88 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 122.731 1.253 . . . . 0.0 112.45 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -101.17 133.09 46.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.72 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 N--CA 1.469 0.481 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.678 -177.45 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.65 -23.56 11.75 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.71 23.55 77.7 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.341 0.972 . . . . 0.0 114.87 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.7 ptp -118.32 -37.56 3.32 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.3 m -65.57 -29.88 70.54 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.113 0.87 . . . . 0.0 112.198 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 p -71.71 -20.2 61.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.726 1.61 . . . . 0.0 114.505 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.0 p -63.13 -34.98 78.79 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 tp -65.94 -44.53 84.79 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.101 0.561 . . . . 0.0 111.691 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 tt -62.16 -40.82 97.28 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.13 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 38' ' ' ALA . 73.1 t -61.47 -45.0 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.488 1.115 . . . . 0.0 109.717 175.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -59.08 -40.35 84.98 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -65.87 -44.23 86.0 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.9 ptm -77.99 -21.56 50.67 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -67.34 -46.07 74.51 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.857 0.863 . . . . 0.0 111.52 166.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.37 84.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.006 0.908 . . . . 0.0 112.758 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -75.6 -33.12 60.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.88 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.61 84.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.928 0.491 . . . . 0.0 111.323 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.76 -42.78 77.03 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 111.332 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -63.53 -52.09 62.65 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.444 0.698 . . . . 0.0 111.764 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -85.04 11.8 8.9 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 51.88 51.06 17.29 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 123.958 1.837 . . . . 0.0 112.774 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.2 t -102.05 111.66 64.51 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 112.971 -1.922 . . . . 0.0 107.977 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.71 87.6 1.5 Allowed 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 121.995 1.797 . . . . 0.0 112.781 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.07 152.37 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.589 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.4 mt -112.18 105.75 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.395 -1.73 . . . . 0.0 107.91 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 20' ' ' VAL . 23.2 mt -105.78 118.97 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.83 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -149.44 139.34 21.94 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.457 1.098 . . . . 0.0 112.606 -171.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -104.23 138.15 41.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 113.248 -1.796 . . . . 0.0 112.684 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -139.32 151.49 67.26 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.777 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -66.36 152.95 79.8 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 122.412 2.075 . . . . 0.0 112.7 168.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -22.73 62.74 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.076 -1.42 . . . . 0.0 114.664 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -60.32 -28.34 68.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.386 1.474 . . . . 0.0 113.667 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.6 mt -99.08 19.81 14.51 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.14 86.75 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.89 -51.96 31.57 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -61.21 -59.3 5.53 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.642 -1.279 . . . . 0.0 112.918 -172.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -78.85 -24.35 44.41 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.21 -29.37 72.76 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.869 0.747 . . . . 0.0 113.577 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.07 -29.57 70.7 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -109.95 30.09 7.02 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.026 0.917 . . . . 0.0 112.439 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.33 140.55 45.81 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.481 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.34 -49.8 11.02 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.084 170.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.3 140.85 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 122.089 0.947 . . . . 0.0 110.46 171.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.94 122.01 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 113.074 -1.875 . . . . 0.0 107.811 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.5 mt -116.94 115.51 25.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 113.553 -1.658 . . . . 0.0 112.688 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.2 mt -88.89 139.29 30.61 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 112.508 -2.133 . . . . 0.0 112.095 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.02 140.83 45.87 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 113.747 -1.569 . . . . 0.0 110.083 167.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -58.58 -24.85 72.1 Favored 'Trans proline' 0 C--N 1.331 -0.386 0 C-N-CA 122.299 1.999 . . . . 0.0 114.428 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 -64.79 -31.42 72.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.48 26.82 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.159 0.981 . . . . 0.0 111.988 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.56 -29.33 68.68 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.419 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -64.29 -21.8 66.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.1 mtm -89.26 13.25 13.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.6 tp -55.7 -50.71 85.49 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-O 114.903 -2.475 . . . . 0.0 112.382 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.46 -28.84 87.45 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 CA-C-N 122.716 2.006 . . . . 0.0 114.471 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -78.12 -43.39 29.03 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 70' ' ' LEU . 80.2 mt -76.5 -31.42 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.513 1.125 . . . . 0.0 111.539 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -72.35 -31.01 65.25 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.862 0.465 . . . . 0.0 111.247 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.8 ttp-105 -64.48 -43.24 94.8 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.853 0.461 . . . . 0.0 110.292 172.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 67' ' ' ILE . 35.0 mt -62.73 -44.35 96.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.372 1.069 . . . . 0.0 112.305 174.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -124.67 80.27 62.01 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 124.712 1.205 . . . . 0.0 110.179 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.84 -22.71 3.49 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 121.505 1.47 . . . . 0.0 115.621 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -97.72 14.06 28.19 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -127.2 129.65 23.89 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 118.067 -0.968 . . . . 0.0 108.646 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.45 119.14 6.12 Favored 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 122.656 2.238 . . . . 0.0 112.09 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -122.47 112.56 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 111.556 -2.566 . . . . 0.0 107.879 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -126.65 159.79 32.59 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 125.717 1.886 . . . . 0.0 111.267 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.9 t -98.37 140.78 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.559 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.78 132.32 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.4 1.08 . . . . 0.0 108.411 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 13.7 t0 -59.68 125.36 23.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.248 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -54.39 -33.06 58.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.517 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 49.5 tp -72.57 -46.51 54.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.674 1.19 . . . . 0.0 112.271 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.16 -37.36 79.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.699 0.8 . . . . 0.0 112.56 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -65.72 -40.39 92.17 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.216 1.406 . . . . 0.0 111.354 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.32 -47.96 79.21 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.003 1.287 . . . . 0.0 112.066 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.73 -30.66 71.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.557 0.743 . . . . 0.0 112.586 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 t 57.09 63.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 127.522 2.329 . . . . 0.0 108.241 -169.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -105.7 94.17 5.05 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 112.604 -2.089 . . . . 0.0 109.089 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.72 -46.94 91.67 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 111.751 -2.477 . . . . 0.0 112.869 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.4 tp -63.58 -37.18 86.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.475 0.71 . . . . 0.0 112.302 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.94 -46.06 94.21 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.577 1.56 . . . . 0.0 112.448 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -73.02 -33.84 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.096 0.959 . . . . 0.0 110.929 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.25 -43.58 98.64 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.65 0.78 . . . . 0.0 110.614 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.91 -35.26 76.63 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.431 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.06 81.86 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.191 0.932 . . . . 0.0 111.926 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.06 -43.93 77.51 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.027 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.64 -31.62 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.324 0.65 . . . . 0.0 111.215 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.99 -37.3 83.97 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.987 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.53 0 C-N-CA 123.559 0.744 . . . . 0.0 112.929 176.119 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 11.4 tptt . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.532 ' HB2' HG12 ' A' ' 34' ' ' VAL . 4.4 mptp? -107.37 136.48 47.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.999 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -99.26 110.45 22.98 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.165 1.459 . . . . 0.0 111.71 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.2 mt -111.94 103.69 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.819 -1.991 . . . . 0.0 106.633 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -110.62 126.58 54.62 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.92 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.47 140.04 37.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 112.746 -2.024 . . . . 0.0 111.737 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 N--CA 1.47 0.529 0 CA-C-N 113.872 -1.513 . . . . 0.0 113.828 -176.239 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.87 -26.55 10.19 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.27 40.36 20.11 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.052 0.834 . . . . 0.0 113.859 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.9 mtm -111.71 -58.09 2.17 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 92.3 p -60.56 -29.65 69.29 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 p -61.4 -25.18 67.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.973 1.709 . . . . 0.0 114.429 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.3 p -55.9 -40.62 73.31 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -171.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.6 tp -67.45 -43.53 80.88 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.737 0.415 . . . . 0.0 111.606 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.74 -40.49 92.61 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.966 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.44 -45.3 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.583 1.153 . . . . 0.0 110.03 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 t -57.64 -46.86 83.64 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -64.66 -36.19 83.46 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.597 ' HB3' HD13 ' A' ' 36' ' ' ILE . 46.0 mmm -61.71 -47.56 84.74 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.735 1.214 . . . . 0.0 111.436 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -64.99 -38.71 91.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.643 0.777 . . . . 0.0 112.061 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.26 -41.38 81.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -69.49 -30.85 68.81 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.912 0.485 . . . . 0.0 112.276 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.98 92.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.122 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.59 -41.59 79.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.663 0.785 . . . . 0.0 111.818 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -59.32 -42.1 90.64 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.125 0.97 . . . . 0.0 112.91 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -109.54 26.04 11.1 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 22.57 68.29 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 125.374 2.512 . . . . 0.0 115.277 -170.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.9 t -98.32 107.34 41.23 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 112.513 -2.13 . . . . 0.0 106.463 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 72.9 Cg_endo -75.18 87.55 1.33 Allowed 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.189 1.926 . . . . 0.0 112.636 -176.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 4' ' ' LYS . 15.4 m -141.93 152.21 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 113.066 -1.879 . . . . 0.0 113.577 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.84 110.55 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 112.333 -2.212 . . . . 0.0 106.671 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.597 HD13 ' HB3' ' A' ' 23' ' ' MET . 8.7 mt -116.25 115.32 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.508 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -145.5 142.84 29.59 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.836 1.335 . . . . 0.0 112.112 -172.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.34 145.64 31.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 113.674 -1.603 . . . . 0.0 113.513 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.36 154.22 56.73 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 125.103 1.361 . . . . 0.0 112.909 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -68.5 155.01 70.53 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 122.355 2.037 . . . . 0.0 113.43 167.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -31.65 67.77 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -170.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 t -62.48 -24.51 67.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.992 1.317 . . . . 0.0 113.942 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.4 mt -95.64 15.73 19.16 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.46 99.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.408 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.06 -62.56 5.33 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.27 -54.68 44.03 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 112.825 -1.688 . . . . 0.0 113.426 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.4 -31.89 29.39 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.57 -23.84 65.39 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.87 0.748 . . . . 0.0 113.282 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -58.03 -29.17 65.13 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.856 1.262 . . . . 0.0 113.983 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -116.78 33.11 5.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.197 0.999 . . . . 0.0 112.228 176.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.62 136.71 47.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.812 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -80.55 -29.92 37.08 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.091 173.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.31 138.81 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 122.656 1.217 . . . . 0.0 109.609 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.4 t -104.76 121.26 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 112.262 -2.245 . . . . 0.0 106.734 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.5 mt -113.69 136.4 52.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.793 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.6 mt -111.65 140.55 46.19 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.974 -1.921 . . . . 0.0 112.584 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.81 136.33 41.19 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.149 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.8 -24.44 55.74 Favored 'Trans proline' 0 C--N 1.33 -0.413 0 C-N-CA 122.414 2.076 . . . . 0.0 114.861 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.2 pm0 -65.08 -29.95 70.87 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.605 1.562 . . . . 0.0 115.141 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 pt -110.92 22.33 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.757 0.789 . . . . 0.0 112.037 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.52 -29.22 69.26 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.111 -0.95 . . . . 0.0 113.466 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -60.55 -24.54 65.48 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.0 mtm -88.62 11.04 18.46 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.5 tp -52.97 -47.88 93.83 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-O 114.902 -2.475 . . . . 0.0 112.545 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.38 -35.03 90.93 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 122.335 2.024 . . . . 0.0 114.252 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -78.89 -41.27 30.15 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.811 0.815 . . . . 0.0 112.829 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -67.11 -39.34 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.282 1.033 . . . . 0.0 109.214 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.86 -32.23 71.75 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.606 0.763 . . . . 0.0 111.58 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -63.02 -40.13 96.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.052 0.941 . . . . 0.0 110.806 172.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.8 mt -68.95 -44.76 72.34 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.003 1.321 . . . . 0.0 112.289 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.3 mt -124.35 76.22 61.55 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 124.943 1.297 . . . . 0.0 111.093 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.33 -27.43 5.36 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 C-N-CA 121.612 1.541 . . . . 0.0 114.659 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -97.56 23.85 7.29 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.473 1.13 . . . . 0.0 113.16 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -130.03 133.91 25.52 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.704 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.12 112.56 3.17 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 122.253 1.968 . . . . 0.0 110.149 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -118.26 112.18 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 110.852 -2.885 . . . . 0.0 108.07 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -127.16 153.45 46.03 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.12 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.0 t -93.55 136.04 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.842 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.6 mt -69.53 128.76 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -56.61 125.85 24.07 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.754 -1.566 . . . . 0.0 111.42 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.5 p -54.26 -34.99 62.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.975 -1.92 . . . . 0.0 114.326 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.1 tp -74.07 -44.81 52.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.092 1.357 . . . . 0.0 112.081 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.06 -37.75 80.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.948 0.899 . . . . 0.0 112.603 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -66.58 -40.92 89.15 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.346 1.459 . . . . 0.0 111.372 175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.94 -49.55 62.37 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.019 1.295 . . . . 0.0 112.355 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -66.27 -24.76 66.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.813 0.845 . . . . 0.0 112.968 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 t 56.56 62.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 127.388 2.275 . . . . 0.0 108.458 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -105.92 99.4 8.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 112.522 -2.126 . . . . 0.0 111.261 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.45 -33.52 81.64 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 111.704 -2.498 . . . . 0.0 113.762 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.43 -47.14 57.73 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.63 -0.335 . . . . 0.0 111.276 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.93 -43.97 92.66 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.975 1.274 . . . . 0.0 112.571 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.7 t -75.06 -35.88 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.377 0.671 . . . . 0.0 111.138 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.94 -44.49 96.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.873 0.844 . . . . 0.0 111.712 176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -68.01 -34.15 75.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.307 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.65 -39.88 80.5 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.359 1.037 . . . . 0.0 112.066 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.12 -44.2 84.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.965 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.76 -31.58 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.195 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.28 -36.4 81.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.716 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 C-N-CA 123.683 0.793 . . . . 0.0 112.99 177.074 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.459 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 34.9 mttp . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 121.256 0.551 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -103.1 150.14 23.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 112.542 -2.117 . . . . 0.0 113.251 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -105.4 116.05 31.29 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.943 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.1 mt -115.36 108.5 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 112.588 -2.096 . . . . 0.0 106.52 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -112.44 129.13 56.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 122.418 1.104 . . . . 0.0 112.912 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.02 136.02 46.43 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.153 -1.84 . . . . 0.0 111.102 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 N--CA 1.47 0.528 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.473 -175.255 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.33 -31.86 8.41 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.77 16.33 54.88 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.914 1.245 . . . . 0.0 115.219 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.8 ptp -103.66 -42.04 5.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.4 p -58.47 -36.14 73.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.8 p -64.92 -23.31 67.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.892 2.077 . . . . 0.0 113.885 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.0 t -46.81 -50.41 18.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.14 -45.98 89.4 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -57.34 -45.73 84.01 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.727 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.84 -49.69 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.972 1.309 . . . . 0.0 109.717 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -56.39 -45.05 80.76 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.502 0.721 . . . . 0.0 112.652 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -66.23 -41.43 90.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.447 ' HB3' HD13 ' A' ' 36' ' ' ILE . 97.4 mtp -61.4 -44.03 97.85 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.779 0.832 . . . . 0.0 110.868 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -61.19 -46.08 91.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.534 1.134 . . . . 0.0 112.013 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.88 89.01 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -71.28 -35.91 71.5 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.372 0.669 . . . . 0.0 111.621 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.52 -38.74 92.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.298 1.039 . . . . 0.0 111.067 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.31 -43.75 76.91 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.655 1.182 . . . . 0.0 111.384 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -58.98 -41.94 88.76 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.463 1.105 . . . . 0.0 112.812 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -105.28 24.92 11.3 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 28.07 58.31 0.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.589 2.356 . . . . 0.0 116.558 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.6 t -96.87 111.72 58.39 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 111.922 -2.399 . . . . 0.0 107.94 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 73.1 Cg_endo -78.37 84.21 2.06 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 121.467 1.445 . . . . 0.0 113.16 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.43 152.09 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 112.855 -1.975 . . . . 0.0 112.659 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.5 mt -111.91 109.34 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.285 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 23' ' ' MET . 17.4 mt -109.16 118.4 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 112.664 -2.062 . . . . 0.0 107.535 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -143.98 143.7 31.34 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 126.234 2.209 . . . . 0.0 111.186 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.8 142.11 44.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.186 -1.37 . . . . 0.0 114.224 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -143.25 154.24 60.64 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 124.853 1.261 . . . . 0.0 113.34 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.2 156.03 59.97 Favored 'Trans proline' 0 C--N 1.33 -0.422 0 C-N-CA 122.311 2.008 . . . . 0.0 112.962 166.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -27.11 68.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.816 -1.538 . . . . 0.0 114.258 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.8 p -56.86 -26.32 58.35 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.14 1.776 . . . . 0.0 113.817 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.7 mt -102.57 16.28 26.83 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.388 1.075 . . . . 0.0 113.833 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.56 93.81 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.421 1.088 . . . . 0.0 113.859 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.64 -54.52 35.01 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' OE1' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -61.81 -62.05 2.07 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.213 -0.993 . . . . 0.0 112.554 -171.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE2' ' OE1' ' A' ' 46' ' ' GLU . 74.0 mmtt -72.13 -31.58 66.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.92 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.17 -28.44 66.66 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.905 0.764 . . . . 0.0 113.063 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -61.82 -29.72 70.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.395 1.078 . . . . 0.0 113.504 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -110.31 20.57 17.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.135 0.974 . . . . 0.0 113.602 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.72 145.05 26.15 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.687 170.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -89.69 -29.43 18.77 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.092 168.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.95 141.39 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 122.436 1.112 . . . . 0.0 110.54 163.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.8 t -107.17 121.85 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 112.847 -1.979 . . . . 0.0 107.459 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.4 mt -116.33 127.68 54.89 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.291 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 mt -105.74 141.55 36.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 112.739 -2.028 . . . . 0.0 112.828 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.69 137.26 44.37 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.202 168.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.32 -35.14 43.18 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 123.157 2.571 . . . . 0.0 114.424 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.7 pm0 -60.11 -31.07 69.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.041 1.736 . . . . 0.0 115.19 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 pt -111.34 19.77 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.11 -28.12 69.56 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.281 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -61.17 -23.8 65.83 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.1 mtm -87.63 6.59 33.88 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.8 tp -51.17 -52.15 61.52 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-O 114.435 -2.698 . . . . 0.0 112.812 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.82 -35.24 98.01 Favored 'Trans proline' 0 C--N 1.33 -0.396 0 CA-C-N 122.803 2.037 . . . . 0.0 114.149 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -73.59 -45.28 54.07 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.003 0.906 . . . . 0.0 112.028 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.02 -36.06 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.448 1.099 . . . . 0.0 111.111 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -58.95 -41.46 87.47 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.267 1.027 . . . . 0.0 110.42 171.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -66.02 -40.6 91.19 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.702 1.201 . . . . 0.0 110.957 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.3 -43.53 97.59 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.516 1.526 . . . . 0.0 112.557 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.9 mt -123.16 73.08 47.74 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 124.741 1.216 . . . . 0.0 111.583 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.16 -10.97 14.96 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 121.512 1.474 . . . . 0.0 114.845 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -102.07 17.41 23.33 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -133.6 132.46 21.79 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.03 116.3 4.52 Favored 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 122.024 1.816 . . . . 0.0 109.836 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.9 t -115.83 113.18 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 110.085 -3.234 . . . . 0.0 107.746 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -125.93 154.02 43.41 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 126.306 2.254 . . . . 0.0 111.189 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.43 136.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 113.154 -1.839 . . . . 0.0 108.615 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.26 129.26 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -55.99 126.17 24.73 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.534 1.159 . . . . 0.0 111.39 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 p -54.19 -34.32 60.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.81 -1.995 . . . . 0.0 114.894 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.9 tp -75.32 -47.94 25.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.563 1.145 . . . . 0.0 111.845 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.3 mt -57.34 -39.15 75.32 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.124 1.37 . . . . 0.0 111.742 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.99 -44.52 92.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.275 1.83 . . . . 0.0 111.389 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.07 -45.01 96.41 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.758 1.171 . . . . 0.0 112.191 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -68.75 -19.99 64.36 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.274 1.43 . . . . 0.0 113.563 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . 0.256 2.8 m 39.14 59.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 127.041 2.136 . . . . 0.0 113.048 -163.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -89.91 87.46 6.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 111.803 -2.453 . . . . 0.0 108.739 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.4 -38.07 56.84 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 111.511 -2.586 . . . . 0.0 113.731 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.7 tp -74.04 -44.83 52.95 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.766 0.426 . . . . 0.0 111.875 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.06 -51.19 51.79 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.638 1.59 . . . . 0.0 111.839 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.08 -40.56 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 114.221 -0.99 . . . . 0.0 110.673 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -45.56 91.7 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.285 0.634 . . . . 0.0 110.985 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -61.34 -41.77 97.58 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.82 0.848 . . . . 0.0 112.626 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.99 92.28 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.515 1.135 . . . . 0.0 111.566 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.49 96.58 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.309 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.91 -32.41 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.689 0.796 . . . . 0.0 111.468 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.91 80.59 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.995 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.494 0 C-N-CA 124.427 1.091 . . . . 0.0 112.832 175.702 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 120.971 0.415 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -116.54 149.18 40.03 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.949 2.031 . . . . 0.0 111.909 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -106.85 118.35 36.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.645 -174.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.12 101.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 112.9 -1.955 . . . . 0.0 106.131 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -109.31 127.63 54.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.459 -1.246 . . . . 0.0 112.162 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.15 137.84 40.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.583 -2.098 . . . . 0.0 110.474 -177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 N--CA 1.471 0.589 0 CA-C-N 113.232 -1.804 . . . . 0.0 112.875 -177.818 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.85 -13.73 13.14 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.02 45.71 25.23 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.952 0.787 . . . . 0.0 112.756 -172.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.1 mmt -106.34 -72.36 0.72 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 -174.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 m -61.65 -35.03 76.79 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 p -55.24 -33.05 62.81 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.42 1.488 . . . . 0.0 113.654 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.6 t -54.06 -36.74 63.43 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.7 tp -67.37 -47.18 71.13 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.4 -39.11 93.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.288 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 38' ' ' ALA . 70.1 t -60.31 -46.12 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.858 1.263 . . . . 0.0 109.992 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.3 t -55.65 -49.77 71.99 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.808 0.843 . . . . 0.0 112.531 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -63.65 -39.51 94.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.563 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.2 ttp -70.52 -37.52 74.13 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.909 0.755 . . . . 0.0 112.797 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.9 mtt-85 -61.16 -45.71 93.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.545 1.138 . . . . 0.0 111.599 171.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.87 92.04 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.2 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.62 -33.9 69.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.976 0.51 . . . . 0.0 112.186 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.02 99.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.463 0.705 . . . . 0.0 111.248 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.94 -41.98 77.36 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.186 0.994 . . . . 0.0 111.614 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -62.07 -42.2 98.95 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.149 0.979 . . . . 0.0 112.651 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -104.87 30.79 5.22 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 32.47 65.05 0.23 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 125.074 2.369 . . . . 0.0 115.537 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -114.21 105.82 53.64 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.456 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.92 87.74 1.46 Allowed 'Trans proline' 0 C--N 1.33 -0.42 0 C-N-CA 122.15 1.9 . . . . 0.0 113.242 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.85 154.3 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 112.96 -1.927 . . . . 0.0 112.767 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.1 mt -113.78 110.41 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.128 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.28 117.54 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.851 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -138.65 149.83 45.59 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 125.073 1.483 . . . . 0.0 110.744 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -116.11 134.21 55.19 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.311 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -136.05 154.77 77.74 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 113.98 -1.463 . . . . 0.0 112.85 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -67.39 152.23 79.22 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 C-N-CA 122.388 2.059 . . . . 0.0 112.587 169.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -24.49 63.53 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 113.923 -1.49 . . . . 0.0 114.681 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.3 p -57.77 -30.55 65.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.756 1.622 . . . . 0.0 113.894 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.4 mt -98.84 16.53 22.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.39 97.08 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.12 -60.47 6.76 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.66 -55.32 36.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.758 -1.721 . . . . 0.0 113.361 -170.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -83.4 -27.82 29.33 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.12 -24.81 67.5 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.247 0.927 . . . . 0.0 113.341 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -57.91 -30.91 66.29 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.96 1.304 . . . . 0.0 113.467 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -112.48 29.94 7.51 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.334 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.59 140.86 42.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.674 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -82.66 -34.6 27.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.759 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.4 p -140.73 139.98 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 122.479 1.133 . . . . 0.0 109.197 164.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.22 122.08 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.878 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.8 mt -113.47 132.31 55.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.915 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.7 mt -109.46 141.4 41.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.241 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.59 138.73 45.02 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 113.384 -1.734 . . . . 0.0 110.282 167.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.46 -25.02 64.3 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.251 1.967 . . . . 0.0 114.472 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -64.62 -30.71 71.73 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.989 1.315 . . . . 0.0 114.534 173.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 pt -110.89 27.94 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 122.359 1.076 . . . . 0.0 111.446 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.33 65.64 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.084 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -61.8 -22.18 65.23 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 85.4 mtp -86.62 3.25 45.32 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.67 -52.77 64.25 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-O 114.607 -2.616 . . . . 0.0 113.111 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.38 -29.81 91.12 Favored 'Trans proline' 0 C--N 1.33 -0.418 0 CA-C-N 122.971 2.097 . . . . 0.0 114.038 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.96 -45.18 24.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.931 0.872 . . . . 0.0 112.288 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.5 mt -71.55 -34.97 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.812 1.245 . . . . 0.0 111.058 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.77 -37.41 87.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.482 0.713 . . . . 0.0 110.716 172.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -64.2 -40.5 96.21 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.57 0.748 . . . . 0.0 110.979 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.3 mt -65.67 -42.61 91.11 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.954 1.302 . . . . 0.0 112.631 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 mt -123.7 72.63 52.05 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.061 1.344 . . . . 0.0 111.159 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.19 -19.11 12.26 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 121.617 1.545 . . . . 0.0 114.932 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -91.15 9.0 32.88 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -125.52 138.16 31.3 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.876 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.99 112.5 3.31 Favored 'Trans proline' 0 C--N 1.331 -0.386 0 C-N-CA 122.111 1.874 . . . . 0.0 109.92 170.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -116.45 111.81 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 110.789 -2.914 . . . . 0.0 107.175 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -124.81 157.72 35.13 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 125.984 2.052 . . . . 0.0 111.509 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.9 137.63 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 113.393 -1.73 . . . . 0.0 109.263 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.15 123.96 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.48 131.78 43.26 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.072 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 m -52.75 -41.07 63.68 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.05 -1.886 . . . . 0.0 114.006 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.5 tp -72.59 -46.08 56.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.27 1.028 . . . . 0.0 111.874 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.9 mt -58.21 -36.59 73.35 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.09 0.956 . . . . 0.0 112.772 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.06 -42.79 89.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.802 1.641 . . . . 0.0 111.502 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.47 -47.4 78.83 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.852 1.215 . . . . 0.0 112.64 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -61.74 -30.3 70.69 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.905 1.282 . . . . 0.0 112.498 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.4 t 55.59 58.68 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 127.523 2.329 . . . . 0.0 108.485 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -96.06 90.04 5.4 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 112.425 -2.171 . . . . 0.0 110.13 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -52.86 -47.48 59.06 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 111.923 -2.399 . . . . 0.0 112.496 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.01 -41.67 81.88 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.898 -0.651 . . . . 0.0 112.552 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.67 -50.14 70.19 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.577 1.56 . . . . 0.0 112.22 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.0 t -68.42 -34.58 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.777 0.831 . . . . 0.0 110.617 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp -61.04 -45.73 93.61 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.654 0.782 . . . . 0.0 111.018 176.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -66.12 -36.81 84.14 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.36 -36.23 71.41 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.052 0.845 . . . . 0.0 112.501 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.07 -43.31 78.9 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.894 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.7 m -72.36 -24.35 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.39 -41.05 70.12 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 113.13 -1.85 . . . . 0.0 111.356 173.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 124.263 1.025 . . . . 0.0 111.916 171.362 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mttp . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -100.75 139.84 35.87 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 125.672 1.858 . . . . 0.0 111.298 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -102.65 113.83 27.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.879 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.03 106.55 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 113.267 -1.788 . . . . 0.0 106.765 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -113.08 125.5 54.45 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.709 1.242 . . . . 0.0 112.42 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.85 139.84 33.91 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.287 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.47 0.541 0 CA-C-N 113.833 -1.53 . . . . 0.0 113.524 -174.97 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.51 -30.19 12.3 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.81 31.85 47.62 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.257 0.932 . . . . 0.0 114.043 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.1 ptt? -113.9 -42.69 3.36 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.9 m -70.11 -27.86 64.92 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 p -65.57 -20.83 66.48 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.976 1.31 . . . . 0.0 114.283 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.1 p -61.08 -36.66 80.23 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -172.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.13 -43.4 74.48 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.428 0.691 . . . . 0.0 111.769 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 tt -63.54 -40.41 96.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.162 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.543 HG21 ' HB2' ' A' ' 38' ' ' ALA . 79.4 t -61.8 -46.54 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.621 1.168 . . . . 0.0 109.799 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 t -60.92 -38.76 86.89 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.235 0.614 . . . . 0.0 112.647 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -66.99 -47.21 72.21 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 17.8 ptm -75.46 -15.36 60.43 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -72.82 -45.01 60.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.35 0.66 . . . . 0.0 111.672 166.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.93 81.11 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.609 1.195 . . . . 0.0 112.358 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -74.61 -32.66 62.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.28 1.032 . . . . 0.0 112.014 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -33.46 75.82 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.739 0.649 . . . . 0.0 111.238 170.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -74.37 -39.46 62.73 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.942 0.776 . . . . 0.0 112.025 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -64.81 -46.02 83.75 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.498 0.719 . . . . 0.0 111.645 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -96.78 22.27 8.43 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.943 0.777 . . . . 0.0 112.619 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 29.53 69.2 0.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.942 2.497 . . . . 0.0 115.2 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.19 110.34 51.1 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 112.024 -2.353 . . . . 0.0 107.021 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.3 90.92 1.15 Allowed 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 122.498 2.132 . . . . 0.0 113.168 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 m -141.23 146.88 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 113.309 -1.769 . . . . 0.0 112.88 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.8 mt -106.43 108.5 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.205 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.423 HG22 HG13 ' A' ' 20' ' ' VAL . 18.4 mt -112.67 111.02 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.66 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -132.48 150.43 52.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.217 1.007 . . . . 0.0 112.325 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -110.64 140.94 44.53 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.613 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -142.88 150.8 54.6 Favored Pre-proline 0 N--CA 1.47 0.568 0 O-C-N 124.791 1.307 . . . . 0.0 112.981 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -67.94 156.22 66.73 Favored 'Trans proline' 0 C--N 1.33 -0.415 0 C-N-CA 122.604 2.203 . . . . 0.0 112.128 165.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -17.24 52.41 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -175.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -59.34 -28.34 66.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.773 1.629 . . . . 0.0 113.692 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.8 mt -107.13 24.24 13.14 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.31 1.044 . . . . 0.0 113.195 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.47 82.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.58 -60.15 6.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -57.61 -57.08 14.26 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.749 1.22 . . . . 0.0 113.421 -172.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -78.62 -29.63 46.05 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.04 -28.26 68.56 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.015 0.817 . . . . 0.0 113.015 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -61.6 -25.36 67.29 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.434 1.494 . . . . 0.0 114.322 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -113.98 8.81 17.25 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -91.91 142.35 27.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.972 0.415 . . . . 0.0 110.625 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -87.55 -28.73 21.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.215 172.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.22 139.09 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 122.249 1.023 . . . . 0.0 109.168 162.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.7 t -107.52 126.23 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.11 -1.859 . . . . 0.0 106.969 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 96' ' ' ALA . 70.5 mt -112.45 137.51 50.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.417 -1.72 . . . . 0.0 111.057 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -113.89 141.03 47.87 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 113.013 -1.903 . . . . 0.0 111.892 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.53 140.87 47.54 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.527 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.72 -23.6 72.37 Favored 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.388 2.059 . . . . 0.0 114.605 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -66.19 -30.0 70.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.685 1.194 . . . . 0.0 114.036 173.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.5 pt -111.36 35.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 122.494 1.14 . . . . 0.0 111.916 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.43 -26.28 63.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.538 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -63.97 -21.45 66.49 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 43.3 mtp -85.26 -5.93 59.29 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 tp -54.56 -49.66 89.8 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 115.417 -2.23 . . . . 0.0 113.749 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.77 -30.14 84.25 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 CA-C-N 122.758 2.021 . . . . 0.0 114.405 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -82.01 -37.99 25.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.602 0.715 . . . . 0.0 112.8 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 84.1 mt -74.64 -30.07 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.169 0.988 . . . . 0.0 111.217 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.46 -39.06 88.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.281 0.632 . . . . 0.0 111.115 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -43.93 85.18 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.883 1.273 . . . . 0.0 110.384 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.96 -44.23 97.62 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.451 1.1 . . . . 0.0 112.303 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -123.5 78.52 54.73 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 124.748 1.219 . . . . 0.0 109.707 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.72 -26.54 8.17 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.03 1.82 . . . . 0.0 114.476 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -82.15 5.31 20.1 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 51' ' ' ALA . 74.9 mmtt -122.68 134.7 25.11 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.325 -176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -73.13 115.64 4.42 Favored 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 122.397 2.065 . . . . 0.0 110.328 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 t -118.96 114.76 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 111.948 -2.387 . . . . 0.0 107.52 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -121.98 158.9 28.09 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 125.987 2.054 . . . . 0.0 111.774 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.4 t -104.55 136.27 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.783 174.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.5 mt -67.05 129.54 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -58.34 126.79 29.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 125.015 1.447 . . . . 0.0 110.667 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.4 m -55.56 -36.76 67.17 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.961 -173.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.71 -46.84 65.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.009 0.924 . . . . 0.0 111.827 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.84 -35.41 76.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.421 0.688 . . . . 0.0 112.815 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -67.35 -43.54 81.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.483 1.513 . . . . 0.0 111.605 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.16 -49.28 62.73 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.986 1.279 . . . . 0.0 111.999 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -65.28 -26.54 68.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.017 0.927 . . . . 0.0 112.445 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.33 64.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.873 2.469 . . . . 0.0 108.053 -173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -103.23 89.17 3.32 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 112.769 -2.014 . . . . 0.0 108.606 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.92 -41.97 94.53 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 112.164 -2.289 . . . . 0.0 112.869 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.4 tp -66.57 -38.93 88.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.74 0.816 . . . . 0.0 112.027 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.45 -42.6 97.63 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.122 1.344 . . . . 0.0 112.23 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.9 -33.54 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.186 0.994 . . . . 0.0 111.062 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.38 -43.79 96.61 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.853 0.835 . . . . 0.0 110.638 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.9 -34.38 75.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.97 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.52 -34.11 71.94 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.358 1.036 . . . . 0.0 112.263 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -71.89 -42.17 67.11 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.808 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.0 -31.42 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.033 0.533 . . . . 0.0 111.166 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.94 -35.57 80.98 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.283 0.99 . . . . 0.0 110.894 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 176.843 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.1 mttp . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 122.47 1.129 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.485 ' HB2' HG12 ' A' ' 34' ' ' VAL . 64.4 mttm -114.31 146.25 40.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.127 -2.306 . . . . 0.0 112.808 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -99.1 116.02 30.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.41 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.6 mt -114.24 99.07 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.4 m-30 -107.36 120.63 42.68 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.638 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -100.21 137.41 38.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.742 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 . . . . . 0 N--CA 1.47 0.537 0 CA-C-N 113.61 -1.632 . . . . 0.0 113.7 -174.784 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.49 -7.41 13.42 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.77 42.69 92.96 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.731 1.158 . . . . 0.0 113.771 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.537 ' HG3' ' H ' ' A' ' 15' ' ' SER . 4.1 ptt? -101.6 -71.37 0.71 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -174.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.537 ' H ' ' HG3' ' A' ' 14' ' ' MET . 96.2 p -68.03 -26.17 65.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.619 1.554 . . . . 0.0 113.517 -174.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.3 p -57.95 -34.24 69.7 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.758 1.223 . . . . 0.0 113.523 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.3 p -58.75 -34.85 71.86 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.4 tp -66.77 -47.2 72.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.783 0.833 . . . . 0.0 111.666 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.62 -40.87 96.39 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.274 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 38' ' ' ALA . 53.0 t -56.28 -50.67 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.269 1.428 . . . . 0.0 109.346 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -55.15 -42.51 73.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.454 0.702 . . . . 0.0 112.817 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -65.66 -45.1 84.2 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.8 ptm -75.66 -20.93 58.11 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -67.44 -47.36 70.4 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.21 1.004 . . . . 0.0 111.425 166.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.27 -33.93 76.57 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.545 1.164 . . . . 0.0 113.151 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.41 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 73.4 mt-30 -79.28 -27.33 42.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.151 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.04 71.07 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.867 0.467 . . . . 0.0 111.273 168.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.79 -48.51 58.9 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.309 1.044 . . . . 0.0 110.975 171.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.8 -47.06 87.24 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.478 1.111 . . . . 0.0 113.512 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -99.02 20.44 13.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.074 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 30.32 69.76 0.09 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 125.059 2.362 . . . . 0.0 115.167 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.06 108.26 55.4 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 111.929 -2.396 . . . . 0.0 107.839 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.52 85.4 1.8 Allowed 'Trans proline' 0 C--N 1.33 -0.443 0 C-N-CA 122.238 1.959 . . . . 0.0 113.714 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 4' ' ' LYS . 15.2 m -138.32 146.35 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 112.834 -1.985 . . . . 0.0 112.905 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.0 mt -105.73 107.41 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 112.811 -1.995 . . . . 0.0 107.226 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.402 HG22 HG13 ' A' ' 20' ' ' VAL . 13.6 mt -110.36 112.22 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 112.704 -2.044 . . . . 0.0 108.189 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -137.48 143.94 41.99 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 124.588 1.18 . . . . 0.0 111.483 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -110.68 134.52 52.38 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 113.227 -1.806 . . . . 0.0 111.955 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -134.36 154.62 79.96 Favored Pre-proline 0 N--CA 1.471 0.575 0 CA-C-N 113.458 -1.701 . . . . 0.0 112.699 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.03 151.51 83.7 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.118 1.879 . . . . 0.0 112.335 166.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -23.2 62.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.993 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.2 p -54.98 -31.63 60.93 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.597 1.559 . . . . 0.0 113.999 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.75 17.29 18.33 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.75 89.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.435 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.9 -58.47 12.75 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 47' ' ' LYS . 1.5 tm-20 -57.28 -60.0 4.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 112.504 -1.848 . . . . 0.0 112.892 -169.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HD2' ' OE1' ' A' ' 46' ' ' GLU . 5.5 mptp? -77.4 -32.84 55.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.429 -1.26 . . . . 0.0 113.668 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.16 -26.07 65.4 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.419 1.009 . . . . 0.0 113.345 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.01 -30.15 65.86 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.305 1.442 . . . . 0.0 113.981 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -110.96 0.35 17.01 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.37 135.69 40.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.92 0.39 . . . . 0.0 110.002 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -80.0 -29.94 39.55 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.545 172.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.69 141.48 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 122.577 1.18 . . . . 0.0 109.63 162.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -107.44 119.13 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 112.497 -2.138 . . . . 0.0 106.807 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 76.0 mt -112.21 132.07 55.12 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.261 -1.791 . . . . 0.0 112.063 176.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.404 HD21 HG13 ' A' ' 67' ' ' ILE . 10.2 mp -106.09 141.22 37.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 113.426 -1.715 . . . . 0.0 113.487 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.75 136.34 41.37 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.243 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.12 -26.33 68.64 Favored 'Trans proline' 0 C--N 1.329 -0.469 0 C-N-CA 122.371 2.047 . . . . 0.0 114.75 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -65.74 -27.58 68.41 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.2 pt -111.04 22.49 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.666 0.746 . . . . 0.0 112.353 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.09 69.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.391 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -59.37 -26.72 65.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.406 ' O ' HG12 ' A' ' 67' ' ' ILE . 52.3 mtm -85.46 2.73 43.38 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.3 tp -52.25 -48.1 90.27 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 115.025 -2.417 . . . . 0.0 113.053 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.77 -37.92 84.8 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 122.565 2.176 . . . . 0.0 114.227 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 3.9 tp10 -77.78 -38.34 46.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.093 0.949 . . . . 0.0 112.653 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 63' ' ' MET . 48.2 mm -69.65 -39.69 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.424 1.09 . . . . 0.0 109.408 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -60.78 -40.57 93.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.662 1.185 . . . . 0.0 110.828 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.525 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 28.8 tpt85 -60.51 -41.85 95.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.407 1.483 . . . . 0.0 111.643 176.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.5 mt -68.89 -45.69 70.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.604 1.561 . . . . 0.0 112.616 175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -123.29 76.34 52.62 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.912 1.285 . . . . 0.0 110.848 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.2 -21.94 8.78 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 121.391 1.394 . . . . 0.0 113.917 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -86.68 8.09 23.88 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -128.19 140.41 38.21 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-O 118.714 -0.66 . . . . 0.0 110.081 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -71.76 112.72 3.45 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.196 1.931 . . . . 0.0 109.774 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.6 t -117.93 110.29 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 110.675 -2.966 . . . . 0.0 108.006 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -128.34 155.95 43.86 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 112.923 -1.944 . . . . 0.0 112.223 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.11 136.77 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 113.197 -1.819 . . . . 0.0 109.439 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.4 mt -72.87 128.55 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 10.0 t0 -56.22 126.73 27.46 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.959 174.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.0 m -50.75 -35.94 34.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 113.275 -1.784 . . . . 0.0 114.108 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 46.7 tp -71.41 -47.77 53.96 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.513 1.125 . . . . 0.0 111.944 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.63 -38.13 77.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.143 0.977 . . . . 0.0 112.713 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.35 -41.19 85.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.373 1.469 . . . . 0.0 111.728 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.77 -49.08 61.43 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.155 1.36 . . . . 0.0 112.443 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.73 -25.63 65.74 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.543 0.737 . . . . 0.0 112.648 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 t 56.33 63.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.733 2.413 . . . . 0.0 109.079 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -102.72 90.28 3.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.481 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.5 -45.09 85.29 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 112.227 -2.26 . . . . 0.0 113.341 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.41 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 48.9 tp -67.53 -41.0 85.05 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.218 0.607 . . . . 0.0 112.41 -175.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.39 -46.17 81.12 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.431 1.491 . . . . 0.0 111.69 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.6 t -72.26 -38.24 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.832 0.853 . . . . 0.0 110.587 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.1 tp -60.95 -44.92 96.58 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.274 1.029 . . . . 0.0 111.491 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -67.94 -36.99 81.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.87 85.06 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.092 0.87 . . . . 0.0 111.699 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.79 -42.51 85.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.867 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -31.26 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.935 0.874 . . . . 0.0 111.658 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.73 79.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.43 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 177.557 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.6 108.56 1.42 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.717 1.886 . . . . 0.0 110.426 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -131.16 137.34 48.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.249 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.25 147.8 26.22 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 126.002 2.064 . . . . 0.0 111.521 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -105.26 115.78 30.83 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 123.154 1.454 . . . . 0.0 112.25 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.7 mt -116.92 102.45 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.38 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -108.62 127.42 53.95 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.278 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.51 135.59 45.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.872 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.19 130.1 44.26 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.429 -1.714 . . . . 0.0 113.208 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CSP . . . . . 0.511 ' O3P' ' HB2' ' A' ' 15' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -55.33 -46.22 76.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -173.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.93 -31.68 8.23 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.88 -0.34 59.15 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -102.12 -36.84 8.4 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 118.375 2.732 . . . . 0.0 118.375 -168.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.511 ' HB2' ' O3P' ' A' ' 10' ' ' CSP . 41.0 m -69.62 -31.92 70.31 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.099 1.318 . . . . 0.0 113.609 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 p -62.67 -18.98 63.38 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.862 1.665 . . . . 0.0 114.49 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -53.96 -41.73 68.12 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.27 -42.74 83.33 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.937 0.495 . . . . 0.0 111.861 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.16 -45.69 90.34 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.393 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.23 -50.52 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.369 1.068 . . . . 0.0 109.86 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.8 t -54.7 -46.02 74.07 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.275 1.03 . . . . 0.0 112.782 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.52 -42.86 82.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.374 0.67 . . . . 0.0 112.801 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 96.5 mtp -59.3 -43.66 92.6 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.173 0.92 . . . . 0.0 110.699 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -62.45 -48.28 80.34 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.355 1.062 . . . . 0.0 111.687 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.09 79.72 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -79.0 -32.17 45.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.785 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.02 -35.15 79.78 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.857 0.863 . . . . 0.0 111.474 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -69.91 -46.65 64.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.865 0.866 . . . . 0.0 110.944 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.81 -40.81 94.09 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.02 0.928 . . . . 0.0 113.162 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -104.2 24.59 11.25 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 31.95 56.92 0.34 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.525 2.33 . . . . 0.0 116.223 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.74 108.43 51.16 Favored Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 112.691 -2.05 . . . . 0.0 107.737 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.12 87.1 1.56 Allowed 'Trans proline' 0 C--N 1.33 -0.425 0 C-N-CA 122.111 1.874 . . . . 0.0 113.363 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 m -139.15 148.39 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 113.168 -1.833 . . . . 0.0 113.032 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.7 mt -106.83 115.94 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 113.056 -1.883 . . . . 0.0 107.438 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -119.28 114.63 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.419 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -139.56 147.7 41.54 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.755 1.284 . . . . 0.0 111.929 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.12 137.74 48.42 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.384 -1.735 . . . . 0.0 112.253 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -139.59 154.18 71.08 Favored Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.347 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -70.58 152.74 65.29 Favored 'Trans proline' 0 C--N 1.33 -0.424 0 C-N-CA 122.001 1.801 . . . . 0.0 112.341 168.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -26.33 61.63 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.108 1.763 . . . . 0.0 114.893 -173.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.6 p -56.07 -32.97 64.59 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.017 1.727 . . . . 0.0 113.624 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.5 mt -96.51 15.4 21.61 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.82 90.96 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.222 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.25 -63.06 4.38 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -57.66 -49.19 77.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 112.964 -1.618 . . . . 0.0 113.808 -168.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -90.17 -31.25 17.14 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.19 -24.26 63.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.897 0.76 . . . . 0.0 113.228 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -57.99 -29.91 65.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.319 1.447 . . . . 0.0 114.221 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -106.08 4.51 29.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.6 142.88 33.62 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.193 0.521 . . . . 0.0 110.273 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -89.05 -29.52 19.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.465 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.9 p -146.25 142.68 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.789 1.281 . . . . 0.0 109.259 162.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.59 123.27 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 112.279 -2.237 . . . . 0.0 107.142 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 96' ' ' ALA . 80.0 mt -113.19 132.9 55.31 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.858 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.5 mt -110.62 142.29 42.69 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 113.133 -1.849 . . . . 0.0 112.357 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.82 136.84 38.53 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.685 169.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.3 -27.68 68.07 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.32 2.014 . . . . 0.0 114.506 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -61.81 -28.53 69.54 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 pt -113.71 26.97 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.999 0.904 . . . . 0.0 111.918 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.25 -31.29 72.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.33 -21.04 64.97 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 78.2 mtp -86.63 -0.26 55.87 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.666 1.187 . . . . 0.0 114.12 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 12.6 tp -52.82 -50.15 82.83 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 114.104 -2.855 . . . . 0.0 112.414 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.01 -37.9 86.54 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 122.583 2.189 . . . . 0.0 113.876 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 4.9 tp10 -78.41 -37.57 43.64 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.3 mt -75.9 -33.82 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.753 1.221 . . . . 0.0 110.901 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -58.72 -40.79 84.75 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.682 0.793 . . . . 0.0 110.557 168.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 5.7 tmm_? -60.89 -45.0 96.32 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.669 1.188 . . . . 0.0 111.436 173.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.8 mt -63.96 -42.9 97.15 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.57 1.148 . . . . 0.0 113.011 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -124.02 71.01 51.91 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.317 1.447 . . . . 0.0 110.846 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.21 -8.68 18.81 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 122.029 1.819 . . . . 0.0 115.044 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -109.85 4.46 21.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -121.62 134.25 24.53 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.52 117.54 5.13 Favored 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 122.077 1.851 . . . . 0.0 110.812 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.9 t -121.01 114.28 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 111.078 -2.783 . . . . 0.0 108.114 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -128.59 154.86 45.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 112.827 -1.988 . . . . 0.0 111.56 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.1 t -96.23 139.8 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.143 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.0 mt -74.4 129.28 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.42 131.03 48.88 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 113.726 -1.579 . . . . 0.0 112.229 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.3 t -48.2 -46.89 35.6 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 111.909 -2.405 . . . . 0.0 113.858 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.3 tp -70.41 -43.82 69.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.998 0.919 . . . . 0.0 111.964 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.76 -38.97 83.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.05 0.94 . . . . 0.0 112.789 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -68.68 -45.68 71.05 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.802 1.241 . . . . 0.0 111.162 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.84 -35.78 92.46 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.784 1.183 . . . . 0.0 112.886 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -83.02 -17.04 44.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.906 1.283 . . . . 0.0 113.055 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.0 t 45.36 65.1 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 128.377 2.671 . . . . 0.0 111.046 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -102.49 93.52 5.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 112.62 -2.082 . . . . 0.0 110.098 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.47 -43.13 90.47 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 111.875 -2.421 . . . . 0.0 113.865 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.2 tp -67.23 -43.95 80.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.772 0.429 . . . . 0.0 112.14 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.73 -48.63 65.15 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.998 1.761 . . . . 0.0 111.85 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.79 -39.84 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 114.68 -0.76 . . . . 0.0 110.829 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.0 tp -61.16 -44.44 97.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.824 0.85 . . . . 0.0 110.934 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -63.11 -40.12 96.71 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.81 0.844 . . . . 0.0 112.306 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.31 87.53 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.138 0.899 . . . . 0.0 112.108 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -65.19 -46.86 79.06 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.555 1.142 . . . . 0.0 112.292 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.2 t -66.24 -39.39 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.062 1.345 . . . . 0.0 110.408 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.87 98.59 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.706 1.202 . . . . 0.0 110.944 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.59 -38.97 81.09 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.146 0.978 . . . . 0.0 112.484 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.09 -48.6 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.898 0.879 . . . . 0.0 108.718 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -66.91 -27.93 67.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 116.378 -1.772 . . . . 0.0 115.079 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -84.42 12.33 7.03 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 123.445 1.593 . . . . 0.0 111.955 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -119.01 -50.89 2.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 112.729 -2.032 . . . . 0.0 111.658 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.56 -24.2 62.74 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.27 -169.09 1.88 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.342 1.457 . . . . 0.0 109.225 -168.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 32.3 m120 . . . . . 0 C--O 1.249 1.068 0 C-N-CA 127.494 2.317 . . . . 0.0 113.294 169.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.801 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -108.05 105.6 15.43 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 125.53 1.769 . . . . 0.0 109.485 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -132.54 152.79 51.47 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.348 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -102.85 148.12 26.04 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 125.846 1.967 . . . . 0.0 110.638 172.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -108.11 120.6 42.78 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.629 -1.168 . . . . 0.0 112.008 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.8 mt -120.76 108.89 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.513 -1.676 . . . . 0.0 106.495 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -114.85 125.76 54.03 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.214 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.37 127.51 46.67 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.382 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.77 133.93 52.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.275 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CSP . . . . . 0.435 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.8 m -54.61 -48.62 71.98 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -172.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.85 -15.16 11.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.77 45.25 76.57 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.896 0.76 . . . . 0.0 112.605 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 24.8 mmt -115.25 -71.15 0.76 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 p -66.83 -18.67 65.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -60.32 -28.97 68.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.166 1.387 . . . . 0.0 114.626 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.7 p -60.14 -34.59 73.76 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -65.88 -46.25 79.07 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.394 0.678 . . . . 0.0 111.551 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 tp -62.24 -43.35 99.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.609 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.585 HG21 ' HB2' ' A' ' 38' ' ' ALA . 74.6 t -61.82 -43.67 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.427 1.091 . . . . 0.0 110.742 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -60.51 -44.7 95.74 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.529 0.732 . . . . 0.0 112.557 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -66.21 -39.15 89.42 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.503 ' HB3' HD13 ' A' ' 36' ' ' ILE . 95.7 mtp -64.72 -40.62 95.64 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.978 0.799 . . . . 0.0 111.625 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -67.54 -41.86 83.64 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.976 0.91 . . . . 0.0 112.786 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.03 -39.25 90.05 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.811 0.815 . . . . 0.0 112.827 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -77.44 -29.24 52.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.645 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.57 78.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.535 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -72.27 -41.18 67.0 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.015 0.822 . . . . 0.0 111.676 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -63.66 -51.61 64.34 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.485 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -90.64 23.2 3.15 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 29.28 63.19 0.14 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 124.853 2.263 . . . . 0.0 115.047 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.67 108.81 59.28 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 112.403 -2.18 . . . . 0.0 106.815 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.16 89.44 1.17 Allowed 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 122.296 1.997 . . . . 0.0 112.601 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 m -144.91 150.3 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.804 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -110.72 106.6 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.027 176.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.503 HD13 ' HB3' ' A' ' 23' ' ' MET . 14.6 mt -111.48 112.3 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.011 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -134.59 151.92 51.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.644 1.178 . . . . 0.0 111.931 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -119.14 137.47 53.58 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.612 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -144.25 154.37 57.32 Favored Pre-proline 0 N--CA 1.47 0.526 0 O-C-N 124.75 1.282 . . . . 0.0 112.552 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 9.5 Cg_endo -62.19 152.29 77.0 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 122.379 2.053 . . . . 0.0 112.62 169.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -22.77 47.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.032 1.733 . . . . 0.0 114.827 -173.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.3 p -58.42 -29.89 66.45 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.682 1.593 . . . . 0.0 113.702 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.7 mt -99.75 20.68 13.68 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.92 -45.3 64.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.107 -0.952 . . . . 0.0 113.075 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.12 -15.89 76.71 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.758 0.694 . . . . 0.0 113.833 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -97.13 -57.91 2.15 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.7 0.882 . . . . 0.0 112.884 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -85.25 -27.6 25.92 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.95 -15.98 56.58 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.112 0.863 . . . . 0.0 113.863 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -60.5 -27.0 67.25 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.771 1.228 . . . . 0.0 114.079 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -117.37 24.39 11.16 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.15 138.38 32.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.41 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.87 -23.23 24.04 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.342 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.56 133.76 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 122.442 1.115 . . . . 0.0 109.64 160.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.5 t -97.73 119.06 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 112.644 -2.071 . . . . 0.0 106.256 172.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 96' ' ' ALA . 74.9 mt -107.09 134.15 50.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.15 176.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.53 140.26 47.42 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.66 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.13 144.51 48.76 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.396 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.1 -26.82 83.12 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 C-N-CA 122.265 1.977 . . . . 0.0 114.291 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -64.69 -28.63 69.73 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 pt -114.71 30.09 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 122.411 1.1 . . . . 0.0 111.734 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.98 64.83 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -64.02 -22.59 66.99 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 84.7 mtp -85.3 6.45 26.21 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.26 -51.35 81.53 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-O 115.189 -2.339 . . . . 0.0 113.159 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.99 -28.05 80.19 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 CA-C-N 122.872 2.062 . . . . 0.0 114.031 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 2.0 tt0 -80.21 -37.79 32.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.3 mt -79.75 -29.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.813 1.245 . . . . 0.0 111.35 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -34.22 75.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.113 0.565 . . . . 0.0 110.552 171.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -61.77 -43.37 98.99 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.911 0.884 . . . . 0.0 110.74 172.036 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.1 mt -66.37 -42.22 88.31 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.984 0.914 . . . . 0.0 112.808 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.8 mt -124.1 76.69 59.6 Favored Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 124.931 1.293 . . . . 0.0 110.149 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.44 -11.26 10.71 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 121.895 1.73 . . . . 0.0 115.57 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -105.75 15.45 26.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.261 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.29 137.92 31.67 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.814 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.53 117.71 5.28 Favored 'Trans proline' 0 C--N 1.33 -0.421 0 C-N-CA 122.441 2.094 . . . . 0.0 110.34 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 t -120.73 110.71 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 111.956 -2.383 . . . . 0.0 106.835 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.12 146.81 50.59 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 125.866 1.979 . . . . 0.0 111.309 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.66 136.53 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.619 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.4 mt -70.48 133.71 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.409 1.083 . . . . 0.0 108.311 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.31 127.43 32.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.653 1.216 . . . . 0.0 110.957 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.1 m -56.21 -36.02 67.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 113.167 -1.833 . . . . 0.0 114.095 -174.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.9 tp -78.8 -36.51 42.65 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.206 0.603 . . . . 0.0 112.55 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.3 mt -60.46 -35.46 75.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.296 0.638 . . . . 0.0 112.713 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -67.84 -39.41 83.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.302 1.441 . . . . 0.0 111.23 174.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.5 -47.77 80.52 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.127 1.346 . . . . 0.0 112.452 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.99 -28.56 70.18 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.391 1.076 . . . . 0.0 112.244 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 t 53.67 62.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 127.511 2.325 . . . . 0.0 108.531 -170.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -100.73 92.32 5.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 112.184 -2.28 . . . . 0.0 109.908 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.69 -38.06 93.26 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 111.943 -2.39 . . . . 0.0 113.232 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.9 tp -71.79 -40.58 69.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.422 0.689 . . . . 0.0 111.908 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.71 -45.37 96.55 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.282 1.42 . . . . 0.0 112.733 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.17 -32.63 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.782 0.833 . . . . 0.0 110.997 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -44.74 95.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.416 0.627 . . . . 0.0 111.503 175.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -66.78 -33.74 76.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.223 1.009 . . . . 0.0 113.026 176.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.72 -34.36 67.05 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.204 0.94 . . . . 0.0 112.677 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.403 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -70.22 -43.08 71.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.01 0.924 . . . . 0.0 111.704 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.16 -36.6 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.595 1.158 . . . . 0.0 110.705 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.73 81.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.913 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.66 -34.4 71.99 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.648 0.779 . . . . 0.0 112.806 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.1 mt -70.21 -43.8 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.328 0.651 . . . . 0.0 109.306 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -60.42 -41.66 94.42 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.227 0.611 . . . . 0.0 112.567 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -66.35 -41.98 88.75 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.008 0.923 . . . . 0.0 111.101 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.28 99.01 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.794 1.308 . . . . 0.0 112.154 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.43 92.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.886 0.874 . . . . 0.0 111.926 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 137.45 94.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 130.898 3.679 . . . . 0.0 109.794 171.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 C--O 1.25 1.105 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.927 173.341 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tmm? . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -143.71 104.52 4.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 125.068 1.48 . . . . 0.0 109.562 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 89.0 mttt -132.65 144.37 50.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.882 172.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -102.1 148.07 25.84 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 125.859 1.974 . . . . 0.0 111.646 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -106.16 118.85 37.69 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.343 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.8 mt -118.83 105.54 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -110.09 128.4 55.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.503 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -100.48 134.94 42.68 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.012 -1.903 . . . . 0.0 110.077 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -129.84 131.74 46.23 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.601 -1.636 . . . . 0.0 113.245 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CSP . . . . . 0.453 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.0 t -52.29 -45.56 65.56 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.68 -34.32 7.02 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.62 37.12 12.36 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 123.943 0.782 . . . . 0.0 113.448 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 8.9 ptp -121.44 -48.93 2.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.7 m -63.63 -32.73 74.3 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 p -64.58 -24.36 67.57 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.2 p -58.83 -35.82 73.52 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.0 tp -69.31 -45.72 68.84 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.66 0.384 . . . . 0.0 111.441 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' A' ' 23' ' ' MET . 1.0 OUTLIER -60.89 -35.62 77.13 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 175.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.606 HG13 HG22 ' A' ' 36' ' ' ILE . 74.7 t -61.83 -48.72 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.429 1.091 . . . . 0.0 110.252 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.7 p -68.52 -26.85 65.65 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -65.0 -44.35 89.53 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.175 0.99 . . . . 0.0 112.3 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 18.3 ptm -85.01 -13.0 51.96 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -71.96 -41.53 67.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.544 0.338 . . . . 0.0 110.938 164.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.81 86.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.691 0.758 . . . . 0.0 112.242 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.456 HE21 ' HB2' ' A' ' 90' ' ' LEU . 15.2 mm100 -70.17 -34.62 73.22 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.611 173.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.5 98.76 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.18 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.16 -33.48 73.47 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.698 0.799 . . . . 0.0 112.486 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -65.49 -51.83 57.23 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.206 0.603 . . . . 0.0 111.015 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -90.24 24.57 2.48 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.863 0.865 . . . . 0.0 113.305 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 28.31 64.85 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 124.947 2.308 . . . . 0.0 115.192 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.08 105.49 57.29 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-N 112.885 -1.961 . . . . 0.0 107.084 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 76.3 Cg_endo -75.81 93.99 1.0 Allowed 'Trans proline' 0 C--N 1.331 -0.371 0 C-N-CA 122.396 2.064 . . . . 0.0 112.183 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.07 152.68 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 113.915 -1.493 . . . . 0.0 114.319 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.99 107.13 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 112.179 -2.282 . . . . 0.0 107.144 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.606 HG22 HG13 ' A' ' 20' ' ' VAL . 20.6 mt -112.6 113.35 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.102 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -136.58 148.78 47.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 125.311 1.632 . . . . 0.0 112.201 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.96 139.62 46.14 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.036 -1.438 . . . . 0.0 113.101 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -142.57 152.18 59.29 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.477 1.111 . . . . 0.0 113.128 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 10.6 Cg_endo -67.23 154.08 75.29 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.376 2.051 . . . . 0.0 113.128 167.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -22.59 63.93 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.577 1.551 . . . . 0.0 114.154 -175.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 p -60.36 -31.02 69.94 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.507 1.523 . . . . 0.0 113.164 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -98.77 21.79 10.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.29 1.036 . . . . 0.0 113.093 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.3 -48.91 77.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.057 -0.973 . . . . 0.0 112.673 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.27 -57.61 17.49 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.148 0.905 . . . . 0.0 111.589 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.21 -53.57 53.37 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 113.231 -1.484 . . . . 0.0 113.59 -170.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -80.45 -31.53 37.43 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.339 1.236 . . . . 0.0 114.339 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.33 -20.21 54.47 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.73 1.157 . . . . 0.0 113.643 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -59.68 -32.7 70.74 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.244 1.018 . . . . 0.0 113.396 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.5 -16.38 18.34 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.677 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.53 135.47 48.58 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.143 0.497 . . . . 0.0 111.087 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -86.55 -26.22 24.63 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.391 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.17 140.62 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 122.191 0.996 . . . . 0.0 109.248 163.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 76' ' ' VAL . 94.5 t -109.12 126.55 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.349 175.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 96' ' ' ALA . 84.2 mt -115.96 122.82 46.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.245 -1.798 . . . . 0.0 111.356 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 mt -100.45 142.08 32.41 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.421 -1.718 . . . . 0.0 111.925 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.23 144.14 49.07 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.668 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.66 -24.93 77.36 Favored 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 122.272 1.981 . . . . 0.0 114.335 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -67.8 -28.66 67.78 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 pt -113.12 25.29 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 122.053 0.93 . . . . 0.0 112.141 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.3 -29.21 65.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.992 -1.003 . . . . 0.0 113.437 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -61.52 -24.24 66.48 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.675 173.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.0 mtm -87.74 7.43 30.29 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.1 tp -50.86 -46.2 87.22 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 116.418 -1.753 . . . . 0.0 113.823 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.6 -29.12 61.01 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 122.192 1.928 . . . . 0.0 114.827 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -81.61 -36.96 28.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.725 0.774 . . . . 0.0 112.846 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 mm -65.39 -40.55 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.029 1.332 . . . . 0.0 109.509 173.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -73.58 -25.54 60.4 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -65.07 -39.81 93.77 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 170.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.7 mt -65.62 -53.6 39.33 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.537 1.135 . . . . 0.0 112.338 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.87 75.49 71.15 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 124.369 1.068 . . . . 0.0 111.481 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.96 -22.31 23.27 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.256 1.971 . . . . 0.0 115.629 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -86.38 -0.73 56.57 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.46 134.46 20.83 Favored Pre-proline 0 N--CA 1.47 0.526 0 C-N-CA 123.217 0.607 . . . . 0.0 110.771 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.93 116.88 4.88 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 122.42 2.08 . . . . 0.0 110.513 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.583 HG22 ' HB ' ' A' ' 54' ' ' VAL . 59.9 t -123.58 119.59 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 112.087 -2.324 . . . . 0.0 108.352 -175.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -125.51 158.48 34.42 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 126.24 2.213 . . . . 0.0 111.753 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.8 t -99.79 138.22 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.419 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.0 mt -72.11 126.64 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.14 131.45 50.54 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.676 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.1 m -57.83 -34.35 69.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 112.85 -1.977 . . . . 0.0 113.907 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -38.61 53.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.595 0.758 . . . . 0.0 112.48 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.58 -38.25 86.84 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.325 0.65 . . . . 0.0 112.092 171.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -66.57 -41.38 88.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.568 1.547 . . . . 0.0 111.331 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.58 -43.02 99.6 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.071 1.319 . . . . 0.0 112.498 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -75.54 -28.25 58.97 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t 58.35 70.22 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 127.376 2.271 . . . . 0.0 108.078 -168.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.86 99.49 8.39 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 113.198 -1.819 . . . . 0.0 110.589 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.81 -43.19 98.15 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 111.77 -2.468 . . . . 0.0 113.867 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HB2' HE21 ' A' ' 26' ' ' GLN . 65.0 tp -64.22 -43.27 95.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.86 -42.22 91.95 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 124.708 1.146 . . . . 0.0 112.743 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.9 t -77.75 -38.21 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.668 0.787 . . . . 0.0 110.993 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.94 -39.66 95.3 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.773 0.829 . . . . 0.0 111.603 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -64.8 -43.26 93.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.902 1.281 . . . . 0.0 111.278 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.44 83.7 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.058 0.849 . . . . 0.0 112.381 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -67.85 -44.12 77.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.163 -1.38 . . . . 0.0 112.35 176.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.53 -27.58 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 121.814 -0.554 . . . . 0.0 112.209 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.85 83.85 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.187 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.65 -29.39 61.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.679 0.792 . . . . 0.0 113.045 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.94 -42.58 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -57.68 -39.29 76.76 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.639 ' HA ' ' HB2' ' A' ' 106' ' ' ASN . 65.1 tttp -65.66 -48.88 70.62 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.109 0.88 . . . . 0.0 110.942 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.6 -37.28 72.97 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.438 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.05 -73.99 0.13 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.194 0.998 . . . . 0.0 110.244 173.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.15 87.09 0.16 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.888 0.875 . . . . 0.0 111.414 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.639 ' HB2' ' HA ' ' A' ' 102' ' ' LYS . 26.2 m120 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.925 1.69 . . . . 0.0 110.718 169.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 mmt . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -100.81 -40.07 7.5 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.535 1.772 . . . . 0.0 111.496 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.9 mttt 63.23 146.98 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.757 1.623 . . . . 0.0 113.886 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -110.06 143.71 39.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 112.908 -1.951 . . . . 0.0 112.227 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -101.69 116.69 33.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.958 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.7 mt -114.4 103.02 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 113.309 -1.769 . . . . 0.0 106.471 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -110.29 127.17 54.88 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 122.731 1.253 . . . . 0.0 112.45 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -101.17 133.09 46.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.72 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -126.23 133.79 51.39 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.678 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CSP . . . . . 0.494 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m -50.32 -45.86 55.13 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.65 -23.56 11.75 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.71 23.55 77.7 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.341 0.972 . . . . 0.0 114.87 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.7 ptp -118.32 -37.56 3.32 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.477 ' HB2' ' O3P' ' A' ' 10' ' ' CSP . 32.3 m -65.57 -29.88 70.54 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.113 0.87 . . . . 0.0 112.198 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 p -71.71 -20.2 61.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.726 1.61 . . . . 0.0 114.505 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.0 p -63.13 -34.98 78.79 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 tp -65.94 -44.53 84.79 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.101 0.561 . . . . 0.0 111.691 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 tt -62.16 -40.82 97.28 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.13 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 38' ' ' ALA . 73.1 t -61.47 -45.0 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.488 1.115 . . . . 0.0 109.717 175.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -59.08 -40.35 84.98 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -65.87 -44.23 86.0 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.9 ptm -77.99 -21.56 50.67 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -67.34 -46.07 74.51 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.857 0.863 . . . . 0.0 111.52 166.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.37 84.06 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.006 0.908 . . . . 0.0 112.758 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -75.6 -33.12 60.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.88 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.61 84.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.928 0.491 . . . . 0.0 111.323 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -68.76 -42.78 77.03 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 111.332 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -63.53 -52.09 62.65 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.444 0.698 . . . . 0.0 111.764 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -85.04 11.8 8.9 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 51.88 51.06 17.29 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 123.958 1.837 . . . . 0.0 112.774 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.2 t -102.05 111.66 64.51 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 112.971 -1.922 . . . . 0.0 107.977 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.71 87.6 1.5 Allowed 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 121.995 1.797 . . . . 0.0 112.781 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.07 152.37 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.589 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.4 mt -112.18 105.75 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 113.395 -1.73 . . . . 0.0 107.91 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 20' ' ' VAL . 23.2 mt -105.78 118.97 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.83 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -149.44 139.34 21.94 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.457 1.098 . . . . 0.0 112.606 -171.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -104.23 138.15 41.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 113.248 -1.796 . . . . 0.0 112.684 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -139.32 151.49 67.26 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.777 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 17.8 Cg_endo -66.36 152.95 79.8 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 122.412 2.075 . . . . 0.0 112.7 168.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -22.73 62.74 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.076 -1.42 . . . . 0.0 114.664 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -60.32 -28.34 68.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.386 1.474 . . . . 0.0 113.667 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.6 mt -99.08 19.81 14.51 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.14 86.75 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.89 -51.96 31.57 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -61.21 -59.3 5.53 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.642 -1.279 . . . . 0.0 112.918 -172.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -78.85 -24.35 44.41 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.21 -29.37 72.76 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.869 0.747 . . . . 0.0 113.577 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.07 -29.57 70.7 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -109.95 30.09 7.02 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.026 0.917 . . . . 0.0 112.439 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.33 140.55 45.81 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.481 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.34 -49.8 11.02 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.084 170.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.3 140.85 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 122.089 0.947 . . . . 0.0 110.46 171.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.94 122.01 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 113.074 -1.875 . . . . 0.0 107.811 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.5 mt -116.94 115.51 25.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 113.553 -1.658 . . . . 0.0 112.688 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.2 mt -88.89 139.29 30.61 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 112.508 -2.133 . . . . 0.0 112.095 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.02 140.83 45.87 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 113.747 -1.569 . . . . 0.0 110.083 167.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -58.58 -24.85 72.1 Favored 'Trans proline' 0 C--N 1.331 -0.386 0 C-N-CA 122.299 1.999 . . . . 0.0 114.428 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 -64.79 -31.42 72.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.48 26.82 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.159 0.981 . . . . 0.0 111.988 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.56 -29.33 68.68 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.419 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -64.29 -21.8 66.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.1 mtm -89.26 13.25 13.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.6 tp -55.7 -50.71 85.49 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-O 114.903 -2.475 . . . . 0.0 112.382 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.46 -28.84 87.45 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 CA-C-N 122.716 2.006 . . . . 0.0 114.471 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -78.12 -43.39 29.03 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 70' ' ' LEU . 80.2 mt -76.5 -31.42 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.513 1.125 . . . . 0.0 111.539 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -72.35 -31.01 65.25 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.862 0.465 . . . . 0.0 111.247 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.8 ttp-105 -64.48 -43.24 94.8 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.853 0.461 . . . . 0.0 110.292 172.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 67' ' ' ILE . 35.0 mt -62.73 -44.35 96.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.372 1.069 . . . . 0.0 112.305 174.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -124.67 80.27 62.01 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 124.712 1.205 . . . . 0.0 110.179 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.84 -22.71 3.49 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 121.505 1.47 . . . . 0.0 115.621 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -97.72 14.06 28.19 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -127.2 129.65 23.89 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 118.067 -0.968 . . . . 0.0 108.646 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.45 119.14 6.12 Favored 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 122.656 2.238 . . . . 0.0 112.09 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -122.47 112.56 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 111.556 -2.566 . . . . 0.0 107.879 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -126.65 159.79 32.59 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 125.717 1.886 . . . . 0.0 111.267 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.9 t -98.37 140.78 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.559 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.78 132.32 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.4 1.08 . . . . 0.0 108.411 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 13.7 t0 -59.68 125.36 23.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.248 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -54.39 -33.06 58.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.517 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 49.5 tp -72.57 -46.51 54.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.674 1.19 . . . . 0.0 112.271 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.4 mt -60.16 -37.36 79.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.699 0.8 . . . . 0.0 112.56 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -65.72 -40.39 92.17 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.216 1.406 . . . . 0.0 111.354 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.32 -47.96 79.21 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.003 1.287 . . . . 0.0 112.066 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.73 -30.66 71.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.557 0.743 . . . . 0.0 112.586 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 t 57.09 63.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 127.522 2.329 . . . . 0.0 108.241 -169.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -105.7 94.17 5.05 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 112.604 -2.089 . . . . 0.0 109.089 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.72 -46.94 91.67 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 111.751 -2.477 . . . . 0.0 112.869 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.4 tp -63.58 -37.18 86.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.475 0.71 . . . . 0.0 112.302 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.94 -46.06 94.21 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.577 1.56 . . . . 0.0 112.448 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -73.02 -33.84 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.096 0.959 . . . . 0.0 110.929 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.25 -43.58 98.64 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.65 0.78 . . . . 0.0 110.614 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.91 -35.26 76.63 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.431 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.06 81.86 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.191 0.932 . . . . 0.0 111.926 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.06 -43.93 77.51 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.027 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.64 -31.62 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.324 0.65 . . . . 0.0 111.215 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.99 -37.3 83.97 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.987 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.68 -32.78 66.06 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.559 0.744 . . . . 0.0 112.929 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.0 mt -68.59 -44.55 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -61.2 -38.27 85.95 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -66.03 -41.29 91.12 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.541 0.737 . . . . 0.0 110.926 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.09 85.95 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.925 173.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.88 33.39 1.05 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.699 1.2 . . . . 0.0 111.804 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 59.61 105.83 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.39 2.276 . . . . 0.0 113.97 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.156 1.782 . . . . 0.0 107.456 171.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.487 ' O ' ' HD2' ' A' ' 3' ' ' LYS . 5.2 tp10 -121.02 106.53 11.67 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.933 1.396 . . . . 0.0 109.549 -175.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' A' ' 2' ' ' GLU . 11.4 tptt -150.83 129.11 11.98 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 170.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.532 ' HB2' HG12 ' A' ' 34' ' ' VAL . 4.4 mptp? -107.37 136.48 47.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.999 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -99.26 110.45 22.98 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 123.165 1.459 . . . . 0.0 111.71 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.2 mt -111.94 103.69 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.819 -1.991 . . . . 0.0 106.633 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -110.62 126.58 54.62 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.92 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.47 140.04 37.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 112.746 -2.024 . . . . 0.0 111.737 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -133.0 129.13 37.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 113.872 -1.513 . . . . 0.0 113.828 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CSP . . . . . 0.436 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -45.37 -47.51 13.47 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -171.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.87 -26.55 10.19 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.27 40.36 20.11 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.052 0.834 . . . . 0.0 113.859 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.9 mtm -111.71 -58.09 2.17 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 92.3 p -60.56 -29.65 69.29 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 p -61.4 -25.18 67.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.973 1.709 . . . . 0.0 114.429 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.3 p -55.9 -40.62 73.31 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -171.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.6 tp -67.45 -43.53 80.88 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.737 0.415 . . . . 0.0 111.606 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.74 -40.49 92.61 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.966 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.44 -45.3 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.583 1.153 . . . . 0.0 110.03 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 t -57.64 -46.86 83.64 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -64.66 -36.19 83.46 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.597 ' HB3' HD13 ' A' ' 36' ' ' ILE . 46.0 mmm -61.71 -47.56 84.74 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.735 1.214 . . . . 0.0 111.436 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -64.99 -38.71 91.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.643 0.777 . . . . 0.0 112.061 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.26 -41.38 81.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -69.49 -30.85 68.81 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.912 0.485 . . . . 0.0 112.276 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.98 92.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.122 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.59 -41.59 79.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.663 0.785 . . . . 0.0 111.818 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -59.32 -42.1 90.64 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.125 0.97 . . . . 0.0 112.91 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -109.54 26.04 11.1 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 22.57 68.29 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 125.374 2.512 . . . . 0.0 115.277 -170.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.9 t -98.32 107.34 41.23 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 112.513 -2.13 . . . . 0.0 106.463 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 72.9 Cg_endo -75.18 87.55 1.33 Allowed 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.189 1.926 . . . . 0.0 112.636 -176.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 4' ' ' LYS . 15.4 m -141.93 152.21 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 113.066 -1.879 . . . . 0.0 113.577 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.84 110.55 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 112.333 -2.212 . . . . 0.0 106.671 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.597 HD13 ' HB3' ' A' ' 23' ' ' MET . 8.7 mt -116.25 115.32 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.508 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -145.5 142.84 29.59 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.836 1.335 . . . . 0.0 112.112 -172.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.34 145.64 31.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 113.674 -1.603 . . . . 0.0 113.513 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.36 154.22 56.73 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 125.103 1.361 . . . . 0.0 112.909 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 14.4 Cg_endo -68.5 155.01 70.53 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 122.355 2.037 . . . . 0.0 113.43 167.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -31.65 67.77 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -170.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 t -62.48 -24.51 67.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.992 1.317 . . . . 0.0 113.942 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.4 mt -95.64 15.73 19.16 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.46 99.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.408 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.06 -62.56 5.33 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.27 -54.68 44.03 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 112.825 -1.688 . . . . 0.0 113.426 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.4 -31.89 29.39 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.57 -23.84 65.39 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.87 0.748 . . . . 0.0 113.282 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -58.03 -29.17 65.13 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.856 1.262 . . . . 0.0 113.983 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -116.78 33.11 5.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.197 0.999 . . . . 0.0 112.228 176.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.62 136.71 47.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.812 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -80.55 -29.92 37.08 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.091 173.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.31 138.81 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 122.656 1.217 . . . . 0.0 109.609 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.4 t -104.76 121.26 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 112.262 -2.245 . . . . 0.0 106.734 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.5 mt -113.69 136.4 52.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.793 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.6 mt -111.65 140.55 46.19 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.974 -1.921 . . . . 0.0 112.584 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.81 136.33 41.19 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.149 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.8 -24.44 55.74 Favored 'Trans proline' 0 C--N 1.33 -0.413 0 C-N-CA 122.414 2.076 . . . . 0.0 114.861 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.2 pm0 -65.08 -29.95 70.87 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.605 1.562 . . . . 0.0 115.141 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 pt -110.92 22.33 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.757 0.789 . . . . 0.0 112.037 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.52 -29.22 69.26 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.111 -0.95 . . . . 0.0 113.466 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -60.55 -24.54 65.48 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.0 mtm -88.62 11.04 18.46 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.5 tp -52.97 -47.88 93.83 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-O 114.902 -2.475 . . . . 0.0 112.545 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.38 -35.03 90.93 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 122.335 2.024 . . . . 0.0 114.252 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -78.89 -41.27 30.15 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.811 0.815 . . . . 0.0 112.829 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -67.11 -39.34 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.282 1.033 . . . . 0.0 109.214 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.86 -32.23 71.75 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.606 0.763 . . . . 0.0 111.58 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -63.02 -40.13 96.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.052 0.941 . . . . 0.0 110.806 172.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.8 mt -68.95 -44.76 72.34 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.003 1.321 . . . . 0.0 112.289 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.3 mt -124.35 76.22 61.55 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 124.943 1.297 . . . . 0.0 111.093 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.33 -27.43 5.36 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 C-N-CA 121.612 1.541 . . . . 0.0 114.659 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -97.56 23.85 7.29 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.473 1.13 . . . . 0.0 113.16 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -130.03 133.91 25.52 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.704 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.12 112.56 3.17 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 122.253 1.968 . . . . 0.0 110.149 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -118.26 112.18 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 110.852 -2.885 . . . . 0.0 108.07 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -127.16 153.45 46.03 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.12 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.0 t -93.55 136.04 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.842 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.6 mt -69.53 128.76 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -56.61 125.85 24.07 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.754 -1.566 . . . . 0.0 111.42 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.5 p -54.26 -34.99 62.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.975 -1.92 . . . . 0.0 114.326 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.1 tp -74.07 -44.81 52.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.092 1.357 . . . . 0.0 112.081 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.06 -37.75 80.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.948 0.899 . . . . 0.0 112.603 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -66.58 -40.92 89.15 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.346 1.459 . . . . 0.0 111.372 175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.94 -49.55 62.37 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.019 1.295 . . . . 0.0 112.355 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -66.27 -24.76 66.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.813 0.845 . . . . 0.0 112.968 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 t 56.56 62.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 127.388 2.275 . . . . 0.0 108.458 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -105.92 99.4 8.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 112.522 -2.126 . . . . 0.0 111.261 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.45 -33.52 81.64 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 111.704 -2.498 . . . . 0.0 113.762 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.43 -47.14 57.73 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.63 -0.335 . . . . 0.0 111.276 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.93 -43.97 92.66 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.975 1.274 . . . . 0.0 112.571 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.7 t -75.06 -35.88 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.377 0.671 . . . . 0.0 111.138 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.94 -44.49 96.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.873 0.844 . . . . 0.0 111.712 176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -68.01 -34.15 75.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.307 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.65 -39.88 80.5 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.359 1.037 . . . . 0.0 112.066 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.12 -44.2 84.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.965 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.76 -31.58 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.195 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.28 -36.4 81.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.716 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.77 -37.05 67.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.683 0.793 . . . . 0.0 112.99 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.2 mt -66.4 -49.5 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -62.49 -32.18 73.04 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -67.91 -47.17 69.51 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.431 0.692 . . . . 0.0 109.137 176.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.03 79.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.201 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.47 -44.22 83.34 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 174.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.19 59.39 0.72 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.199 0.999 . . . . 0.0 110.508 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-N 113.511 -1.677 . . . . 0.0 111.297 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 tpt . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 115.657 -2.115 . . . . 0.0 107.35 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 64.2 126.65 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 125.92 2.012 . . . . 0.0 113.57 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.459 ' HG2' ' HB2' ' A' ' 33' ' ' PRO . 34.9 mttp -136.03 137.17 40.9 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.687 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -103.1 150.14 23.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 112.542 -2.117 . . . . 0.0 113.251 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -105.4 116.05 31.29 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.943 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.1 mt -115.36 108.5 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 112.588 -2.096 . . . . 0.0 106.52 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -112.44 129.13 56.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 122.418 1.104 . . . . 0.0 112.912 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.02 136.02 46.43 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.153 -1.84 . . . . 0.0 111.102 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -132.06 133.69 44.66 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.473 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CSP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -53.96 -44.09 70.44 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.33 -31.86 8.41 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.77 16.33 54.88 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.914 1.245 . . . . 0.0 115.219 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.8 ptp -103.66 -42.04 5.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.4 p -58.47 -36.14 73.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.8 p -64.92 -23.31 67.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.892 2.077 . . . . 0.0 113.885 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.0 t -46.81 -50.41 18.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.14 -45.98 89.4 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -57.34 -45.73 84.01 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.727 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.84 -49.69 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.972 1.309 . . . . 0.0 109.717 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -56.39 -45.05 80.76 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.502 0.721 . . . . 0.0 112.652 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -66.23 -41.43 90.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.447 ' HB3' HD13 ' A' ' 36' ' ' ILE . 97.4 mtp -61.4 -44.03 97.85 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.779 0.832 . . . . 0.0 110.868 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -61.19 -46.08 91.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.534 1.134 . . . . 0.0 112.013 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.88 89.01 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -71.28 -35.91 71.5 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.372 0.669 . . . . 0.0 111.621 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.52 -38.74 92.29 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.298 1.039 . . . . 0.0 111.067 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.31 -43.75 76.91 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.655 1.182 . . . . 0.0 111.384 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -58.98 -41.94 88.76 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.463 1.105 . . . . 0.0 112.812 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -105.28 24.92 11.3 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 28.07 58.31 0.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.589 2.356 . . . . 0.0 116.558 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.6 t -96.87 111.72 58.39 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 111.922 -2.399 . . . . 0.0 107.94 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 73.1 Cg_endo -78.37 84.21 2.06 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 121.467 1.445 . . . . 0.0 113.16 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.43 152.09 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 112.855 -1.975 . . . . 0.0 112.659 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.5 mt -111.91 109.34 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.285 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 23' ' ' MET . 17.4 mt -109.16 118.4 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 112.664 -2.062 . . . . 0.0 107.535 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -143.98 143.7 31.34 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 126.234 2.209 . . . . 0.0 111.186 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.8 142.11 44.58 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.186 -1.37 . . . . 0.0 114.224 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -143.25 154.24 60.64 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 124.853 1.261 . . . . 0.0 113.34 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.2 156.03 59.97 Favored 'Trans proline' 0 C--N 1.33 -0.422 0 C-N-CA 122.311 2.008 . . . . 0.0 112.962 166.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -27.11 68.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.816 -1.538 . . . . 0.0 114.258 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.8 p -56.86 -26.32 58.35 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.14 1.776 . . . . 0.0 113.817 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.7 mt -102.57 16.28 26.83 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.388 1.075 . . . . 0.0 113.833 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.56 93.81 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.421 1.088 . . . . 0.0 113.859 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.64 -54.52 35.01 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' OE1' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -61.81 -62.05 2.07 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.213 -0.993 . . . . 0.0 112.554 -171.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE2' ' OE1' ' A' ' 46' ' ' GLU . 74.0 mmtt -72.13 -31.58 66.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.92 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.17 -28.44 66.66 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.905 0.764 . . . . 0.0 113.063 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -61.82 -29.72 70.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.395 1.078 . . . . 0.0 113.504 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -110.31 20.57 17.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.135 0.974 . . . . 0.0 113.602 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.72 145.05 26.15 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.687 170.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -89.69 -29.43 18.77 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.092 168.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.95 141.39 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 122.436 1.112 . . . . 0.0 110.54 163.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.8 t -107.17 121.85 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 112.847 -1.979 . . . . 0.0 107.459 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.4 mt -116.33 127.68 54.89 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.291 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 mt -105.74 141.55 36.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 112.739 -2.028 . . . . 0.0 112.828 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.69 137.26 44.37 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.202 168.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.32 -35.14 43.18 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 123.157 2.571 . . . . 0.0 114.424 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.7 pm0 -60.11 -31.07 69.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.041 1.736 . . . . 0.0 115.19 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 pt -111.34 19.77 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.11 -28.12 69.56 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.281 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -61.17 -23.8 65.83 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.1 mtm -87.63 6.59 33.88 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.8 tp -51.17 -52.15 61.52 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-O 114.435 -2.698 . . . . 0.0 112.812 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.82 -35.24 98.01 Favored 'Trans proline' 0 C--N 1.33 -0.396 0 CA-C-N 122.803 2.037 . . . . 0.0 114.149 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -73.59 -45.28 54.07 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.003 0.906 . . . . 0.0 112.028 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.02 -36.06 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.448 1.099 . . . . 0.0 111.111 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -58.95 -41.46 87.47 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.267 1.027 . . . . 0.0 110.42 171.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -66.02 -40.6 91.19 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.702 1.201 . . . . 0.0 110.957 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.3 -43.53 97.59 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.516 1.526 . . . . 0.0 112.557 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.9 mt -123.16 73.08 47.74 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 124.741 1.216 . . . . 0.0 111.583 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.16 -10.97 14.96 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 121.512 1.474 . . . . 0.0 114.845 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -102.07 17.41 23.33 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -133.6 132.46 21.79 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.564 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 48.6 Cg_endo -70.03 116.3 4.52 Favored 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 122.024 1.816 . . . . 0.0 109.836 173.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.9 t -115.83 113.18 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 110.085 -3.234 . . . . 0.0 107.746 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -125.93 154.02 43.41 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 126.306 2.254 . . . . 0.0 111.189 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.43 136.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 113.154 -1.839 . . . . 0.0 108.615 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.26 129.26 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -55.99 126.17 24.73 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.534 1.159 . . . . 0.0 111.39 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 p -54.19 -34.32 60.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.81 -1.995 . . . . 0.0 114.894 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.9 tp -75.32 -47.94 25.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.563 1.145 . . . . 0.0 111.845 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.3 mt -57.34 -39.15 75.32 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.124 1.37 . . . . 0.0 111.742 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.99 -44.52 92.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.275 1.83 . . . . 0.0 111.389 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.07 -45.01 96.41 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.758 1.171 . . . . 0.0 112.191 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -68.75 -19.99 64.36 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.274 1.43 . . . . 0.0 113.563 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . 0.256 2.8 m 39.14 59.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 127.041 2.136 . . . . 0.0 113.048 -163.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -89.91 87.46 6.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 111.803 -2.453 . . . . 0.0 108.739 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.4 -38.07 56.84 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 111.511 -2.586 . . . . 0.0 113.731 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.7 tp -74.04 -44.83 52.95 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.766 0.426 . . . . 0.0 111.875 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.06 -51.19 51.79 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.638 1.59 . . . . 0.0 111.839 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.08 -40.56 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 114.221 -0.99 . . . . 0.0 110.673 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -45.56 91.7 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.285 0.634 . . . . 0.0 110.985 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -61.34 -41.77 97.58 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.82 0.848 . . . . 0.0 112.626 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.99 92.28 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.515 1.135 . . . . 0.0 111.566 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.49 96.58 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.309 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.428 ' HA ' HD12 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -70.91 -32.41 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.689 0.796 . . . . 0.0 111.468 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.91 80.59 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.995 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.74 -35.63 70.19 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.427 1.091 . . . . 0.0 112.832 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 97' ' ' VAL . 86.9 mt -62.06 -44.23 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.96 0.904 . . . . 0.0 109.375 171.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 21.3 mtpp -65.58 -36.7 84.51 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 174.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -64.08 -42.6 96.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.541 0.736 . . . . 0.0 109.918 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.564 ' HB2' ' HG3' ' A' ' 75' ' ' PRO . . . -62.61 154.55 28.71 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 113.782 -1.553 . . . . 0.0 107.161 158.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 62.85 -32.61 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -163.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 103' ' ' ALA . . . 120.56 128.82 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 131.472 3.909 . . . . 0.0 113.702 166.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 101' ' ' LYS . 1.1 t-20 . . . . . 0 C--O 1.25 1.122 0 C-N-CA 126.819 2.048 . . . . 0.0 107.116 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.4 tpp . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.77 95.32 4.01 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 125.183 1.552 . . . . 0.0 109.382 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -137.42 155.23 49.59 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.729 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.555 ' HD3' HG21 ' A' ' 100' ' ' ILE . 58.0 mttm -116.54 149.18 40.03 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.949 2.031 . . . . 0.0 111.909 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -106.85 118.35 36.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.645 -174.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.12 101.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 112.9 -1.955 . . . . 0.0 106.131 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -109.31 127.63 54.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.459 -1.246 . . . . 0.0 112.162 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.15 137.84 40.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.583 -2.098 . . . . 0.0 110.474 -177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -130.27 128.94 42.59 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.232 -1.804 . . . . 0.0 112.875 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CSP . . . . . 0.412 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 m -43.2 -53.68 4.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -169.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.85 -13.73 13.14 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.02 45.71 25.23 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.952 0.787 . . . . 0.0 112.756 -172.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.1 mmt -106.34 -72.36 0.72 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 -174.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 m -61.65 -35.03 76.79 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 p -55.24 -33.05 62.81 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.42 1.488 . . . . 0.0 113.654 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.6 t -54.06 -36.74 63.43 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.7 tp -67.37 -47.18 71.13 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.4 -39.11 93.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.288 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 38' ' ' ALA . 70.1 t -60.31 -46.12 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.858 1.263 . . . . 0.0 109.992 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.3 t -55.65 -49.77 71.99 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.808 0.843 . . . . 0.0 112.531 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -63.65 -39.51 94.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.563 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.2 ttp -70.52 -37.52 74.13 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.909 0.755 . . . . 0.0 112.797 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.9 mtt-85 -61.16 -45.71 93.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.545 1.138 . . . . 0.0 111.599 171.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.87 92.04 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.2 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.62 -33.9 69.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.976 0.51 . . . . 0.0 112.186 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.02 99.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.463 0.705 . . . . 0.0 111.248 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.94 -41.98 77.36 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.186 0.994 . . . . 0.0 111.614 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -62.07 -42.2 98.95 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.149 0.979 . . . . 0.0 112.651 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -104.87 30.79 5.22 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 32.47 65.05 0.23 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 125.074 2.369 . . . . 0.0 115.537 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -114.21 105.82 53.64 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.456 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.92 87.74 1.46 Allowed 'Trans proline' 0 C--N 1.33 -0.42 0 C-N-CA 122.15 1.9 . . . . 0.0 113.242 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.85 154.3 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 112.96 -1.927 . . . . 0.0 112.767 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.1 mt -113.78 110.41 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.128 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.28 117.54 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.851 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -138.65 149.83 45.59 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 125.073 1.483 . . . . 0.0 110.744 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -116.11 134.21 55.19 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.311 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -136.05 154.77 77.74 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 113.98 -1.463 . . . . 0.0 112.85 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 18.4 Cg_endo -67.39 152.23 79.22 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 C-N-CA 122.388 2.059 . . . . 0.0 112.587 169.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -24.49 63.53 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 113.923 -1.49 . . . . 0.0 114.681 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.3 p -57.77 -30.55 65.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.756 1.622 . . . . 0.0 113.894 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.4 mt -98.84 16.53 22.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.39 97.08 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.12 -60.47 6.76 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.66 -55.32 36.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.758 -1.721 . . . . 0.0 113.361 -170.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -83.4 -27.82 29.33 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.12 -24.81 67.5 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.247 0.927 . . . . 0.0 113.341 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -57.91 -30.91 66.29 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.96 1.304 . . . . 0.0 113.467 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -112.48 29.94 7.51 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.334 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.59 140.86 42.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.674 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -82.66 -34.6 27.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.759 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.4 p -140.73 139.98 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 122.479 1.133 . . . . 0.0 109.197 164.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.22 122.08 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.878 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.8 mt -113.47 132.31 55.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.915 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.7 mt -109.46 141.4 41.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.241 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.59 138.73 45.02 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 113.384 -1.734 . . . . 0.0 110.282 167.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.46 -25.02 64.3 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.251 1.967 . . . . 0.0 114.472 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -64.62 -30.71 71.73 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.989 1.315 . . . . 0.0 114.534 173.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 pt -110.89 27.94 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 122.359 1.076 . . . . 0.0 111.446 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.66 -29.33 65.64 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.084 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -61.8 -22.18 65.23 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 85.4 mtp -86.62 3.25 45.32 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.67 -52.77 64.25 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-O 114.607 -2.616 . . . . 0.0 113.111 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.38 -29.81 91.12 Favored 'Trans proline' 0 C--N 1.33 -0.418 0 CA-C-N 122.971 2.097 . . . . 0.0 114.038 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.96 -45.18 24.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.931 0.872 . . . . 0.0 112.288 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.5 mt -71.55 -34.97 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.812 1.245 . . . . 0.0 111.058 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.77 -37.41 87.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.482 0.713 . . . . 0.0 110.716 172.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -64.2 -40.5 96.21 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.57 0.748 . . . . 0.0 110.979 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.3 mt -65.67 -42.61 91.11 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.954 1.302 . . . . 0.0 112.631 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 mt -123.7 72.63 52.05 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.061 1.344 . . . . 0.0 111.159 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.19 -19.11 12.26 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 121.617 1.545 . . . . 0.0 114.932 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -91.15 9.0 32.88 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -125.52 138.16 31.3 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.876 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.99 112.5 3.31 Favored 'Trans proline' 0 C--N 1.331 -0.386 0 C-N-CA 122.111 1.874 . . . . 0.0 109.92 170.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -116.45 111.81 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 110.789 -2.914 . . . . 0.0 107.175 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -124.81 157.72 35.13 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 125.984 2.052 . . . . 0.0 111.509 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.9 137.63 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 113.393 -1.73 . . . . 0.0 109.263 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.15 123.96 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.48 131.78 43.26 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.072 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 m -52.75 -41.07 63.68 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.05 -1.886 . . . . 0.0 114.006 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.5 tp -72.59 -46.08 56.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.27 1.028 . . . . 0.0 111.874 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.9 mt -58.21 -36.59 73.35 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.09 0.956 . . . . 0.0 112.772 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.06 -42.79 89.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.802 1.641 . . . . 0.0 111.502 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.47 -47.4 78.83 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.852 1.215 . . . . 0.0 112.64 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -61.74 -30.3 70.69 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.905 1.282 . . . . 0.0 112.498 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.4 t 55.59 58.68 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 127.523 2.329 . . . . 0.0 108.485 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -96.06 90.04 5.4 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 112.425 -2.171 . . . . 0.0 110.13 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -52.86 -47.48 59.06 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 111.923 -2.399 . . . . 0.0 112.496 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.01 -41.67 81.88 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.898 -0.651 . . . . 0.0 112.552 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.67 -50.14 70.19 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.577 1.56 . . . . 0.0 112.22 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.0 t -68.42 -34.58 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.777 0.831 . . . . 0.0 110.617 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp -61.04 -45.73 93.61 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.654 0.782 . . . . 0.0 111.018 176.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -66.12 -36.81 84.14 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.36 -36.23 71.41 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.052 0.845 . . . . 0.0 112.501 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.07 -43.31 78.9 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.894 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.7 m -72.36 -24.35 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.39 -41.05 70.12 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 113.13 -1.85 . . . . 0.0 111.356 173.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.58 -32.9 73.96 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.263 1.025 . . . . 0.0 111.916 171.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.64 HG22 ' H ' ' A' ' 101' ' ' LYS . 6.7 mt -77.61 179.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 159.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.64 ' H ' HG22 ' A' ' 100' ' ' ILE . 14.5 mtpp 57.24 -41.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 119.773 -1.829 . . . . 0.0 113.799 -147.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 100' ' ' ILE . 8.5 tmtt? 111.77 84.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 130.96 3.704 . . . . 0.0 107.406 162.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 49.71 43.72 24.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 111.657 -2.519 . . . . 0.0 110.251 -168.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 48.37 76.01 0.13 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.633 1.573 . . . . 0.0 112.501 -166.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 28.39 76.43 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.985 1.714 . . . . 0.0 115.12 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 112.577 -2.101 . . . . 0.0 108.471 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 116.537 -1.697 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 62.41 78.05 0.31 Allowed 'General case' 0 N--CA 1.471 0.624 0 O-C-N 125.917 2.011 . . . . 0.0 112.775 171.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -136.19 155.44 50.14 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.254 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -100.75 139.84 35.87 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 125.672 1.858 . . . . 0.0 111.298 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -102.65 113.83 27.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.879 -177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.03 106.55 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 113.267 -1.788 . . . . 0.0 106.765 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -113.08 125.5 54.45 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.709 1.242 . . . . 0.0 112.42 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.85 139.84 33.91 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.287 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.01 133.83 39.84 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.833 -1.53 . . . . 0.0 113.524 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CSP . . . . . 0.456 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m -47.07 -46.47 22.5 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -170.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.51 -30.19 12.3 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.81 31.85 47.62 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.257 0.932 . . . . 0.0 114.043 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.1 ptt? -113.9 -42.69 3.36 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.9 m -70.11 -27.86 64.92 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 p -65.57 -20.83 66.48 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.976 1.31 . . . . 0.0 114.283 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.1 p -61.08 -36.66 80.23 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -172.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.13 -43.4 74.48 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.428 0.691 . . . . 0.0 111.769 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 tt -63.54 -40.41 96.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.162 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.543 HG21 ' HB2' ' A' ' 38' ' ' ALA . 79.4 t -61.8 -46.54 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.621 1.168 . . . . 0.0 109.799 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 t -60.92 -38.76 86.89 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.235 0.614 . . . . 0.0 112.647 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -66.99 -47.21 72.21 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 17.8 ptm -75.46 -15.36 60.43 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -72.82 -45.01 60.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.35 0.66 . . . . 0.0 111.672 166.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.93 81.11 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.609 1.195 . . . . 0.0 112.358 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -74.61 -32.66 62.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.28 1.032 . . . . 0.0 112.014 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.11 -33.46 75.82 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.739 0.649 . . . . 0.0 111.238 170.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -74.37 -39.46 62.73 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.942 0.776 . . . . 0.0 112.025 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -64.81 -46.02 83.75 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.498 0.719 . . . . 0.0 111.645 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -96.78 22.27 8.43 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.943 0.777 . . . . 0.0 112.619 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 29.53 69.2 0.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.942 2.497 . . . . 0.0 115.2 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.19 110.34 51.1 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 112.024 -2.353 . . . . 0.0 107.021 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.3 90.92 1.15 Allowed 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 122.498 2.132 . . . . 0.0 113.168 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 m -141.23 146.88 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 113.309 -1.769 . . . . 0.0 112.88 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.8 mt -106.43 108.5 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.205 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.423 HG22 HG13 ' A' ' 20' ' ' VAL . 18.4 mt -112.67 111.02 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.66 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -132.48 150.43 52.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.217 1.007 . . . . 0.0 112.325 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -110.64 140.94 44.53 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.613 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -142.88 150.8 54.6 Favored Pre-proline 0 N--CA 1.47 0.568 0 O-C-N 124.791 1.307 . . . . 0.0 112.981 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 16.5 Cg_endo -67.94 156.22 66.73 Favored 'Trans proline' 0 C--N 1.33 -0.415 0 C-N-CA 122.604 2.203 . . . . 0.0 112.128 165.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -17.24 52.41 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -175.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -59.34 -28.34 66.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.773 1.629 . . . . 0.0 113.692 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.8 mt -107.13 24.24 13.14 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.31 1.044 . . . . 0.0 113.195 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.47 82.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.58 -60.15 6.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -57.61 -57.08 14.26 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.749 1.22 . . . . 0.0 113.421 -172.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -78.62 -29.63 46.05 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.04 -28.26 68.56 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.015 0.817 . . . . 0.0 113.015 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -61.6 -25.36 67.29 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.434 1.494 . . . . 0.0 114.322 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -113.98 8.81 17.25 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -91.91 142.35 27.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.972 0.415 . . . . 0.0 110.625 175.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -87.55 -28.73 21.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.215 172.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.22 139.09 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 122.249 1.023 . . . . 0.0 109.168 162.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.7 t -107.52 126.23 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 113.11 -1.859 . . . . 0.0 106.969 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 96' ' ' ALA . 70.5 mt -112.45 137.51 50.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.417 -1.72 . . . . 0.0 111.057 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -113.89 141.03 47.87 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 113.013 -1.903 . . . . 0.0 111.892 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.53 140.87 47.54 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.527 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.72 -23.6 72.37 Favored 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.388 2.059 . . . . 0.0 114.605 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -66.19 -30.0 70.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.685 1.194 . . . . 0.0 114.036 173.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.5 pt -111.36 35.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 122.494 1.14 . . . . 0.0 111.916 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.43 -26.28 63.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.538 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -63.97 -21.45 66.49 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 43.3 mtp -85.26 -5.93 59.29 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 tp -54.56 -49.66 89.8 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-O 115.417 -2.23 . . . . 0.0 113.749 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.77 -30.14 84.25 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 CA-C-N 122.758 2.021 . . . . 0.0 114.405 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -82.01 -37.99 25.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.602 0.715 . . . . 0.0 112.8 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 84.1 mt -74.64 -30.07 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.169 0.988 . . . . 0.0 111.217 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.46 -39.06 88.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.281 0.632 . . . . 0.0 111.115 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -43.93 85.18 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.883 1.273 . . . . 0.0 110.384 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.96 -44.23 97.62 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.451 1.1 . . . . 0.0 112.303 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -123.5 78.52 54.73 Favored Pre-proline 0 N--CA 1.471 0.588 0 C-N-CA 124.748 1.219 . . . . 0.0 109.707 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.72 -26.54 8.17 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 122.03 1.82 . . . . 0.0 114.476 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -82.15 5.31 20.1 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 51' ' ' ALA . 74.9 mmtt -122.68 134.7 25.11 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.325 -176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -73.13 115.64 4.42 Favored 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 122.397 2.065 . . . . 0.0 110.328 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 t -118.96 114.76 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 111.948 -2.387 . . . . 0.0 107.52 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -121.98 158.9 28.09 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 125.987 2.054 . . . . 0.0 111.774 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.4 t -104.55 136.27 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.783 174.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.5 mt -67.05 129.54 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -58.34 126.79 29.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 125.015 1.447 . . . . 0.0 110.667 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.4 m -55.56 -36.76 67.17 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.961 -173.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.71 -46.84 65.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.009 0.924 . . . . 0.0 111.827 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.84 -35.41 76.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.421 0.688 . . . . 0.0 112.815 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -67.35 -43.54 81.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.483 1.513 . . . . 0.0 111.605 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.16 -49.28 62.73 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.986 1.279 . . . . 0.0 111.999 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -65.28 -26.54 68.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.017 0.927 . . . . 0.0 112.445 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.33 64.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.873 2.469 . . . . 0.0 108.053 -173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -103.23 89.17 3.32 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 112.769 -2.014 . . . . 0.0 108.606 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.92 -41.97 94.53 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 112.164 -2.289 . . . . 0.0 112.869 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.4 tp -66.57 -38.93 88.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.74 0.816 . . . . 0.0 112.027 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.45 -42.6 97.63 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.122 1.344 . . . . 0.0 112.23 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.9 -33.54 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.186 0.994 . . . . 0.0 111.062 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.38 -43.79 96.61 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.853 0.835 . . . . 0.0 110.638 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.9 -34.38 75.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.97 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.52 -34.11 71.94 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.358 1.036 . . . . 0.0 112.263 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 55' ' ' LEU . . . -71.89 -42.17 67.11 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.808 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.0 -31.42 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.033 0.533 . . . . 0.0 111.166 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.94 -35.57 80.98 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.283 0.99 . . . . 0.0 110.894 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.78 -32.82 63.96 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.2 mt -69.65 -48.72 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -60.1 -38.1 81.97 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.5 0.72 . . . . 0.0 112.879 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -70.7 -43.03 69.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.517 1.127 . . . . 0.0 110.619 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.15 89.05 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 125.544 1.777 . . . . 0.0 111.883 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.11 -68.44 0.33 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.183 170.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 159.92 98.97 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.516 2.726 . . . . 0.0 107.854 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.293 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.79 127.85 34.16 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.912 1.382 . . . . 0.0 110.428 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.1 mttp 67.53 147.6 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.433 1.893 . . . . 0.0 112.708 -165.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.542 ' HD3' HG21 ' A' ' 100' ' ' ILE . 64.4 mttm -114.31 146.25 40.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.127 -2.306 . . . . 0.0 112.808 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -99.1 116.02 30.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.41 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.6 mt -114.24 99.07 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.4 m-30 -107.36 120.63 42.68 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.638 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -100.21 137.41 38.68 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.742 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -130.06 129.32 43.49 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 113.61 -1.632 . . . . 0.0 113.7 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CSP . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.9 m -42.8 -50.71 5.62 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 -165.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.49 -7.41 13.42 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.77 42.69 92.96 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.731 1.158 . . . . 0.0 113.771 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.537 ' HG3' ' H ' ' A' ' 15' ' ' SER . 4.1 ptt? -101.6 -71.37 0.71 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -174.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.537 ' H ' ' HG3' ' A' ' 14' ' ' MET . 96.2 p -68.03 -26.17 65.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.619 1.554 . . . . 0.0 113.517 -174.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.3 p -57.95 -34.24 69.7 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.758 1.223 . . . . 0.0 113.523 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.3 p -58.75 -34.85 71.86 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.4 tp -66.77 -47.2 72.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.783 0.833 . . . . 0.0 111.666 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.62 -40.87 96.39 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.274 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 38' ' ' ALA . 53.0 t -56.28 -50.67 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.269 1.428 . . . . 0.0 109.346 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -55.15 -42.51 73.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.454 0.702 . . . . 0.0 112.817 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -65.66 -45.1 84.2 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.8 ptm -75.66 -20.93 58.11 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -67.44 -47.36 70.4 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.21 1.004 . . . . 0.0 111.425 166.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.27 -33.93 76.57 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.545 1.164 . . . . 0.0 113.151 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.41 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 73.4 mt-30 -79.28 -27.33 42.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.151 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.04 71.07 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.867 0.467 . . . . 0.0 111.273 168.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.79 -48.51 58.9 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.309 1.044 . . . . 0.0 110.975 171.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.8 -47.06 87.24 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.478 1.111 . . . . 0.0 113.512 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -99.02 20.44 13.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.074 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 30.32 69.76 0.09 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 125.059 2.362 . . . . 0.0 115.167 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.06 108.26 55.4 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 111.929 -2.396 . . . . 0.0 107.839 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.52 85.4 1.8 Allowed 'Trans proline' 0 C--N 1.33 -0.443 0 C-N-CA 122.238 1.959 . . . . 0.0 113.714 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 4' ' ' LYS . 15.2 m -138.32 146.35 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 112.834 -1.985 . . . . 0.0 112.905 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.0 mt -105.73 107.41 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 112.811 -1.995 . . . . 0.0 107.226 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.402 HG22 HG13 ' A' ' 20' ' ' VAL . 13.6 mt -110.36 112.22 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 112.704 -2.044 . . . . 0.0 108.189 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -137.48 143.94 41.99 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 124.588 1.18 . . . . 0.0 111.483 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB2' HG21 ' A' ' 20' ' ' VAL . . . -110.68 134.52 52.38 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 113.227 -1.806 . . . . 0.0 111.955 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -134.36 154.62 79.96 Favored Pre-proline 0 N--CA 1.471 0.575 0 CA-C-N 113.458 -1.701 . . . . 0.0 112.699 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 10' ' ' CSP . 9.4 Cg_endo -66.03 151.51 83.7 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.118 1.879 . . . . 0.0 112.335 166.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -23.2 62.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.993 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.2 p -54.98 -31.63 60.93 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.597 1.559 . . . . 0.0 113.999 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.75 17.29 18.33 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.75 89.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.435 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.9 -58.47 12.75 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 47' ' ' LYS . 1.5 tm-20 -57.28 -60.0 4.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 112.504 -1.848 . . . . 0.0 112.892 -169.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HD2' ' OE1' ' A' ' 46' ' ' GLU . 5.5 mptp? -77.4 -32.84 55.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.429 -1.26 . . . . 0.0 113.668 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.16 -26.07 65.4 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.419 1.009 . . . . 0.0 113.345 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.01 -30.15 65.86 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.305 1.442 . . . . 0.0 113.981 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -110.96 0.35 17.01 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.37 135.69 40.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.92 0.39 . . . . 0.0 110.002 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -80.0 -29.94 39.55 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.545 172.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.69 141.48 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 122.577 1.18 . . . . 0.0 109.63 162.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -107.44 119.13 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 112.497 -2.138 . . . . 0.0 106.807 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 76.0 mt -112.21 132.07 55.12 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.261 -1.791 . . . . 0.0 112.063 176.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.404 HD21 HG13 ' A' ' 67' ' ' ILE . 10.2 mp -106.09 141.22 37.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 113.426 -1.715 . . . . 0.0 113.487 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.75 136.34 41.37 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.243 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.12 -26.33 68.64 Favored 'Trans proline' 0 C--N 1.329 -0.469 0 C-N-CA 122.371 2.047 . . . . 0.0 114.75 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -65.74 -27.58 68.41 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.2 pt -111.04 22.49 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.666 0.746 . . . . 0.0 112.353 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.09 69.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.391 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -59.37 -26.72 65.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.406 ' O ' HG12 ' A' ' 67' ' ' ILE . 52.3 mtm -85.46 2.73 43.38 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.3 tp -52.25 -48.1 90.27 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 115.025 -2.417 . . . . 0.0 113.053 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.77 -37.92 84.8 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 122.565 2.176 . . . . 0.0 114.227 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 3.9 tp10 -77.78 -38.34 46.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.093 0.949 . . . . 0.0 112.653 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 63' ' ' MET . 48.2 mm -69.65 -39.69 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.424 1.09 . . . . 0.0 109.408 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -60.78 -40.57 93.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.662 1.185 . . . . 0.0 110.828 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.525 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 28.8 tpt85 -60.51 -41.85 95.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.407 1.483 . . . . 0.0 111.643 176.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.5 mt -68.89 -45.69 70.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.604 1.561 . . . . 0.0 112.616 175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -123.29 76.34 52.62 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.912 1.285 . . . . 0.0 110.848 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.2 -21.94 8.78 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 121.391 1.394 . . . . 0.0 113.917 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -86.68 8.09 23.88 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -128.19 140.41 38.21 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-O 118.714 -0.66 . . . . 0.0 110.081 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -71.76 112.72 3.45 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.196 1.931 . . . . 0.0 109.774 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.6 t -117.93 110.29 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 110.675 -2.966 . . . . 0.0 108.006 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -128.34 155.95 43.86 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 112.923 -1.944 . . . . 0.0 112.223 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.11 136.77 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 113.197 -1.819 . . . . 0.0 109.439 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.4 mt -72.87 128.55 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 82' ' ' LEU . 10.0 t0 -56.22 126.73 27.46 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.959 174.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.0 m -50.75 -35.94 34.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 113.275 -1.784 . . . . 0.0 114.108 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 46.7 tp -71.41 -47.77 53.96 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.513 1.125 . . . . 0.0 111.944 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.63 -38.13 77.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.143 0.977 . . . . 0.0 112.713 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.35 -41.19 85.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.373 1.469 . . . . 0.0 111.728 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.77 -49.08 61.43 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.155 1.36 . . . . 0.0 112.443 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -67.73 -25.63 65.74 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.543 0.737 . . . . 0.0 112.648 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 t 56.33 63.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.733 2.413 . . . . 0.0 109.079 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -102.72 90.28 3.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.481 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.5 -45.09 85.29 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 112.227 -2.26 . . . . 0.0 113.341 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.41 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 48.9 tp -67.53 -41.0 85.05 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.218 0.607 . . . . 0.0 112.41 -175.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.39 -46.17 81.12 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.431 1.491 . . . . 0.0 111.69 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.6 t -72.26 -38.24 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.832 0.853 . . . . 0.0 110.587 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.1 tp -60.95 -44.92 96.58 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.274 1.029 . . . . 0.0 111.491 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -67.94 -36.99 81.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.87 85.06 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.092 0.87 . . . . 0.0 111.699 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.79 -42.51 85.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.867 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -70.06 -31.26 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.935 0.874 . . . . 0.0 111.658 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -46.73 79.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.43 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.7 -29.98 70.59 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.542 HG21 ' HD3' ' A' ' 4' ' ' LYS . 81.4 mt -68.09 -47.14 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.909 0.883 . . . . 0.0 109.155 171.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -61.56 1.09 0.25 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 170.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 75.33 70.48 0.09 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 129.24 3.016 . . . . 0.0 109.913 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 44.95 45.08 8.5 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 109.293 -3.594 . . . . 0.0 110.937 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 50.24 62.76 2.51 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.139 1.775 . . . . 0.0 113.203 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 28.14 81.25 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 111.527 -2.578 . . . . 0.0 114.45 -174.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 C--O 1.249 1.079 0 CA-C-N 111.795 -2.457 . . . . 0.0 110.136 179.216 . . . . . . . . 0 0 . 1 stop_ save_